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Abstract 
The Application of Protein Mass Spectrometry to the Understanding of 
Behaviour in Mus Species 
The urine of mice contains a large amount of protein, approximately 99% of which are 
major urinary proteins (MUPs).  These 18 – 19 kDa proteins have been shown to 
have a significant role in chemosignalling. MUPs bind, protect and slowly release the 
volatile components in scent marks that have been found to elicit various behavioural 
and physiological responses in mice, including aggression between male mice and 
the onset of puberty in female mice.  MUPs themselves have also been found to be 
significant in chemical signalling, having roles in modulating identity signalling, 
attractiveness and aggressive responses.   
Whilst the MUPs of the house mouse have been comprehensively characterised, 
including their roles in social and reproductive behaviour, much less in known 
regarding the urinary proteins of other closely related Mus species and their roles in 
communication amongst conspecifics. In the first part of this thesis, protein 
expression in the urine of Mus spicilegus was investigated.  Whilst M. spicilegus are 
genetically close to the Mus musculus subspecies group, their mating patterns and 
social behaviour are different to those of the house mouse, Mus musculus 
domesticus. Urinary MUPs play a significant part in the social and reproductive 
behaviours displayed by M. m. domesticus, yet little is known regarding the molecular 
causes of the unique social and reproductive behaviours displayed by M. spicilegus.  
Therefore, this part of the thesis determined whether M. spicilegus also invested in 
MUPs, and by inference, whether these could play a key role in their unusual 
behaviours.  The protein content of the urine of male and female M. spicilegus was 
examined, and mass spectrometry was used to identify four MUPs (three of them 
male-specific) and characterise their primary structure in the absence of genomic 
data.  Male mice expressed more MUP in their urine than female mice, with MUP 
expression patterns between different males varying quite significantly.  In 
experiments relating to their sexual and social behaviour, male mice altered their 
MUP expression upon contact with females, and a link between male MUP output 
and aggressive behaviour amongst male mice was observed.   
As MUPs have roles in modulating a number of behaviours in the house mouse, 
including kin recognition, the second part of the thesis focuses on communal nursing 
in the house mouse, where kin recognition appears to play a role in the lactative 
investment in pups in a communal nest.  Previous studies suggest communal nursing 
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increases reproductive success, but that mutualistic cooperation is higher in nests 
where females are related. This study involved the metabolic labelling of adult female 
mice, who were communally nursing, using stable isotope labelled amino acids.  The 
mass spectrometric analysis of MUPs expressed in adult female mice (mothers) 
urine, proteins in pup stomach contents and proteins in pup tissue samples enabled 
the confirmation of amino acid label incorporation into nursing mothers, and the 
determination of label incorporation into pups. Therefore, the investment received by 
pups from their mothers, in litters where their mothers are related and in litters where 
their mothers are unrelated was determined, assessing whether any discrimination in 
investment is evident in relation to relatedness of the female pairs in the nest.  Stable 
isotope labelling strategies and mass spectrometry successfully enabled investment 
from communally nursing female mice to be tracked in their pups, determining that no 
females, related or unrelated, discriminated between their own pups and their female 
partners’ when investing.  In most cases, however, one female appeared to invest 
significantly more in the entire communal litter than the other. 
Mass spectrometry has been the main tool for the accurate identification and 
characterisation of MUPs present in scent marks, but MUP quantification has proved 
more difficult due to the highly homologous nature of these proteins. Previous 
absolute quantification of MUPs has been based on QconCAT technology, but 
difficulties arose due to the high sequence similarity between MUP variants. It was 
therefore considered whether quantification of MUPs could take place at the intact 
protein level, since intact protein analysis by ESI-MS is already well established for 
the accurate identification of MUP isoforms.  For ESI-MS analysis to be a suitable 
method for absolute quantification of MUPs, the responses of each individual MUP in 
ESI-MS analysis were determined using recombinant MUPs, assessing the 
relationship of MUP concentration and instrument response whilst considering how 
charge state distribution profiles and sample complexity affected MUP ionisation and 
instrument response.  Despite the homology of MUPs, the differences in their 
ionisation efficiencies in ESI-MS analysis as part of an equimolar mixture compared 
to as a single protein means that whilst ESI-MS analysis of MUPs can be useful for 
the relative quantification of these proteins in urine samples, further preparatory 
experiments would be required to determine whether ESI-MS analysis of intact 
proteins could be suitable for absolute quantification. 
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1.1 Olfactory communication in mice 
Communication between animals occurs when one individual’s actions provide a 
signal that changes the behaviour of another (Wiley 1983).  Communication in most 
mammals, including mice, takes place via a mixture of the senses, but is primarily 
through their sense of smell. Detection of olfactory cues from the environment are 
essential for avoiding predators, navigating and foraging for food (Doty 1986; Yang 
and Crawley 2009) but mice also use separate olfactory cues to provide information 
regarding their sex, social status, health and territories (Beynon et al. 2008).  These 
cues, when detected by the recipients’ olfactory systems, evoke a number of 
physiological and psychological responses in the recipient (Bruce 1970). 
The term ‘pheromones’ was first defined by Karlson and Luscher as “substances 
which are secreted to the outside by an individual and received by a second individual 
of the same species, in which they release a specific reaction, for example, a definite 
behaviour or a developmental process” (Karlson and Luscher 1959). Pheromonal 
communication varies considerably between species, and is key in the regulation of 
behaviours in mice, such as reproduction, maternal care and aggression (Swnaney 
and Kaverne 2009). Pheromones can be defined as ‘releasers’, which trigger 
immediate, short-lived responses in the receiver; ‘primers’, which trigger longer-term 
behavioural or physiological responses; or ‘signallers’, which convey information 
about an individual, the responses being dependent on the individuals sending and 
receiving the signal (Swnaney and Kaverne 2009). 
Research into olfactory communication in mammals has primarily focused on the 
chemical signalling and chemosensory systems of rodents, which has enabled us to 
gain understanding on the physiological processes and complex psychological 
behaviours seen in mice, and the different components of the olfactory cues that 
trigger these various responses. 
1.2 Scent marking 
Mice introduce chemical signals into their environment mainly in the form of scent 
marks, enabling an individual to leave information about themselves to conspecifics 
when they are no longer present (Johnson 1973).  Scent marks are usually deposited 
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via urine, but can also be set down in the form of faeces or specialised scent gland 
excretions (Brown and MacDonald 1985). 
Scent marks deposited by mice contain information regarding the sex, individual 
identity, social status, health and territories of the individual (Hurst et al. 2001; Beynon 
et al. 2008).  The location and spatial arrangement of an individual’s scent mark define 
their territory, and help in defending their territory against others in their environment.  
Dominant male mice will deposit scent marks frequently in order to keep their marks 
constantly fresh, to defend their territory against intruders and advertise themselves 
to, and attract, a female mate (Gosling 1982; Hurst 1993; Rich and Hurst 1999; 
Humphries et al. 1999).  Dominant male mice will also counter-mark scents deposited 
by intruders in their territory to re-affirm their status and territorial boundaries, but will 
not counter-mark their own scent marks or scent marks from another male who is 
genetically identical to himself (Hurst 1990a; Nevison et al. 2003).   
1.2.1 Behavioural responses to scent marks 
Scent marks, from both male and female mice, can elicit various psychological and 
physiological responses in conspecifics of the same and opposite sex.  The majority 
of the behavioural responses observed in mice to scent marks relate to their attraction 
to particular scent marks, in order to find a suitable mate.  Generally, post-puberty 
female mice are more attracted to scent marks from a sexually active male (Hurst 
1990(b); Petrulis 2013). In response to male mouse scent marks, reproductively-
active adult female mice scent mark in response to a male’s scent marking in order 
to advertise their sexual receptivity (Rich and Hurst 1999).  A female prefers scents 
from male mice they have previously encountered, and appear to develop a 
preference for the volatiles present in a particular male’s scent marks upon contacting 
that male’s urine (Ramm et al. 2008).  A female’s attracted response to male urine is 
also modulated by the spatial arrangement of scent deposition which indicates that 
the male is a territory owner (Gosling et al. 2001).   
In response to female scent marks, male mice produce ultrasonic vibrations (USVs) 
(Nyby et al. 1977).  Male urine induces aggressive behaviour in other adult males, 
but resident males will not attack a castrated male or female intruder (Mugford and 
Nowell 1971; Mucignat – Caretta et al. 2004).  A dominant male will also countermark 
an intruder’s scent mark to reaffirm its status and territory. 
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1.2.2 Physiological responses to scent marks 
Several physiological responses to scent marks have been observed in female mice, 
often to a dominant, reproductively active male’s scent.  In juvenile females, exposure 
to these male scents accelerate the onset of puberty, this response being known at 
the ‘Vandenbergh effect’ (Vandenbergh 1969).  Urine from singly housed females, 
who are pregnant, lactating or in oestrus, can also cause this response in juvenile 
females (Drickamer and Hoover 1979).  Also in response to a dominant, reproductive 
male’s scent, ovulation in females can be induced; this has been termed the ‘Whitten 
effect’ (Whitten et al. 1968).  Conversely, ovulation can be inhibited in single-sex-
group-housed female mice if they are exposed to urine from group-housed females; 
this is known as the ‘Lee-Boot effect’ (Van der Lee and Boot 1956).  This particular 
situation can also delay puberty in female mice. (Colby and Vandenbergh 1974).  The 
urine of an unfamiliar male will cause a recently mated female to lose her pregnancy 
and return to oestrus (known as the ‘Bruce effect’) (Bruce 1960). 
Much less is known about the physiological responses to scent marks by male mice 
(Koyama 2004), but as with females, it appears that male reproductive physiology is 
sensitive to chemosignals (Petrulis 2013).  For example, puberty in males can also 
be delayed if exposed to urine of group-housed females, the same as in females 
(Jemiolo and Novotny 1994).  Female scents can also cause dominant (but not 
subordinate) males to increase sperm production (Petrulis 2013) and to release 
luteinising hormone (LH) within half an hour of exposure to female urine (Macrides et 
al. 1975; Schulz et al. 2009). 
The behavioural and physiological responses observed in mice are largely due to the 
detection of a number of pheromonally active compounds found in scent marks, some 
of which are volatile, some of which are involatile, and these compounds are explored 
further in the next section. 
1.3 Volatile chemical signals 
Research into the chemical components of scent marks has focused on the volatile 
and non-volatile compounds present, which are associated with signalling the 
information on species, sex and individual identity of the depositor of the scent mark 
(Beynon et al. 1999).  Volatile pheromones are often metabolic by-products, and so 
the production of these signals requires no extra energy input from the scent mark 
depositor (Wyatt 2009).  Airborne volatile pheromones can draw an animal to 
investigate a scent mark even when the depositor is no longer in the immediate 
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vicinity; however, the volatile nature of these compounds means that they are present 
for a relatively short space of time.  A number of volatile pheromones have been 
identified in mouse urine, the names and structures of which are outlined in Table 1.1.  
At least four of these volatiles (2-sec-butyl-4,5-dihydrothiazole, 2,3-dehydro-exo-
brevicomin, α and β farnesenes) have been associated with social dominance in adult 
male laboratory mice (Humphries et al. 1999).  2-sec-butyl-4,5-dihydrothiazole 
(thiazole) and 2,3-dehydro-exo-brevicomin (brevicomin) are both volatile but are 
normally bound to protein in the urine.  They are detected by the vomeronasal organ 
(VNO) of the olfactory system, acting as ‘releaser’ pheromones on a male recipient 
and ‘primers’ on female recipients, and their production is dependent on testosterone 
(Swaney and Keverne 2009).  In male mice, the presence of these compounds in 
urine causes a persistent aggressive response.  If either one of these compounds is 
mixed into a castrated male’s urine and placed on their fur, intact males do not show 
aggressive behaviour towards the castrated male, but if both compounds were mixed 
into the castrated urine, this causes males to attack as they would if the urine was 
from an intact male (Novotny et al. 1985; Jemiolo et al. 1985).  Either one of these 
volatiles have been found to accelerate the onset of puberty in females, as does 6-
hydroxy-6-methyl-3-heptanone (Novotny et al. 1999), while a mixture of both thiazole 
and brevicomin has been found to induce oestrus (Jemiolo et al. 1986).  Male urine 
also contains α and β farnesenes, which are produced by the preputial gland and 
released into the deposited urine.  These volatiles are detected by the VNO and are 
also known to attract females, as well as signalling dominance to other males, 
inhibiting investigation and countermarking in subordinate male mice (Novotny et al. 
1990; Jemiolo et al. 1991, Jemiolo et al. 1992).  Also present in male urine, 
(methylthio)-methanethiol, detected by the main olfactory epithelium (MOE), is an 
attractant to female mice (Lin et al. 2005).   
Present in female urine, 2.5-dimethylpyrazine delays the onset of puberty in juvenile 
female mice (Ma et al. 1998), and 2-heptanone has been seen to extend the length 
of oestrus in females (Jemiolo et al. 1989).  Both of these volatiles are detected in the 
VNO. 
1.4 Non-volatile chemical signals 
While volatile signals draw an animal to investigate a scent mark, an animal must 
physically contact the scent mark in order to detect the non-volatile components.  
Non-volatile chemical signals offer information about the individuality of the signaller  
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Table 1.1 Volatile compounds found in mouse urine and their structures 
(obtained from www.chemspider.com) 
 
Volatile Structure Origin 
 
2-sec-butyl-4,5-dihydrothiazole 
 
 
Male urine 
 
2,3-dehydro-exo-brevicomin 
 
 
Male urine 
 
6-hydroxy-6-methyl-3-heptanone 
 
 
Male urine 
 
(methylthio)-methanethiol 
 
 
Male urine 
 
α farnesene 
 
 
Male preputial gland 
 
β farnesene 
 
 
Male preputial gland 
 
2-heptanone 
 
 
Female urine 
 
2.5-dimethylpyrazine 
 
 
Female urine 
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and the genetic relationship between the scent mark depositor and the detecting 
animal, information which is important for mate choice decisions and post-mating 
behaviours such as kin recognition (Hurst et al. 2001; Boehm and Zufall 2006; 
Cheetham et al. 2007; Sherborne et al. 2007; Thom et al. 2008).  Unlike volatiles, 
which are only present for a relatively short space of time, non-volatiles are much 
more stable and remain in the scent mark for a longer period of time, allowing the 
individual identity of the depositor to be detected by another animal as the scent mark 
ages.  The non-volatiles identified as significant in mouse social behaviour and 
interactions are exocrine gland-secreting peptides (ESPs), major histocompatibility 
complex (MHC) peptides and major urinary proteins (MUPs).   
ESPs 
Non-volatile chemical signals have been identified in the tear fluid of mice; a total of 
38 ESP family genes have been identified in mice, clustered on chromosome 17, 14 
of which are pseudogenes (Kimoto et al. 2005, 2007).  ESP genes encode peptides 
that are secreted into tear fluid via the extraorbital lachrymal gland, or from the 
harderian gland or submaxilliary gland, and appear to elicit a response in the 
vomeronasal epithelium via direct contact (Kimoto et al. 2007).   To date, one peptide 
has been found to be male-specific, another has been found to be female-specific, 
and great variation in ESP expression has been observed between different mouse 
strains (Kimoto et al. 2007).  This variation between sexes and strains, plus the 
responses to the peptides in the VNO, suggests that ESPs may convey information 
regarding sex and individuality amongst conspecifics (Kimoto et al. 2007). 
MHC peptides 
The genes of MHC are highly polymorphic loci that encode cell surface glycoproteins, 
that are membrane-bound and anchored in the lipid bilayer (class I and class II 
molecules), that bind peptides for T lymphocyte–mediated immune recognition of 
pathogens (Klein 1986; Novotny et al. 2007; Tirindelli et al. 2009).  The genetic 
diversity of MHC genes is reflected into structurally diverse peptide binding regions 
of MHC molecules (Apanius et al. 1997; Edwards and Hedrick 1998), meaning that 
different MHC molecules bind to different peptides (Tirindelli et al. 2009).  These 
peptides, typically nine amino acid residues in length, are presented by the MHC 
molecules at the cell surface (Thompson et al. 2007).  As the MHC is cleared from 
the cell, the peptide binding region of the MHC molecule releases the peptide into 
extracellular fluid, and the peptides or their fragments are then excreted in urine and 
other secretions (Singh et al. 1987).  The structures of these peptide ligands, and 
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therefore the structures of the MHC molecules, provide a unique molecular identity 
signature for each individual (Leinders-Zufall et al. 2004). 
MHC genes are crucial in influencing resistance and susceptibility to infectious and 
autoimmune diseases, with the class I and class II molecules initiating specific 
immune responses against pathogens and parasites (Klein 1986; Penn 2002).  
Laboratory mice prefer to mate with mice that possess a dissimilar MHC type to its 
own (Yamazaki et al. 1976; Penn and Potts 1998a), and it is thought that the aim may 
be to produce offspring with increased MHC heterozygosity, resulting in increased 
resistance to disease (Potts and Wakeland 1993; Kurtz et al 2006). Further studies 
have presented evidence for the effects of MHC genes in mating preference (Penn 
and Potts 1998a; 1999; Beauchamp and Yamazaki 2003).  Whilst it has been 
suggested that these MHC effects serve to increase MHC heterozygosity and 
increased resistance to infectious diseases in offspring (Penn and Potts 1999), 
evidence for this immunological advantage to mate selection is extremely limited, with 
one study suggesting that MHC heterozygosity appears to provide no immunological 
advantage (Ilmonen et al. 2007).  Another hypothesis was that MHC similarity, used 
to recognise kin, served to avoid inbreeding (Brown and Eklund 1994).  The MHC 
genotype has again been linked to recognition when considering the ‘Bruce effect’ 
seen in female mice (Bruce 1959).  Leinders-Zufall et al. demonstrated that 
pregnancy block was brought about in female mice by exposing them to MHC class I 
peptides of a different mouse strain (Leinders-Zufall et al. 2004). 
MHC diversity between individual mice has also been proposed as a primary source 
of scents used in individual identity signalling, however, since native MHC peptides 
have not been identified in mouse urine, it remains uncertain whether they have role 
in individual recognition.  Hurst et al. discovered that MHC-associated odours were 
not necessary nor sufficient for scent owner recognition amongst male mice (Hurst et 
al. 2005), and further studies confirmed that female recognition of scents from male 
mice depends on a difference in MUP type, and not MHC type (Cheetham et al. 2007).  
It has been demonstrated that wild mice breeding in a semi-natural environment 
showed no avoidance of mates with the same MHC genotype when genome-wide 
similarity was controlled, but by contrast, sharing of both MUP haplotypes had a highly 
significant effect on the likelihood of successful mating, with the strong deficit 
explaining inbreeding avoidance and kin recognition (Sherborne et al. 2007).  Whilst 
it has been demonstrated that mice are able to discriminate between urinary MHC 
odours, suggesting that MHC type can influence the volatile profile of mouse urine 
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(Yamaguchi et al. 1981; Yamazaki et al. 1983; Penn and Potts 1998b; Carroll et al. 
2002), individual recognition and assessment of genetic heterozygosity in house mice 
is mediated by major urinary proteins (Hurst et al. 2001; Cheetham et al. 2007; Thom 
et al. 2008). 
1.4.1 Major Urinary Proteins (MUPs) 
Mouse urine contains a large amount of protein – in humans, an excess of protein in 
urine would be of medical concern, as it is usually indicative of impaired kidney 
function or diabetes, but rodents excrete a significant amount of protein (up to 20 
mg/ml per day) whilst maintaining renal function (Gosling et al. 2000).  In mice, 99% 
of the proteins excreted in urine are major urinary proteins (MUPs).  Mouse MUPs 
are encoded by a multigene cluster located on chromosome 4, and are mainly 
synthesised in the liver before being directly excreted in urine (Krauter et al. 1982).  
These proteins are 18 – 20 kDa monomeric proteins that have been shown to have a 
significant role in chemosignalling (Beynon and Hurst 2003), and are part of the 
lipocalin superfamily. 
Lipocalins are a large family of small, secreted proteins that exhibit great sequence 
diversity, but share short, conserved motifs that indicate family membership (Flower 
et al. 1993).  Despite their sequence dissimilarity, their crystal structures are highly 
conserved, comprising of a single eight-stranded antiparallel β-barrel which encloses 
an internal ligand binding site (Flower 1996).  The amino acid sequence diversity in 
this site gives this family of proteins the ability to bind to a wide range of small 
hydrophobic molecules, giving rise to various biological functions such as 
prostaglandin synthesis, retinol transport and, importantly in mice, olfaction and 
pheromone transport (Flower 1996).  X-ray crystallography has allowed the structures 
of mouse MUPs to be determined (Bocskei et al. 1991; Bocskei et al. 1992; Lucke et 
al. 1999; Timm et al. 2001), showing they have the characteristic lipocalin structure, 
with the eight-stranded β-sheet barrel enclosing the ligand binding site which contains 
numerous hydrophobic amino acid residues (Figure 1.1).  The binding site contains 
the characteristic tryptophan residue (Try 19) in the centre, which is conserved 
amongst all lipocalins (Flower et al. 1993). 
MUP genetics 
Sequencing of the C57BL/6 laboratory mouse strain genome allowed the targeted 
sequencing, annotation, phylogenetic and genomic analysis of the MUP genes in this 
particular strain by Mudge et al. in 2008, work which was built upon by Logan et al.   
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Figure 1.1 The tertiary structure of mouse MUP 1 with ligand.  
A ribbon diagram of the 3D structure of mouse MUP 1 along with secondary domains.  In 
yellow is the β sheet forming the β barrel, in red is the the α helix. At the centre of the cavity 
is the male specific ligand 2-sec-butyl -4, 5 dihydrothiazole, which is coloured blue. The 
tertiary structure and ligand was solved by Timm et al. 2001, and this figure was generated 
using PyMOL molecular visualisation software (Schrodinger, Inc).  
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2008.  Manual annotation of the MUP cluster allowed Mudge et al. to identify 19 
functional MUP genes and 19 pseudogenes, with Logan et al. later finding evidence 
for 21 functional and 21 pseudogenes.  The MUP cluster was then separated into 
three groups based on phylogenetic analysis – one group contained highly 
homologous functional MUP genes, another contained only pseudogenes, and the 
final group contained functional and pseudogenes that were more divergent and 
shared lower homology with the other MUP genes.  Mudge et al. 2008 localised these 
groups within the MUP locus to two areas, named as the ‘central’ and ‘peripheral’ 
regions.  The central region, containing 15 functional MUP genes and 16 
pseudogenes, is flanked at either end by the peripheral region, which contains 6 
functional MUP genes and 5 pseudogenes (Figure 1.2) (Mudge et al. 2008; Logan et 
al. 2008).  The peripheral genes are those that share less sequence homology (Figure 
1.3), and the oldest divergence for the functional genes in this region is thought to be 
around 11.2 – 22.4 million years ago, whilst the functional genes in the central region 
(which share high sequence homology (Figure 1.3)) are thought to be as a result of 
divergence from a peripheral MUP gene, with the oldest divergence event for these 
genes estimated at a much more recent 1.2 – 2.4 million years ago (Mudge et al. 
2008). 
MUP ligand binding 
Mouse MUPs have been found to bind a number of volatile components identified as 
having pheromonal activity in their hydrophobic internal ligand binding site with some 
specificity (Robertson et al. 1993; Armstrong et al. 2005).  Separation of mouse urine 
into high and low molecular weight fractions using dialysis and/or chromatography 
allowed the association between MUPs and the following pheromonal compounds to 
be identified - 2-sec-butyl-4,5-dihydrothiazole, 2,3-dehydro-exobrevicomin and 6-
hydroxy-6-methyl-3-heptanone (Bacchini et al. 1992; Robertson et al. 1993; Novotny 
et al. 1999).  As discussed previously, the volatile nature of these pheromones means 
that they only remain in a deposited scent mark for a very short period of time.  
However, when these pheromonal ligands are bound to MUPs, their release into the 
environment is delayed and their lifetimes are extended, remaining detectable by 
conspecifics up to 24 hours after being deposited (Hurst et al. 1998; Humphries et al. 
1999).  If these ligands are not bound to MUPs, it takes a matter of minutes for them 
to be lost to the surrounding environment (Robertson et al. 2001). 
The interactions of MUPs and the pheromones 2-sec-butyl-4,5-dihydrothiazole and 
6-hydroxy-6-methyl-3-heptanone have been mapped using NMR analysis,   
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Figure 1.4 Phylogentic tree of mouse MUPs.  
Phylogenetic analysis was performed using the ‘One Click’ mode at www.phylogeny.fr 
(Dereeper et al. 2008). Sequences were aligned using MUSCLE (v3.8.31), configured for 
highest accuracy. Gblocks (v0.91b) was used to remove any ambiguous regions. The 
phylogenetic tree was reconstructed using the maximum likelihood method implemented 
in the PhyML program (v3.1/3.0 aLRT). Graphical representation of the tree was performed 
with TreeDyn (v198.3). Bootstrap values are labelled in red. 
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characterised using thermodynamic analysis and observed using x-ray 
crystallography (Bockskei et al. 1992; Zidek et al. 1999; Timm et al. 2001; Sharrow et 
al. 2003).  Both pheromonal ligands have been seen to bind to within the hydrophobic 
MUP ligand binding site at one end of the β-barrel, formed by the side chains of 
Phe56, Leu58, Leu60,Ile63, Leu72, Phe 74, Met87, Val100, Tyr102, Phe108, Ala121, 
Leu123, Leu134, and Tyr138 (Timm et al. 2001).  The precise orientation of the ligand 
binding has also been established, with a water-mediated hydrogen bond to the 2-
sec-butyl-4,5-dihydrothiazole nitrogen, and the ketone oxygen group in 6-hydroxy-6-
methyl-3-heptanone (Timm et al. 2001).  The fact that the MUP hydrophobic binding 
site is completely enclosed by side chains means that the way in which ligands reach 
the binding site remains undetermined, but could be through the MUP undertaking 
large conformational changes (Lucke et al. 1999).  Through NMR relaxation 
experiments, it was discovered that the backbone flexibility of the MUP increases as 
it binds to 2-sec-butyl-4,5-dihydrothiazole, enabling access of the ligand to the MUP’s 
binding site whilst stabilising the MUP-ligand complex (Zidek et al. 1999). 
The specificity of ligand binding by MUP isoforms was identified by analysis of MUP 
containing fractions from anion-exchange chromatography (Robertson et al. 1993; 
Armstrong et al. 2005), with a study using fluorescent probes supporting this.  Darwish 
Marie et al. (2001) proved that the differences in amino acid composition in the ligand 
binding sites of different MUP isoforms resulted in a decreased ligand binding affinity, 
causing a decreased fluorescence yield for the probe.   
More recently, a male-specific MUP with the molecular weight of 18,893 Da (known 
as ‘darcin’) has been found to bind to more 2-sec-butyl-4,5-dihydrothiazole than other 
MUP isoforms – Armstrong et al. (2005) demonstrated that in a C57BL/6 male mouse 
urine sample, darcin (making up about 13% of the urinary protein concentration) 
bound to over 40% of the 2-sec-butyl-4,5-dihydrothiazole present in the urine, whilst 
the other 87% of urinary protein bound to less than 40% of the 2-sec-butyl-4,5-
dihydrothiazole.  As well as increased ligand binding affinity, darcin was found to bind 
to 2-sec-butyl-4,5-dihydrothiazole more tightly and release the volatile component 
more slowly (Armstrong et al. 2005; Roberts et al. 2010).  Behavioural studies have 
shown that female mice are more attracted to darcin than other MUPs in male urine, 
and showed no preference between the native (ligand-bound) darcin and its 
recombinant form, suggesting that darcin itself may also have a role in pheromonal 
communication (Roberts et al. 2010), as well as, like other MUP isoforms, the role in 
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transporting, protecting and extending the lifetime of the volatile pheromones present 
in urinary scent marks.   
MUP expression 
Urinary MUPs are primarily synthesised in the liver and are excreted into urine, 
avoiding glomerular filtration due to their small size and monomeric nature.   The 
synthesis of MUPs is hormone-controlled; growth hormone, thyroxine, glucocorticoids 
and insulin all play a role in normal MUP synthesis (Knopf et al. 1983; Spiegelberg et 
al. 1988; Johnson et al. 1995), whilst androgens have been found to actively induce 
MUP synthesis – the administration of testosterone to female or castrated male mice 
increases MUP mRNA levels to those seen in intact male mice (Ruemke and Thung 
1964). MUPs are synthesised with a signal peptide, 19 amino acids in length, which 
is cleaved from the rest of the protein prior to excretion into the bloodstream 
(Finlayson et al. 1965).   MUPs have also been detected in the salivary, lachrymal 
and mammary glands, as well as in nasal tissues (Shaw et al. 1983; Shahan et al. 
1987; Shi et al. 1989; Logan et al. 2008).  Five of the 21 identified functional MUPs 
(4 central, 1 peripheral) are known to be expressed in the submaxillary glands of the 
laboratory strain C57BL/6 (Logan et al. 2008). 
Several different MUP isoforms have been identified in urine, and although many are 
highly homologous, their differing masses have allowed the majority of urinary MUPs 
to be separated and identified using isoelectric focusing (IEF) and mass spectrometry 
(Robertson et al. 1996, 1997; Beynon et al. 2002; Cheetham et al. 2009; Mudge et 
al. 2008). In laboratory mouse strains, adult males excrete around 10 – 20 mg/ml of 
protein in their urine, with adult females generally excreting significantly less 
(Cheetham et al. 2009).  Laboratory mice are inbred and so all mice of the same sex 
are genetically identical and are homozygous for their MUP genes.  Therefore, mice 
of the same sex and strain have practically identical MUP expression profiles.  In wild 
mice, both adult male and females excrete around three times as much protein as 
their laboratory counterparts (Beynon and Hurst 2004), and their MUP expression 
profiles are far more complex, with significant variation in the profiles of unrelated 
individuals (Robertson et al. 1997; Beynon et al. 2002).  This variation is due to wild 
mice inheriting different MUP haplotypes from their parents, and maintained by the 
avoidance of inbreeding (Sherborne et al. 2007).  It is this variation in MUP profiles 
which provides the genetic identity of an individual, as the expressed MUP profile 
provides the MUP genotype information to a conspecific.  Various behavioural 
experiments have confirmed this role of MUPs, with males countermarking a scent 
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containing a different MUP profile to its own, but not one with the same MUP profile 
(Hurst et al. 2001).  Also, the addition of a recombinant MUP to a male’s scent mark, 
thus changing the MUP expression profile, causes that animal to countermark his 
own scent mark (Hurst et al. 2001).   
Roles of MUPs in behaviour 
As well as their roles in the binding, protection and release of the volatile components 
found to elicit behavioural responses in mice, MUPs themselves have roles in 
modulating identity signalling, attraction and aggressive responses in mice.  The 
countermarking study by Hurst et al. 2001 suggests the actual components of urine, 
rather than just scent, are used by mice to evaluate and respond to the scent mark, 
with recognition depending on the differences of the male’s MUP type.  The male-
specific MUP darcin, when bound to no pheromonal ligands, attracts female mice, 
indicating its role in pheromonal communication (Roberts et al. 2010).  MUPs also 
appear to cause aggression between male mice, with ligand-free MUPs inducing male 
aggression and partially activating vomeronasal neurons (Chamero et al. 2007). 
1.5 Pheromone detection 
For chemical signals to elicit behavioural and physiological responses in mice, they 
must be received and processed by their olfactory systems.  The olfactory systems 
that mice chiefly use for the detection and processing of airborne, volatile odours and 
non-volatile pheromones are the main olfactory system (MOS) and the accessory 
olfactory system (AOS).  The MOE (part of the MOS) is located at the end of the nasal 
cavity, and the VNO (part of the AOS) is based in the vomer (Figure 1.5).  The MOE 
and VNO detect chemical signals and process the information in separate neural 
pathways (Swaney and Kaverne 2009).  The two systems converge at the level of the 
amygdala (Swanson and Petrovich 1998), but the segregation of the MOS and AOS 
and their functional differences has resulted in the basic view that the MOE is 
responsible for detecting volatile signals and the VNO detects non-volatile signals 
(Buck 2000).  However, there is in fact overlap in their roles of chemosignal detection 
– the MOE has been shown to be activated by non-volatile peptides (Spehr et al. 
2006), and the VNO has been seen to respond to volatile odours (Xu et al. 2005).  
Despite this overlap, each system appears to mediate different behavioural 
responses (Restrepo et al. 2004; Spehr et al. 2006). 
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Figure 1.5 Anatomical organisation of the mouse olfactory system.  
The location of the chemosensory subsystems found in the nose of a mouse, including the 
Gruenberg ganglion (GG), the vomeronasal organ (VNO), the main olfactory epithelium 
(MOE), the accessory olfactory bulb (AOB) and main olfactory bulb (MOB).  Adapted from 
Brennan and Zufall 2006. 
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1.5.1 Main olfactory system 
The MOE of the main olfactory system generally detects volatile, airborne odours, 
since it is the only one of the two detection systems that has the appropriate 
morphology and complexity of sensory receptors, plus, sequencing analysis shows 
that the MOE receptor gene sequences are well conserved across vertebrates 
(Swaney and Keverne 2009).  This suggests that MOE receptors broadly function to 
detect and process environmental cues rather than species–specific pheromonal 
cues (Swaney and Keverne 2009). 
In the MOS, the MOE is located at the posterior end of the nasal cavity and consists 
mainly of olfactory sensory neurons (OSNs).  The bipolar OSNs project their axons 
into the main olfactory bulb (MOB), which then projects nerve fibres to the olfactory 
cortex (Ma 2010).  These nerve fibres are then projected from the MOB to the higher 
sensory centres.  Each OSN represents a different olfactory receptor type, of which 
mice have around 1300 (Zhang and Firestein 2002).  These olfactory receptors are 
from the G-protein-coupled receptor (GPCR) superfamily, and each has a different 
amino acid sequence, enabling them to bind to a wide range of odourants with 
different affinities (Zhang and Firestein 2002).  Whilst OSNs appear uniform in their 
morphology, they can be divided into subpopulations based on their chemoreceptors 
or signal transduction machineries (Ma 2010).  These include guanylyl cyclase type–
D sensory neurons, which may serve as carbon dioxide sensors and detectors for 
natriuretic peptides and components of urine; trace amine–associated receptor 
expressing neurons, which are involved in the recognition of volatile amines found in 
urine and so might be involved in receiving cues related to sexuality and fear (Liberles 
and Buck 2006); and transient receptor potential channel expressing cells, which in 
mammals are grouped into six different subfamilies, some of which have roles in the 
detection of semiochemicals (Lin et al. 2007; Ma 2010). 
Sexual behaviour in male mice has been found to be dependent on a functioning 
MOE, with ablation of the MOE resulting in disrupted investigative and copulatory 
behaviour (Keller et al. 2006).  The attraction of female mice to the male pheromone 
(methylthio)methanethiol has been found to be as a result of mediation by the MOS 
(Lin et al. 2005).  As well as the detection and processing of volatile chemical signals, 
calcium imaging studies have shown that sensory neurons in the MOE respond to 
MHC peptides (Spehr et al. 2006), which supports the more recent view that the MOB 
and AOB do not operate in mutually exclusive sensory domians (Brennan and 
Kendrick. 2006). 
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1.5.2 Accessory olfactory system 
The VNO of the accessory olfactory system mostly detects pheromones and so plays 
a more important role in species-specific communication, a theory supported by the 
fact that species-specific VNO receptor genes exist, indicating more rapid evolution 
of the VNO receptor repertoire (Swaney and Keverne, 2009).  Alongside the detection 
of non-volatile components, the AOS has also been seen to respond to certain volatile 
odours – the mouse pheromone 2–heptanone (found in female urine) and general 
urine odour were found to elicit significant responses in the accessory olfactory bulb 
(AOB) (Xu et al. 2005). 
In the AOS, the VNO is located at the base of the septum which is tubular in shape, 
blind-ended and filled with fluid, opening into the basal part of the nasal cavity 
(Droving and Trotier 1998).  Similar to the MOE, the VNO contains sensory neurons 
which project axons, but into the accessory olfactory bulb (AOB) (Keverne 1999).  
Generally, mammals are seen to curl their top lips back in order to maximise 
vomeronasal exposure when physically contacting sent marks (known as the 
Flehman response), causing semiochemicals to be pumped into the lumen of the 
VNO (Meredith 1994; Swaney and Keverne 2009).  These semiochemicals bind to 
receptors based on the surface of the sensory neurons, triggering them to project into 
the AOB. 
In rodents, the VNO sensory neurons possess two different types of receptors that 
belong to the G-protein-coupled receptor seven-transmembrane protein superfamily 
– vomeronasal type 1 and type 2 receptors (V1Rs and V2Rs, respectively) (Dulac 
and Axel 1995; Herrada and Dulac 1997; Matsunami and Buck 1997; Ryba and 
Tirindelli 1997).  V1Rs and V2Rs are different to one another in terms of sequence, 
location in the VNO, signalling proteins, and stimuli response.  V1Rs are expressed 
in the apical part of the VNO, binding to the Gαi2-protein, and the sensory neurons 
which express V1Rs project only to the anterior AOB (Keverne 1999; Halpern and 
Martinez-Marcos 2003).  V1R-expressing sensory neurons respond to the male 
specific mouse pheromones 2-sec-butyl-4,5-dihydrothiazole and 2,3-dehydro-
exobrevicomin (Leinders-Zufall et al. 2000).  V2Rs are expressed in the basal part of 
the VNO, binding to the Gα0-protein and the sensory neurons expressing V2Rs have 
been found to bind to MHC class 1 proteins, projecting only to the posterior AOB 
(Keverne 1999; Halpern and Martinez-Marcos 2003; Leinders-Zufall et al. 2004). 
Activation of the mouse VNO in terms of behavioural response to pheromones has 
been studied in some detail, indicating that the VNO plays a significant role in sexual 
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behaviour in male mice and maternal aggression in female mice (Del Punta et al. 
2002), in aggressive behaviour between male mice (Stowers et al. 2002), the 
pregnancy block effect (Kelliher et al. 2006), copulatory behaviour (Keller et al. 2006), 
the suppression of oestrus in group housed female mice and the induction of puberty 
in females exposed to male odours (Keverne 1983). 
1.6 Discovery, identification and quantification of scent mark components 
The approaches for the discovery, identification and quantification of the volatile and 
non-volatile components of scent marks are multidisciplinary, but primarily involve 
mass spectrometry.  Once a pheromonally active compound has been identified and 
characterised, synthetic versions can be produced and used in behavioural 
experiments to confirm their roles in the physiological and psychological responses 
seen in, for example, mice (Novotny 2003). 
In mammals, pheromones are typically embedded in a complex biological matrix, 
such as urine, requiring the first step in the discovery of volatiles to involve separation 
of the volatiles of interest from the rest of the sample.  Volatiles are extracted from a 
sample or the headspace above the sample in a sealed container using a solvent, or 
utilising solid phase microextraction (SPME)/stir bar sorptive extraction (SBSE) 
techniques before being analysed using capillary gas chromatography coupled with 
mass spectrometry (GC-MS) (Robertson et al. 1993; Soini et al. 2005).  Since 
pheromone production is known to be affected by hormones, the metabolic profiles 
of volatiles of animals in different behavioural or endocrine situations can be assessed 
by GC-MS, giving an insight into the compounds of interest in these situations 
(Novotny 2003).  This information can then allow more detailed analysis of the 
pheromones of interest and the conduction of the relevant behavioural experiments.  
This particular approach has allowed the identification and characterisation of the 
volatile signals confirmed to be responsible for puberty induction and delay, oestrus 
induction, attraction, aggression and dominance in mice (Jemiolo et al. 1985, 1986, 
1991; Ma et al. 1999; Novotny et al. 1985, 1986, 1990,1999). 
The term ‘proteomics’ was coined by Wilkins et al. 1996, and advanced proteomic 
analysis has been instrumental in the identification, characterisation and 
quantification of the non-volatile protein components of scent marks, even in the 
absence of genomic data.  The use of a wide range of mass spectrometric techniques, 
including matrix assisted laser desorption ionisation–time of flight mass spectrometry 
(MALDI-ToF-MS), electrospray ionisation–mass spectrometry (ESI-MS), liquid 
chromatography coupled with mass spectrometry (LC-MS) and liquid 
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chromatography with tandem mass spectrometry (LC-MS/MS) has allowed proteins 
in scent marks to be identified and characterised in terms of their molecular weight, 
peptide mass fingerprints and amino acid sequences.  Chromatographic techniques 
have enabled the isolation of proteins of interest from complex matrices, and the use 
of recombinant proteins of interest can be used in behavioural experiments to provide 
a further insight into their roles in communication.  The remainder of this section shall 
focus on the biochemical methods commonly utilised for the identification and 
characterisation of major urinary proteins, which have proven to be of great interest 
in mouse olfactory communication. 
1.6.1 Discovery of MUPs in a scent mark 
A commonly used method for the discovery of MUPs in a scent mark is by analysing 
the sample using sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-
PAGE). SDS, an anionic detergent, linearises and negatively charges proteins in the 
sample, allowing them to be separated on the polyacrylamide gel according to their 
molecular weight.  Staining of the gel post-electrophoresis allows the protein content 
of the sample to be visualised by eye, and the presence of MUPs in the sample would 
usually result in a band(s) at approximately 20 kDa on the gel (the use of a molecular 
weight marker on the gel allows the location of ~ 20 kDa proteins to be determined).  
The MUP darcin, with a mass of 18,893 Da, however, is seen at around 16 kDa on a 
gel – even after treatment with SDS, darcin does not completely linearise, indicating 
that protein folding and shape can also affect the migration of proteins during SDS-
PAGE analysis (Armstrong et al. 2005; Phelan et al. 2014).  The number of protein 
bands seen on a gel gives an indication of the protein complexity of a scent mark, 
whilst the density of the bands gives an approximate indication of the abundance of 
that protein.  In mouse urine (particularly male), a high concentration of a number of 
different MUPs gives a large, dense band at around 20 kDa, meaning initial 
identification of the number of MUPs and their relative abundances cannot be 
determined.  Methods such as native PAGE (non-denaturing, meaning proteins can 
be separated according to folding and shape as well as molecular weight) and 2D-
PAGE (where proteins are first separated by charge before being separated again by 
their molecular weight) allow proteins such as MUPs to be visualised more effectively 
prior to further biochemical analysis. 
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1.6.2 Identification of MUPs in a scent mark 
Whilst SDS-PAGE analysis can give an approximation of the molecular weights of 
proteins in a scent mark, mass spectrometry is the primary tool for accurate 
identification of proteins.  An accurate molecular weight for proteins in a sample can 
be determined via electrospray ionisation mass spectrometry (ESI-MS).  Electrospray 
ionisation is a ‘soft’ ionisation technique, meaning very little fragmentation occurs 
during ionisation and so allows the formation of gas phase molecular ions.  ESI can 
also produce multiply charged ions, which extends the mass range of the analyser to 
accommodate the higher orders of magnitude observed in proteins (Ho et al. 2003; 
Pitt 2009).  Emitted ions are accelerated into the mass analyser and are subjected to 
mass spectrometric analysis, where proteins will exhibit their multiply-charged ions in 
a cluster (Ho et al. 2003).  The number of charges on a protein molecule will depend 
on its molecular weight and the number of accessible basic sites (Ho et al. 2003).  
The molecular weight of the protein(s) can be calculated from the observed protein 
envelope using software provided by the mass spectrometer manufacturer, which can 
process and transform the raw mass spectrum to a true mass scale and determine 
the molecular weight (Armstrong et al. 2005).  This is an important step in identifying 
MUPs in a scent mark, as calculated molecular weights can be compared and 
matched to the known MUP molecular weights to confirm their presence. 
To identify the protein bands observed in SDS-PAGE analysis, parts of the bands can 
be excised before being digested with a protease to create peptide fragments suitable 
for mass spectrometric analysis.  A protease hydrolyses the bonds between amino 
acids, and the use of different specific proteases (such as Lys-C, which only 
hydrolyses at the carboxyl side of lysine residues, and Glu-C which specifically 
hydrolyses at the carboxyl side of aspartic or glutamic acid residues) for proteolysis 
creates different peptide mass patterns.  The peptides resulting from protein digestion 
can be subjected to mass spectrometric analysis to create what is known as a ‘peptide 
mass fingerprint’ (PMF), which can then be searched against a database containing 
known PMFs to help determine the identity of the protein (Perkins et al. 1999).  
MALDI-ToF-MS is a popular method for accurately measuring the m/z of each peptide 
and generating peptide mass fingerprints.  Again, MALDI is a soft ionisation 
technique, resulting in no undesired fragmentation of peptides and it usually produces 
singly-charged ions, generating relatively simple mass spectra suitable for searching 
against a peptide mass fingerprint database.  Searching against a relevant PMF 
database involves matching the experimental peptide masses to a theoretical dataset 
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from a matching protein digestion protocol, and a high score assigned by the 
database search engine indicates a strong match. 
If no definitive identification can be made with a PMF, further peptide information can 
be obtain by analysing digested material using tandem mass spectrometry (MS/MS), 
which involves two stages of mass spectrometry.  During the first stage, ionised intact 
peptides (often referred to as ‘precursor ions’) are measured before being isolated 
and fragmented.  The fragmentation stage in MS/MS is most often via collision 
induced dissociation (CID), where the precursor ions collide with the molecules of an 
inert gas.  The resulting fragments (known as the ‘product ions’) are measured in the 
second MS analyser, creating a peptide fragmentation pattern which can be searched 
against a database in a similar manner to a PMF search.  The strength of a peptide 
match is based on the incidences of the observed precursor ion and product ion 
masses against the theoretical masses derived from the peptide sequence (Perkins 
et al. 1999).  Again, a high score assigned by the database search engine indicates 
a strong match. 
The identification of proteins significant in chemical signalling proves more difficult if 
there is little or no genomic data available for the species of interest, as there is limited 
database information to identify peptides and proteins against.  In this case, MS/MS 
fragmentation spectra can be sequenced de novo, either manually or using software, 
where the mass difference between each product ion fragment denotes the mass of 
an amino acid.  An example of the de novo sequencing of a peptide from an MS/MS 
spectrum is shown in Figure 1.6. The assembled amino acid sequence for that 
peptide can then be searched using the basic local alignment search tool for protein 
sequences (BLASTp), which searches against sequences in a selected database in 
the aim of identifying similar sequences or sequence tags that may denote the family 
membership of the protein (Atschul et al. 1990). 
1.7 Mass spectrometry for protein quantification 
The quantification of the signalling proteins in scent marks is essential since the 
regulation of the expression of these proteins is thought to be altered by a number of 
situations, including social setting and reproductive status (Stopka et al. 2007).  Over 
the past decade, protein quantification methods have developed rapidly.  Although 
more ‘classical’ quantification methods are still in use, such as western blotting and 
2D gel analysis, mass spectrometry-based techniques have gained increased 
popularity for the analysis of proteins; due to the fact that these techniques are able  
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to not only quantify, but to also identify large groups of proteins (Bantschaff et al. 
2007).   
For mass spectrometry based quantification of proteins larger than around 15 kDa, 
such as MUPs, a ‘bottom up’ workflow is usually required, as the distribution of protein 
charge states renders ‘top down’ methods insensitive.  ‘Bottom up’ protein analysis 
involves the proteolytic digestion of proteins prior to mass spectrometric analysis, 
whilst ‘top down’ involves isolating a protein ion for mass measurement and tandem 
mass spectrometry analysis (Brun et al. 2009). The quantitative data obtained can 
either be the absolute amount of protein in a sample, or the relative change of the 
amount of protein between two states.  The data can be obtained via various 
methods, which can be label-mediated or label-free.  The choice of quantification 
method to be used must be carefully considered prior to sample analysis. 
1.7.1 Label-free quantification 
In mass spectrometry based label-free quantitative proteomics, each sample of 
interest is prepared separately and analysed individually by LC-MS (Zhu et al. 2010). 
After fragmentation in the mass spectrometer, an ion with a particular mass-to-charge 
ratio (m/z) is detected, with the time that the ion arrives at the detector and its intensity 
being recorded. Label-free quantification is typically based on either peptide peak 
intensities in chromatography or the spectral counting of proteins post mass 
spectrometric analysis (Old et al. 2005; Silva et al. 2006; Zhu et al. 2010). 
Relative label-free quantification of proteins is achieved via the comparison of the 
peak height of each peptide ion in multiple LC-MS datasets, as the signal intensity 
from electrospray ionisation correlates with ion (and therefore protein) concentration. 
The three most abundant peptides from each protein are used to calculate the relative 
amount of the protein (Zhu et al. 2010). Relative quantification of proteins can also be 
obtained by the comparison of the number of MS/MS spectra from a particular protein 
across numerous datasets.  This is known as spectral counting, where the number of 
identified MS/MS spectra for a protein is determined by the number of unique peptides 
(Liu et al. 2004; Zhu et al. 2010). This results from the amount of coverage of a protein 
sequence, caused by the number of proteolytic peptides and therefore protein 
abundance. Comparing two sample types can therefore allow the relative amount of 
protein to be calculated, once normalisation and statistical analysis of the datasets 
has taken place (Zhu et al. 2010). These methods offer a simpler sample preparation 
workflow, which must be conducted extremely carefully to avoid errors.  
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A modified spectral counting strategy is used for the absolute quantification of 
proteins in label-free quantitative proteomics, termed absolute protein expression 
profiling, or APEX (Zhu et al. 2010). The absolute abundance of a protein per cell is 
calculated from the proportionality between the number of peptides observed and 
protein abundance; protein abundance being indicated by an APEX score calculated 
from the peptide mass spectra. Another method used for the absolute quantification 
of proteins is emPAI – the exponential form of PAI (protein abundance index). PAI is 
the number of identified peptides divided by the number of theoretical peptides for 
each protein, enabling approximate absolute protein abundance to be determined 
without undertaking any additional experimentation after a protein identification 
experiment (Rappsilber et al. 2002; Ishihama et al. 2005; Zhu et al. 2010).  These 
absolute quantification methods suffer the same limitations as the previous relative 
quantification methods, but also allow the analysis of data from numerous 
experiments rather than samples analysed in a single experiment (Zhu et al. 2010). 
1.7.2 Label-mediated quantification 
The gold standard approach to quantitative proteomics is based on stable isotope 
dilution, which states that a peptide and its isotope-labelled analogue will behave in 
the same way when subjected to chromatographic and mass spectrometric analysis, 
due to their identical chemical nature (Brun et al. 2009).  A known amount of the 
isotope-labelled peptide is added to the sample prior to analysis.  In mass 
spectrometry, accurate peak ratios between the labelled and unlabelled peptides are 
observed, with the mass spectrometer being able to differentiate between their 
masses.  Isotopic label based protein quantification exhibits good precision and 
linearity, however the accuracy depends on the method chosen, and all methods 
require complex sample preparation (Brun et al. 2009).    
The relative quantification of proteins in label-mediated approaches involves 
calculating the ratio between the labelled and unlabelled peptides.  Commonly used 
methods for relative quantification are isotope coded affinity tagging (ICAT) involving 
the labelling of cysteine residues in a sample using heavy and light isotope ICAT 
reagents to compare the relevant amounts of two samples (Gygi et al. 1999), and 
iTRAQ, which involves tagging amino acid N terminal and side chain amino groups, 
enabling 8 different samples to be quantified simultaneously due to the development 
of 8 different iTRAQ reagents (Boehm et al. 2007). Another method is stable isotope 
labelling by amino acids in cell culture (SILAC), a metabolic labelling technique where 
the labelled amino acids are grown in a medium with the cells of interest before being 
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pooled with unlabelled cells before being subjected to analysis (Ong et al. 2002).  One 
cell culture is labelled with, for example, an amino acid in which every carbon atom is 
carbon-13 (heavy) and a second culture is labelled with the same amino acid in which 
every carbon atom is carbon-12 (light) (Claydon et al. 2011). This means that every 
peptide that contains that amino acid will appear as a heavy-light doublet in mass 
spectrometric analysis, and the relative intensities of these labelled and unlabelled 
ion peaks will indicate the relative expression of the protein (Claydon et al. 2011).   
Absolute quantification methodologies based on stable isotope dilution strategies 
(Barr et al. 1996; Stocklin et al. 1997) rely on the sample of interest being spiked with 
known amounts of labelled analogues of specific peptides or proteins, which can be 
added before or after proteolysis (Brun et al. 2009).  
 A common method which involves adding the standards after proteolysis is the use 
of AQUA peptides. AQUA peptides are synthetic isotope-labelled peptides that 
correspond to the proteotypic peptides of interest, and are added to the sample just 
before LC-MS analysis (Brun et al. 2009).  There is a limited choice of peptides that 
may be used as standards for quantification – peptides shorter than 15 amino acids 
in length are usually required, whilst reactive residues, such as methionine, should 
be avoided (Brun et al. 2009).  For this reason, along with the cost of producing and 
quantifying each peptide, proteins are often quantified using a single AQUA standard, 
which is successful providing that complete proteolysis of the target protein has been 
achieved.  
A method where the labelled standard is added prior to sample digestion involves the 
synthesis of an artificial concatamer of numerous different peptides of various protein 
targets. These standards are named QconCATs, and when digested release the 
isotope-labelled ‘Qpeptides’ which act as standards for the target peptides in the 
sample in LC-MS analysis (Beynon et al. 2005; Pratt et al. 2006; Brun et al. 2009).  
Quantification of analyte peptides by mass spectrometry is by the ratio between the 
analyte and QconCAT peptides (Pratt et al. 2006).   This method is useful if analysing 
a set of related proteins, as analysis can take place in a single mass spectrometric 
run, reducing the potential for instrument error.  However, suitable peptides must be 
chosen when designing a QconCAT, for example, peptides containing PTM sites or 
those that ionise poorly may not be suitable.  
Finally, an increasingly popular quantification method utilises isotope-labelled full 
length proteins as standards for absolute quantification, termed PSAQ standards.  
PSAQ standards share the same biochemical properties as their targets, and so 
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behave identically to the proteins in the sample throughout sample preparation and 
MS analysis (Dupuis et al. 2008; Brun et al. 2009).   In addition, these standards are 
spiked in defined amounts at the beginning of sample preparation; an advantage of 
this being the lack of differences between standard and sample digestion efficiency, 
providing more accurate quantification at MS level (Kaiser et al. 2011).   Unlike AQUA 
standards, PSAQ standards have been shown to be compatible with any type of 
sample prefractionation method, including SDS-PAGE.  Along with these various 
advantages over other absolute quantification methods, PSAQ provides greater 
sequence coverage due to the use of a full length protein standard, meaning isoforms 
and variants may also be distinguishable (Brun et al. 2009).   Despite its numerous 
advantages, it must be remembered that PSAQ standards are currently costly and 
challenging to produce (Brun et al. 2009). 
1.7 Aims 
The project is based on the use of proteomic techniques to study communication in 
mice, involving the analysis of major urinary proteins (MUPs), whose function is 
chemical signalling amongst various Mus species.  Mass spectrometry–based 
proteomics shall be used for three aspects of research into chemical signalling: 
1. For the discovery of MUPs in Mus species where no genome sequence is 
available. 
Hypothesis: Mus spicilegus mouse urine will contain MUPs not previously 
observed in other mouse populations.   
The urinary proteins of Mus spicilegus are currently uncharacterised – the 
identification, and subsequent primary sequence determination, of major urinary 
proteins using various mass spectrometric methods may provide insight into their 
protein expression patterns, their roles in scent communication and their 
reproductive and social behaviour.   
2. To use stable isotope labelling of amino acids to track complex 
communication issues and investments.  
Hypothesis: Whole animal dynamic labelling studies can be used to determine the 
proportion of lactation investment from communally nursing female house mice to 
ascertain any discriminatory factors through analysis of MUPs.   
In previous literature, it appears that communal nursing is more beneficial 
amongst related females due to a more mutually cooperative nursing system.  It 
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could be that females recognise their own young and invest in those more than 
their non-offspring, and it could also be that females invest more in the offspring 
of their closer relatives (i.e. sisters) than their more distant relatives (cousins).  It 
may be that females do not discriminate between their offspring and their non-
offspring, and invest cooperatively more in larger, healthier pups.  To answer 
these questions, whole animal metabolic labelling with stable isotope amino acids, 
introduced using a semi-synthetic diet, combined with the analysis of MUPs in 
female urine and various pup samples can provide relative proportions of 
investment from each mother to each pup.  Heavy and light isotopes of the same 
amino acid are required, as this causes the resultant heavy/light peptides from 
the proteins expressed by the animal to behave the same under mass 
spectrometric analysis, yet provide a reasonable mass difference to differentiate 
between isotopes for calculation of label incorporation. 
3. To be able to quantify the dynamics of communication by absolutely 
quantifying MUPs – MUPs are extremely homologous, meaning quantitative 
approaches using MUP peptides is challenging. 
Hypothesis: Intact mass is an appropriate method for the quantification of MUPs.   
Whilst intact mass analysis is an established valuable method for the identification 
of MUPs, the quantification of MUPs in a sample proves far more challenging – 
the high homology of MUP sequences has presented problems when 
implementing label-mediated absolute quantification methodologies at the 
peptide level.  For protein quantification via electrospray ionisation of intact 
proteins, it would be essential to firstly determine whether the response factor 
varies for each protein, relating the signal intensity and ionisation efficiency 
observed to the concentration of the protein.  Then, synthesis of the standard 
isotope labelled protein would be required – using a labelling method such as 
PSAQ.  A labelled full–length protein would be particularly useful as a MUP 
quantification standard due to MUP sequence similarity.  Labelling MUPs of a 
known concentration, which would then be spiked into an unknown MUP 
containing solution, would possess the same chemical properties as their 
unlabelled analogues, but a notably different mass, enabling a difference in mass 
to be seen in a mass spectrum.  A number of synthetic MUPs of known 
concentration could be made and used as internal standards for electrospray 
ionisation of intact proteins.    
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2.1 Sample collection 
2.1.1 Mus spicilegus mice 
Urine was collected using a recovery method.  Mice were individually placed on a 
wire grid over a clear plastic container, with another over the top to confine the animal. 
Urine was collected by pipetting from the container and samples were stored at -20 
°C in microcentrifuge tubes until required. Mice were housed in a temperature (20 °C) 
and humidity controlled (50 – 60 °C) environment with a 12 hour light cycle (12 hours 
of light/12 hours of darkness).  Males were housed individually; females were housed 
in groups of two to three per cage.  
2.1.2 C57BL/6 and BALB/c laboratory mice 
Urine was collected from adult C57BL/6 and BALB/c mice by gentle bladder massage 
by members of staff based at Leahurst campus, University of Liverpool.  Urine was 
collected in microcentrifuge tubes and stored at -20 °C until required for analysis.  
Mice were housed in a temperature (20 °C) and humidity controlled (50 – 60 °C) 
environment with a 12 hour light cycle (12 hours of light/12 hours of darkness).  
BALB/c pup samples (stomach contents, urine, liver and muscle) were recovered 
from pups by members of staff based at Leahurst campus, University of Liverpool, 
and tissue samples were rinsed with phosphate buffered saline, pH 7.5 to remove the 
majority of residual blood. These samples were stored in microcentrifuge tubes at -
20 °C until required for analysis. 
2.2 Preparation of labelled diet for BALB/c laboratory mice 
Labelled diets were prepared by Dr J. P. Green of the Mammalian Behaviour and 
Evolution group, University of Liverpool.  5002 LabDiet® (Purina Mills PMI®), in pellet 
form, was used to separately prepare [2H8] valine, [13C6] lysine, [2H4] lysine and [2H9] 
lysine labelled diets. The amount of valine or lysine present in 1 kg of diet was 
determined, and the equivalent amount of the required labelled amino acid was 
dissolved in reverse osmosis (RO) purified water (1 L).  1 kg of 5002 LabDiet® was 
stirred into the mixture and left for two hours.  A further 125 ml RO water was added 
to the mixture, which was then stirred before being left for a further hour.  The mixture 
was then transferred to a blender along with 125 ml RO water, and blended until 
smooth.  A piping bag was used to pipe the labelled diet onto dehydrator trays lined 
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with baking paper, and pellet lines were scored across the diet.  The diet was placed 
in a dehydrator for approximately 48 hours at 40 °C before being split into pellets. 
2.3 Protein assay of mouse urine and tissue samples 
Total protein concentration in mouse urine and tissue samples was measured using 
a Coomassie Plus protein assay kit (Pierce, Rockford, USA).  A standard curve, 
ranging from 0-50 µg/ml, was produced by diluting a stock solution of Bovine Serum 
Albumin (BSA, 1 mg/ml) with MilliQ water. Samples were diluted as required with 
MilliQ water.  Absorbance readings were measured at 620 nm using a Thermo 
Scientific™ Multiskan™ plate reader, and sample dilutions were accounted for when 
calculating total protein amounts in samples. 
2.4 Creatinine assay of mouse urine 
Creatinine in mouse urine was quantified using a creatinine assay kit from Sigma, 
UK.  The creatinine standard curve ranged from 0-30 µg/ml.  Urine samples were 
diluted with MilliQ water as required, and absorbance readings were measured at 570 
nm using a Thermo Scientific™ Multiskan™ plate reader.  Sample dilutions were 
accounted for when calculating total creatinine amounts in urine. 
2.5 SDS-PAGE 
SDS-PAGE was performed based on the method described by Laemmli (1970). 
Approximately 10 µg of protein was mixed 1:1 with reducing sample buffer and loaded 
onto a 15% (w/v) acrylamide gel.  Electrophoresis was carried out at a constant 
voltage of 200 V.  The SDS gels were stained, allowing protein bands to be visualised, 
using Coomassie blue stain (Sigma) for several hours before being  destained in 
80:10:10 MilliQ water:methanol:acetic acid. 
2.6 Urine fractionation by strong anion exchange chromatography 
Separation of individual MUPs from Mus spicilegus urine and C57BL/6 laboratory 
mouse urine was by strong anion-exchange chromatography with UV detection using 
a Dionex BioLC system. Pooled urine (typically 15-20 µl) was desalted using Thermo 
Zeba spin columns (7 kDa MWCO) and loaded onto a Thermo Dionex Propac™ SAX-
10 2×450 mm column using a mobile phase of 25 mM Tris HCl pH 8.8. Elution took 
place over a 25 minute gradient from 0%-30% 25 mM Tris HCl buffer, pH 8.8 with 1 
M NaCl using a flow rate of 0.2 ml/min.  Eluent from the column was monitored at 280 
nm in a 9 mm path length flow cell.  Fractions were manually collected in 
microcentrifuge tubes and run on a SDS-PAGE gel to determine the protein 
containing fractions. 
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2.7 ESI-MS of intact proteins 
Mus spicilegus urine samples were diluted to approximately 2 pmol/µl in 0.1% (v/v) 
formic acid before analysis using a Waters nanoAqcuity UPLC coupled to a Waters 
Synapt™ G1 Q-ToF mass spectrometer fitted with an electrospray source (Waters, 
Manchester, UK).  The mass spectrometer was externally calibrated with horse heart 
myoglobin (1 pmol/μl, Sigma). Diluted urine was injected onto a Waters MassPREP™ 
micro desalting column (2.1 x 5 mm, 20 μm particle size, 1000 Å pore size) and protein 
was eluted using a mixture of two solvents - solvent A (HPLC grade water with 0.1% 
(v/v) formic acid) and solvent B (HPLC grade acetonitrile with 0.1% (v/v) formic acid). 
Separations were performed using a stepwise gradient of 5% to 95% solvent B over 
10 min at a flow rate of 40 μl/min, and mass spectra were acquired between m/z 300 
– 2000.  Mass spectra were processed, deconvoluted and protein molecular weight 
calculated using Waters MassLynx 4.1 software. 
C57BL/6 urine samples and recombinant MUP samples were diluted as required in 
0.1% (v/v) formic acid before analysis using a Waters nanoAqcuity UPLC coupled to 
a Waters Synapt™ G1 or G2 Q-ToF mass spectrometer fitted with an electrospray 
source (Waters, Manchester, UK).  The mass spectrometer was externally calibrated 
with horse heart myoglobin (500 fmol/μl, Sigma). Samples were injected onto a 
Waters MassPREP™ micro desalting column (2.1 x 5 mm, 20 μm particle size, 1000 
Å pore size) and protein was eluted using a mixture of two solvents - solvent A (HPLC 
grade water with 0.1% (v/v) formic acid) and solvent B (HPLC grade acetonitrile with 
0.1% (v/v) formic acid). Separations were performed using a stepwise gradient of 5% 
to 95% solvent B over 12 min at a flow rate of 20 μl/min, and mass spectra were 
acquired between m/z 300 – 2000.  Mass spectra were processed, deconvoluted and 
protein molecular weight calculated using Waters MassLynx 4.1 software. 
2.8 Homogenisation of mouse tissue samples 
Liver and muscle samples from BALB/c pups were weighed and placed into 
microcentrifuge tubes, and kept on ice. 9 volumes of 25 mM NH4HCO3 (or 18 volumes 
if tissue sample weighed less than 20 mg) (4 °C) was added to each tissue sample 
and samples were homogenised manually in the microcentrifuge tube using a small 
plastic pestle.  The pestle was rinsed with 25 mM NH4HCO3 between each sample.  
Homogenates were centrifuged at 16,000 x g for 15 minutes at 4 °C, and all 
supernatant was transferred to a new microcentrifuge tube before being stored at -20 
°C until required for analysis. 
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2.9 Protein digestion 
2.9.1 In-gel protein digestion 
Pieces of protein bands (plugs) from SDS-PAGE analysis were excised and placed 
in microcentrifuge tubes, then destained in 50:50 ACN:25 mM NH4HCO3 for 15 
minutes at 37°C.  This was repeated until all stain was removed from the plugs.  Plugs 
were reduced in 25 µl of 10 mM dithiothreitol (DTT) at 60 °C for 1 hour, to reduce the 
disulfide bonds between the cysteine residues in the protein.  The DTT was discarded 
and 25 µl of 55 mM iodoacetamide was added to the plugs to prevent the re-formation 
of the disulfide bonds between cysteine residues.  This alkylation step was carried 
out in the dark at room temperature for 45 minutes.  The gel plugs were then 
dehydrated in acetonitrile for 15 minutes at 37 °C.  10 µl of 10 ng/ml endoprotease 
Lys-C was added to each of the gel plugs and samples were incubated at 37 °C for 
16 hours.  The digestion reaction was stopped with the addition of formic acid (1% 
v/v). 
2.9.2 In-solution protein digestion of mouse urine and SAX chromatography 
fractions 
Urine samples were diluted in 25 mM NH4HCO3 to a concentration of 10 µg/µl of 
protein.  Samples were incubated for 10 minutes with 0.1% w/v RapiGest™ SF 
Surfactant (Waters) at 80 °C.  The samples were then reduced for 10 minutes with 
DTT (3 mM final concentration) at 60 °C, followed by alkylation with iodoacetamide 
(9 mM final concentration) in the dark at room temperature for 30 minutes.  2.5 µl of 
protease (endoprotease Lys-C or endoprotease Glu-C, 0.1 µg/µl diluted in 25 mM Tris 
HCl pH 8.5), was added to the samples which were then incubated at 37 °C for 16 
hours.  Following incubation, 5 µl of each digested sample was taken to run on an 
SDS-PAGE gel to check for complete digestion.  The remaining digest was treated 
with trifluoroacetic acid, final concentration of 0.5% (v/v) and incubated at 37 °C for 
45 minutes to hydrolyse the RapiGest™ SF Surfactant prior to LC-MS analysis.  
Samples were centrifuged at 7,000 x g for 15 minutes and the supernatant transferred 
to a new microcentrifuge tube. 
2.9.3 In-solution protein digestion of homogenised mouse tissue samples 
For each sample, approximately 100 µg of protein (as determined by protein assay, 
section 2.3) was made up to a volume of 160 µl with 25 mM NH4HCO3.  Samples 
were incubated for 10 minutes with 1% w/v RapiGest™ SF Surfactant (Waters) at 80 
°C.  The samples were then reduced for 10 minutes with DTT (3 mM final 
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concentration) at 60 °C, followed by alkylation with iodoacetamide (9 mM final 
concentration) in the dark at room temperature for 30 minutes.  2.5 µl of endoprotease 
Lys-C (0.1 µg/µl diluted in 25mM Tris HCl pH 8.5), was added to the samples which 
were then incubated at 37 °C for 16 hours.  Following incubation, 5 µl of each digested 
sample was taken to run on an SDS-PAGE gel to check for complete digestion.  The 
remaining digest was treated with trifluoroacetic acid (to a final concentration of 0.5% 
(v/v)) and incubated at 37 °C for 45 minutes to hydrolyse the RapiGest™ SF 
Surfactant prior to LC-MS analysis.  Samples were centrifuged at 7,000 x g for 15 
minutes and the supernatant transferred to a new microcentrifuge tube. 
2.10 Peptide mass fingerprinting by MALDI-ToF-MS 
Peptide mixtures from in-gel and in-solution digestion of proteins were mixed 1:1 with 
a MALDI matrix (10 mg/ml α-cyano-4-hydroxycinnamic acid in 50% ACN/0.1% TFA) 
and were spotted onto a target plate which was left to air dry.  MALDI-ToF-MS was 
carried out using a Bruker UltrafleXtreme™, which was operated in reflectron mode 
with positive ion detection.  The mass spectrometer was externally calibrated with a 
mixture of stndards from Sigma - Des-Arg bradykinin (904.47 Da), angiotensin I 
(1296.69 Da), neurotensin (1672.92 Da), ACTH 1-17 fragment (2093.09 Da) ACTH 
(corticotrophin, 2465.2 Da) and ACTH 7- 38 fragment (3657.93 Da).  All standards 
apart from ACTH 7 – 38 (at 9 pmol/µl) were at a concentration of 6 pmol/µl. Spectra 
were acquired between 800 – 4000 m/z.  Laser frequency was set to 1000 Hz and 
laser energy was set between 27 – 33 % of the maximum energy, with 500 shots per 
spectrum.  Spectra were then searched against an appropriate database via the 
Mascot search engine to identify peptides and produce a peptide mass fingerprint. 
2.11 Protein discovery by LC-MS/MS 
Digested protein samples were diluted to approximately 500 fmol/µl in 97:3 
water:ACN + 0.1% (v/v) formic acid before analysis using a Waters nanoAqcuity 
UPLC coupled to a Waters Synapt™ G2 Q-ToF mass spectrometer fitted with a 
nanospray source (Waters, Manchester, UK).  The mass spectrometer was operated 
in positive ion MSE mode, with the conditions for analysis set as follows: capillary 
voltage - 3 kV; cone voltage - 45 V; source temperature - 80 °C; desolvation 
temperature - 150 °C; cone gas flow - 50 L/hr; desolvation gas flow - 500 L/hr. The 
mass spectrometer detectors were calibrated with Leucine-enkephelin (50 pmol/μl) 
(Waters, Manchester, UK), and Glu-fibrinopeptide (5 pmol/μl) (Waters, Manchester, 
UK) was used for the mass calibration. Samples were injected onto a Waters C18 
trapping column (180 μm x 20 mm) before being separated using an ACQUITY 
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UPLC® BEH column C18 analytical column (75μm x 150mm, 1.7μm) and a mixture 
of two solvents - solvent A (HPLC grade water with 0.1% (v/v) formic acid) and solvent 
B (HPLC grade acetonitrile with 0.1% (v/v) formic acid). Separations were performed 
using a linear gradient of 3% to 85% solvent B over 35 minutes at a flow rate of 300 
nl/min, and mass spectra were acquired between m/z 300 – 3000.  Mass spectra 
were viewed using Waters MassLynx 4.1 software. 
2.12 Discovery and de novo sequencing by LC-MS/MS 
Digested protein samples were diluted to approximately 500 fmol/µl in 97:3 
water:ACN + 0.1% (v/v) formic acid before analysis using an Ultimate 3000 nano 
system (Dionex/Thermo Fisher Scientific, Hemel Hempstead, UK) coupled to a 
QExactive mass spectrometer (Thermo Fisher Scientific, Hemel Hempstead, UK). 
The mass spectrometer was calibrated using a positive ion calibration solution 
containing a mixture of caffeine, MRFA, Ultramark1621 and n-butylamine (Thermo 
Fisher Scientific, Hemel Hempstead, UK).  The mass spectrometer was operated in 
data dependent ESI+ mode, which automatically switched between MS and MS/MS 
acquisition. Survey full scan MS spectra (300-2000 m/z) were acquired in the Orbitrap 
with 70,000 resolution (200 m/z) and dynamic exclusion was set to 20 seconds. The 
10 most intense multiply charged ions (z ≥ 2) were sequentially isolated and 
fragmented in the octapole collision cell by higher energy collisional dissociation 
(HCD) with a fixed injection time of 120 milliseconds and a resolution of 35,000. 
Conditions for the analysis were as follows: spray voltage - 1.9 kV (no sheath or 
auxillary gas flow); heated capillary temperature – 250 °C; normalised HCD collision 
energy - 30%. The MS/MS ion selection threshold was set to 1 x 104 ion counts and 
a 2 m/z isolation width was set. Samples were injected onto a C18 Acclaim PepMap 
100 trap columnn (2 cm x 75 μm inner diameter, 3 μm, 100Å) (Dionex) before being 
separated using a C18 Easy-Spray PepMap® RSLC (15 cm x 75 μm inner diameter, 
2 μm, 100Å) (Dionex) and a mixture of two solvents - solvent A (HPLC grade water 
with 0.1% (v/v) formic acid) and solvent B (HPLC grade acetonitrile 80% (v/v) with 
0.1% (v/v) formic acid). Separations were performed using a linear gradient of 3.8% 
to 50% solvent B over 35 min at a flow rate of 300 nl/min. 
2.13 De novo sequencing analysis using PEAKS 6 
De novo sequencing analysis of mass spectrometric data from digested Mus 
spicilegus urine and digested fractions from SAX chromatography of Mus spicilegus 
urine (acquired using the QExactive) was assisted using PEAKS 6 software 
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(Bioinformatics Solutions Inc, Canada). Data were processed using a precursor error 
tolerance of 10 ppm, and a fragment ion error tolerance of 0.01 Da.  Post translational 
modifications (carbamidomethylation – fixed, oxidation of methionine residues – 
variable) and fragmentation type of high-energy C-type dissociation (HCD) were also 
included in the processing parameters. The confidence score assigned by the 
software which indicates the likelihood of a peptide being assigned the correct 
sequence was set at a minimum ‘score’ of 55%, which is the value recommended by 
PEAKS. 
2.14 Bacterial transformation of rMUPs 
The transformation process was carried out by Mrs L McLean, University of Liverpool.  
The genes encoding MUPs 4, 7, 11 and 20 (darcin) were cloned into E. coli 
expression vectors pET28b resulting in the first fourteen residues of the recombinant 
proteins corresponding to the cloning and N-terminal hexa-histidine purification tag 
which are not part of the native sequences.  Transformation was into E. coli BL21 
(DE3) cells at 37 °C. Competent E. coli BL21 (DE3) cells were thawed on ice for 10 
minutes before being mixed, then 50 μl of each were transferred to separate tubes 
and kept on ice. Plasmid DNA (5 μl) was added to each cell mixture, the contents 
were mixed, and were placed on ice for 10 minutes.  The mixtures were heat shocked 
at 42 °C, using a water bath, for 10 seconds, then placed on ice for a further 5 minutes. 
A super optimal broth (SOC) solution (950 µl), containing 2% (w/v) tryptone, 0.5% 
(w/v) Yeast extract, NaCl (10 mM), KCl (2.5 mM), MgCl2 (anhydrous 10 mM) and 
deionised water,  was added to the mixtures. The SOC solution was supplied by 
Promega UK. The mixtures were incubated at 37 °C for 60 minutes, on a mixer at 250 
rpm. Cells were then mixed by inversion and diluted ten-fold in SOC. LB agar plates 
were heated to 37 °C before the diluted transformation mixtures (50 μl) were added 
to the plates, which were then incubated at 37 °C overnight. The next day, glycerol 
stocks of the plasmids were produced for long-term storage. A single colony from 
each LB plate was added to a culture of LB medium (5 ml) containing ampicillin (100 
μg/ml). The cultures were incubated at 37 °C for 6 hours, shaking at 300 rpm. The 
bacterial cells were then harvested by centrifugation (15 minutes at 2400 x g) at 4 °C. 
The centrifuged bacteria were then added 1:1 to sterilised 60% glycerol solutions. 
The glycerol bacterial stocks were aliquoted (100 μl) and stored at -80 °C prior to 
protein expression. 
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2.15 Expression and purification of recombinant MUPs 
Expression of recombinant MUPs 4, 7, 11 and 20 was carried out by Mrs L. McLean, 
University of Liverpool.  Glycerol stocks were defrosted and streaked onto LB agar 
plates containing ampiciliin (50 mg/ml), using a loop and sterile technique. The plates 
were then incubated at 37 °C overnight. The next day, individual colonies were 
incubated in LB broth (10 ml) and ampicillin (10 μl, 50 mg/ml) at 37 °C for six hours. 
Each LB culture (100 µl) was added to minimal media containing disodium phosphate 
(0.24 M), potassium phosphate (0.11 M), sodium chloride (11 mM), ammonium 
chloride (93 mM), magnesium sulphate (1 M), calcium chloride (0.1 M), glucose (20%, 
1 g in 5 ml), thiamine (0.5 % (w/v)) and deionised water. The cultures were incubated 
at 37 °C, shaking at 300 rpm, overnight. The next day, 6 ml of each culture was added 
to 200 ml of minimal media plus a full set of unlabelled amino acids (10 mg/ml of 
hydrophilic amino acids and 20 mg/ml of hydrophobic amino acids). The cultures were 
incubated at 37 °C, shaking at 300 rpm, for 40 minutes. The absorbance readings of 
the cultures (at 600 nm) were taken every hour until it absorbance readings reached 
0.6, with the minimal media used as a reference. MUP expression was induced with 
isopropyl-D-thiogalactopyranoside (IPTG) and cells were harvested by centrifugation 
for 15 minutes (3500 rpm) at 4 °C. Inclusion bodies containing the proteins were 
recovered using BugBuster Protein Extraction Reagent (Novagen, Nottingham, UK). 
Inclusion bodies were re-suspended in 80 mM phosphate buffer, 6 M guanidinium 
chloride, 2 M NaCl, 40 mM imidazole, pH 7.4. Each recombinant MUP was then 
purified from these solutions using affinity chromatography with a nickel-based resin 
(HisTrap kit, GE Healthcare, Bucks., UK).  Protein samples were loaded and then the 
HisTrap columns were washed with 80 mM phosphate:2 M NaCl buffer, pH 7.4. 
Protein samples were then eluted with 80 mM phosphate:2 M NaCl: 0.5 M imidazole 
buffer, pH 7.4 during which 1 ml fractions were collected. Purified rMUPs were 
then desalted by dialysis against 100 volumes of 100 mM ammonium bicarbonate 
buffer, pH 8.5, for three hours. 
2.16 Database searching 
2.16.1 PEAKS 6 
Raw mass spectra from QExactive analyses were imported into PEAKS 6 software 
(Bioinformatics Solutions Inc, Canada). Peptides (and the proteins from which they 
were generated) were identified by searching against a Uniprot mouse database, a 
mature MUPs database and a custom-made Mus spicilegus MUPs database.  The 
Mus spicilegus MUPs database was added to the PEAKS software using the 
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sequences constructed for the Mus spicilegus MUPs in FASTA format.  Spectra were 
searched using a precursor error tolerance of 10 ppm, and a fragment ion error 
tolerance of 0.01 Da, and to allow 1 missed cleavage.  Post translational modifications 
(carbamidomethylation – fixed, oxidation of methionine residues – variable) and 
fragmentation type of high-energy C-type dissociation (HCD) were also included in 
the processing parameters. 
2.16.2 Protein Lynx Global Server (PLGS) 
Raw mass spectra from Synapt G2 analyses were imported into Waters PLGS 
(version 2.5.2) software.  Peptides (and the proteins from which they were generated) 
were identified by searching against a database of mouse proteins obtained from 
Uniprot. The parameters set for the database searches were an FDR of 4%, to allow 
1 missed cleavage, a minimum of 1 peptide match per protein, a minimum of 3 
fragment ion matches per peptide, and a minimum of 7 fragment ion matches per 
protein. Post translational modifications (carbamidomethylation – fixed, oxidation of 
methionine residues – variable) were also included in the processing parameters. 
2.16.3 Mascot 
Raw mass spectra from Bruker UltrafleXtreme™ analyses were imported into 
Biotools™ (Bruker) and then searched using Mascot (Matrix Science).  Peptide mass 
fingerprint searches were carried out searching against the Swissprot database 
(taxonomy – Mus musculus).  The parameters set for the database searches were to 
allow 1 missed cleavage, a peptide mass tolerance ± 100 ppm, a peptide charge state 
of 1+, and post translational modifications (carbamidomethylation – fixed, oxidation 
of methionine residues – variable). 
2.17 Determination of label incorporation in adult female BALB/c urine 
Raw mass spectra from Bruker UltrafleXtreme™ analyses were imported into 
Biotools™ (Bruker) and then searched using Mascot (Matrix Science).  MUP peptides 
were identified by peptide mass fingerprint searches (as described in section 2.16.3).  
The corresponding labelled MUP peptides were identified from the ‘light’ (unlabelled) 
peptide masses, their sequence information, and the mass shift expected for the 
‘heavy’ (labelled) peptide.  The label incorporation into MUP peptides was determined 
by calculating the precursor relative isotopic abundance (RIA): 
RIA = IH / (IH + IL) 
where IH is the signal intensity displayed by the heavy labelled peptide (calculated by 
summing the intensities of the monoisotopic (M0), M0 + 13C (M1) and M0 + 2 13C (M2) 
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isotopic peaks), and IL is the signal intensity of the light (unlabelled) peptide, 
calculated in the same way.  
2.18 Determination of label incorporation in pup urine, stomach contents and 
tissue samples 
Raw mass spectra from Synapt G2 analyses were imported into Waters PLGS 
(version 2.5.2) software.  Unlabelled and their corresponding [13C6] lysine labelled 
peptide masses were identified by database searches as described in section 2.16.2, 
including [13C6] lysine as a post translational modification in the processing 
parameters.  The label incorporation into peptides of interest was determined by 
calculating the precursor RIA, as described in section 2.17. 
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Chapter 3: Major Urinary Proteins in Mus spicilegus 
 
3.1 Introduction 
Mus spicilegus, also known as the mound-building mouse, is a non-commensal 
species from the steppe grassland habitats in eastern Europe (Bonhomme 1992, 
Sokolov et al. 1998; Patris et al. 2002). M. spicilegus are unique in their construction 
of mounds, which are thought to provide shelter and protection during the winter 
months, and are believed to be built and inhabited by members of the same family. 
Despite M. spicilegus being genetically close to the Mus musculus group of the Mus 
species group (Figure 3.1), the mating patterns and social behaviour observed in M. 
spicilegus are very different to those seen in the house mouse, Mus musculus 
domesticus. M. spicilegus female mice show a preference for one particular mate 
(suggestive of a possible monogamous mating system), whilst M. m. domesticus 
exhibits polygamous mating behaviour (Patris and Baudoin 1998; Patris et al. 2000).  
Unlike M. m. domesticus, where females have a sexual preference for dominant 
males and have developed a communal nesting and nursing system, M. spicilegus 
are not cooperative breeders; they exhibit strong mating pair bonds and females 
appear to be very aggressive towards each other (Tong et al. 2012). In studies 
comparing behavioural characteristics of M. m. domesticus and M. spicilegus, many 
differences have been observed, in particular their tolerance towards siblings and 
strangers (Sczenczi et al. 2012). In the behavioural study conducted by Szenczi et al. 
(2012) (Figure 3.2), male M. m. domesticus expressed more time in agonistic 
behaviour towards both siblings and strangers to a similar extent. Male M. spicilegus 
showed an increase in time spent in agonistic behaviour with age, with a very 
significant difference in the time spent in offensive and defensive behaviour towards 
strangers compared to siblings. With increasing age, female M. m domesticus and 
female M. spicilegus expressed agonistic behaviour towards strangers, but none 
towards siblings. Female M. spicilegus display significantly more agnostic behaviour 
towards strangers than female M. m. domesticus. Also apparent is that female M. 
spicilegus display low levels of tolerance not only to unfamiliar females, but also to 
unfamiliar males.  This, along with the higher levels of cooperation in terms of paternal 
care compared to M. m. domesticus, suggest the possibility of a monogamous mating 
system (Gouat et al. 2003).  
Relatively little is known regarding the role of chemical communication in the unique  
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Figure 3.1 Phylogenetic tree of Mus species. 
Domesticus, musculus, castaneus and bactrianus are all members of the Mus musculus 
subspecies group.  Spicilegus are most closely related to macedonicus, but also closely 
related to spretus and the Mus musculus group.  Estimated times of divergence between 
evolutionary lines are given as the number of millions of years before present (my bp). 
Adapted from Silver 1995. 
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social and reproductive behaviours displayed by M. spicilegus (Tong et al. 2012). As 
urinary MUPs play a significant part in the social and reproductive behaviours 
displayed by mice such as M. m. domesticus, this study sought to evaluate whether 
M. spicilegus also invested in MUPs, and by inference, whether these could play a 
key role in their unusual behaviours.  To do this, the protein content of the urine of 
male and female M. spicilegus was examined, and then mass spectrometry was used 
to identify the proteins and characterise their primary structure.   The possible roles 
of these proteins in scent communication was then investigated by observing changes 
in urinary protein expression in experiments relating to their sexual and social 
behaviour. 
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3.2 Results and discussion 
3.2.1 The protein content of Mus spicilegus urine 
Male mice were singly housed, and female mice were housed in sibling groups. Urine 
was collected from a number of males and females as described in Chapter 2, and 
was initially analysed by SDS-PAGE.  An intensely staining group of proteins at 
approximately 20 kDa were identified in the male M. spicilegus urine, the number and 
intensity of which varied between individuals. A single, low intensity protein band of 
similar mobility was identified in all female M. spicilegus urine samples (Figure 3.3).  
Protein assays of the male and female urine samples confirmed varied protein 
concentrations in male urine (0.5 mg/ml – 2 mg/ml), and less varied in female urine 
(0.7 mg/ml – 1 mg/ml) (Figure 3.4). 
3.2.2 Determination of accurate molecular weight of proteins of interest using 
ESI-MS 
To obtain a more accurate molecular weight of the proteins observed in SDS-PAGE, 
desalted urine was analysed by ESI-MS (Figure 3.5). Three clearly resolved masses 
(18585 Da, 18742 Da and 18762 Da) were identified in the male M. spicilegus 
samples. These protein masses are between 18 – 19 kDa, as are the masses of 
known MUPs from other Mus species (Beynon et al. 2014). The intensity of these 
three masses varied between male samples, and in some individuals, a fourth mass 
at 18918 Da was present. None of the masses identified in M. spicilegus urine 
matched those of known M. m. domesticus MUPs.  Several of the female M. 
spicilegus urine samples revealed a protein mass (18918 Da) that was also present 
in some male samples. However, due to the low concentration of protein in female 
urine, it was not possible to identify the protein in all samples.   
From SDS-PAGE and intact protein analysis, protein expression patterns in M. 
spicilegus urine appear less complex than in M. m. domesticus urine (Robertson et. 
al. 2007) but there was greater variation in protein expression between the male M. 
spicilegus than between inbred M. m. domesticus individuals (Cheetham et. al. 2009). 
3.2.3 Peptide mass fingerprinting of urine samples 
Pieces of SDS-PAGE gel from the region containing the 20 kDa bands were subjected 
to in-gel digestion with endoprotease Lys-C. Endoprotease Lys-C was chosen as it 
results in fewer, larger peptides than trypsin, suitable for analysis using MALDI-TOF-
MS (Robertson et. al. 2007). Comparison of the peptide mass fingerprints (PMFs)  
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Figure 3.3 SDS-PAGE analysis of male and female Mus spicilegus urine.  
Urine (5 μl) from both male and female Mus spicilegus was mixed 1:1 with sample buffer, 
loaded onto a 15% SDS gel and resolved by SDS-PAGE. The gel was stained with 
Coomassie blue to visualise the proteins. The protein bands of interest at approximately 
20 kDa are highlighted in red. 
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Figure 3.4 Determination of protein concentration, creatinine concentration and 
protein:creatinine values in male and female M. spicilegus urine.  
Protein concentration was determined using a Coomassie Plus protein assay kit. A 
standard curve (0-50 μg/ml) was prepared using BSA. Samples were diluted appropriately 
in milliQ water, and absorbance readings were measured at 620 nm. Creatinine 
concentration was measured using a creatinine assay kit. A creatinine standard curve (0-
30 μg/ml) was prepared and samples diluted appropriately in milliQ water. Absorbance 
readings were measured at 570 mm. Top panel: protein: creatinine ratio calculations to 
correct for urine dilution (error bars ± SD: male (n=13) female (n=9)).  The difference 
between the ratios in male and female urine was statistically significant (Welch t-test, t = 
5.06; df = 17.97; p = 8.2 x 10-5). Bottom panel: calculated protein and creatinine 
concentrations. 
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Figure 3.5 Determination of an accurate molecular weight of the ~ 18 kDa proteins 
in male and female M. spicilegus by ESI-MS.  
Urine samples from male and female M. spicilegus were desalted as described in Chapter 
2 and diluted 1:2 into 0.1% formic acid. Samples were injected onto a C4 desalting trap 
and the masses of the proteins of interest at approximately 20 kDa were determined by 
ESI-MS. Data was processed using maximum entropy software MAX ENT1 (MassLynx 
4.1, Waters). In female urine samples, there is a peak that is + 16 Da of the 18918 Da 
peak.  This mass increase is likely to be due to the oxidation of a methionine residue in the 
18918 Da protein. 
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with known M. m domesticus MUPs highlighted many similarities between the 
proteins in male urine and central M. m. domesticus MUPs, but several endoprotease 
Lys-C peptide masses present in all male M. spicilegus samples did not match any 
known MUP peptide masses (Figures 3.6 and 3.7).  In the two major bands selected 
from the male SDS-PAGE analysis, many peptides of the same mass were observed 
in both bands.  For example, two masses identified by database searching as central 
MUP peptides, 1567 Da and 1596 Da, were seen in the spectra for both male bands, 
along with the unidentified masses 1139 Da and 1857 Da (Figures 3.6, 3.7 and 3.9).  
There were differences in the PMFs obtained for the two male bands, for example the 
central MUP peptide 2592 Da was present in just the PMF for the lower, less intense 
male protein band, and the unidentified peptide mass of 1450 Da was only present in 
the more intense, upper male band (Figures 3.6 and 3.7).  Peptide mass fingerprints 
from female samples had fewer peptides, with most of them matching M. m. 
domesticus peripheral MUP masses (Figures 3.8 and 3.9). The peak at 1613 Da (+ 
16 Da of the 1597 Da MUP 6 peptide), which could result from the oxidation of a 
methionine residue in the peptide sequence, confers with the + 16 Da mass shift in 
the intact mass analysis of female urine (Figure 3.5). There were no peptide mass 
similarities between the female and male bands apart from the unidentified mass of 
1450 Da, which was seen in the female and the larger, upper male band (Figures 3.6, 
3.8 and 3.9). In the female band, this was the only high-intensity observed mass that 
was not matched to peripheral MUP peptide masses via database searching. 
The fact that numerous peptide peaks in the PMF spectra matched masses of 
peptides generated from Lys-C digestion of known house mouse MUPs provided 
presumptive evidence for these M. spicilegus urinary proteins also being MUPs.  
3.2.4 Protein discovery by LC-MS 
Male and female urine samples were digested in-solution with endoprotease Lys-C 
as described in Chapter 2, and the resulting digested material was analysed using an 
Ultimate 3000 nano system coupled to a QExactive mass spectrometer.  PEAKS 7 
software was used to process the raw data.  Peptides (and the proteins from which 
they were generated) were identified by searching against a Uniprot mouse protein 
database.  The database search parameters used were those described in Chapter 
2. 
In the male urine sample, PEAKS software identified 740 peptide-spectrum matches  
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Figure 3.6 Peptide mass fingerprinting of male M. spicilegus urine sample. 
Pieces of gel were extracted from the protein bands of interest on the SDS-PAGE gels 
(Figure 3.3), subjected to in-gel digestion and resulting peptides were analysed using 
MALDI-TOF-MS. The spectra were searched against the MUPS_mat database using 
Mascot. The digested protein band from male urine showed peptides that matched MUP 
7 peptides (highlighted in red), the peptide mass fingerprint of which is shown below the 
spectrum.  Novel peptides are highlighted in black boxes. 
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Figure 3.7 Peptide mass fingerprinting of male M. spicilegus urine sample.  
Pieces of gel were extracted from the protein bands of interest on the SDS-PAGE gels 
(Figure 3.3), subjected to in-gel digestion and resulting peptides were analysed using 
MALDI-TOF-MS. The spectra were searched against the MUPS_mat database using 
Mascot. The digested protein band from male urine showed peptides that matched MUP 
7 peptides (highlighted in red), the peptide mass fingerprint of which is shown below the 
spectrum.  Novel peptides are highlighted in black boxes. 
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Figure 3.8 Peptide mass fingerprinting of female M. spicilegus urine sample. 
 Pieces of gel were extracted from the protein band of interest on the SDS-PAGE gels 
(Figure 3.3), subjected to in-gel digestion and resulting peptides were analysed using 
MALDI-TOF-MS. The spectra were searched against the MUPS_mat database using 
Mascot. The digested protein band from female urine showed peptides that matched MUP 
6 peptides (highlighted in red), the peptide mass fingerprint of which is shown below the 
spectrum.  Novel peptides are highlighted in black boxes.   
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Figure 3.9 Identified MUP peptides in male and female M. spicilegus urine samples.  
Pieces of gel were extracted from the protein band of interest on the SDS-PAGE gels 
(Figure 3.3), subjected to in-gel digestion and resulting peptides were analysed using 
MALDI-ToF-MS. The spectra (Figures 3.6 - 3.8) were searched against the MUPS_mat 
database using Mascot. The digested protein bands from male urine resulted in peptides 
that matched MUP 7 peptides (indicated in blue). The digested protein band from female 
urine resulted in peptides that matched MUP 6 peptides (indicated in red).   
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and 116 proteins.  The top 20 identified proteins, along with the number of peptides 
identified, protein coverage and the presence of any post-translational modifications 
(PTMs), are outlined in Table 3.1.  Of great interest is that the top two identified 
proteins are both MUPs – the top identified protein is central MUP 1 – with 72% 
protein sequence coverage and 25 identified peptides, closely followed by peripheral 
MUP 6, with the same sequence coverage and 24 identified peptides.  Also identified 
are MUPs 3, 4, 5 and 20, all of which are peripheral MUPs.  
In female urine, PEAKS software identified 441 peptide-spectrum matches and 83 
proteins.  The top 20 identified proteins are outlined in Table 3.2.  In general, the 
proteins identified in female urine are similar to those identified in male urine – 
however, only peripheral MUPs 3 and 4 were in the top 20 identified proteins, with 
MUPs 5 and 20 (peripheral) also being identified, with only 18% and 20% of the 
protein sequence covered, respectively.  
Thus, predicted from SDS-PAGE, ESI-MS and MALDI-ToF-MS analysis, and 
confirmed by LC-MS/MS, M. spicilegus urine does contain MUPs that are similar to 
those seen in M. m. domesticus urine. However, the fact that the molecular weights 
of the identified M. spicilegus MUPs do not match to the molecular weights of any 
known M. m. domesticus MUPs, and that LC-MS/MS analysis indicates less than full 
sequence coverage of any known MUPs, means that M. spicilegus MUPs are different 
in sequence to known M. m. domesticus MUPs.  To identify the sequences of each 
M. spicilegus MUP, each protein was separated from other urinary constituents and 
digested, and the peptides resulting from proteolysis were sequenced de novo using 
MS/MS spectra generated from LC-MS/MS analyses. 
3.2.5 Separation of MUPs using strong anion exchange (SAX) 
chromatography 
To associate identified sequences to specific male M. spicilegus MUPs, strong anion 
exchange (SAX) chromatography was used to separate the proteins in male urine. 
The buffers used and the pH conditions of the analysis were chosen based on the 
isoelectric point (pI) of previously studied MUPs – as MUPs have a pI of around 3.2 
– 3.9 (Cheetham et al. 2009), a buffer pH of 8.8 was selected to confer the proteins 
with the negative charge necessary for anion exchange chromatography (Robertson 
et al. 1996).    
Whole urine was desalted and separated into fractions using SAX chromatography 
with UV detection at 280 nm. Fraction collection was manual to ensure that each peak  
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Accession Protein 
description 
Protein 
coverage 
(%) 
No. of 
peptides 
PTM(s) 
P11588 Major urinary 
protein 1 
72 25 Carbamidomethylation; 
Oxidation (M) 
P02762 Major urinary 
protein 6 
72 24 Carbamidomethylation; 
Oxidation (M) 
P07724 Serum albumin 50 26 Carbamidomethylation 
P01132 Pro-epidermal 
growth factor 
20 21 Carbamidomethylation; 
Oxidation (M) 
Q91X17 Uromodulin 17 12 Carbamidomethylation; 
Oxidation (M) 
P11590 Major urinary 
protein 4 
62 12 Carbamidomethylation 
P04939 Major urinary 
protein 3 
36 11 Carbamidomethylation 
Q61646 Haptoglobin 23 7 Carbamidomethylation 
Q61838 Alpha-2-
macroglobulin 
8 12  
Q00897 Alpha-1-antitrypsin 
1-4 
26 10  
P11087 Collagen alpha-1(I) 
chain 
5 9 Carbamidomethylation 
P11591 Major urinary 
protein 5 
36 8 Carbamidomethylation 
Q5FW60 Major urinary 
protein 20 
30 9  
O09043 Napsin-A 12 4 Carbamidomethylation 
P51910 Apolipoprotein D 39 6 Carbamidomethylation; 
Oxidation (M) 
A2ARV4 Low-density 
lipoprotein 
receptor-related 
protein 2 
2 10 Carbamidomethylation 
P15947 Kallikrein-1 12 4 Carbamidomethylation 
Q60648 Ganglioside GM2 
activator 
32 4 Carbamidomethylation 
Q9DAU7 WAP four-disulfide 
core domain 
protein 2 
19 3 Carbamidomethylation 
P07758 Alpha-1-antitrypsin 
1-1 
18 8  
  
Table 3.1 A list of the proteins identified in male M. spicilegus urine from PEAKS 
database search. 
Raw data was processed using PEAKS software and spectra were searched against a 
Uniprot mouse protein database.  PEAKS identified a large number of peptides matching 
to MUP peptides.  MUPs are highlighted in red.  
   
 55 
 
 Chapter 3: Major Urinary Proteins in Mus spicilegus 
 
 
 
 
Accession Protein 
description 
Protein 
coverage 
(%) 
No. of 
peptides 
PTM(s) 
P07724 Serum albumin 48 24 Carbamidomethylation; 
Oxidation (M) 
Q60574 Haptoglobin 37 12 Carbamidomethylation; 
Oxidation (M) 
P07759 Serine protease 
inhibitor A3K 
25 9 Oxidation (M) 
Q61646 Haptoglobin 34 11 Carbamidomethylation; 
Oxidation (M) 
P15947 Kallikrein-1 41 8 Carbamidomethylation; 
Oxidation (M) 
P01132 Pro-epidermal 
growth factor 
14 11 Carbamidomethylation; 
Oxidation (M) 
P07758 Alpha-1-
antitrypsin 1-1 
25 9 Oxidation (M) 
Q00896 Alpha-1-
antitrypsin 1-3 
25 9 Oxidation (M) 
Q921I1 Serotransferrin 22 12 Carbamidomethylation 
Q61838 Alpha-2-
macroglobulin 
12 14 Carbamidomethylation 
O70570 Polymeric 
immunoglobulin 
receptor 
11 6 Carbamidomethylation 
Q07456 Protein AMBP 23 5 Carbamidomethylation 
P22599 Alpha-1-
antitrypsin 1-2 
21 8  
Q00897 Alpha-1-
antitrypsin 1-4 
21 8  
P51910 Apolipoprotein D 36 7 Carbamidomethylation 
P11590 Major urinary 
protein 4 
42 6 Carbamidomethylation 
Q9DAU7 WAP four-
disulfide core 
domain protein 2 
37 6 Carbamidomethylation; 
Oxidation (M) 
P04939 Major urinary 
protein 3 
33 4 Carbamidomethylation; 
Oxidation (M) 
O09043 Napsin-A 13 2 Carbamidomethylation 
P23953 Liver 
carboxylesterase 
N 
9 4 Carbamidomethylation 
 
Table 3.2 A list of the proteins identified in female M. spicilegus urine from PEAKS 
database search. 
Raw data was processed using PEAKS software and spectra were searched against a 
Uniprot mouse protein database.  PEAKS identified a number of peptides matching to MUP 
peptides. MUPs are highlighted in red. 
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at 280 nm was collected in a single fraction.  Each fraction was desalted and diluted 
1 in 10 in 0.1% (v/v) formic acid before being subjected to ESI-MS analysis to 
determine the MUP(s) present in each fraction.  The 18585 Da MUP could not 
however be resolved from the other two male MUPs (Figure 3.11). Fraction 1 
contained the 18742 Da MUP only, Fraction 3 contained the 18762 Da MUP only, 
and Fraction 2 contained proteins of masses 18742 Da, 18762 Da and 18585 Da. 
Due to the lower complexity in protein expression and lower abundance of protein in 
female urine (confirmed by SDS-PAGE and intact mass analysis, Figures 3.3 and 
3.5), fractionation prior to protein sequencing analysis was not performed.  
3.2.6 Sequencing of Mus spicilegus MUPs de novo 
In order to determine full protein sequences for each male M. spicilegus MUP 
observed, the MUP fractions collected from the SAX chromatographic separation 
were desalted and separately digested with endoproteases Lys-C and Glu-C.  The 
18742 Da and 18762 Da MUPs that were completely isolated in their SAX fractions 
were sequenced first, so the peptides present in Fraction 2 that were not part of either 
of these sequences would be peptides from 18585 Da MUP. This, supported by the 
intact protein mass measurement, would enable the definitive sequencing of each 
male M. spicilegus MUP.  To sequence the 18918 Da MUP, desalted and 
concentrated female urine was separately digested with each endoprotease.  After 
proteolysis, all samples were subjected to LC-MS/MS analysis using the Thermo 
QExactive.  
Raw data were processed using PEAKS software, which sequences the identified 
peptides de novo.  MS/MS analysis yielded complete and accurate sequence 
information for the majority of the M. spicilegus MUP peptides; in all but one case, 
overlapping sequence information solved sequence ambiguities. Most sequences 
were above the 85% confidence threshold (Supplementary Material), and MS/MS 
spectra were good quality.  All peptide sequences were searched against a database 
of Mus proteins using BLASTp, an online local alignment search tool, to determine 
any similarities or differences between the M. spicilegus MUP peptides and known 
mouse MUPS.  BLAST search results determined that the peptides from proteins 
specifically in male M. spicilegus urine (18585 Da, 18742 Da and 18762 Da) were 
highly homologous in sequence to M. m. domesticus central MUPs, and the non-sex 
specific protein 18918 Da in M. spicilegus was homologous to M. m. domesticus 
peripheral MUP 6 (Tables 3.3 and 3.4).  
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Table 3.3 BLAST results from male-specific MUP Lys-C de novo sequenced peptides. 
Peptide sequences were assessed using the BLASTp algorithm.  Highlighted in red are the 
amino acid differences between male-specific M. spicilegus MUP and M. musculus central 
MUP peptides. The score of the alignment is assigned by the program, and the E value 
indicates the significance of the sequence match. Identified peptides were searched for in the 
previous MALDI-ToF-MS analysis of protein bands from SDS-PAGE of male urine (Figures 
3.6 - 3.7).   
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Table 3.4 BLAST results from the non-sex specific MUP Lys-C de novo sequenced 
peptides. 
Peptide sequences were assessed using the BLASTp algorithm.  Highlighted in red are the 
amino acid differences between non sex specific M. spicilegus MUP and M. musculus 
peripheral MUP peptides. The score of the alignment is assigned by the program, and the E 
value indicates the significance of the sequence match. Identified peptides were searched for 
in the previous MALDI-ToF-MS analysis of protein bands from SDS-PAGE of female urine 
(Figure 3.8).   
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Each M. spicilegus MUP peptide resulting from the analysis had extremely high 
sequence homology to known MUP peptides – many of the sequenced peptides were 
identical to those seen in M. m. domesticus MUPs, with all sequenced peptides 
sharing at least 87% sequence identity with known MUP peptides.  Many of the M. 
spicilegus peptides that are identical in sequence to known MUP peptides were 
initially identified in the peptide mass fingerprinting analysis (Figures 3.6 - 3.9), but 
LC-MS/MS analysis enabled the confirmation of these sequences as well as 
identifying the unknown peptide masses.  The G-X-W sequence motif (where X 
represents any amino acid) was present in the peptide sequences of all digested M. 
spicilegus MUP fractions.  This sequence motif is highly conserved across all 
lipocalins, including MUPs, reaffirming that these M. spicilegus proteins are indeed 
MUPs.  The high sequence homology of all M. spicilegus MUP peptides to M. m. 
domesticus MUP peptides allowed the definitive construction of the peptides of each 
MUP into the correct protein sequence.  Reference to the calculated molecular 
weights of each MUP confirmed that the correct sequences had been assigned.  The 
MS/MS spectra for the Lys-C digested peptides of the most abundant male specific 
MUP 18742 Da, from Fraction 1 of the SAX chromatography analysis, are displayed 
in protein sequence order in Figures 3.12 – 3.21.  The MS/MS spectra for the Lys-C 
digested peptides of MUPs 18762 Da, 18585 Da and 18918 Da, along with the 
spectra for the Glu-C digested peptides of all four M. spicilegus MUPs, are displayed 
in the Supplementary Material.  The sequence coverage obtained from both Lys-C 
and Glu-C digests for each MUP can be found in Figures 3.22 - 3.25.   
For the three male specific MUPs (18742 Da, 18762 Da and 18585 Da), the use of 
two proteases provided overlapping and therefore full definitive sequence 
information.  For the non sex specific MUP 18918 Da, however, a small part of the 
protein sequence was not covered (8 amino acid residues).  Female urine was then 
digested using a third protease, Asp-N, to try and deduce the missing sequence, but 
the use of this protease provided no additional sequence information.  Since the 
18918 Da MUP peptides show high sequence homology to the peripheral M. 
musculus MUP 6, it was possible that the M. musculus MUP sequence NGETFQLM 
(the sequence usually found in the same part of the MUP where the 18918 Da 
sequence was missing) might complete this MUP sequence.  However, placing this 
sequence in the otherwise fully sequenced 18918 Da MUP resulted in a molecular 
weight of just 18882 Da for this protein (36 Da less than the calculated molecular 
weight).  The only amino acid substitution in the sequence NGETFQLM that would 
give rise to a 36 Da increase in molecular weight would be T → H, resulting in the  
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Figure 3.22 Peptide map of the male-specific 18742 Da MUP. 
The sequence of the MUP can be confirmed by analysis of the peptides generated 
separately using two different proteases, Lys-C (in red) and Glu-C (in blue).  The solid 
coloured blocks show sequence confirmation with full peptide sequences.  The white blocks 
highlight unsequenced parts of the peptide. 
Figure 3.23 Peptide map of the male-specific 18762 Da MUP. 
The sequence of the MUP can be confirmed by analysis of the peptides generated 
separately using two different proteases, Lys-C (in red) and Glu-C (in blue).  The solid 
coloured blocks show sequence confirmation with full peptide sequences.   
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Figure 3.24 Peptide map of the male-specific 18585 Da MUP. 
The sequence of the MUP can be confirmed by analysis of the peptides generated 
separately using two different proteases, Lys-C (in red) and Glu-C (in blue).  The solid 
coloured blocks show sequence confirmation with full peptide sequences.  The white 
blocks highlight unsequenced parts of the peptide. 
Figure 3.25 Peptide map of the non-sex specific 18918 Da MUP. 
The majority of the sequence of the MUP can be confirmed by analysis of the peptides 
generated separately using two different proteases, Lys-C (in red) and Glu-C (in blue).  The 
solid coloured blocks show sequence confirmation with full peptide sequences.  The white 
blocks highlight unsequenced parts of the peptide. 
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sequence NGEHFQLM.  This sequence was searched for in MS/MS spectra, but no 
product ions could be identified.  For the purpose of aligning M. spicilegus MUP 
sequences, this sequence was used to complete the 18918 Da MUP sequence, due 
to the relatively high likelihood of this being the correct sequence when considering it 
results in the correct protein molecular weight (determined by intact protein analysis) 
and the similarity to the known MUP 6 sequence, which is seen throughout the 18918 
Da MUP. 
Once the full protein sequences for each M. spicilegus MUP were constructed, they 
were aligned with M. m. domesticus MUPs using online sequence alignment tool 
Clustal Omega (http://www.ebi.ac.uk), and viewed in JalView.  Male M. spicilegus 
MUPs were very similar to each other in terms of sequence, and the non sex specific 
18918 Da MUP was less homologous to all the male-specific MUPs.  Figure 3.26 
highlights the sequence differences between each of the M. spicilegus MUPs.  The 
similarity of the male-specific MUPs 18742 Da, 18762 Da, and 18585 Da to central 
M. m. domesticus MUPs, particularly male-specific MUP 7, is shown in Figure 3.27, 
which also confirms the sequence similarity of the M. spicilegus 18918 Da MUP found 
in both sexes to peripheral MUPs. 
To further confirm the sequences of the proteins, and to determine which MUP 
corresponded to each of the protein bands in SDS-PAGE analysis of M. spicilegus 
urine, peptide mass fingerprinting using the MALDI-ToF-MS spectra generated 
previously from the Lys-C in-gel digestions of the MUP bands (Figures 3.2, 3.6 – 3.8) 
was undertaken by searching against a custom made database of the M. spicilegus 
MUPs.  In the larger, upper male MUP band, peptide masses matching some of those 
present in all four M. spicilegus MUPs were identified.  Numerous peptide masses 
common between the three male specific MUPs were identified, as well as masses 
unique to the 18742 Da and 18918 Da MUPs.  The previously unidentified peptide 
masses of 1139 Da, 1147 Da, 1302 Da, 1450 Da, 1857 Da and 2038 Da in the 
spectrum were identified as M. spicilegus MUP peptide masses.  The presence of 
peptide masses unique to the 18742 Da and 18918 Da MUPs, and high peptide map 
coverage of 18585 Da MUP, suggest that this larger protein band corresponds to 
these three proteins.  In the smaller, lower male MUP band, peptide masses matching 
many of those present in the three male specific M. spicilegus MUPs were identified.  
Again, a number of peptide masses common between these three MUPs were 
identified, and in this band, peptide masses unique to 18742 Da and 18762 Da MUPs.  
The previously unidentified masses of 1117 Da, 1139 Da, 1302 Da, 1507 Da, 1857 
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Da, 1872 Da and 2123 Da were identified as male specific M. spicilegus MUP peptide 
masses.  The presence of a number of peptide masses unique to the 18762 Da MUP 
indicates that this smaller band corresponds to this protein.  The identification of a 
peptide mass unique to the 18742 Da protein in this spectrum is likely to be due the 
fact a small amount of the larger, upper band was also removed when excising this 
band from the gel for digestion.  In the female MUP band, peptide masses matching 
to the 18918 Da MUP peptides were identified – all these masses were unique to the 
18918 Da MUP, and there was no evidence of peptides from any of the male-specific 
MUPs.  In this spectrum, the previously unidentified masses of 1450 Da and 2038 Da 
were identified as 18918 Da MUP peptide masses. 
No complete peptide mass fingerprints were obtained for any of the four M. spicilegus 
MUPs; the L4 peptides of each of the male specific MUPs were not identified in any 
spectra.  In LC-MS/MS analysis of the Lys-C digestions of these proteins, this peptide 
was not identified or sequenced (in each protein, it was successfully sequenced in 
the analysis of Glu-C digestions).  The L4 peptide of central MUP 7 (2840.5 Da) has 
previously been determined to ionise very poorly (Dr. S. Armstrong, Ph.D thesis), and 
the sequence similarity of this peptide to the male specific M. spicilegus MUP L4 
peptides indicate that poor ionisation is the reason this peptide isn’t observed in the 
MALD-ToF-MS spectra.  The 18585 Da L5 peptide, not identified in the spectra in 
Figures 3.28 – 3.29, was identified in the analysis of the Lys-C digestion of other 
‘upper’ male MUP bands (Supplementary Material).  Four of the 18918 Da peptide 
masses were not identified in the MALDI-ToF-MS spectrum of the female band, likely 
to be due to the fact that this MUP is only present in very small amounts in urine 
samples.  The peptide mapping of these four M. spicilegus MUPs, plus the 
identification of a number of previously unidentified peptide masses in male and 
female MALDI-ToF-MS spectra of digested M. spicilegus MUP bands, further 
supports that the LC-MS/MS analysis and de novo sequencing have enabled the 
correct sequence determination of all four M. spicilegus proteins. 
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Figure 3.27 Phylogentic tree of M. spicilegus and M. m. domesticus MUPs.  
Phylogenetic analysis was performed using the ‘One Click’ mode at www.phylogeny.fr 
(Dereeper et al. 2008). Sequences were aligned using MUSCLE (v3.8.31), configured for 
highest accuracy. Gblocks (v0.91b) was used to remove any ambiguous regions. The 
phylogenetic tree was reconstructed using the maximum likelihood method implemented 
in the PhyML program (v3.1/3.0 aLRT). Graphical representation of the tree was 
performed with TreeDyn (v198.3). Bootstrap values are labelled in red, peripheral and 
central M. m. domesticus MUPs are identified, and M. spicilegus MUPs are highlighted in 
blue. 
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Figure 3.28 M. spicilegus MUP peptide mass fingerprinting of a male M. spicilegus 
urine sample. 
The MALDI-ToF-MS spectrum generated from a Lys-C in-gel digestion of SDS-PAGE gel 
pieces (Figures 3.2 and 3.6) was searched against a custom made M. spicilegus MUPs 
database using Mascot. The digested protein band from male urine showed peptides that 
matched peptides from all M. spicilegus MUPs, the peptide maps of which are shown below 
the spectrum.  In the peptide maps, the coloured peptides are those masses observed in 
the spectrum. The red peptides are those with masses shared between two or more of the 
M. spicilegus MUPs, and peptide masses unique to each MUP are coloured differently to 
one another – peptide masses unique to 18742 Da are coloured green; to 18762 Da, 
purple; to 18918 Da; blue.  No unique peptides from the 18585 Da MUP were observed. 
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Figure 3.29 M. spicilegus MUP peptide mass fingerprinting of a male M. spicilegus 
urine sample. 
The MALDI-ToF-MS spectrum generated from a Lys-C in-gel digestion of SDS-PAGE gel 
pieces (Figures 3.2 and 3.7) was searched against a custom made M. spicilegus MUPs 
database using Mascot. The digested protein band from male urine showed peptides that 
matched peptides from M. spicilegus MUPs, the peptide maps of which are shown below 
the spectrum.  In the peptide maps, the coloured peptides are those masses observed in 
the spectrum. The red peptides are those with masses shared between two or more of the 
M. spicilegus MUPs, and peptide masses unique to each MUP are coloured differently to 
one another – peptide masses unique to 18742 Da are coloured green; to 18762 Da, 
purple.  No unique peptides from the 18585 Da or 18918 Da MUPs were observed. 
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Figure 3.30 M. spicilegus MUP peptide mass fingerprinting of a female M. spicilegus 
urine sample. 
The MALDI-ToF-MS spectrum generated from a Lys-C in-gel digestion of SDS-PAGE gel 
pieces (Figures 3.2 and 3.8) was searched against a custom made M. spicilegus MUPs 
database using Mascot. The digested protein band from female urine showed peptides that 
matched peptides from one M. spicilegus MUP, the peptide map of which is shown below 
the spectrum.  In the peptide maps, the blue peptides are those masses observed in the 
spectrum. No peptides from the 18742 Da, 18762 Da or 18585 Da MUPs were observed. 
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3.2.7 Investigating the roles of M. spicilegus MUPs in their behaviour 
The MUP pattern in M. spicilegus, though simpler than in M. m. domesticus, is 
variable between individual males, suggesting that the MUPs do have a degree of 
polymorphism. Whilst inbred laboratory strains of the house mouse exhibit very 
similar MUP expression patterns in their urine, which is expected since inbreeding 
results in genetically identical mice, this random-bred strain of M. spicilegus 
(particularly males) exhibit variable MUP expression.  When the behavioural studies 
previously conducted with this species are considered, it is possible that the MUPs 
play an important role in either reproductive behaviour, social behaviour, or both.  The 
fact that female M. spicilegus are very aggressive towards each other, yet their MUP 
expression patterns are extremely simple and do not vary between individuals, may 
point to the male-specific MUPs being involved in reproductive behavioural 
characteristics.  As a result, a more in-depth experiment that includes the recovery of 
mouse urine and assessment of MUP expression during different reproductive states 
and social situations would give an insight into the function of M. spicilegus MUPs. 
Three different experiments were set up at the Leahurst campus, where the M. 
spicilegus mice were based, to determine whether contact between males and 
females, breeding between males and females and contact between males caused 
differences in their MUP expression output in the aim of determining a possible role 
of MUPs in their behaviour.  Prior to the experiments, male mice were singly housed 
and female mice were housed with their female siblings.  All had no prior contact with 
the opposite sex as adults. 
Experiment 1 – Contact between male and female mice 
In the first experiment, five non-sibling male/female pairs were placed in large split 
cages, where a mesh barrier was placed between them through which they could 
contact each other, but not gain full access (Figure 3.31).  The male/female pairs 
were housed in this setting for 23 days, with their urine being sampled using the 
recovery method on the day prior to them coming into contact, one day after they 
began contact,  ten days after they began contact and on the final day.  The aim of 
this experiment was to determine whether the mice, particularly males, exhibited 
different MUP expression patterns upon initial contact with a mouse of the opposite 
sex that they had not encountered before, and whether MUP expression patterns 
changed with prolonged contact with the opposite sex. 
   
 84 
 
 Chapter 3: Major Urinary Proteins in Mus spicilegus 
All urine samples were frozen upon collection until further analysis.  All samples 
recovered from male mice were analysed for the presence and relative abundance of 
MUPs using SDS-PAGE, and samples were then analysed using ESI-MS to provide 
an insight into the relevant amounts of each MUP expressed at each stage of the 
experiment.  If there was sample remaining, protein and creatinine assays were 
carried out to confirm the changing concentration of protein in the urine.  All samples 
recovered from female mice were initially subjected to SDS-PAGE analysis, and upon 
initial ESI-MS analyses of female urine, it was determined that the amount of MUP in 
the majority of female samples was too low to be detected. 
All five paired female mice showed no difference in their urinary protein output during 
the course of the contact experiment, as assessed by SDS-PAGE (Figure 3.32).  All 
show a very low intensity band on the SDS-PAGE gels at approximately 20 kDa, 
which from previous analyses is the 18918 Da MUP.  In male samples, MUP 
expression patterns were similar between individuals prior to contact with their female 
pair, but differed between individuals in terms of the amount of MUP expressed.  The 
male-specific 18742 Da and 18762 Da MUPs were identified in the urine of most 
males prior to female contact, with the male-specific 18585 Da and non-sex specific 
18918 Da MUPs in two of the male samples obtained prior to contact.  The intensity 
of the MUP bands in SDS-PAGE gave an indication of the amount of MUP present in 
the samples, confirmed by the calculation of protein:creatinine ratios (Figure 3.33 – 
3.37).  In four of the five males, MUP output increased upon contact with the female 
(after one day of contact) and had increased further after ten days of contact.  One 
male, however, expressed less MUP when urine was collected on the final day of the 
experiment (Figure 3.34). ESI-MS analysis enabled the identification of differing MUP 
expression patterns in different samples, quantifying MUPs relative to the others in 
the sample.  Of particular interest is the significant increase of the male-specific 18762 
Da MUP upon continuing contact with a female – prior to contact with females, and in 
all other intact mass analyses of male urine until this point, the most abundant MUP 
relative to the others has always been the male-specific 18742 Da MUP (usually the 
18762 Da MUP is only approximately 20 – 50% of the intensity of the 18742 Da MUP 
in ESI-MS spectra).  As the time in contact with females increases, the male 
expression of the 18762 Da MUP increased (Figures 3.33 – 3.37).  In ESI-MS data 
analysis, the MaxENT 1 function (based on maximum entropy) measures the 
relatively quantitative intensities of the sample components by summing the peak 
intensities from the original multiply-charged spectra, and this is represented by the 
area under the molecular weight peak in the processed spectra (Cottrell and Green  
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Figure 3.31 Set-up of Experiment 1. 
Set-up of Experiment 1 – Contact between male and female mice.  Urine samples were 
taken from a singly-housed male and an unrelated group-housed female before the pair 
were housed in a split cage, separated by a mesh barrier which allowed contact between 
the male and female, but not full physical access to one another.  Male and female pairs 
were housed in the split cages for 23 days, with urine collected from mice on days 1, 10 
and 23 of contact. 
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Figure 3.32 SDS-PAGE analysis of female M. spicilegus urine.  
Urine (5 μl) from a female M. spicilegus, taken prior to contact with the male, one day after 
contact began, after ten days of contact and on the final day of contact, was mixed 1:1 with 
sample buffer, loaded onto a 15% SDS gel and resolved by SDS-PAGE. The gel was 
stained with Coomassie blue to visualise the proteins. The very low intensity MUP bands 
at approximately 20 kDa are highlighted in red. 
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Figure 3.33 SDS-PAGE and ESI-MS analyses of male M. spicilegus urine.  
Urine (5 μl) from a male M. spicilegus, taken prior to contact with the female, one day after 
contact began, after ten days of contact and on the final day of contact.  (a) Urine was 
mixed 1:1 with sample buffer, loaded onto a 15% SDS gel and resolved by SDS-PAGE. 
The gel was stained with Coomassie blue to visualise the proteins. MUPs are seen at 
approximately 20 kDa. (b) Urinary protein and creatinine concentrations were measured 
as described in Chapter 2, and protein:creatinine ratio calculations to correct for urine 
dilution.  (c) Accurate molecular weights of the MUPs present in the SDS-PAGE bands 
were identified by ESI-MS. Urine samples were diluted 1:2 into 0.1% formic acid. Samples 
were injected onto a C4 desalting trap and the masses of the proteins of interest at 
approximately 20 kDa were determined by ESI-MS. Data was processed using maximum 
entropy software MAX ENT1 (MassLynx 4.1, Waters).   
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Figure 3.34 SDS-PAGE and ESI-MS analyses of male M. spicilegus urine.  
Urine (5 μl) from a male M. spicilegus, taken prior to contact with the female, one day after 
contact began, after ten days of contact and on the final day of contact.  (a) Urine was 
mixed 1:1 with sample buffer, loaded onto a 15% SDS gel and resolved by SDS-PAGE. 
The gel was stained with Coomassie blue to visualise the proteins. MUPs are seen at 
approximately 20 kDa. (b) Urinary protein and creatinine concentrations were measured 
as described in Chapter 2, and protein:creatinine ratio calculations to correct for urine 
dilution.  (c) Accurate molecular weights of the MUPs present in the SDS-PAGE bands 
were identified by ESI-MS. Urine samples were diluted 1:2 into 0.1% formic acid. Samples 
were injected onto a C4 desalting trap and the masses of the proteins of interest at 
approximately 20 kDa were determined by ESI-MS. Data was processed using maximum 
entropy software MAX ENT1 (MassLynx 3.1, Waters).   
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Figure 3.35 SDS-PAGE and ESI-MS analyses of male M. spicilegus urine.  
Urine (5 μl) from a male M. spicilegus, taken prior to contact with the female, one day after 
contact began, after ten days of contact and on the final day of contact.  (a) Urine was 
mixed 1:1 with sample buffer, loaded onto a 15% SDS gel and resolved by SDS-PAGE. 
The gel was stained with Coomassie blue to visualise the proteins. MUPs are seen at 
approximately 20 kDa. (b) Urinary protein and creatinine concentrations were measured 
as described in Chapter 2, and protein:creatinine ratio calculations to correct for urine 
dilution.  (c) Accurate molecular weights of the MUPs present in the SDS-PAGE bands 
were identified by ESI-MS. Urine samples were diluted 1:2 into 0.1% formic acid. Samples 
were injected onto a C4 desalting trap and the masses of the proteins of interest at 
approximately 20 kDa were determined by ESI-MS. Data was processed using maximum 
entropy software MAX ENT1 (MassLynx 4.1, Waters).   
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Figure 3.36 SDS-PAGE and ESI-MS analyses of male M. spicilegus urine.  
Urine (5 μl) from a male M. spicilegus, taken prior to contact with the female, one day after 
contact began, after ten days of contact and on the final day of contact.  (a) Urine was 
mixed 1:1 with sample buffer, loaded onto a 15% SDS gel and resolved by SDS-PAGE. 
The gel was stained with Coomassie blue to visualise the proteins. MUPs are seen at 
approximately 20 kDa. (b) Urinary protein and creatinine concentrations were measured 
as described in Chapter 2, and protein:creatinine ratio calculations to correct for urine 
dilution (NS = not enough sample for protein and creatinine assays).  (c) Accurate 
molecular weights of the MUPs present in the SDS-PAGE bands were identified by ESI-
MS. Urine samples were diluted 1:2 into 0.1% formic acid. Samples were injected onto a 
C4 desalting trap and the masses of the proteins of interest at approximately 20 kDa were 
determined by ESI-MS. Data was processed using maximum entropy software MAX ENT1 
(MassLynx 4.1, Waters).   
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Figure 3.37 SDS-PAGE and ESI-MS analyses of male M. spicilegus urine.  
Urine (5 μl) from a male M. spicilegus, taken prior to contact with the female, one day after 
contact began, after ten days of contact and on the final day of contact.  (a) Urine was 
mixed 1:1 with sample buffer, loaded onto a 15% SDS gel and resolved by SDS-PAGE. 
The gel was stained with Coomassie blue to visualise the proteins. MUPs are seen at 
approximately 20 kDa. (b) Urinary protein and creatinine concentrations were measured 
as described in Chapter 2, and protein:creatinine ratio calculations to correct for urine 
dilution.  (c) Accurate molecular weights of the MUPs present in the SDS-PAGE bands 
were identified by ESI-MS. Urine samples were diluted 1:2 into 0.1% formic acid. Samples 
were injected onto a C4 desalting trap and the masses of the proteins of interest at 
approximately 20 kDa were determined by ESI-MS. Data was processed using maximum 
entropy software MAX ENT1 (MassLynx 4.1, Waters).   
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Figure 3.38 Summary of the analyses of M. spicilegus urine from male mice in 
Experiment 1.  
Top left: The average protein:creatinine ratios calculated for the urine samples from each 
of the five males at each sample collection point (error bars ± SD). Data points for each 
sample are shown.  Top right: The ~20 kDa region (MUP bands) of the SDS-PAGE analysis 
of the urine from each of the five males.  Bottom left: The average total peak area of all M. 
spicilegus MUP peaks in ESI-MS analysis (error bars ± SD). MUP peak areas (providing a 
relative quantification) observed in each of the ESI-MS spectra were calculated using 
MaxENT software and summed for each sample. Data points for each sample are shown. 
Bottom right: The average peak areas of each M. spicilegus MUP peak in the ESI-MS 
analysis (error bars ± SD). The peak area of each MUP peak in each spectrum were 
calculated using MaxENT software.  For each male urine sample, the MUP peak areas 
were expressed as a percentage of the maximum MUP peak area. 
   
 98 
 
 Chapter 3: Major Urinary Proteins in Mus spicilegus 
 
 
 
 
  
   
 99 
 
 Chapter 3: Major Urinary Proteins in Mus spicilegus 
1998).  Figure 3.38 shows that the total MUP peak area increases in each male 
sample as time in contact with a female increases up until day 10 of contact, yet 
decreases slightly by day 23 of contact.  Upon contact with females, the amount of 
the 18762 Da MUP (relative to the other MUPs in the sample) increases in all male 
urine samples, and remains the most abundant MUP throughout the experiment 
(Figure 3.38).  The increase in the amount of 18762 Da MUP expressed with female 
contact compared to the amount expressed before contact was not significant (Welch 
t-test, p = 0.99), and the decrease in the 18742 Da MUP expressed with female 
contact compared to before contact was also not significant (Welch t-test, p = 0.32). 
Experiment 2 – Breeding between male and female mice 
In the second experiment, five non-sibling male/female pairs were placed in large split 
cages, where initially a mesh barrier was placed between them through which they 
could contact each other (Figure 3.39).  The male/female pairs were housed in this 
setting for ten days, with urine samples collected from each animal prior to contact, 
after one day of being in contact and after ten days of contact.  On the tenth day, the 
contact barrier was removed to allow the pairs to live together, giving them the 
opportunity to interact and mate, for a further seven days, after which a final urine 
sample was recovered from each animal.  The aim of this experiment was to 
determine whether the mice, particularly males, exhibited altered MUP expression 
patterns upon complete physical contact and possible mating with the opposite sex, 
compared to through-barrier contact.  Out of the five male/female pairs, three of them 
reproduced. 
All urine samples were frozen upon collection until required for analysis.  All samples 
recovered from male mice were analysed for the presence and relative abundance of 
MUPs using SDS-PAGE.  Samples were then analysed using ESI-MS to provide an 
insight into the relevant amounts of each MUP expressed at each stage of the 
experiment.  If there was sample remaining, protein and creatinine assays were 
carried out to confirm the changing concentration of protein in the urine.  All samples 
recovered from female mice were initially subjected to SDS-PAGE analysis, and upon 
initial ESI-MS analyses of female urine, it was determined that the amount of MUP in 
the majority of female samples was too low to be detected. 
SDS-PAGE analysis showed that all five paired female mice showed no difference in 
their urinary protein output during the course of the contact experiment.  The majority 
of all collected female urine samples show a very low intensity band on the SDS-  
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Figure 3.39 Set-up of Experiment 2. 
Set-up of Experiment 2 – Breeding between male and female mice.  Urine samples were 
taken from a singly-housed male and an unrelated group-housed female before the pair 
were housed in a split cage, separated by a mesh barrier which allowed contact between 
the male and female, but not full physical access to one another.  Male and female pairs 
were housed in the split cages for 10 days, with urine collected from mice on days 1 and 
10 of contact.  On day 10, the mesh barrier was removed, and male/female pairs lived 
together, able to interact and mate, for a further 7 days.  A final urine sample was taken 
from each animal on the final day of the experiment (Day 17). 
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PAGE gels at approximately 20 kDa, which from previous analyses is the 18918 Da 
MUP.  In male samples, MUP expression patterns were variable between individuals 
prior to contact with their female pair as well as differing between individuals in terms 
of the amount of MUP expressed.  The male-specific 18742 Da and 18762 Da MUPs 
were identified in the urine of all males prior to female contact, with the non sex 
specific 18918 Da MUPs in four of the male samples obtained prior to contact.  The 
intensity of the MUP bands in SDS-PAGE gave an indication of the amount of MUP 
present in the samples, confirmed by the calculation of protein:creatinine ratios 
(Figures 3.40 – 3.44).  In three of the males, urinary MUP output increased 
immediately upon contact with the female (after one day of contact) and all five males 
increased MUP output after ten days of contact. All males expressed less MUP when 
urine was collected on the final day of the experiment, after being put together to 
interact and mate, with three out of the five males expressing substantially less MUP.  
Protein and creatinine assays confirmed that protein was present in these urine 
samples, indicating that MUP expression had been significantly reduced (Figures 
3.40 – 3.44).  Again, of particular interest is the significant increase of the male-
specific 18762 Da MUP upon continuing contact with a female – this was observed in 
the samples from all five males, and of further interest is the fact that this MUP was 
reduced in expression after complete contact/breeding.  Again, as the time in contact 
with females increases, the male expression of the 18762 Da MUP increases (Figures 
3.40 – 3.44), and after complete contact/breeding, reduces again to amounts similar 
to those seen in the urine taken prior to female contact.  Figure 3.45 confirms that the 
total MUP peak area increases in each male sample as time in contact with a female 
increases up until day 10 of contact, and decreases after complete contact/breeding.  
Upon contact with females, the amount of the 18762 Da MUP (relative to the other 
MUPs in the sample) increases in all male urine samples, and remains the most 
abundant MUP throughout contact, with the amount of the 18742 Da MUP 
decreasing.  After complete contact/breeding, the expression of these two MUPs 
return to that identified in the urine prior to female contact (Figure 3.45). 
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Figure 3.40 SDS-PAGE and ESI-MS analyses of male M. spicilegus urine.  
Urine (5 μl) from a male M. spicilegus, taken prior to contact with the female, one day after 
contact began, after ten days of contact and after being put together for breeding.  (a) Urine 
was mixed 1:1 with sample buffer, loaded onto a 15% SDS gel and resolved by SDS-
PAGE. The gel was stained with Coomassie blue to visualise the proteins. MUPs are seen 
at approximately 20 kDa. (b) Urinary protein and creatinine concentrations were measured 
as described in Chapter 2, and protein:creatinine ratio calculations to correct for urine 
dilution.  (c) Accurate molecular weights of the MUPs present in the SDS-PAGE bands 
were identified by ESI-MS. Urine samples were diluted 1:2 into 0.1% formic acid. Samples 
were injected onto a C4 desalting trap and the masses of the proteins of interest at 
approximately 20 kDa were determined by ESI-MS. Data was processed using maximum 
entropy software MAX ENT1 (MassLynx 4.1, Waters).   
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Figure 3.41 SDS-PAGE and ESI-MS analyses of male Mus spicilegus urine.  
Urine (5 μl) from a male Mus spicilegus, taken prior to contact with the female, one day after contact 
began, after ten days of contact and after being put together for breeding.  (a) Urine was mixed 1:1 
with sample buffer, loaded onto a 15% SDS gel and resolved by SDS-PAGE. The gel was stained 
with Coomassie blue to visualise the proteins. MUPs are seen at approximately 20 kDa. (b) Urinary 
protein and creatinine concentrations were measured as described in Chapter 2, and 
protein:creatinine ratio calculations to correct for urine dilution.  (c) Accurate molecular weights of 
the MUPs present in the SDS-PAGE bands were identified by ESI-MS. Urine samples were diluted 
1:2 into 0.1% formic acid. Samples were injected onto a C4 desalting trap and the masses of the 
proteins of interest at approximately 20 kDa were determined by ESI-MS. Data was processed using 
maximum entropy software MAX ENT1 (MassLynx 4.1, Waters).   
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Figure 3.42 SDS-PAGE and ESI-MS analyses of male M. spicilegus urine.  
Urine (5 μl) from a male M. spicilegus, taken prior to contact with the female, one day after 
contact began, after ten days of contact and after being put together for breeding.  (a) Urine 
was mixed 1:1 with sample buffer, loaded onto a 15% SDS gel and resolved by SDS-
PAGE. The gel was stained with Coomassie blue to visualise the proteins. MUPs are seen 
at approximately 20 kDa. (b) Urinary protein and creatinine concentrations were measured 
as described in Chapter 2, and protein:creatinine ratio calculations to correct for urine 
dilution.  (c) Accurate molecular weights of the MUPs present in the SDS-PAGE bands 
were identified by ESI-MS. Urine samples were diluted 1:2 into 0.1% formic acid. Samples 
were injected onto a C4 desalting trap and the masses of the proteins of interest at 
approximately 20 kDa were determined by ESI-MS. Data was processed using maximum 
entropy software MAX ENT1 (MassLynx 4.1, Waters).   
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Figure 3.43 SDS-PAGE and ESI-MS analyses of male M. spicilegus urine.  
Urine (5 μl) from a male M. spicilegus, taken prior to contact with the female, one day after 
contact began, after ten days of contact and after being put together for breeding.  (a) 
Urine was mixed 1:1 with sample buffer, loaded onto a 15% SDS gel and resolved by SDS-
PAGE. The gel was stained with Coomassie blue to visualise the proteins. MUPs are seen 
at approximately 20 kDa. (b) Urinary protein and creatinine concentrations were measured 
as described in Chapter 2, and protein:creatinine ratio calculations to correct for urine 
dilution.  (c) Accurate molecular weights of the MUPs present in the SDS-PAGE bands 
were identified by ESI-MS. Urine samples were diluted 1:2 into 0.1% formic acid. Samples 
were injected onto a C4 desalting trap and the masses of the proteins of interest at 
approximately 20 kDa were determined by ESI-MS. Data was processed using maximum 
entropy software MAX ENT1 (MassLynx 4.1, Waters).   
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Figure 3.44 SDS-PAGE and ESI-MS analyses of male M. spicilegus urine.  
Urine (5 μl) from a male M. spicilegus, taken prior to contact with the female, one day after 
contact began, after ten days of contact and after being put together for breeding.  (a) Urine 
was mixed 1:1 with sample buffer, loaded onto a 15% SDS gel and resolved by SDS-
PAGE. The gel was stained with Coomassie blue to visualise the proteins. MUPs are seen 
at approximately 20 kDa. (b) Urinary protein and creatinine concentrations were measured 
as described in Chapter 2, and protein:creatinine ratio calculations to correct for urine 
dilution.  (c) Accurate molecular weights of the MUPs present in the SDS-PAGE bands 
were identified by ESI-MS. Urine samples were diluted 1:2 into 0.1% formic acid. Samples 
were injected onto a C4 desalting trap and the masses of the proteins of interest at 
approximately 20 kDa were determined by ESI-MS. Data was processed using maximum 
entropy software MAX ENT1 (MassLynx 4.1, Waters).   
   
 111 
 
 Chapter 3: Major Urinary Proteins in Mus spicilegus 
 
 
 
  
   
 112 
 
 Chapter 3: Major Urinary Proteins in Mus spicilegus 
 
 
 
 
  
Figure 3.45 Summary of the analyses of M. spicilegus urine from male mice in 
Experiment 2.  
Top left: The average protein:creatinine ratios calculated for the urine samples from each 
of the five males at each sample collection point (error bars ± SD). Data points for each 
sample are shown.  Top right: The ~20 kDa region (MUP bands) of the SDS-PAGE analysis 
of the urine from each of the five males.  Bottom left: The average total peak area of all M. 
spicilegus MUP peaks in ESI-MS analysis (error bars ± SD). MUP peak areas (providing a 
relative quantification) observed in each of the ESI-MS spectra were calculated using 
MaxENT software and summed for each sample. Data points for each sample are shown. 
Bottom right: The average peak areas of each M. spicilegus MUP peak in the ESI-MS 
analysis (error bars ± SD). The peak area of each MUP peak in each spectrum were 
calculated using MaxENT software.  For each male urine sample, the MUP peak areas 
were expressed as a percentage of the maximum MUP peak area. 
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Experiment 3 – Contact and interactions between male/male pairs 
In the final experiment, six non-sibling male/male pairs were placed in large split 
cages, where a mesh barrier was placed between them which they could contact 
each other through, but not gain full access to each other (Figure 3.46).  The 
male/male pairs were housed in this setting for 12 days, however only three pairs 
were kept in this setting successfully for this time – three of the pairs managed to 
displace the barriers between them at various times.  For the remaining three pairs, 
after 12 days of being housed in contact, they were observed interacting with each 
other with no barrier between them, to make note of any dominant behaviour exhibited 
by any of the animals.  These controlled interactions took place for ten minutes each 
day for the following three days.  Following the final interaction, the bedding from their 
cages was removed and replaced with paper to collect and view their scent marks, 
with the contact barrier remaining between them.  The urine of these three male/male 
pairs was sampled using the recovery method on the day prior to them coming into 
contact, one day after they began contact, 12 days after they began contact (prior to 
controlled interactions) and on the final day (after the controlled interactions).  The 
aim of this experiment was to determine whether contact with an unknown male would 
cause a male to alter his own MUP expression, possibly to express dominance, and 
the behaviour observed and noted during the interactions would allow the 
determination of any link between behaviour and MUP expression.  The collection of 
scent marks would allow us to see any further link between any dominant behaviour, 
dominant scent marking and MUP expression patterns, assuming the scent marking 
behaviour of M. spicilegus was the same as M. m. domesticus (Rich and Hurst 1998; 
1999). 
All urine samples were frozen upon collection until further analysis.  All samples 
recovered from male mice were analysed for the presence and relative abundance of 
MUPs using SDS-PAGE analysis, and samples were then analysed using ESI-MS to 
provide an insight into the relevant amounts of each MUP expressed at each stage 
of the experiment.  Protein and creatinine assays were carried out to confirm the 
changing concentration of protein in the urine.  Scent marking paper was immediately 
collected, viewed under UV light and photographed.  The behaviour observed from 
all mice during the interactions was noted throughout each interaction. 
In the first male/male pair, SDS-PAGE gels indicated that animal A expressed a 
similar amount of MUP during the contact period as it did prior to contact to the  
 
   
 115 
 
 Chapter 3: Major Urinary Proteins in Mus spicilegus 
 
 
 
 
 
 
 
 
 
Figure 3.46 Set-up of Experiment 3. 
Set-up of Experiment 3 – contact and interaction between male/male pairs.  Urine samples 
were taken from two non-sibling singly-housed males before the pair were housed in a split 
cage, separated by a mesh barrier which allowed contact between the males, but not full 
physical access to one another.  Pairs were housed in the split cages for 12 days, with urine 
collected from mice on days 1 and 12 of contact.  On days 13 – 15 of contact, males were 
allowed to interact in a handling bin for 10 minutes daily.  A final urine sample and scent 
marks were taken from each animal on the final day of the experiment (Day 15). 
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unknown male.  Animal B expressed less MUP than animal A in general, but 
expressed an increasing amount of MUP after 12 days of contact with animal A.  This 
was confirmed by the calculated protein:creatinine ratios in each of these samples 
(Figure 3.47).  ESI-MS showed that the two males had similar MUP expression 
profiles prior to their contact, and whilst the MUP expression pattern of animal A 
remained fairly similar up until the interactions took place, animal B appeared to 
express increased amounts of the 18762 Da MUP after 12 days of contact (Figure 
3.48).  During the first interaction, both A and B exhibited investigative behaviour 
(sniffing, approaching) to a similar extent, but animal B exhibited aggressive 
behaviour (chasing, attempting to fight) towards animal A towards the end of the ten 
minute period.  During the second and third interactions, both A and B exhibited 
significant aggressive behaviour towards each other and had to be split up on both 
occasions (Supplementary Material).  When returned to their barrier-split cage, both 
mice deposited many scent marks, with animal A marking close to the barrier and 
animal B marking away from the barrier (Figure 3.49).  The SDS-PAGE analysis 
showed that after interactions, animal A (who previously expressed less MUP) 
expressed significantly more MUP, and animal B, the converse.  This was confirmed 
by ESI-MS, with total MUP peak area increasing significantly in Animal A after 
interactions, and decreasing in Animal B (Figure 3.50).  Animal A expressed more of 
the 18742 Da and 18762 Da MUPs relatively after interactions, and animal B 
expressed less of these MUPs (Figure 3.50). 
In the second male/male pair, SDS-PAGE gels indicated that both animals C and D 
expressed similar amounts of MUP during the contact period as they did prior to 
contact with the unknown male (Figure 3.51).  Animal C expressed slightly less MUP 
after 12 days of contact, but MUP expression increased after the controlled 
interactions.  The levels of expression were confirmed by the calculated 
protein:creatinine ratios in each of these samples (Figure 3.51).  MUP expression 
patterns for both animals were very similar to each other throughout the experiment, 
with little change in MUP expression in each urine sample taken – at no point was the 
expression of the 18762 Da MUP increased significantly, unlike the first male/male 
pair (Figures 3.52 and 3.54).  During the first interaction, both animals C and D 
exhibited investigative behaviour initially, but animal C approached and chased 
animal D, with animal D retreating and trying to avoid animal C.  No aggressive 
behaviour was observed at any point.  During the second interaction, investigative 
behaviour was observed in both animals, with animal C showing more than animal D.  
Animal C was seen to try and climb on top of animal D, and animal D kept avoiding  
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Figure 3.47 SDS-PAGE analysis and protein:creatinine ratios of male M. spicilegus 
urine from the first male/male pair.  
Urine (5 μl) from the first male/male M. spicilegus pair, (male A and male B), taken prior to 
contact with the unfamiliar male, one day after contact began, after 12 days of contact and 
after being put together for controlled interactions. (a) Urine was mixed 1:1 with sample 
buffer, loaded onto a 15% SDS gel and resolved by SDS-PAGE. The gel was stained with 
Coomassie blue to visualise the proteins. MUPs are seen at approximately 20 kDa. (b) 
Urinary protein and creatinine concentrations were measured as described in Chapter 2, 
and protein:creatinine ratio calculations to correct for urine dilution.   
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Figure 3.49 Photographs of male M. spicilegus scent marks deposited by the first 
male/male pair.  
Males A and B were placed on scent marking paper in their barrier-split cage for ten 
minutes.  The paper was recovered and scent marks were visualised under UV light.  
Deposited scent marks fluoresce under UV light and are the light grey areas seen on the 
paper. 
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Figure 3.50 Summary of the analyses of M. spicilegus urine from the first male pair 
in Experiment 3.  
Top: MUP peak areas (providing a relative quantification) observed in each of the ESI-MS 
spectra were calculated using MaxENT software and summed for each sample.  Bottom: 
The average peak areas of each M. spicilegus MUP peak in the ESI-MS analysis of urine 
from Animal A and Animal B. The peak area of each MUP peak in each spectrum were 
calculated using MaxENT software.  For each urine sample, the MUP peak areas were 
expressed as a percentage of the maximum MUP peak area. 
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animal C.  During the final interaction, both mice showed a little investigative 
behaviour but largely ignored each other.  When returned to their barrier-split cage, 
neither animal scent marked (Figure 3.53).  The lack of significant dominant behaviour 
during interactions, lack of scent marking and little change in MUP output and 
expression indicates that changes in MUP output may be related to dominant, 
aggressive behaviour. 
In the third male/male pair, SDS-PAGE gels indicated that animal E expressed very 
little MUP prior to contact with an unknown male, and increased MUP expression 
throughout contact.  MUP expression was increased further after interactions with 
animal F.  Animal F expressed some MUP prior to contact, and showed little 
difference in MUP expression throughout contact and after interactions. Animal F had 
notably higher levels of albumin in all urine samples (Figure 3.55).  ESI-MS spectra 
show that MUP expression patterns by animal E remain fairly similar throughout 
contact, with slight variation in the relative intensity of the 18762 Da MUP (Figures 
3.56 and 3.58).  MUP expression patterns by animal F also remain fairly similar 
throughout contact, with the 18762 Da MUP more intense than the 18742 Da MUP in 
each urine sample (Figure 3.56).  Relative quantification of the MUPs in samples from 
animal F shows that the expression of the 18742 Da and 189818 Da MUPs decreases 
upon contact with animal E (Figure 3.58).  During all three interactions, neither animal 
displayed any aggressive or avoidance behaviour, with investigative behaviour 
displayed during the first interaction, and remaining in close proximity to each other 
for the remainder of the interactions.  When returned to their barrier-split cage, animal 
E scent marked fairly significantly, whilst animal F did not (Figure 3.57).  This, along 
with animal E expressing more urinary MUP after the controlled interactions (Figure 
3.58), suggests a link between MUP output and scent marking behaviour.  The fact 
that MUP expression patterns in both animals did not change significantly throughout 
the contact period/after interactions, and that harmonious behaviour during the 
interactions was observed, suggests that changes in the total amount of MUP 
expressed may be related to dominant behaviour. 
There have not been enough samples to determine a definitive link between MUP 
expression patterns and behavioural characteristics observed between unfamiliar 
male/male pairs, but the fact that the only pair out of the three to show any significant 
changes in the total amount of MUP expressed were the only pair to display 
aggressive behaviour, suggests that the up-regulation of MUPs may be linked to the 
assertion of dominance, whilst the down-regulation of these MUPs may be linked to  
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Figure 3.51 SDS-PAGE analysis and protein:creatinine ratios of male M. spicilegus 
urine from the second male/male pair.  
Urine (5 μl) from the second male/male M. spicilegus pair, (male C and male D), taken prior 
to contact with the unfamiliar male, one day after contact began, after 12 days of contact 
and after being put together for controlled interactions. (a) Urine was mixed 1:1 with sample 
buffer, loaded onto a 15% SDS gel and resolved by SDS-PAGE. The gel was stained with 
Coomassie blue to visualise the proteins. MUPs are seen at approximately 20 kDa. (b) 
Urinary protein and creatinine concentrations were measured as described in Chapter 2, 
and protein:creatinine ratio calculations to correct for urine dilution.   
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Figure 3.53 Photographs of male M. spicilegus scent marks deposited by the second 
male/male pair.  
Males C and D were placed on scent marking paper in their barrier-split cage for ten 
minutes.  The paper was recovered and scent marks were visualised under UV light.  
Deposited scent marks fluoresce under UV light and are the light grey areas seen on the 
paper. 
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Figure 3.54 Summary of the analyses of M. spicilegus urine from the second male 
pair in Experiment 3.  
Top: MUP peak areas (providing a relative quantification) observed in each of the ESI-MS 
spectra were calculated using MaxENT software and summed for each sample.  Bottom: 
The average peak areas of each M. spicilegus MUP peak in the ESI-MS analysis of urine 
from Animal A and Animal B. The peak area of each MUP peak in each spectrum were 
calculated using MaxENT software.  For each urine sample, the MUP peak areas were 
expressed as a percentage of the maximum MUP peak area. 
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submissiveness.  Male MUP expression, particularly the 18762 Da MUP, was also 
seen to increase with contact with a female.  This could suggest a link between MUP 
expression (particularly the 18762 Da MUP) and the attempts of the male to increase 
his attractiveness to a female – possibly through the indication of dominance. 
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Figure 3.55 SDS-PAGE analysis and protein:creatinine ratios of male M. spicilegus 
urine from the third male/male pair.  
Urine (5 μl) from the third male/male M. spicilegus pair, (male E and male F), taken prior 
to contact with the unfamiliar male, one day after contact began, after 12 days of contact 
and after being put together for controlled interactions. (a) Urine was mixed 1:1 with sample 
buffer, loaded onto a 15% SDS gel and resolved by SDS-PAGE. The gel was stained with 
Coomassie blue to visualise the proteins. MUPs are seen at approximately 20 kDa. (b) 
Urinary protein and creatinine concentrations were measured as described in Chapter 2, 
and protein:creatinine ratio calculations to correct for urine dilution.   
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Figure 3.57 Photographs of male M. spicilegus scent marks deposited by the third 
male/male pair.  
Males E and F were placed on scent marking paper in their barrier-split cage for ten 
minutes.  The paper was recovered and scent marks were visualised under UV light.  
Deposited scent marks fluoresce under UV light and are the light grey areas seen on the 
paper. 
   
 130 
 
 Chapter 3: Major Urinary Proteins in Mus spicilegus 
 
 
 
 
 
  
Figure 3.58 Summary of the analyses of M. spicilegus urine from the third male pair 
in Experiment 3.  
Top: MUP peak areas (providing a relative quantification) observed in each of the ESI-MS 
spectra were calculated using MaxENT software and summed for each sample.  Bottom: 
The average peak areas of each M. spicilegus MUP peak in the ESI-MS analysis of urine 
from Animal A and Animal B. The peak area of each MUP peak in each spectrum were 
calculated using MaxENT software.  For each urine sample, the MUP peak areas were 
expressed as a percentage of the maximum MUP peak area. 
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3.3 Conclusions 
Four major urinary proteins were identified and sequenced in the urine of M. 
spicilegus mice in the absence of genomic data.  Male mice expressed more MUP in 
their urine than female mice, with the amount of MUP expressed by different males 
varying quite significantly – urinary protein:creatinine mass concentration ratios in 
singly housed males with no previous adult contact with other males or females 
ranged from 0.3 – 1.3; the urinary protein:creatinine concentration ratios in males 
contacting/interacting with other males or females ranged from 0.4 – 12.5.  The 
amount of MUP expressed appeared almost identical amongst females.   
In male mice, MUP expression patterns also varied between individuals.  All male 
mice expressed the 18742 Da and 18762 Da MUPs in their urine; some also 
expressed the 18585 Da MUP, and some expressed the 18918 Da MUP (Figure 
3.59).  All female urine samples that contained enough MUP for ESI-MS analysis only 
contained the 18918 Da MUP. There was no evidence of the 18742 Da, 18762 Da 
and 18585 Da MUPs in any female urine sample (Figure 3.5).  For this reason, it was 
likely that these three MUPs were male specific, whilst the 18918 Da, seen in both 
male and female urine samples, was not sex specific.  The molecular weights of the 
four identified M. spicilegus MUPs did not match the molecular weights of any 
previously identified M. m. domesticus MUPs, therefore further analysis was needed 
to identify the sequences of the M. spicilegus MUPs. 
Further mass spectrometric analysis confirmed numerous similarities between the 
peptide mass fingerprints of M. spicilegus MUPs and known M. m. domesticus MUPs 
(Figures 3.6 – 3.9).  In the peptide mass fingerprints of the two distinct MUP bands 
observed in the SDS-PAGE gels of male urine, there were many similarities between 
the two bands, and upon database searching, many of the observed peptide masses 
matched to those of central M. m. domesticus MUPs.  In the peptide mass fingerprints 
of the MUP band observed in the SDS-PAGE gels of female urine, there were minimal 
similarities between the female and male spectra.  Database searches matched many 
of the peptides in the female MUP band to those of peripheral M. m domesticus 
MUPs.  From these analyses, it was determined that the non sex specific 18918 Da 
MUP was similar in sequence to peripheral M. m. domesticus MUPs, and that the 
male specific 18742 Da, 18762 Da and 18585 Da MUPs were similar in sequence to 
central M. m. domesticus MUPs. 
The male specific MUPs 18742 Da and 18762 Da were successfully separated using 
strong anion exchange chromatography for de novo sequencing analysis.  Both of  
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Figure 3.59 Summary of MUP expression patterns in male M. spicilegus urine.  
Accurate molecular weights of the MUPs in M. spicilegus urine from six different males was 
determined by ESI-MS. Urine samples were desalted as described in Chapter 2 and diluted 
1:2 into 0.1% formic acid. Samples were injected onto a C4 desalting trap and the masses 
of the proteins of interest at approximately 20 kDa were determined by ESI-MS. Data was 
processed using maximum entropy software MAX ENT1 (MassLynx 4.1, Waters).  All 
males were singly housed with no previous adult contact with other males/females when 
urine samples were recovered. 
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these MUPs were present in the 18585 Da MUP fraction, but sequencing the two 
purified MUPs first allowed definitive sequencing of the 18585 Da MUP.  The use of 
two proteases provided overlapping peptide sequence information, and de novo 
sequencing was using PEAKS software.  The peptide sequence data produced by 
the software was usually high quality with high confidence scores.  The non-sex 
specific 18918 Da could not be purified by SAX chromatography due to its 
consistently low concentrations in both male and female urine.  De novo sequencing 
of this MUP was by using low-complexity female urine samples, which was again 
digested using two proteases to produce overlapping sequence information.  
Unfortunately, only the majority of the 18918 Da MUP could be sequenced – no 
MS/MS spectra was observed for a small part of the protein sequence.  The software 
uses a data refinement step which discards low quality spectra and poorly sequenced 
peptides, which may explain this.  Despite manual searching of MS/MS spectra, no 
likely sequence was discovered.  The fact that this MUP was not purified prior to de 
novo sequencing meant care had to be taken to not assign a sequence that ‘fitted’ 
into the rest of the protein sequence mass-wise, as it may have belonged to another 
protein present in the sample.  
For the purposes of sequence alignment, the unsequenced part of the 18918 Da MUP 
was assumed to be the same as the sequence seen in M. m domesticus MUP 6, due 
to the high similarity between the sequences of the two.  This resulted in the MUP 
sequence having a molecular mass 36 Da less than 18918 Da. An amino acid 
substitution gave the protein the correct molecular weight, and this was used for 
sequence alignment.  The three male specific MUPs had sequences highly 
homologous to each other, and the non sex specific MUP shared much less homology 
with the three male specific MUPs.  All M. spicilegus MUPs were aligned with all 21 
M. m. domesticus MUPs and phylogenetic analysis was performed.  It was confirmed 
that the three male specific M. spicilegus MUPs were very similar to central M. m. 
domesticus MUPs, with 18742 Da and 18585 Da MUPs being very similar to the male 
specific M. m. domesticus MUP 7 in particular.  The 18762 Da MUP appears to be 
most similar to M. m domesticus MUPs 13 and 17.  The non sex specific 18918 Da 
MUP is very similar to the peripheral M. m. domesticus MUP 6. 
The presence of male specific MUPs in male urine, along with the variance in MUP 
expression seen in male urine and the similarity of these MUPs to M. m. domesticus 
MUPs, suggested that these MUPs may have a functional role in the unusual sexual 
and social behaviour observed in M. spicilegus, recorded in previous literature.  Three 
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different experiments were set up at the Leahurst campus to determine whether 
contact between males and females, breeding between males and females and 
contact between males caused differences in their MUP expression output in the aim 
of determining a possible role of MUPs in their behaviour.  Female mice did not alter 
their MUP expression upon contact with male mice, but male mice increased their 
MUP expression fairly significantly upon contact with females.  Of particular interest 
was the apparent increase in male specific 18762 Da MUP expression in male urine 
upon contact with females, indicating that this MUP may play a role in the attraction 
of females.  After male and female pairs were put together for breeding, all five males 
reduced their MUP expression, three of them significantly, including that of the 18762 
Da MUP.  Again, female MUP expression did not appear to change.  In male/male 
pairs, the only pair of mice that appeared to significantly alter their MUP output during 
contact and after interactions were the mice that displayed significant aggressive 
behaviour during the interactions.  One male in this pair, after interactions, 
significantly increased their MUP output; the other male significantly reduced their 
MUP output after interactions, along with their expression of the male-specific 18742 
Da and 18762 Da MUPs, suggesting that increased MUP output (especially of these 
two male-specific MUPs) may also have a role in signalling dominance.  More of these 
experiments need to be undertaken to definitively link male MUP expression and 
dominant behaviour.  These experiments only gave a brief insight into the possible 
roles of M. spicilegus MUPs, in particular the male-specific MUPs, due to the relatively 
small number of animals sampled.  There does, however, seem to be a fairly 
noticeable link between male MUP expression and contact with females, as well as 
male MUP output and aggressive behaviour amongst males.   
Even though the male specific MUPs, which are those of particular interest in terms 
of possible roles in M. spicilegus behaviour, have been fully sequenced, it would be 
beneficial to obtain full accurate sequence information for the 18918 Da MUP.  An 
alternative mass spectrometric method, such as electron transfer dissociation (ETD), 
may provide additional sequence coverage, or the development of a SAX 
chromatography method that provides better resolution of MUPs may allow the 18918 
Da MUP to be purified from male urine, where MUP concentration is higher than in 
female urine.  This would allow the possibility of producing recombinant versions of 
all four M. spicilegus MUPs to be used in further behavioural experiments, for 
example, are female mice attracted to the male specific MUPs? Are they more 
attracted to the 18762 Da MUP than the others? Do these MUPs promote aggressive 
behaviour in male mice? Does the 18918 Da MUP, seen in both sexes, elicit a 
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response in male or female mice?  Answers to these questions would build 
significantly on the behavioural experiments conducted in this Chapter, providing a 
deeper insight into the unusual social and sexual behaviours this species has been 
found to exhibit. Further studies into the interactions of M. spicilegus MUPs with 
volatile pheromonal components in urine may also provide information on the roles of 
these MUPs in M. spicilegus behaviour. 
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Chapter 4: Communal nursing in the house mouse 
 
4.1 Introduction 
4.1.1 Communal nursing 
Communal care, the sharing of parental responsibilities between multiple individuals, 
is common in many animals, including rodents (Gittleman 1985; Jennisons & 
MacDonald 1994; Emlen 1995; Hayes 2000).  Communal nesting is a form of 
communal care where multiple females raise their offspring in the same nest, usually 
formed by groups of females residing and giving birth in one male’s territory (Manning 
et al. 1995; Weber & Olsson 2008). Some communally nesting mammals also exhibit 
communal nursing, which is the sharing of milk with non-offspring (Packer et al. 1992).  
Female house mice communally nurse offspring in communal nests, in wild, semi-
wild and laboratory environments (Wilkinson & Baker 1988; Konig 1994; Manning et 
al. 1995).  This has led to many hypotheses being formed as to whether communal 
nursing is beneficial to mothers or offspring. Lactation involves high energetic costs 
and influences a mother’s future reproduction, so it is unlikely that females provide 
milk to non-offspring without advantage (Konig et al. 1988; Hayes 2000). 
Hayes (2000) reviewed hypotheses that have been formulated regarding the benefits 
and costs of communal nesting and nursing in rodents, including the likelihood that 
communal nursing increases reproductive success and provides fitness benefits, with 
increased pup survival, growth and weaning weights, group defence and 
thermoregulation (Gittleman 1985; Konig 1994).  Hypotheses also suggest that 
communal nursing is a means by which females can be rid of excess milk that may 
cause discomfort.  Despite this, along with the energetic cost of communal nursing, 
other possible disadvantages include food competition, increased visibility to 
predators and transmission of parasites.  Other non-adaptive arguments include that 
nursing is indiscriminate, and that mothers are unable to prevent milk stealing (Konig 
2006). 
Konig (2006) was able to reject the hypothesis that milk stealing occurs, as non-
offspring nursing is an integral part of female house mouse behaviour.  Indiscriminate 
nursing can also be rejected, as female house mice are able to breed and nurse 
solitarily despite another female reproducing in the same territory.  The study was 
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able to confirm that communal nursing increased reproductive success, whether or 
not the females were related. It was observed, however, that mutualistic cooperation 
was higher in nests where females were related.  This indicates that kin recognition 
and selection were important during the evolution of communal nursing. 
The fact that kin recognition appears to play a role in communal nursing provides 
further questions, especially since the hypotheses regarding indiscriminate nursing 
and milk stealing have been rejected.  The benefits of communal nursing have been 
outlined, and while female house mice appear to take turns to feed the pups in the 
nest (Wilkinson and Baker, 1998; Konig 1989), it could be that females recognise their 
own young and invest in those more than non-offspring, and it could also be that 
females invest more in the offspring of their closer relatives (i.e. sisters) than their 
more distant relatives (e.g. cousins).  It may be that females do not discriminate 
between their offspring and their non-offspring, and invest cooperatively more in 
larger, healthier pups.  
Previous studies have been primarily based on the time a female spends retrieving 
pups, and on pup weaning weights. Analyses on communal nursing in BALB/c mice 
include age differences in litters nesting communally, survival rate of pups in 
communal nests, and the relatedness of communally nesting mothers. Manning et al. 
(1995) discovered that in communal litters where there was an age difference of 3-4 
days, mothers of the older litters preferentially retrieved their own pups, but the 
mothers of younger litters did not discriminate between their own offspring and alien 
offspring.  In the same paper, Manning describes how pup survival is greater in 
communal nests, with the probability of pup survival to weaning over double that of in 
single nests (69% compared to 33%).  Konig (1994) stated that under natural 
conditions, females sharing a nest are often related and their pups typically have the 
same father, meaning it his highly likely that females nurse closely related offspring 
when nesting with a familiar female.  Whilst familiar females (regardless of 
relatedness) nesting communally improved female reproduction and pup survival, 
female groups which were familiar and related also produced the largest litters with 
heaviest pups, suggesting that relatedness of females results in increased investment 
in litters. 
 
 
 
 
  
 138 
 
 Chapter 4: Communal nursing in the house mouse 
4.1.2 Metabolic stable isotope labelling 
Since the work of Schoenheimer et al. (1938), it has been realised that proteins in a 
cell are in a dynamic state of turnover, and whilst proteins in a cell or tissue can be 
synthesised at a similar rate, differences in their rate of degradation result in 
differences in steady–state concentrations of these proteins (Claydon et al. 2012).  
Simple proteome turnover studies in isolated cells often take place in minimal media 
with the introduction of labelled amino acids (for example, [13C6] arginine), allowing 
the labelling of all proteins containing that amino acid residue in a sample.  The size 
of the labelled amino acid pool is substantially larger than the intracellular pool, 
meaning proteins are rapidly fully labelled (Claydon et al. 2012).  In more complex 
systems, such as animals, protein turnover studies using stable isotope labelling is 
more difficult: incorporation of the labelled amino acid cannot be instantaneous due 
to the biomass of the animal tissues contributing to the precursor pool, and the 
introduction of labelled amino acid is best done via diet (causing fluctuations in label 
incorporation due to the active/inactive periods spent by an animal).  Different tissues 
are affected differently, in terms of label incorporation, by feeding fluctuations; the 
liver and small intestine are most exposed to labelling variation, whereas tissues such 
as muscle are more metabolically remote and so are less affected by feeding 
fluctuations (Claydon et al. 2012).  Claydon et al. (2012) designed a simple 
experiment to incorporate labelled amino acids into mice via a 50% labelled (therefore 
palatable to the mice, since they find a fully synthetic diet unpalatable) rodent diet, 
using MUPs in urine to monitor the labelling of the liver - after synthesis in the liver, 
MUPs are transported to the kidneys through the bloodstream and excreted in urine 
(Robertson et al. 1998; Beynon and Hurst 2003; Hurst and Beynon 2004). There is 
no evidence of MUP uptake during renal filtration, and so MUPs reflect the properties 
of the precursor RIA in the liver (Armstrong et al. 2005).  This non-invasive sampling 
method would allow the kinetics of the labelling of the liver precursor pool to be 
evaluated. 
This relatively inexpensive and simple experimental technique used for assessing the 
turnover of proteins in mice could, in principle, be used in determining the proportion 
of lactation investment from communally nursing female mice – female mice could be 
fed a labelled diet, and the kinetics of labelling could be determined by mass 
spectrometric analysis of MUPs in urine.  These mice, feeding their pups, should pass 
their labelled proteins onto their pups, which then allows the label to be incorporated 
and tracked in their offspring.  Analysis of stomach contents and tissue samples from 
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pups, nursed by the mice who are fed a labelled diet, will determine whether the label 
is being passed on from the mothers and being incorporated into the pup precursor 
pool. 
4.1.3 Aims 
Whole animal metabolic labelling with stable isotope labelled amino acids can be 
used to determine the proportion of lactation investment from communally nursing 
female house mice and to ascertain any discriminatory factors.  In this study, the aim 
was to introduce a suitably labelled amino acid into the animals via a semi-synthetic 
diet until whole animal metabolic labelling had been reached, and these labelled 
amino acids would be passed on to the offspring through feeding, determining the 
proportion of investment from each mother in the nest. An experiment was set up 
where two female mice nest communally with their new-born pups, and each mother 
has access to a semi-synthetic isotope - labelled diet.  These diets are differently 
labelled, in order to track the different labels in their offspring, and each mother only 
has access to one of these diets. Heavy and light isotopes of the amino acid are 
required as this causes the resultant heavy/light peptides from the proteins expressed 
by the animal to behave the same in mass spectrometry analysis, yet provide a 
reasonable mass difference to differentiate between isotopes for calculation of label 
incorporation. Labelled amino acid incorporation can be assessed in the female mice 
(mothers) by mass spectrometric analysis of MUPs expressed in urine, and analysis 
of the stomach contents of their pups (containing the milk and resultant labelled amino 
acids passed on from the mothers) can be used to ensure the labels have been 
passed on.  Analysis of other pup samples (liver, muscle, urine) can be used to 
determine the proportion of lactation investment from mothers over a period of time.  
Label incorporation, and therefore investment, are observed in litters of pups where 
their mothers are related and in litters where their mothers are unrelated, to assess 
whether any discrimination in investment is evident in relation to relatedness of the 
female pairs in the nest. Weight of pups, litter age differences and litter sizes are also 
considered when assessing label incorporation, aiming to identify whether these 
factors affect the proportion of investment received. 
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4.2 Results and discussion 
 
4.2.1 Successful incorporation of labels into mouse diet 
4.2.1.1 Diet 
To ensure the diets provided to the mice were 50% labelled with [2H8] valine or [13C6] 
lysine, two unlabelled diets (of Certified Rodent Diet 5002) were separately prepared, 
having obtained the percentage of valine and lysine in the diet.  In one diet, [2H8] 
valine was added in an amount to achieve a percentage of 50% labelled valine, and 
in the other diet, [13C6] lysine was added in an amount to achieve 50% labelled lysine. 
The diet was prepared as described in Chapter 2 and the Supplementary Material, 
and fed to mice by Dr J.P. Green at the Mammalian Behaviour and Evolution Group, 
Leahurst Campus, University of Liverpool. 
The initial preparatory experiment for the lactation investment study was to ensure 
the semi-synthetic heavy labelled diets were palatable to adult female mice, in order 
to ensure rapid and complete whole animal metabolic labelling.  Four female BALB/c 
mice were fed either a [13C6] (heavy) lysine or [2H8] (heavy) valine labelled diet, with 
the label incorporated so that the precursor relative isotopic abundance (RIA) should 
be approximately 0.5, over a period of five days.  Precursor RIA values are calculated 
by 
RIA = IH / (IH + IL) 
where IH is the signal intensity displayed by the heavy labelled peptide (calculated by 
summing the intensities of the monoisotopic (M0), M0 + 13C (M1) and M0 + 2 13C (M2) 
isotopic peaks), and IL is the signal intensity of the light (unlabelled) peptide, 
calculated in the same way. The incorporation of the labels into the mice result in all 
proteins in the animal to be 50% either heavy valine or heavy lysine labelled; the rate 
at which a protein reaches a labelling maximum depends on that protein’s rate of 
turnover. The most simple and effective way of assessing label incorporation was 
through the analysis of MUPs present in urine; the fact that MUPs are quantitatively 
excreted in urine would determine whether the diet was being consumed by the mice, 
and how long it would take for labelling of the liver precursor pool to reach a maximum.  
Calculating RIA values in MUPs do not allow determination of protein turnover rates 
as these proteins are simply excreted from the animal, and so do not degrade, but 
these values do allow analysis of the liver precursor pool (Claydon et al. 2012). The 
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rate at which both semi-synthetic diets were consumed by the mice is indicative of 
the diets being found palatable by the mice (Figure 4.1), and should ensure rapid 
labelling of the precursor pool.  As the mice being fed the diet were fully-grown adults, 
their rate of growth is negligible and so this did not need to be factored in when 
calculating the RIA in urinary proteins.  
4.2.1.2 Assessing the rate of label incorporation 
The urine was digested in-solution and analysed using MALDI-ToF-MS as described 
in Chapter 2.  The MUP peptides in the MALDI-ToF-MS spectra of the digested 
mouse urine (Figure 4.2) were identified by searching the MUPs_mature database 
via the Mascot search engine.  Analysing the sequences of each identified MUP 
peptide allowed the identification of valine-containing peptides – all peptides 
contained one lysine residue as endoprotease Lys-C was used as the protease, 
resulting in all peptides being lysine-terminated. Lys-C was chosen as the most 
suitable endoprotease as it gives better peptide coverage of MUPs for MALDI-ToF-
MS analysis (Beynon et al. 2002).  This also ensured that each peptide generated 
from the proteolysis of MUPs contained a lysine residue, resulting in more [13C6] lysine 
labelled peptides for calculating precursor RIAs. 
Four valine-containing peptides were identified in the spectra, two of which were di-
valine peptides (contained two valine residues).  From the ‘light’ (unlabelled) peptide 
masses and the sequence information, the masses of the corresponding ‘heavy’ 
lysine and valine peptides were calculated. For all lysine-containing peptides, the 
mass of the corresponding ‘heavy’ labelled peptide is 6 Da heavier than the ‘light’ 
unlabelled peptide, due to the incorporation of six 13C into the lysine residue. For the 
two single valine-containing peptides, the mass of the corresponding ‘heavy’ peptide 
should be 8 Da heavier due to the incorporation of eight deuterium atoms into the 
valine residue. For the two di-valine peptides, a fully labelled peptide should be 16 Da 
heavier than the ‘light’ unlabelled peptide, as eight deuterium atoms are incorporated 
into each of the valine residues (Table 4.1). 
4.2.1.3 Transamination of [2H8] valine 
During analysis of the mono-valine containing peptides seen in the mass 
spectrometric analysis, it was noted that the corresponding heavy labelled peptide 
was only +7 Da heavier, rather than the expected +8 Da shift. In di–valine peptides, 
a mass shift of +14 Da was seen, rather than the expected +16 Da. In both instances, 
the labelled peptide isotopologue profiles were different to that of the unlabelled  
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Figure 4.1 The consumption of the two different labelled diets. 
Top: The average amount of unlabelled diet consumed by the four mice (two assigned the 
[13C6] lysine labelled diet (left) and two assigned the [2H8] valine labelled diet (right)), over 
the seven day period prior to the introduction of the labelled diets, are shown in blue (error 
± SD, n=7); the average amount of labelled diets consumed by the mice during the five 
day experiment are shown in red (error ± SD, n = 5).  There was no significant difference 
in the amount of unlabelled/ [13C6] lysine labelled diet consumed (Welch two sample t-test: 
t = 0.62, df = 2.14, p = 0.59) or in unlabelled/ [2H8] valine labelled diet (Welch two sample 
t-test: t = 1.06, df = 4.99, p = 0.33).  Bottom: The residual [2H8] valine labelled diet and 
[13C6] labelled diet, each accessed by two mice, was weighed at various intervals during 
the course of the five day experiment. 
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peptides.  The reason for the 7 Da shift (in mono-valine peptides) and the 14 Da shift 
(in di-valine peptides) is because the deuterium atom present on the α-carbon atom 
of [2H8] valine is metabolically labile and is known to transaminate in vivo (Doherty et 
al. 2005).  The reason for the different isotopologue profiles seen in labelled peptides 
is the overlap of the [2H7] valine (+7 Da) and the [2H8] valine (+8 Da) label 
incorporation.  If the +7 Da and +8 Da peptides were observed alone, they would 
have an isotopologue profile identical to the unlabelled peptide. The overlap causes 
the M0 (12C) peak of the +7 Da peptide to appear smaller than expected, with the +8 
Da peptide M0 peak adding to the intensity of the +7 Da M1 (13C) peak, making the M1 
peak more intense. In di-valine peptides, the +14 Da shift is due to the incorporation 
of transaminated ([2H7]) valine into both of the valine residues; the +15 Da shift is due 
to the incorporation of [2H7] valine into one of the valine residues, and the 
incorporation of [2H8] into the other. The +16 Da shift is due to the incorporation of 
[2H8] valine into both valine residues (Figure 4.3). The overlap of these three observed 
peptide shifts causes the different isotopologue profile seen in the doubly-labelled 
valine containing peptides. 
4.2.1.4 Calculation of precursor RIA 
The precursor RIA values were calculated for the two most abundant MUP peptides 
for the mice fed a [13C6] lysine labelled diet, and for the two single valine-containing 
MUP peptides for the mice fed a [2H8] valine labelled diet. Each of the four mice were 
sampled once prior to being fed the labelled diet, and for days 1 and 2 of labelling, all 
four animals were sampled in the morning, afternoon and evening. For days 3-5 of 
labelling, all animals were sampled morning and evening. MS isotope (UCSF) 
(http://prospector.ucsf.edu/prospector/cgi-bin/msform.cgi?form=msisotope) was 
used to calculate the isotopologue profiles for each unlabelled MUP peptide used for 
the calculations, to confirm that the unlabelled and corresponding labelled peptides 
were suitably separated and that the intensities of unlabelled peptide peaks did not 
significantly contaminate the intensities of the labelled peptide peaks. For example, 
for valine containing MUP peptide 2009 Da (AGEYSVTYDGFNTFTIPK), MS isotope 
determined that the +7 Da labelled peptide would only contain 0.05% of the unlabelled 
peptide peak intensity, and that the +8 Da labelled peptide would contain only 0.01% 
of the unlabelled peptide peak intensity.  For the lysine containing MUP peptide 2471 
Da (DGETFQLMGLYGREPDLSSDIK), the labelled peptide (+6 Da shift) would 
contain only 0.68% of the unlabelled peptide peak intensity.  Although the peak  
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Figure 4.3 Light, light/heavy and heavy isotope profile of a MUP peptide containing 
two valine residues, from the urine of a mouse fed [2H8] valine labelled diet. 
The MALDI-ToF-MS spectrum obtained for the di-valine MUP peptide shows the presence 
of the unlabelled (‘light’) peptide, the peptide where one of the two valines is labelled 
(‘light/heavy’), and the fully labelled (‘heavy’) peptide. The + 7 Da shift (rather than + 8 Da 
expected from the labelling of a valine residue) is due to the transamination of the [2H8] 
valine, resulting into the loss of the alpha-carbon deuteron which is replaced by a 
hydrogen. The + 8 Da shift is the labelling of one of the valine residues in the peptide, and 
the + 16 Da shift signifies the labelling of both valine residues in the peptide, with the + 14 
Da and + 15 Da shifts due to the transamination of [2H8] valine. 
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contamination is slightly higher for the lysine containing peptides, it is still negligible 
and will not significantly affect the RIA calculations.   
The unlabelled and corresponding labelled peptide profiles for these two MUP 
peptides, from urine sampled from mice on the morning of day 0 of being fed a 
labelled diet, and urine sampled in the evenings of days 1 – 5 of the mice being fed a 
labelled diet, are shown in Figure 4.4. Figure 4.4 (a) shows the course of how valine 
containing MUP peptide 2009 Da labels over the course of the 6-day experiment, 
obtained from a mouse fed the [2H8] valine diet, and Figure 4.4 (b) shows the same 
but for lysine containing MUP peptide 2471 Da, from the urine of a mouse fed the 
[13C6] lysine diet.  In both peptides, it was noted that both the labelled and unlabelled 
versions showed a different isotopologue profile than would be normally expected, 
where M0 peak is the most intense, with M1 peak slightly less intense and M2 peak 
less intense again.  This ‘normal’ peptide profile was seen in the smaller MUP 
peptides 1568 Da and 1597 Da, and this profile was confirmed using MS isotope 
(UCSF).  When MS isotope was used to analyse the profiles of the larger MUP 
peptides, it confirmed that the isotopologue profiles seen in the MALD-ToF analysis 
(where the 13C (M1) peak is more intense than 12C (M0) peak) is the peptide profile 
expected.  This is because in larger peptides, there is a greater natural abundance of 
13C present than in smaller peptides. 
From the peptide profiles in Figure 4.4, no corresponding labelled proteins are seen 
on day 0, before the mice were fed the labelled diets, as would be expected. Over the 
course of the five labelling days, the abundance of labelled peptide increases each 
day, indicating that the mice are consuming the diets and that both labels are 
incorporating into the mice assigned either the [2H8] valine or [13C6] lysine labelled 
diet. To determine the point at which the precursor pool of the liver had reached its 
labelling plateau, the urine samples from each of the four mice (two of which were fed 
the [2H8] valine diet, the other two fed the [13C6] lysine diet) were collected on the 
morning of day 0, the morning, afternoon and evening of days 1 and 2 of labelling, 
and in the morning and evening of days 3, 4 and 5 of labelling.  No samples were 
taken at night time as this is the time that the mice are inactive ( as this is their ‘day’ 
period).   
Each urine sample collected was subjected to in-solution digestion with Lys-C and 
analysed using MALDI-ToF-MS.  For each of the samples from the two mice fed the 
[2H8] valine diet, the two mono-valine containing MUP peptides were identified in the 
MALDI-ToF-MS spectra, and for each peptide, the intensities of the unlabelled and  
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Figure 4.4 Incorporation of heavy labelled amino acids over the course of 6 days, 
shown by the relative abundances of heavy/light peptide profiles in urine from two 
BALB/c females, (a) fed a diet labelled with [2H8] valine and (b) fed a diet labelled 
with [13C6] lysine. 
Urine samples were taken from the females at intervals over a six-day period. Shown are 
the unlabelled (‘light’) and labelled (‘heavy’) MUP peptide profiles taken from urine 
collected in the morning (Day 0) and evenings of each day for each mouse. The ‘heavy’ 
valine peptide is only 7 Da larger than the light peptide, though the heavy valine label 
involves the incorporation of 8 deuterium atoms in each valine, due to the transamination 
of [2H8] valine. The ‘heavy’ lysine MUP peptide is 6 Da heavier than the light MUP peptide, 
due to the incorporation of six 13C into the lysine residue. 
 
 
  
 149 
 
 Chapter 4: Communal nursing in the house mouse 
  
 
 
  
 150 
 
 Chapter 4: Communal nursing in the house mouse 
labelled peptides were recorded and the RIA for that peptide was calculated using 
the formula stated previously.  From this, an average RIA for each sample at each 
sampling time point (Figure 4.5).  The same method of calculating RIAs was used for 
the samples collected from mice being fed the [13C6] lysine diet, except any two MUP 
peptides could be selected for the analysis due to the use of Lys-C for proteolysis, 
resulting in all peptides being lysine terminated (Figure 4.5). 
Figure 4.5 shows how the calculated RIAs for samples collected in the morning are 
consistently lower than those calculated from the afternoon and evening samples.  
This fluctuation in RIAs is due to the mice being inactive during their ‘day’ period 
overnight, meaning no (or very little) diet will be consumed during this time.  This 
means the degradation of existing unlabelled proteins over this time will be returning 
unlabelled valine/lysine residues to the precursor pool, without any contribution of 
labelled residues from the diet, diluting the proportion of [2H8] valine/[13C6] lysine 
present in the precursor pool and therefore reducing the calculated RIAs. Over time, 
this fluctuation appears to reduce, and this will be due to the fact that some degraded 
proteins will contain the label, returning both labelled and unlabelled residues to the 
precursor pool, reducing the dilution of the label in the pool. Daily RIA averages for 
each animal were then calculated to determine the time taken for each animal to 
appear to have the label fully incorporated (Figure 4.6). A precursor RIA value of 
around 0.5 indicated that the label is fully incorporated into the animal (as the diet is 
50% labelled).  Three of the mice (two fed [2H8] valine diet, one fed [13C6] lysine diet) 
reached a maximum RIA of 0.43, and the fourth mouse (fed [13C6] lysine) reached a 
maximum RIA of 0.45.  These maximum RIAs were calculated from the average RIA 
calculated on the final day of the experiment for each mouse.  The time taken for each 
mouse to have the label fully incorporated varied – for mouse 10903 (fed [2H8] valine), 
it appeared to take between 1 – 2 days for the precursor pool to become fully labelled, 
but for mouse 10904 (also fed [2H8] valine), it seemed to take between 3 - 4 days.  
For the two mice fed [13C6] lysine, mouse 10910 was fully labelled by day 2 of labelling, 
but for mouse 10911, labelling of the precursor pool took slightly longer at 3 days.  
This difference is likely to be due to the difference in the amount of diet consumed by 
the mice, but the experiment confirmed that the mice found the semi-synthetic 
labelled diets palatable and that full labelling of the protein precursor pool had 
happened by 3 – 4 days after the mice had been provided with the labelled diets.  At 
this point, all proteins being synthesised in the liver and all proteins degrading contain 
both labelled and unlabelled valine/lysine, returning an almost equal amount of these 
to the precursor pool, meaning that the labels are fully incorporated into the mice. 
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Figure 4.5 The rate of heavy amino acid incorporation over 6 days in two mice fed 
[2H8] valine labelled diet and two mice fed [13C6] lysine labelled diet. 
Urine samples were taken from the four BALB/c females at various time intervals over the 
six-day period, subjected to in-solution digestion with Lys-C and analysed using MALDI-
ToF-MS. Red points are morning samples, blue are afternoon samples and black are 
evening samples.  The average RIA was calculated from the three most abundant valine-
containing (a) and lysine-containing (b) MUP peptides in each sample.  Average maximum 
RIAs reached for each mouse are shown by a red line. 
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Figure 4.6 The rate of heavy amino acid incorporation over 6 days in two mice fed 
[2H8] valine labelled diet and two mice fed [13C6] lysine labelled diet. 
Urine samples were taken from the four BALB/c females at various time intervals over the 
six-day period, subjected to in-solution digestion with Lys-C and analysed using MALDI-
ToF-MS. An average RIA was calculated from the three most abundant valine-containing 
(a) and lysine-containing (b) peptides for each day, with error bars showing the standard 
deviation calculated for each daily RIA. Average maximum RIAs reached for each mouse 
are shown by a red line. 
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4.2.2 Proof-of-principle 
4.2.2.1 Feeders analysis 
Having confirmed that the method of labelling mice worked successfully, the next step 
was to find a way to have two mice living in the same cage consuming two differently 
labelled diets, without having access to the other diet.  This is so two female mice are 
able to live together and communally nurse their litters, with their investment in the 
pups tracked via the transfer of two different labels from the mothers to the pups.  It 
is essential that the mothers and their litters can live together, but also that the 
mothers have access to only the diet to which they have been assigned.  If they were 
to consume the labelled diet assigned to the other mouse, they would be 
‘contaminated’ with the other label, and so tracking the investment from both mothers 
in their pups would be inaccurate. Professor J.L. Hurst developed a cage that would 
allow a pair of female mice to live and nest together, having unrestricted access to 
their pups, whilst having access to only the labelled diets each individual was 
assigned to.  Figure 4.7 shows the set-up of the housing, where two female mice are 
able to share the same cage space, water, nest box and access to their respective 
diets.  These diets are contained in feeding traps and are positioned at either end of 
the cage. Each female mouse has a subcutaneous RFID chip, and this chip can be 
read by the feeding mechanism.  If, for example, a mouse assigned a [2H8] valine 
labelled diet approaches the correct diet, the feed will remain within the reach of the 
mouse.  If, however, this mouse was to approach the [13C6] lysine labelled diet, the 
feeding mechanism would sense this via the chip carried by the mouse, and would 
subsequently move the diet away from the cage, out of the reach of the mouse. To 
determine whether this mechanism worked successfully, and whether this housing 
set-up would be suitable in allowing pairs of female mice to nest communally yet 
consume differently labelled diets, three pairs of female mice were chipped and 
housed in this situation for five days.  In each of the three cages, the diets placed in 
one of the feeding traps was [2H8] valine, and in the other was [13C6] lysine.  In each 
of the female pairs, one mouse was assigned the [2H8] valine diet, and the other the 
[13C6] lysine diet.  Urine was sampled from each mouse daily over the course of the 
experiment, for the analysis of label in MUPs. 
4.2.2.2 Analysis of MUPs for labelling 
All urine samples were digested in-solution with Lys-C and subjected to MALDI-ToF-
MS analysis.  In each spectrum, the MUP peptides were analysed for the presence 
of the ‘correct’ label (the label arising from the labelled diet which the mouse was  
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Figure 4.7 Diagram showing the feeding mechanism developed at Leahurst. 
(a) Two feeding traps, each containing a different diet, are positioned at each end of the 
cage, with both mice having access to all parts of the cage. (b) Each female mouse has 
an RFID chip implanted in their necks, and this chip can be read by the sensor coil placed 
at the entrance of each feeding mechanism.  If a mouse assigned a [2H8] valine labelled 
diet approaches the correct diet, the feed will remain in reach of the mouse. If the mouse 
was to approach the [13C6] lysine labelled diet, the feeding mechanism would sense this 
via the chip carried by the mouse, and would subsequently move the diet away from the 
cage, out of reach of the mouse.  The data from these sensors are logged, as is the amount 
of time spent in the nestbox by each mouse. 
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assigned) to ensure the mechanism allowed the mouse to access the diet, and also 
the presence of the ‘wrong’ label (the label from the diet which the other mouse in the 
pair was assigned to) to ensure that the feeding trap moved away when the ‘wrong’ 
mouse approached it.  With the two different labelled diets being [2H8] valine and [13C6] 
lysine, there is only a mass difference of 2 Da if both labels were to be observed in a 
single urine sample (the presence of [2H8] valine in the mouse gives a theoretical shift 
of +8 Da of the unlabelled MUP peptide, and the presence of [13C6] lysine gives a shift 
of +6 Da).  Taking into account the transamination of valine, resulting in just a +7 Da 
shift of the unlabelled peptide, the identification of either label in the mass spectra 
must be done very carefully.  It is easier to identify the presence of [13C6] lysine in an 
animal assigned the [2H8] valine diet, because of the peak seen at + 6 Da which would 
not be seen if the animal had consumed only the [2H8] valine diet.  If both labels are 
present in a mouse assigned the [13C6] lysine diet, the two labelled peptides would 
overlap completely. Figure 4.8 shows how this overlap would appear.  However, due 
to the isotopologue profiles observed, both labels could be identified if present in the 
same sample – the 13C peak (M1) of the [13C6] lysine would be significantly more 
intense than expected due to the addition of the 12C peak (M0) of the [2H8] valine, as 
would the 13C2 peak (M2) due to the addition of the 13C peak of [2H8] valine.  This 
change in peptide profile would indicate the presence of both labels in the urine of a 
mouse fed the [13C6] lysine diet. 
4.2.2.3 Calculation of precursor RIAs 
The precursor RIA values were calculated for the two mono-valine containing MUP 
peptides for the mice fed both labelled diets, as in both cases, valine containing and 
lysine containing peptides were required to determine the presence (or absence) of 
either label in all samples.  The use of endoprotease Lys-C for proteolysis prior to 
mass spectrometric analysis resulted in all peptides being lysine-terminated.    
For each mouse, precursor RIAs for each MUP peptide were calculated as before, 
and an average RIA was calculated for each mouse, each day, based on the 
presence of the ‘correct’ label.  This allowed us to see whether the feeding 
mechanism was allowing the mice to reach their assigned diet, resulting in the mice 
reaching a labelling maximum. Then, the presence of any ‘wrong’ label was searched 
for, to ensure that the feeding mechanism was working in moving feeding traps away 
from the ‘wrong’ mice. Taking into account the care required in identifying the 
presence of ‘wrong’ label in MUP peptides, none of the mice in any of the three pairs 
showed any evidence of the ‘wrong’ label in their urine samples.  All MUP peptides  
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observed in the MALDI-ToF-MS spectra were checked to ensure no trace of the [2H8] 
valine peptide in the urine of mice assigned the [13C6] lysine diet, and vice versa.  The 
absence of any label from the unassigned diet in any mouse confirmed that the 
feeding mechanism worked successfully in terms of removing the diet from reach 
when the mouse not assigned to that diet approached. 
For the mice assigned the [2H8] valine diet, precursor RIA values were calculated, as 
before, from the unlabelled and [2H8] valine labelled peptides.  The daily average RIAs 
for each mouse were averaged again and plotted to determine whether maximum 
labelling had been reached (Figure 4.9 (a)), with standard deviation calculated for 
each daily average RIA.  Mice appeared to be fully labelled by the time the urine 
sample was collected on day 1, with variation most likely due to the averaging of RIA 
values from three different mice. 
The same was done for the mice assigned the [13C6] lysine diet, but from the 
unlabelled and [13C6] lysine labelled peptides (Figure 4.9 (b)).  Again, mice appeared 
to be fully labelled by day 1 of being fed the labelled diet, but the variation in calculated 
RIAs was much greater at day 1.  This is likely to be due to larger differences in RIA 
in the three different mice, which could have arisen due to greater differences in the 
amount of labelled diet eaten by the mice at this time point. 
It was concluded that the feeding mechanism designed at Leahurst was suitable in 
providing pairs of mice differently labelled diets whilst allowing them to be housed in 
the same cage, which means that pairs of female mice will be able to live together, 
with unrestricted access to their nestbox and pup litters, and consume differently 
labelled diets.  This means a single label from each female will be able to be passed 
on to the pups in the communal nest, meaning that maternal investment of each 
female in the pups should be able to be tracked via the presence of labels in the pups’ 
stomach contents (containing labelled milk passed on from the mother). 
4.2.3 Milk labelling pilot 
4.2.3.1 Experiment set-up 
The kinetics of the incorporation of labelled amino acids via a semi-synthetic diet were 
established, and a communal nursing cage set-up with a feeding mechanism to 
enable the feeding of differently labelled diets to two mice has been developed, tested 
and proved successful.  The next aim was to determine whether female mice, housed 
communally and fed labelled diets, pass the label incorporated into them onto their  
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Figure 4.9 The rate of heavy amino acid incorporation over 6 days in (a) three mice 
fed [2H8] valine labelled diet and (b) three mice fed [13C6] lysine labelled diet. 
Three nests with the feeding mechanism contained two mice in each, each mouse in the 
pair was assigned either the [2H8] valine diet or the [13C6] lysine diet.  Urine samples were 
taken from the six BALB/c females every day over the six-day period, subjected to in-
solution digestion with Lys-C and analysed using MALDI-ToF-MS. An average daily RIA 
was calculated from the two most abundant valine and lysine-containing MUP peptides for 
each mouse, each day, with error bars showing the standard deviation calculated for each 
daily RIA. 
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litters of pups via the milk they invest, and the rate at which the label is incorporated 
into the milk. 
A total of six trios (two female BALB/c and one male BALB/c mice in each trio) were 
set up for breeding at Leahurst by Dr. J. P. Green.  The female mice in each trio were 
previously cage-mates, and were fed an unlabelled diet.   After mating, the six pairs 
of female mice were transferred to the communal nursing cage, continuing with the 
unlabelled diet. Out of these, three pairs of female mice successfully reproduced and 
gave birth to litters. 
On day 0, when both litters to a pair of females had been born, the female mice then 
had their diet swapped to a [13C6] lysine labelled diet.  Unlike previous experiments, 
both females were fed the same labelled diet, as the purpose of this experiment was 
simply to identify the rate at which label is incorporated into the milk of the lactating 
mothers.  Immediately before the female mice were given the labelled diet, a single 
pup was taken to sample stomach contents – this was to demonstrate that prior to 
being fed the labelled diet, the mothers’ milk contained no label.  From this point, all 
three female pairs were fed the [13C6] lysine labelled diet until day 6 (Figure 4.10). 
At time intervals during the course of the experiment, urine was sampled from each 
mother to ensure the rapid and complete labelling from the diet.  Over days 1 - 6, one 
pup was removed from two of the three communal litters for analysis of stomach 
contents.  From each of these pups, urine samples were taken from their bladder 
whenever possible, and liver and muscle samples were also taken for future analysis 
of the kinetics of pup tissue labelling over the course of the six days.  Pups were taken 
from a litter no more than two days on the run in order to minimise disruption in the 
communal nests.  Removing so many pups from a single litter may cause mothers to 
invest significantly more in their remaining pups (that would be sampled at later time 
points) than they did in the pups removed from the litter earlier on in the experiment, 
making meaningful determination of the kinetics of milk labelling challenging.  By 
taking a pup from a communal litter on no more than two consecutive days, the rate 
of milk labelling can be determined more accurately. 
4.2.3.2 Analysis of mothers’ urine, pup stomach contents and pup urine 
The proteins in the mothers’ urine, the milk from the pups’ stomach contents and the 
urine from pups’ bladders were digested in-solution with Lys-C and analysed using 
MALDI-ToF-MS.  The digested pup stomach contents proteins and pup urine proteins  
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were also subjected to LC-MS analysis using a Waters Synapt G2 for protein 
discovery.  LC-MS was chosen for protein discovery over MALDI-ToF-MS because 
the additional LC step allows the separation of peptides prior to MS analysis, and the 
use of ESI with a Q-ToF mass spectrometer for MS analysis results in multiply 
charged peptides which are easier to fragment using CID, and so provide better 
product ion information for sequence analysis, therefore allowing more accurate 
peptide identification. For the urine samples from each mother, unlabelled MUP 
peptides were identified in the mass spectra, along with the corresponding [13C6] 
lysine labels at a +6 Da shift, and precursor RIAs for the 2471 Da MUP peptide in 
each sample were calculated using the formula outlined previously.  Only one MUP 
peptide was needed for the calculations as the previous analyses confirmed no 
variation in the rate of labelling of different MUP peptides. 
To identify the peptides (and the proteins from which they were generated) present in 
the MALDI-ToF mass spectra for milk and pup urine samples, the mass spectra 
generated by LC-MS were processed and searched against the UniProt Mus 
musculus database using PLGS (v.2.5.2). The top 20 proteins identified in the milk 
and urine samples are listed in Tables 4.2 and 4.3. 
Figure 4.11 shows the mass spectrum of a milk sample from a pup that had been 
taken just one day after the mothers had begun consuming their [13C6] lysine labelled 
diet. This mass spectrum is a typical representation of the peptides present in all milk 
samples.  The figure includes a list of the peptides identified, and the proteins from 
which they were generated, confirmed by cross referencing the peptide masses with 
those observed in LC-MS analysis. Proteins include LACE1_MOUSE (lactation 
elevated protein) which is highly expressed in the lactating breast of the female, and 
in this case has been passed from the mothers to the pups via milk investment.  Also 
present were proteins found specifically in milk, such as alpha-S2-casein-like A and 
lactadherin.  As the lactation elevated protein peptide 2433 Da was consistently the 
most intense throughout all milk MALDI-ToF-MS spectra, and is specifically 
expressed in lactating breasts of female mice, this was the peptide used to calculate 
the rate of labelling in milk. 
Figure 4.12 shows the mass spectrum of a urine sample from a pup that had been 
taken one day after the mothers had begun consuming their [13C6] lysine labelled diet. 
This mass spectrum is a typical representation of the peptides present in all urine 
samples.  The figure includes a list of the peptides identified, and the proteins from 
which they were generated, confirmed by cross referencing the peptide masses with  
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Table 4.2 The top 20 proteins identified in pup stomach contents (milk) samples 
recovered days 1 – 6 of the experiment.  
Raw mass spectra from LC-MS analysis were processed and searched against a 
database of Mus musculus proteins obtained from UniProt, using PLGS. 
 
 
Protein 
accession 
number 
Protein name Score Sequence 
coverage 
(%) 
No. of 
peptides 
Q02596 Glycosylation-dependent cell 
adhesion molecule 1  
34802 84.1 8 
A0A0G2JGT8  Alpha-S1-casein (Fragment)  33936 100 9 
Q02862 Alpha-S2-casein-like A  28263 59.8 12 
F8WIP8 Osteopontin  25465 57.3 16 
Q921I1 Serotransferrin  18959 38.2 21 
E9Q035 Protein Gm20425  18934 21.9 20 
P01942 Haemoglobin subunit alpha  18044 71.8 8 
P33622 Apolipoprotein C-III  17718 96.0 4 
P02664 Alpha-S2-casein-like B  16748 65.0 22 
B1ARV3 L-amino acid oxidase 1  14894 44.4 22 
Q91VB8 Alpha globin 1  12887 51.4 7 
P02088 Haemoglobin subunit beta-1  12694 55.8 4 
P07724 Serum albumin  11420 43.4 19 
Q00623 Apolipoprotein A-I  11154 61.0 15 
P07759 Serine protease inhibitor A3K  10996 59.8 15 
Q6JHY2 Submandibular gland protein 
C  
9944 56.2 19 
P10598 Beta-casein  9872 55.4 5 
P63260 Actin_ cytoplasmic 2  7699 76.0 15 
P21956 Lactadherin  5555 29.8 17 
P17182 Alpha-enolase  5499 70.3 20 
 
 
. 
 
 
 
 
 
  
 165 
 
 Chapter 4: Communal nursing in the house mouse 
Table 4.3 The top 20 proteins identified in pup urine samples recovered days 1 
– 6 of the experiment.  
Raw mass spectra from LC-MS analysis were processed and searched against a 
database of Mus musculus proteins obtained from UniProt, using PLGS. 
 
 
Protein 
accession 
number 
Protein name Score Sequence 
coverage 
(%) 
No. of 
peptides 
Q7M748 Whey acidic protein  13692 73.3 12 
P07724 Serum albumin  3024 63.0 26 
Q9DAU7 WAP four-disulfide core 
domain protein 2  
2984 40.4 6 
Q02596 Glycosylation-dependent cell 
adhesion molecule 1  
2853 29.8 4 
Q9D3N5 Protein 5430402E10Rik  2739 20.8 3 
Q9D3H2  MCG117626  2498 34.4 4 
P35459 Lymphocyte antigen 6D  2305 22.1 3 
B7ZNJ1 Fibronectin  1710 13.3 12 
P15947 Kallikrein-1  1657 64.0 9 
P02772 Alpha-fetoprotein  1322 39.2 15 
A2BHD2 Protein Gm14743  1032 33.3 6 
A2AEP0 Protein Obp1b  963 27.5 5 
E9Q4P0 KxDL motif-containing protein 
1 (Fragment)  
805 25.9 7 
P29752 Alpha-lactalbumin  740 21.6 2 
Q9JKP7 DNA polymerase epsilon 
subunit 3  
720 7.6 2 
Q68FH0 Plakophilin-4  620 9.9 6 
Q8BHC0 Lymphatic vessel endothelial 
hyaluronic acid receptor 1  
609 4.1 2 
P62984 Ubiquitin-60S ribosomal 
protein L40  
605 13.3 3 
E9Q5F6 Polyubiquitin-C (Fragment)  570 8.0 2 
O09114 Prostaglandin-H2 D-isomerase  567 9.0 2 
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Figure 4.11 Peptide mass fingerprint of pup milk proteins taken on the first day of its 
mother being fed a labelled diet. 
Pup milk was homogenised and digested using the homogenisation and in-solution 
digestion protocols, with Lys-C as the protease. 1µl of digested sample was mixed 1:1 with 
matrix solution before being spotted onto the MALDI target plate. Mass spectrum was 
acquired using the method described in Chapter 2.  Labelled are the most abundant 
peptides identified by matching the masses to those identified in the LC-MS discovery 
analysis of the pup stomach contents (Table 4.2).  Inset is an enlargement of the unlabelled 
and [13C6] lysine labelled lactation elevated protein 1 peptide, at 2433 m/z. 
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Figure 4.12 Peptide mass fingerprint of pup urine proteins taken on the first day of 
its mother being fed a labelled diet. 
Pup urine was digested using the in-solution digestion protocol, with Lys-C as the protease. 
1µl of digested sample was mixed 1:1 with matrix solution before being spotted onto the 
MALDI target plate. Mass spectrum was acquired using the method described in Chapter 
2.  Labelled are the most abundant peptides identified by matching the masses to those 
identified in the LC-MS discovery analysis of the pup urine (Table 4.3).  Inset is an 
enlargement of the unlabelled and [13C6] lysine labelled serum albumin peptide, at 2000 
m/z. 
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those observed in LC-MS analysis. Proteins include ALBU_MOUSE (serum albumin).  
As all pup urine mass spectra showed intense serum albumin peptides, the serum 
albumin peptide 2000 Da was used to calculate precursor RIA and therefore the rate 
of labelling of this protein in pups. 
Initially, the unlabelled and [13C6] lysine labelled peptide profiles for MUP peptide 2471 
Da (which is the same peptide used to assess the kinetics of [13C6] lysine 
incorporation into female mice in the first experiment) were observed at different time 
points over the six days of labelling.  Figure 4.13 (a) shows that in the first urine 
sample taken from a female (mother), taken 7 hours after being provided the [13C6] 
lysine diet, this MUP peptide was already partially labelled.  On the second day of 
labelling (at 31 hours after being fed the labelled diet), this MUP peptide appeared 
fully labelled, and remained fully labelled for the remainder of the experimental period, 
apart from a small dip in labelling on day 2.  This is likely to be due to variation in the 
amount of diet consumed.  Apart from this, the rate of labelling was in agreement with 
the rate seen in the previous proof-of-principle experiment, where the mice fed the 
[13C6] lysine diet appeared to have a fully labelled precursor pool after one day of 
being fed the labelled diet.  For the calculation of precursor RIAs in MUPs, and 
therefore calculation of the labelling of the precursor pool in the liver, an average RIA 
of two MUP peptides in each sample taken from each of the six females was 
calculated. 
The unlabelled and [13C6] lysine labelled peptide profiles for the lactation elevated 
protein peptide 2433 Da in pup stomach contents (milk) were observed at different 
time points over the six days of the experiment. All milk samples were recovered at 
the same time every day, except for the very first sample – this was from the pup 
taken from the communal litter immediately before the mothers were provided with 
the [13C6] lysine diet, in order to prove that no label was present in the mothers’ milk 
prior to mice being fed the labelled diet.  In Figure 4.13 (b), the mass spectrum of the 
2433 Da LACE1_MOUSE peptide, from the milk sample taken 1 hour before labelling, 
shows the presence of only the unlabelled peptide, with no labelled peptide at the 
characteristic +6 Da shift.  All milk samples taken after this point were from pups 
whose mothers were being fed the labelled diet.  Observation of the mass spectra of 
the LACE1_MOUSE 2433 Da peptide over the course of the experiment indicates a 
similar rate of labelling to the labelling of MUPs seen in the mothers’ urine.  On the 
first day of mothers being fed the [13C6] lysine diet, the milk peptide found in the pups’ 
stomach contents appeared fully labelled, with the +6 Da labelled peptide having a  
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Figure 4.13 Incorporation of heavy labelled amino acids over the course of 6 days, 
shown by the relative abundances of heavy/light peptide profiles in urine from a 
BALB/c female (a), stomach contents of a pup (b) and urine from a pup (c), where 
the female (mother of the pups) was fed a diet labelled with [13C6] lysine.  
Urine samples were taken from the females daily over a six-day period. Shown are the 
unlabelled (‘light’) and labelled (‘heavy’) MUP peptide profiles taken from urine collected 
at intervals after the labelled diet being introduced. The ‘heavy’ lysine MUP peptide is 6 Da 
heavier than the light MUP peptide, due to the incorporation of six 13C into the lysine 
residue (a). The stomach contents and urine samples were taken from a different pup at 
each time of sampling, shown are the ‘light’ and ‘heavy’ profiles from a lactation elevation 
protein peptide (b) and from a serum albumin peptide (c). 
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similar intensity to the unlabelled peptide.  This suggested that the proteins in the 
mothers’ milk were labelling at the same rate as MUPs in their urine.  However, the 
proteins in the milk samples recovered on days 2 and 3 of the experiment appeared 
only partially labelled – this could be due to the fact that pups are taken from different 
litters on each day of the experiment, so there may be variation in the investment of 
mothers in different communal litters, or variation in the amount of labelled diet 
consumed by the different mothers, and therefore variation in the amount of label 
passed onto the pups.  Another thing that may have caused this dip in milk labelling 
is the time of day at which pup samples were taken – all pup sampling took place at 
9 am of each day, which is at the beginning of the active period for the mice – mothers 
will have been inactive during their ‘day’ period overnight, and will have been 
consuming less diet over this time and investing less in their litters, causing the ‘dip’ 
in labelling which was also seen in the morning urine samples taken in the initial 
kinetics experiment.  In this experiment, the mothers’ urine samples were collected 
later in the day, between 4 – 5pm.  This is after the ‘night’ period, where mice are 
most active and so will be eating more of the labelled diet, which is why mothers’ urine 
samples appeared to have reached a maximum labelling plateau. The differences in 
the time points where mothers’ urine and mothers’ milk in pups were sampled is a 
likely explanation for the ‘dip’ of labelling seen in the pups’ stomach contents on days 
2 and 3, along with variation in diet consumed by the mother (as a dip in the labelling 
of mothers’ urine was also seen on day 2).  Taking this into account, and referring 
back to the initial kinetics experiment and the variation of labelling seen at different 
times during the course of a day, it seems as though the proteins in the mothers’ milk 
seen in the pups’ stomach reaches a similar labelling maximum at a similar rate to 
that seen in the mothers’ urine.  The calculation of the average precursor RIA values 
for this LACE1_MOUSE protein peptide in milk for each sampled pup will enable us 
to determine the rate of incorporation of [13C6] lysine from diet into the mothers’ milk, 
the milk (and therefore label) which is then passed onto pups.  
Figure 4.13 (c) shows the unlabelled and labelled serum albumin (2000 Da) peptide 
profiles observed in the MALDI-ToF-MS analysis of the urine recovered from the 
pups’ bladders.  No urine sample was recovered from the pup taken immediately 
before the mothers were given the [13C6] lysine diet, so there are only analyses for 
the pup urine samples on days 1 – 6 of the experiment.  From the MALDI-ToF-MS 
analysis, the 2000 Da peptide showed much slower rates of label incorporation than 
the MUP peptide in mother’s urine and the LACE1_MOUSE peptide in milk.  At no 
point in the experiment does the ALBU_MOUSE peptide in pup urine appear fully 
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labelled.  The incorporation of the label into the pup urine, although very slow, 
increases over the course of the six days that the pups’ mothers are being fed the 
labelled diet.  In order to assess the rate of label incorporation into the pups due to 
their mothers’ investment, average precursor RIA values were calculated for the 
ALBU_MOUSE 2000 Da peptide and the ACSM3_MOUSE in each pup sample taken 
over the course of the six day experiment. 
The average precursor RIAs were calculated as previously described for the mothers’ 
urine samples, the pup’s stomach contents and the pup’s urine samples at each time 
point and are shown in Figure 4.14. Figure 4.14 (a) shows that the precursor pool in 
the mothers’ liver has reached a labelling maximum on day 1 of being fed the [13C6] 
lysine labelled diet (31 hours after the diet had been introduced).   The calculated RIA 
is slightly below the maximum on day 2 of labelling (55 hours after the diet had been 
introduced), before returning to the plateau for the remaining days of the experiment.  
Referring back to Figure 4.13, the ‘dip’ in labelling is also evident in the mass 
spectrum of the MUP peptide in the urine taken at this time.  The variation in the RIA 
values calculated in the samples from the different mothers suggests that at this point, 
the differences in the amount of diet consumed by each mouse is the likely cause of 
this ‘dip’ in labelling. 
Milk proteins in the pup’s stomach contents appeared to have labelled at a similar 
rate and to a similar maximum to the mothers’ urine samples, with relatively little 
variation in the RIA values calculated from different proteins in different pups.  Figure 
4.14 (b) shows that label incorporation appears slightly less in samples taken on day 
3, which is likely to be due to the dip in labelling seen in mothers on day 2 due to 
variation in diet consumption.  The labelling of milk proteins appears to reach the 
same maximum as mothers’ urine samples from day 4 onwards, suggesting that the 
full labelling of the milk precursor pool takes slightly longer than the labelling of the 
liver precursor pool in the mothers.  As the milk samples were taken from the pups’ 
stomachs, it can be confirmed that the [13C6] lysine is being successfully passed on 
from the mothers to their pups. 
In order to assess whether the label is then being incorporated into the nursed pups, 
the precursor RIAs were calculated in proteins from the urine samples obtained from 
pups.  Figure 4.14 (c) shows that the incorporation of label into the pup is much 
slower, as would be expected, and at no point during the experiment has it appeared 
to reach a maximum labelling plateau.  This is to be expected because the label  
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incorporation into the pups is much slower because of their rate of growth; at this age, 
protein turnover rates are maximal (Waterlow et. al. 1978). The rate of protein 
synthesis is higher than the rate of protein degradation, and so the label is being 
diluted by a greater amount of newly synthesised unlabelled protein present in the 
precursor pool.  The calculated precursor RIAs in urine increase throughout the 
experiment, which indicates that the label is being successfully incorporated into the 
nursed pups, just at a much slower rate than dietary incorporation into their mothers.  
At the end of the 6 days, precursor RIAs of the serum albumin peptide have reached 
a value of around 0.3 – lower than the RIAs reached in proteins in mothers’ urine and 
pups’ stomach contents (approximately 0.5), but relatively significantly labelled 
nonetheless. 
4.2.3.3. Analysis of liver and muscle samples from pups 
From each pup sampled throughout the 6 day experiment, liver and muscle samples 
were taken to assess the rate of label incorporation into these two tissues.  In general, 
it would be expected that proteins in the pup liver would label quicker than proteins in 
muscle, as the muscle is less metabolically active (Claydon et al. 2012).  It is known 
that different proteins in a sample will have different rates of label incorporation due 
to them having different rates of turnover (Waterlow et al. 1978).  The analysis of RIA 
in proteins with different turnover rates in pup tissue samples can give information 
regarding investment from mothers at different time points during communal nursing 
– for example, a high turnover protein in a pup tissue will degrade and return to the 
protein precursor pool quickly, meaning that upon introduction of a labelled amino 
acid to the precursor pool, previously synthesised (unlabelled) proteins degrade 
quickly and newly synthesised (labelled) proteins take their place. Upon these 
degrading, labelled amino acids are returned to the precursor pool as well as those 
being introduced via diet, causing complete labelling of the precursor pool to occur 
quickly.  These proteins therefore give an indication of the recent label investment 
from mothers.  The opposite is true for a low turnover protein, and so these proteins 
give a picture of the label investment from mothers over a longer time period.  
In order to assess the rates of turnover of a number of proteins in pup liver and muscle 
samples, samples were homogenised, digested with Lys-C and analysed using LC-
MS.  LC-MS was chosen for protein discovery over MALDI-ToF-MS once again due 
to increased protein identification accuracy. Raw mass spectra for all pup liver and 
muscle samples were imported into Waters PLGS (v 2.5.2) software, and peptides 
(and the proteins from which they were generated) were identified by searching 
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against a UniProt database of Mus musculus proteins.  The top 20 protein hits that 
were identified in all liver mass spectra are outlined in Table 4.4, and the top 20 
protein hits that were identified in all muscle mass spectra are outlined in Table 4.5.   
For each of the liver samples obtained from two pups on the final day (day 6) of the 
experiment, the RIA values for the three highest scoring peptides for each of the 20 
identified proteins were calculated.  The average RIA for each protein was calculated 
from the three peptide RIA values. The same was done for each of the muscle 
samples obtained from the two pups on the final day of the experiment. 
The average RIAs calculated for the top 20 liver proteins from the two pups are shown 
in Figure 4.15, and those calculated for the top 20 muscle proteins from the same 
pups are shown in Figure 4.16.  The calculated average RIAs for the proteins in the 
liver samples are similar between the two different pup samples, with the lowest RIA 
values calculated for the two haemoglobin proteins (subunits beta –1 and beta –2) in 
both samples, and the highest RIA value seen in the non-specific lipid transfer protein. 
In most proteins, there was little variation between the RIAs calculated for each 
peptide, with the exception of the highest RIA non-specific lipid transfer protein, 
protein disulphide-isomerase and L-lactate dehydrogenase A chain (Figure 4.17).  
Maximum protein RIAs range widely in the liver samples, from approximately 0.15 in 
the apparently lowest turnover protein to around 0.47 in the highest turnover protein 
(which appears to have reached a labelling maximum).  In the muscle samples, the 
calculated average RIAs for each protein were relatively similar between the two 
different pup samples, with the exception of parvalbumin alpha (0.37 in pup ID 36313, 
0.29 in pup ID 36314) (Figures 4.16 And 4.18). As with the liver samples, the lowest 
calculated RIA was in haemoglobin subunit beta -2, and the highest calculated RIA in 
the muscle samples was in serotransferrin.  Aside from creatine kinase M-type in both 
muscle samples, and parvalbumin alpha in the first pup sample, there was little 
variation between the RIAs calculated for each peptide in each protein (Figure 4.18). 
The average precursor RIA values were calculated using two different peptides from 
each protein, and were calculated for glutamate dehydrogenase 1, mitochondrial (a 
liver protein with a low RIA calculated on the final day of the experiment), non-specific 
lipid transfer protein (cytoplasmic in the liver, with the highest RIA calculated RIA on 
the final day), beta-enolase (a muscle protein with the second-lowest RIA calculated 
on the final day of the experiment) and parvalbumin alpha (a muscle protein with the 
highest calculated RIA) for each day of the experiment to assess the rate of label 
incorporation into these proteins and whether they had reached a maximum labelling  
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Table 4.4 The top 20 common proteins identified in all pup liver samples 
recovered days 1 – 6 of the experiment. 
Raw mass spectra from LC-MS analysis were processed and searched against a 
database of Mus musculus proteins obtained from UniProt, using PLGS. 
 
Protein 
accession 
number 
Protein name Score Sequence 
coverage 
(%) 
No. of 
peptides 
P02088 Haemoglobin subunit beta-1 12045 76.9 19 
P02089 Haemoglobin subunit beta-2 11656 76.9 21 
P12710 Fatty acid-binding protein, liver 4044 55.9 8 
B1AXW4 Peroxiredoxin-1 3570 71.5 8 
P26443 Glutamate dehydrogenase 1, 
mitochondrial 
2521 22.6 10 
Q9QXD6 Fructose-1,6-bisphosphatase 1 2451 17.2 6 
Q05816 Fatty acid-binding protein, 
epidermal 
1259 38.5 4 
P06151 L-lactate dehydrogenase A chain 1224 16.3 5 
P09103 Protein disulfide-isomerase 1106 14.7 8 
P99027 60S acidic ribosomal protein P2 1011 53.0 4 
Q64433 10 kDa heat shock protein, 
mitochondrial 
817 33.3 3 
P16460 Argininosuccinate synthase 717 14.6 7 
Q8C196 Carbamoyl-phosphate synthase 
[ammonia], mitochondrial 
618 14.4 18 
O35490 Betaine--homocysteine S-
methyltransferase 1 
603 20.1 7 
P54869 Hydroxymethylglutaryl-CoA 
synthase, mitochondrial 
563 8.1 5 
P07724 Serum albumin 497 13.3 9 
B1ATY1 Actin, cytoplasmic 2 493 24.2 3 
Q6PHC1 Enolase 468 12.6 3 
Q8QZT1 Acetyl-CoA acetyltransferase, 
mitochondrial 
361 9.7 4 
P32020 Non-specific lipid-transfer protein 355 13.7 9 
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Table 4.5 The top 20 common proteins identified in all pup muscle samples 
recovered days 1 – 6 of the experiment. 
Raw mass spectra from LC-MS analysis were processed and searched against a 
database of Mus musculus proteins obtained from UniProt, using PLGS. 
 
 
Protein 
accession 
number 
Protein name Score Sequence 
coverage 
(%) 
No. of 
peptides 
P32848 Parvalbumin alpha 67264 82.7 20 
P17751 Triosephosphate isomerase 30667 52.8 14 
P02089 Hemoglobin subunit beta-2 26660 64.6 12 
P07310 Creatine kinase M-type 24088 38.1 17 
P21550 Beta-enolase 21418 57.1 22 
P05064 Fructose-bisphosphate 
aldolase A 
15801 34.1 11 
E9Q5U3 Glyceraldehyde-3-phosphate 
dehydrogenase 
10702 50.8 13 
P16065 Carbonic anhydrase 3 8386 39.6 8 
Q9R0Y5 Adenylate kinase isoenzyme 1 7234 56.2 9 
P68134 Actin, alpha skeletal muscle 6817 40.3 11 
P11499 Heat shock protein HSP 90-
beta 
5682 27.5 14 
P09411 Phosphoglycerate kinase 1 4672 49.9 20 
P52480 Pyruvate kinase PKM 4272 26.4 12 
Q6PHC1 Alpha-enolase 4254 51.9 14 
Q921I1 Serotransferrin 3260 11.2 8 
P62631 Elongation factor 1-alpha 2 2091 22.2 6 
Q5SX49 Profilin 1646 61.6 5 
P14152 Malate dehydrogenase 1207 36.2 11 
O70250 Phosphoglycerate mutase 2 1202 40.3 8 
P31001 Desmin 892 27.5 7 
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Figure 4.15 The average RIA calculations of the top 20 proteins in pup liver, common 
in both samples. 
The pup liver samples taken from two different pups on the final day of the milk labelling 
pilot were homogenised and digested with Lys-C as per the methods described in Chapter 
2. The digests were analysed using LC-MS and mass spectra were searched for matches 
in a mouse database using PLGS. For each of the proteins identified here, average RIAs 
were calculated from the intensities of the top three peptides identified in each protein 
(error ± SD). 
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Figure 4.16 The average RIA calculations of the top 20 proteins in pup muscle, 
common in both samples. 
The pup muscle samples taken from two different pups on the final day of the milk labelling 
pilot were homogenised and digested with Lys-C as per the methods described in Chapter 
2. The digests were analysed using LC-MS and mass spectra were searched for matches 
in a mouse database using PLGS. For each of the proteins identified here, average RIAs 
were calculated from the intensities of the top three peptides identified in each protein 
(error ± SD). 
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Figure 4.17 The average RIA calculations of the top 20 proteins in pup liver, seen in 
the both of the pup samples, taken on the final day of the 6-day experiment. 
The pup liver samples taken from two different pups on the final day of the milk labelling 
pilot were homogenised and digested with Lys-C as described in Chapter 2. The digests 
were analysed using LC-MS and mass spectra were searched for matches in a mouse 
database using PLGS. For each of the proteins identified here, average RIAs were 
calculated from the intensities of the top three peptides identified in each protein (error ± 
SD).  Labelled are the proteins with RIA values higher or lower than the majority of the top 
20 proteins identified, which may be suitable for analysis for the tracking of investment at 
different time points in the communal nursing study. 
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Figure 4.18 The average RIA calculations of the top 20 proteins in pup muscle, seen 
in the both of the pup samples, taken on the final day of the 6-day experiment. 
The pup muscle samples taken from two different pups on the final day of the milk labelling 
pilot were homogenised and digested with Lys-C as described in Chapter 2. The digests 
were analysed using LC-MS and mass spectra were searched for matches in a mouse 
database using PLGS. For each of the proteins identified here, average RIAs were 
calculated from the intensities of the top three peptides identified in each protein (error ± 
SD).  Labelled are the proteins with RIA values higher or lower than the majority of the top 
20 proteins identified, which may be suitable for analysis for the tracking of investment at 
different time points in the communal nursing study. 
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plateau at any point during the six days (Figures 4.19 – 4.21).  Figure 4.21 shows that 
each of the two lower turnover proteins label at a similar rate, with the low turnover 
liver protein (glutamate dehydrogenase 1, mitochondrial in liver) and low turnover 
muscle protein (beta-enolase) incorporating the label at the slowest rate, reaching a 
maximum RIA of approximately 0.21 on the final day of the experiment. The higher 
turnover liver protein (non-specific lipid transfer protein) reached an RIA of 0.36 on 
the final day of the experiment, and the higher turnover muscle protein (parvalbumin 
alpha) reached an RIA of 0.29, meaning that these higher turnover proteins were 
incorporating the label at a faster rate than the lower turnover proteins.  All proteins 
showed an almost linear increase in label incorporation throughout the experiment, 
with no sign of labelling reaching a plateau at any point over the time period.   
From this experiment, it was determined that after giving birth in a communal nest, 
females were able to consume a [13C6] lysine labelled diet and have that label fully 
incorporated into them within the space of 2 days, and that this label was successfully 
passed on to their pups via their milk, which labelled at a similar rate and to a similar 
extent to their livers.  The pups’ consumption of the fully labelled milk resulted in the 
label becoming incorporated into their tissues.  Although the rate at which pups were 
labelled was much slower than their mothers’ proteins in these tissues labelled at a 
significant enough rate to deem this method suitable to track investment in the pups 
from their mothers.  
4.2.4 Tracking investment in pups 
Communally housed female mice, who are successfully fed different labelled diets 
through the development of a suitable feeding mechanism, pass the label 
incorporated into themselves onto their pups via their milk, and these labels are then 
incorporated into the pups’ tissues.  The assessment of labelled amino acid 
incorporation into pup tissues by calculating protein precursor RIAs can be used as a 
way to track the investment from the pup’s mother.  In the milk labelling study, both 
female mice were fed a diet labelled with [13C6] lysine.  The aim of the final communal 
nursing experiment is to track the investment from each mother in the communal litter, 
and so each mother is required to consume a differently labelled diet (via the 
established feeding mechanism (Figure 4.9)).  The two different labels will then 
incorporate into each mother, and will be passed on to the communal litter via their 
milk, and the labels will be passed onto whichever pups they invest in (Figure 4.22).  
The hypothesis is that if a pup receives investment from both mothers, both labels  
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Figure 4.19 Incorporation of [13C6] lysine labelled amino acids over the course of 6 
days, shown by the relative abundances of heavy/light peptide profiles in liver 
samples from pups. (a) the incorporation of [13C6] lysine into the 1583.8 Da peptide 
of the low turnover protein glutamate dehydrogenase 1, mitochondrial (b) the 
incorporation of [13C6] lysine into the 916.5 Da peptide of the high turnover protein 
non-specific lipid transfer protein. 
Liver samples were taken from different pups on each day of the six-day experiment. 
Samples were homogenised, digested in-solution with Lys-C and subjected to LC-MS 
analysis. Shown are the unlabelled (‘light’) and labelled (‘heavy’) peptide profiles of a 
glutamate dehydrogenase 1, mitochondrial peptide (a) and a non-specific lipid transfer 
protein peptide (b), confirming the incorporation of [13C6] lysine into these proteins over the 
6-day period. 
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Figure 4.20 Incorporation of [13C6] lysine labelled amino acids over the course of 6 
days, shown by the relative abundances of heavy/light peptide profiles in muscle 
samples from pups. (a) the incorporation of [13C6] lysine into the 800.4 Da peptide of 
the low turnover protein beta-enolase (b) the incorporation of [13C6] lysine into the 
871.5 Da peptide of the high turnover parvalbumin alpha. 
Muscle samples were taken from different pups on each day of the six-day experiment. 
Samples were homogenised, digested in-solution with Lys-C and subjected to LC-MS 
analysis. Shown are the unlabelled (‘light’) and labelled (‘heavy’) peptide profiles of a beta-
enolase peptide (a) and a parvalbumin alpha peptide (b), confirming the incorporation of 
[13C6] lysine into these proteins over the 6-day period. 
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Figure 4.21 The rate of heavy amino acid incorporation over 6 days in the tissue 
samples of pups whose mothers were fed a [13C6] lysine labelled diet. 
Liver and muscle samples were taken from at least one pup each day over the six-day 
period, homogenised and digested with Lys-C and analysed using LC-MS. The plot shows 
the average daily RIAs (calculated from the top two peptide matches in each protein, from 
each animal) for a high and low turnover protein in liver (non-specific lipid transfer protein 
and glutamate dehydrogenase 1, mitochondrial, respectively), and for a high and low 
turnover protein in muscle (parvalbumin alpha and beta-enolase, respectively) (error ± SD, 
n = 4).  
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will be incorporated into its tissues.  The amount of each label present in the pup’s 
tissues will indicate the proportion of investment from each mother.  Conversely, if a 
pup receives investment from only one mother, only that mother’s label will be present 
in the pup’s tissues. 
4.2.4.1 Experimental set up 
The experiment was set up at the Leahurst campus by Dr. J. P. Green (Figure 4.22).  
Each female was ensured to have a functional RFID tag, and were then paired for 
familiarisation: eight of the female pairs were related (sisters), and the other nine pairs 
were unrelated.  Each pair were familiarised with each other, the communal cage with 
feeding mechanism and the unlabelled diet for at least ten days.  Each female pair 
was then mated to two separate males – in related pairs, each female was mated with 
a male pair where each male was unrelated to the other male and the female pair; in 
unrelated pairs, each female was mated with a male pair who were siblings but 
unrelated to the female pair.  Mating was staggered within the pairs – for example, 
the first female of the pair was mated two days before the second female was mated.  
The reason for this was to aim for the two litters in the communal nest to be born two 
days apart (no longer than five days apart), allowing easy identification of the two 
different litters and the number of pups in each based on pup size and skin colour 
(pup skin colour darkens with age).  After mating, each female pair was reintroduced 
to one another in their communal cages and were left to give birth.  When the first 
litter in a communal nest was 7 days old, the unlabelled diet was removed from the 
feeding mechanism and replaced with two new labelled diets, one for each female.  
One of the diets was [D4] lysine labelled, the other was [D9] lysine labelled.  These 
labels were used due to their availability; it was deemed more cost effective than to 
purchase more of the previously used [13C6] lysine and [2H8] valine labels.  The 
females consumed the labelled diet for 7 days whilst nursing their pups.  At the end 
of the 7-day period, urine samples were taken from each female for analysis to ensure 
each female had fully incorporated the label assigned to it, and had consumed none 
of the ‘wrong’ label.  At this point, tissue samples (liver and muscle) were taken from 
each pup for analysis.  All samples were stored in Eppendorf tubes and frozen until 
required. 
4.2.4.2 Communal nursing in related female pairs 
Protein in the mothers’ urine was digested in-solution with Lys-C and analysed using 
LC-MS.  Unlabelled MUP peptides were identified in the mass spectra by searching  
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Figure 4.22 The experimental set up at Leahurst to track investment in communal 
litters. 
Pregnant females lived and gave birth in pairs (8 related pairs, 9 unrelated pairs).  When 
both females had given birth, one female was fed [D4] lysine labelled diet and the other 
was fed [D9] lysine labelled diet.  These labels were then passed to the pups they invested 
in via their labelled milk, allowing the investment from each mother to be tracked due to 
the presence of labels in pup tissue samples. 
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raw data against a mature MUPs database using PLGS, along with the corresponding 
[D4] lysine labels at a +4 Da shift, and the [D9] lysine labels at a +9 Da shift. Precursor 
RIAs for three different MUP peptides in each sample were calculated using the 
formula outlined previously.  Since these peptides (in both their unlabelled and 
labelled forms) were mainly observed as a doubly- charged ions ([M+2H]2+) in the raw 
mass spectrum, the mass shift for the [D4] lysine labelled peptide was at +2 m/z, and 
the [D9] lysine labelled was at +4.5 m/z (Figure 4.23).   
Figure 4.24 shows the calculated precursor RIAs for the 1569 Da MUP peptide in 
each of the urine samples taken from each of the related female pairs on the final day 
(day 7) of the communal nursing experiment.  The precursor RIAs for both the [D4] 
lysine labelled and the [D9] lysine labelled peptide were calculated for each urine 
sample, to identify whether any female had consumed any of the ‘wrong’ label (i.e. 
consumed any of the labelled diet that was not assigned to it).  The difference 
between the monoisotopic (M0) peaks of the two 1569 [M+2H]2+ labelled peptides is 
2.5 m/z, meaning that the profiles for the two different labelled peptides can be easily 
distinguished in the mass spectrum (Figure 4.23). 
In all related female pairs, the female assigned the [D4] lysine diet (female A) 
appeared to have a fully [D4] lysine labelled precursor pool, with all calculated 
precursor RIA values being approximately 0.5 (Figure 4.25).  None of these females 
appeared to consume any of the unassigned [D9] lysine diet, with the low RIA 
calculations for this protein as a result of noise in the spectrum, as no true 
isotopologue profile was observed (Figure 4.25).  Not all females assigned the [D9] 
lysine labelled diet (female B) appeared to have a fully [D9] lysine labelled precursor 
pool – only females in pairs 3, 4 and 7 had calculated precursor RIA values of 
approximately 0.5 (Figure 4.25).  Female B in pair 1 had a partially [D9] lysine labelled 
precursor pool, with a calculated RIA of 0.26.  This female did not appear to consume 
any of the unassigned [D4] lysine diet (Figure 4.25).  Lower precursor RIA values are 
likely to be due to the animal eating less of their labelled diet.  Female B in pairs 2, 5 
and 6 appeared to have a partially [D9] lysine labelled precursor pool, but the 
precursor pool for these animals also appeared to be partially [D4] lysine labelled, with 
RIA calculations of around 0.1.  The mass spectra of the urine from these three mice 
was studied for the presence of the [D4] peptide, rather than just spectral noise, using 
MS isotope to provide a reference of the expected isotope distribution of the ‘light’ 
(unlabelled) peptide (Figure 4.24).  The female assigned the [D9] lysine labelled diet 
in pairs 2 and 5 appeared to have a small amount of the [D4] lysine labelled peptide  
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Figure 4.23 The incorporation of (a) [D4] lysine and (b) [D9] lysine into the 1567 Da 
MUP peptide after 7 days of labelling, and (c) the difference between a [D4] lysine 
containing (black profile) and [D9] lysine containing (red profile) 1567 Da MUP 
peptide. 
Urine samples were taken from the females after the 7 day labelling experiment. (a) The 
labelled (‘heavy’) [D4] lysine peptide is 4 Da heavier than the unlabelled (‘light’) MUP 
peptide due to the incorporation of D4 into the lysine residue. The peptide is observed as 
a [M+2H]2+ ion and so the labelled peptide is at +2 m/z. (b) The labelled [D9] lysine peptide 
is 9 Da heavier than the unlabelled MUP peptide due to the incorporation of D9 into the 
lysine residue. The peptide is observed as a [M+2H]2+ ion and so the labelled peptide is at 
+4.5 m/z.  (c) The difference between labelled profiles is key for ascertaining which label 
is present in the animal. If the feeding mechanism was not working correctly, both ‘heavy’ 
labels would be present in the MUP peptides of a single mouse, as shown in the theoretical 
mass spectrum.  This was generated by overlaying the spectra in (a) and (b). 
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Figure 4.24 (a) Isotope distribution profile of the unlabelled 1569 Da MUP peptide (b) 
the [D9] lysine labelled and unlabelled 1569 Da MUP peptide profiles with no [D4] 
lysine peptide present, and (c) the [D9] lysine labelled and unlabelled 1569 Da MUP 
peptide profiles with [D4] lysine peptide present. 
(a) The isotope distribution profile for the unlabelled (‘light’) 1569 [M+2H]2+ MUP 
peptide as determined by MS Isotope.  This was used to determine whether true 
[D4] lysine isotopologues were present in the urine of females assigned the [D9] 
lysine diet. (b) Mass spectrum of the unlabelled (‘light’) and [D9] lysine (‘heavy’) 
1569 [M+2H]2+ MUP peptide, from LC-MS analysis of urine from female B, from 
pair 1 of related pairs, assigned the [D9] lysine diet.  Shaded in red is the area of 
the spectrum where a [D4] lysine profile would be observed if the female had 
consumed any of the unassigned [D4] lysine diet.  No true isotopologue profile is 
observed. (c) The same as in (b), however a small but true [D4] lysine isotopologue 
profile is present in the spectrum, suggesting this female consumed some of the 
unassigned [D4] lysine diet. 
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in their urine, as a true isotopologue profile was observed (Figure 4.25).  Female B in 
pair 6 just had a partially labelled [D9] lysine labelled precursor pool, with no evidence 
of a true [D4] lysine peptide in the mass spectrum (Figure 4.25).  Since urine samples 
were only taken on the final day of the experiment, it is unknown whether the females 
that appeared partially labelled were partially labelled throughout the whole 
experiment, whether they were less labelled prior to day 7, or possibly fully labelled 
before reducing their food intake on the final couple of days, resulting in the lower 
final calculated RIAs.  It can be assumed that the fully labelled females reached their 
maximum precursor RIA after approximately 1 day of being fed the labelled diet, as 
determined in prior experiments.  For this reason, for the assessment of investment 
in pups, only litters with both fully labelled mothers will be used.  
From each pup in each of the three communal litters from pairs 3, 4 and 7, after the 
7-day labelling experiment, liver and muscle samples were taken, homogenised, 
digested with Lys-C and analysed using LC-MS.  For each liver sample, precursor 
RIAs for non-specific lipid transfer protein (high turnover) and glutamate 
dehydrogenase 1 (low turnover), as determined in the milk labelling pilot study, were 
calculated using the formula stated previously.  For each muscle sample, precursor 
RIAs for parvalbumin alpha (high turnover) and beta-enolase (low turnover), as 
determined in the milk labelling pilot study, were also calculated.  The differences in 
turnover rates of these proteins may provide an insight into the investment received 
by each pup at different points during the 7 day experiment, so will be studied 
separately.  Every pup received investment from both females, with [D4] lysine and 
[D9] lysine labelled peptides present in all pup liver and muscle samples (Figure 4.26). 
For determining whether there was any statistical significance between the 
investment from a female in her own pups and in the pups from a related female, the 
difference between group means and the variation among and between groups was 
assessed for each of the four proteins using analysis of variance (ANOVA).  Where 
sample size was too small for ANOVA, a Welch two-sample t-test was used; all 
ANOVA and t-test tables are in the Supplementary Material.  Statistical analysis was 
conducted using R (www.r-project.org), a free software for statistical analysis and 
graphics.   To determine whether either female invested significantly more (or less) in 
the entire communal litter, the difference between entire group means was assessed 
using the Welch two sample t-test. 
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Figure 4.25 The RIA of heavy amino acid incorporation reached after 7 days in pairs 
of female mice assigned either [D
4
] lysine (female A) or [D
9
] lysine (female B) labelled 
diet in nests where females were related and both gave birth to litters (pages 197 - 
200). 
Urine samples were taken from the BALB/c females on the final day of the communal 
nursing experiment and were subjected to in-solution digestion with Lys-C and analysed 
using LC-MS. The RIAs for [D4] lysine and [D9] lysine were calculated for three MUP 
peptides in each urine sample (error ± SD, n = 3). The isotope distribution patterns for the 
1569 Da [M+2H]2+ MUP peptide are shown for each female urine sample – the [D4] lysine 
peptides are shown in green and the [D9] lysine peptides are shown in red.  The unlabelled 
peptides are shown in green for females assigned the [D4] lysine diet, and red for females 
assigned the [D9] lysine labelled diet. 
 
 
  
 196 
 
 Chapter 4: Communal nursing in the house mouse 
 
 
 
  
 197 
 
 Chapter 4: Communal nursing in the house mouse 
 
 
 
  
 198 
 
 Chapter 4: Communal nursing in the house mouse 
 
 
 
  
 199 
 
 Chapter 4: Communal nursing in the house mouse 
 
 
 
 
   
 
 
  
 200 
 
 Chapter 4: Communal nursing in the house mouse 
Litter 3 (from pair 3) 
The precursor RIAs calculated for each protein of interest for pups from female A and 
for pups from female B were visualised using boxplots (Figure 4.27).  A and B litter 
sizes were similar (4 pups and 3 pups, respectively), with litter B being 3 days older 
than litter A.   
The [D9] lysine RIAs for each protein are higher than the [D4] lysine RIAs, suggesting 
that female B consistently invests slightly more than female A in the communal litter.  
This difference was significant (Welch two sample t-test: t = -2.7058, df = 52.363, p = 
0.009176).  There is no significant difference between the [D4] lysine precursor RIAs 
in A and B pups (ANOVA – glutamate dehydrogenase 1: P =0 .93; beta-enolase: P = 
0.585; parvalbumin alpha: P = 0.821; non-specific lipid transfer protein: P = 0.904).  
There is no significant difference between the [D9] lysine precursor RIAs in A and B 
pups (ANOVA – glutamate dehydrogenase 1: P = 0.202; beta-enolase: P = 0.479; 
parvalbumin alph: P = 0.219; non-specific lipid transfer protein: P = 0.131).  The 
statistical analysis of calculated RIA values indicate neither female invested 
significantly differently in either litter in the communal nest, but female B appeared to 
invest significantly more in all pups than female A. 
Litter 4 (from pair 4) 
The precursor RIAs calculated for each protein of interest for pups from female A and 
for pups from female B were visualised using boxplots (Figure 4.28).  A and B litter 
sizes were 6 pups and 9 pups, respectively, with litter B being 2 days older than litter 
A.   
Again, the [D9] lysine RIAs for each protein are significantly higher than the [D4] lysine 
RIAs, indicating that female B consistently invests slightly more than female A in the 
communal litter (Welch two sample t-test: t = -3.5129, df = 117.3, p = 0.0006304).  
There is no significant difference between the [D4] lysine precursor RIAs in A and B 
pups (ANOVA – glutamate dehydrogenase 1: P = 0.66; beta-enolase: P = 0.149; 
parvalbumin alpha: P = 0.57; non-specific lipid transfer protein: P = 0.895) or the [D9] 
lysine precursor RIAs in A and B pups (ANOVA – glutamate dehydrogenase 1: P = 
0.901; beta-enolase: P = 0.933; parvalbumin alpha: P = 0.932; non-specific lipid 
transfer protein: P = 0.93). Again, neither female appeared to invest significantly 
differently in either litter in the communal nest, but female B appeared to invest more 
in all pups than female A. 
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 Litter 7 (from pair 7) 
The precursor RIAs calculated for each protein of interest for pups from female A and 
for pups from female B were visualised using boxplots (Figure 4.29).  A and B litter 
sizes were similar (4 pups and 5 pups, respectively), with litter B being 1 day older 
than litter A.  The [D4] lysine RIAs for each protein are significantly higher than the 
[D9] lysine RIAs, indicating that female A consistently invests more than female B in 
the communal litter (Welch two sample t-test: t = 7.6728, df = 67.717, p = 8.81e-11).  
Again, there is no significant difference between the [D4] lysine precursor RIAs in A 
and B pups (ANOVA –glutamate dehydrogenase 1: P = 0.157; beta-enolase: P = 
0.931; parvalbumin alpha: P = 0.119; non-specific lipid transfer protein: P = 0.718) or 
the [D9] lysine precursor RIAs in A and B pups (ANOVA –glutamate dehydrogenase 
1: P = 0.194; beta-enolase: P = 0.211; parvalbumin alpha: P = 0.108; non-specific 
lipid transfer protein: P = 0.214).  Again, neither female appeared to invest 
significantly differently in either litter in the communal nest, but in this nest, female A 
appeared to invest more in all pups than female B. 
In all three communal litters, no female appeared to discriminate between their own 
pups and their sister’s pups in terms of investment.  However, in all litters, one female 
appeared to invest more in the entire communal litter than the other.  Due to the small 
sample size, no reason for this could be determined (e.g. did females that gave birth 
first invest more? Did females with smaller litters invest more? etc.). 
4.2.4.3 Communal nursing in unrelated female pairs 
Protein in the mothers’ urine was digested in-solution with Lys-C and analysed using 
LC-MS, and all analysis and calculations were the same as those for the related 
female pairs, described in the previous section.  In all six unrelated female pairs, the 
female assigned the [D4] lysine diet (female A) appeared to have a fully [D4] lysine 
labelled precursor pool, with all calculated precursor RIA values being approximately 
0.5 (Figure 4.30).  None of these females appeared to consume any of the 
unassigned [D9] lysine diet, with the low RIA calculations for this protein as a result of 
noise in the spectrum, as no true isotopologue profile was observed.  In all pairs, the 
female assigned the [D9] lysine diet (female B) appeared to have a fully [D9] lysine 
labelled precursor pool.  None of these females appeared to consume any of the 
unassigned [D4] lysine diet, with the low RIA calculations for this protein as a result of 
the unlabelled peptide ion distribution (Figure 4.30). 
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Figure 4.30 The RIA of heavy amino acid incorporation reached after 7 days in pairs 
of female mice assigned either [D
4
] lysine (female A) or [D
9
] lysine (female B) labelled 
diet in nests where females were unrelated and both gave birth to litters (pages 208 
– 210). 
Urine samples were taken from the BALB/c females on the final day of the communal 
nursing experiment and were subjected to in-solution digestion with Lys-C and analysed 
using LC-MS. The RIAs for [D4] lysine and [D9] lysine were calculated for three MUP 
peptides in each urine sample (error ± SD, n = 3). The isotope distribution patterns for the 
1569 Da [M+2H]2+ MUP peptide are shown for each female urine sample – the [D4] lysine 
peptides are shown in green and the [D9] lysine peptides are shown in red.  The unlabelled 
peptides are shown in green for females assigned the [D4] lysine diet, and red for females 
assigned the [D9] lysine labelled diet. 
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 From each pup in each of the six communal litters from pairs 1 - 6, after the 7-day 
labelling experiment, liver and muscle samples were taken, homogenised, digested 
with Lys-C and analysed using LC-MS.  All analysis was carried out as described in 
the previous section, and again, every pup received investment from both females, 
with [D4] lysine and [D9] lysine labelled peptides present in all pup liver and muscle 
samples (Figure 4.31). 
Litter 1 (from pair 1) 
The precursor RIAs calculated for each protein of interest for pups from female A and 
for pups from female B were visualised using boxplots (Figure 4.32).  A and B litter 
sizes were notably different (7 pups and 2 pups, respectively), with litter B being 1 
days older than litter A.   
The [D9] lysine RIAs for each protein are higher than the [D4] lysine RIAs, suggesting 
that female B consistently invests slightly more than female A in the communal litter; 
however, this difference is not significant (Welch two sample t-test: t = -1.74, df = 
74.72, p = 0.0856).  There is no significant difference between the [D4] lysine 
precursor RIAs in A and B pups (Welch two sample t-test – glutamate dehydrogenase 
1: P = 0.93; beta-enolase: P = 0.585; parvalbumin alpha: P = 0.821; non-specific lipid 
transfer protein: P = 0.904).  There is no significant difference between [D9] lysine 
precursor RIAs in A and B pups (Welch two sample t-test – glutamate dehydrogenase 
1: P = 0.202; beta-enolase: P = 0.479; parvalbumin alpha: P = 0.219; non-specific 
lipid transfer protein: P = 0.131).  Neither female invested significantly differently in 
either litter in the communal nest or in the nest as a whole. 
Litter 2 (from pair 2) 
The precursor RIAs calculated for each protein of interest for pups from female A and 
for pups from female B were visualised using boxplots (Figure 4.33).  A and B litter 
sizes were notably different (2 pups and 7 pups, respectively), with both litters born 
on the same day.   
There was no significant difference between the [D4] and [D9] lysine RIAs in each 
protein, suggesting both females invested equally in the communal litter (Welch two 
sample t-test: t = -1.3797, df = 69.352, p = 0.1721).  Again, there is no significant 
difference between the [D4] lysine precursor RIAs in A and B pups (Welch two sample 
t-test – glutamate dehydrogenase 1: P = 0.364; beta-enolase: P = 0.058; parvalbumin 
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alpha: P = 0.248; non-specific lipid transfer protein: P = 0.229).  There is also no 
significant difference between the [D9] lysine precursor RIAs in A and B pups (Welch 
two sample t-test – glutamate dehydrogenase 1: P = 0.632; beta-enolase: P = 0.325; 
parvalbumin alpha: P = 0.388; non-specific lipid transfer protein: P = 0.903).  Neither 
female appeared to invest significantly differently in either litter in the communal nest, 
and neither female appeared to invest more (or less) than the other in the communal 
litter. 
Litter 3 (from pair 3) 
The precursor RIAs calculated for each protein of interest for pups from female A and 
for pups from female B were visualised using boxplots (Figure 4.34).  A and B litter 
sizes were similar (7 pups and 8 pups, respectively), with litter A born 4 days prior to 
litter B.   
There was no significant difference between the [D4] and [D9] lysine RIAs in each 
protein, suggesting both females invested equally in the communal litter (Welch two 
sample t-test: t = 0.4614, df = 113.197, p = 0.6454).  There is no significant difference 
between the [D4] (ANOVA: P = 0.38) and [D9] lysine (ANOVA: P = 0.344) precursor 
RIAs in A and B pups in the low turnover liver protein (glutamate dehydrogenase 1), 
however in the low turnover muscle protein (beta-enolase), there appeared to be 
significantly higher [D9] lysine RIA (from female B) in her own litter (litter B) than litter 
A (ANOVA: P = 0.066), but there is no significant difference between the [D4] lysine 
precursor RIAs in A and B pups (ANOVA: P = 0.614).  In the high turnover muscle 
protein (parvalbumin alpha), there appeared to be significantly higher [D9] lysine RIA 
(from female B) in her own litter (litter B) than litter A (ANOVA: P = 0.079), but again, 
no significant difference between the [D4] lysine precursor RIAs in A and B pups 
(ANOVA: P = 0.82).  In the high turnover liver protein (non-specific lipid transfer 
protein), there is no significant difference between the [D4] (ANOVA: P = 0.945) and 
[D9] lysine (ANOVA: P = 0.164) precursor RIAs in A and B pups.  Although these 
differences have been deemed significant, they are not highly significant (all P values 
are <0.05, but >0.01). This means there is between 95 – 99% chance that the 
differences between the groups of calculated RIA values are not due to random 
sampling. The significance codes provided in the R outputs of the ANOVA analysis 
are 0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’, and so the ‘.’ symbol is shown on the boxplots in 
Figure 4.32.   
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Litter 4 (from pair 4) 
The precursor RIAs calculated for each protein of interest for pups from female A and 
for pups from female B were visualised using boxplots (Figure 4.35).  A and B litter 
sizes were similar (2 pups and 3 pups, respectively), with litter A born 3 days prior to 
litter B.   
The [D4] lysine RIAs for each protein are higher than the [D9] lysine RIAs, indicating 
that female A consistently invests significantly more than female B in the communal 
litter (Welch two sample t-test: t = 3.2676, df = 37.998, p = 0.0023).  There was no 
significant difference between the [D4] lysine precursor RIAs in A and B pups (Welch 
two sample t-test – glutamate dehydrogenase 1: P = 0.16; beta-enolase: P = 0.335; 
parvalbumin alpha: P = 0.601; non-specific lipid transfer protein: P = 0.129).  There 
is also no significant difference between the [D9] lysine precursor RIAs in A and B 
pups (Welch two sample t-test – glutamate dehydrogenase 1: P = 0.535; beta-
enolase: P = 0.456; parvalbumin alpha: P = 0.442; non-specific lipid transfer protein: 
P = 0.673).  Neither female appeared to invest significantly differently in either litter in 
the communal nest, but female A appeared to invest significantly more in the 
communal litter than female B. 
Litter 5 (from pair 5) 
The precursor RIAs calculated for each protein of interest for pups from female A and 
for pups from female B were visualised using boxplots (Figure 4.36).  A and B litter 
sizes were similar (6 pups and 4 pups, respectively), with litter A born 5 days prior to 
litter B.   
The [D4] lysine RIAs for each protein are significantly higher than the [D9] lysine RIAs, 
with female A consistently investing more than female B in the communal litter (Welch 
two sample t-test: t = 7.7648, df = 75.227, p = 3.285e-11).  There is no significant 
difference between the [D4] (ANOVA: P = 0.994) and [D9] lysine (ANOVA: P = 0.617) 
precursor RIAs in A and B pups in the low turnover liver protein (glutamate 
dehydrogenase 1), however in the low turnover muscle protein (beta-enolase), there 
appeared to be significantly higher [D4] lysine RIA (from female A) in litter B than her 
own (llitter A) (ANOVA: P = 0.094), but there is no significant difference between the 
[D9] lysine precursor RIAs in A and B pups (ANOVA: P = 0.462).  The p-value of 
0.094, <0.1 but >0.05, is not deemed highly significant. In the high turnover muscle 
protein (parvalbumin alpha), there is no significant difference between the [D4]  
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(ANOVA: P = 0.547) and [D9] lysine (ANOVA: P = 0.636) precursor RIAs in A and B 
pups, and this was the case in the high turnover liver protein (non-specific lipid 
transfer protein) ([D4] lysine ANOVA: P = 0.994; [D9] lysine ANOVA: P = 0.617).  In 
this litter, not only did female A invest significantly more than female B in the entire 
communal litter, the boxplots in Figure 4.34 indicate that female A invested more (the 
statistical analysis of the precursor RIAs in beta-enolase suggest somewhat 
significantly) in female B’s litters than her own. 
Litter 6 (from pair 6) 
The precursor RIAs calculated for each protein of interest for pups from female A and 
for pups from female B were visualised using boxplots (Figure 4.37).  A and B litter 
sizes were similar (5 pups and 6 pups, respectively), with litter A born 4 days prior to 
litter B.   
The [D9] lysine RIAs for each protein are significantly higher than the [D4] lysine RIAs, 
indicating female B consistently invests slightly more than female A in the communal 
litter (Welch two sample t-test: t = -2.1432, df = 81.871, p = 0.035).  However, there 
was no significant difference between the [D4] lysine precursor RIAs in A and B pups 
(ANOVA –glutamate dehydrogenase 1: P = 0.862; beta-enolase: P = 0.344; 
parvalbumin alpha: P=0.633; non-specific lipid transfer protein: P=0.99).  There is 
also no significant difference between the [D9] lysine precursor RIAs in A and B pups 
(ANOVA –glutamate dehydrogenase 1: P=0.352; beta-enolase: P=0.166; 
parvalbumin alpha: P=0.68; non-specific lipid transfer protein: P=0.306).  Neither 
female appeared to invest significantly differently in either litter in the communal nest, 
but female B invested more in the communal litter than female A. 
In three of the six unrelated female pairs, both females appeared to invest similarly in 
the entire communal litter. In one of the pairs where one female invested more in the 
entire litter than the other (pair 5 of litter 5), one female invested ‘highly’ significantly 
more than the other, and in the other two pairs, one female invested significantly more 
than the other in the communal litter.  Again, there were no obvious reason for these 
differences.  In four of the six unrelated pairs, no female appeared to discriminate 
between their own pups and the other female’s pups in terms of investment.  In one 
pair (pair 3 of litter 3), there appeared to be a significant difference between pups A 
and B in the [D9] lysine RIAs calculated in both the high and low turnover muscle 
proteins.  In litter 5, there was a significant difference between pups A and B in the  
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[D4] lysine RIAs calculated in just one protein (the low turnover muscle protein beta-
enolase).  Since these communal litters were large (a total of 15 pups in communal 
litter 3 and 10 in litter 5), the differences were not consistent amongst the four 
proteins, and the differences were not highly significant, it is likely that the differences 
are due to random sampling and not discrimination in investment by either female. 
4.2.4.4 Communal nursing of single litters 
As stated in section 4.2.4.1, a total of 8 related female pairs and 9 unrelated female 
pairs were put together for breeding, but only 7 related and 6 unrelated female pairs 
gave birth to and raised communal litters. In the other 4 pairs, only pups from one 
female survived to the beginning of the experiment (day 1 of females being fed a 
labelled diet).  Since both females in each of these four pairs had given birth, all were 
lactating, and so it was of interest whether the females with no surviving pups invested 
in the pups in the communal nest who all belonged to the other female.  One pair of 
females were related, and three pairs were unrelated. 
Protein in the mothers’ urine was digested in-solution with Lys-C and analysed using 
LC-MS, and all analysis and calculations were the same as described in section 
4.2.4.2.  In pair 1 (related females), the female assigned the [D4] lysine diet (female 
A) appeared to have a partially [D4] lysine labelled precursor pool, whilst female B 
appeared to have a fully [D9] lysine labelled precursor pool.  Female A appeared to 
consume some of the unassigned [D9] lysine diet (Figure 4.36).  In the three unrelated 
female pairs, all females assigned the [D4] lysine labelled diet (female A) appeared to 
have a fully [D4] lysine labelled precursor pool.  Female A of pair 4 appeared to 
consume some of the unassigned [D9] lysine diet (Figure 4.38).  Female B in pairs 2 
and 3 appeared to have a partially [D9] lysine labelled precursor pool, and female B 
in pair 4 appeared to have a fully [D9] lysine labelled precursor pool.  Out of these 
three females, only female B in pair 3 appeared to consume some of the [D4] lysine 
diet (Figure 4.38).  After analysis of the pup samples, it was apparent that the 
incomplete labelling of some females, and the fact that three females appeared to 
consume some of the unassigned diet, did not need to be taken into consideration, 
since only the mother of the surviving pups invested in the litter in each case, with 
evidence of only her label being incorporated into pup tissues (Figure 4.39). 
From each pup in each of the four non-communal litters from pairs 1 - 4, after the 7-
day labelling experiment, liver samples were taken, homogenised, digested with Lys-
C and analysed using LC-MS.  Muscle samples were taken from pups in litters 2, 3  
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Figure 4.38 The RIA of heavy amino acid incorporation reached after 7 days in pairs 
of female mice assigned either [D
4
] lysine or [D
9
] lysine labelled diet in nests where 
only one litter survived to the experiment (pages 224 – 225). 
Urine samples were taken from the BALB/c females on the final day of the communal 
nursing experiment and were subjected to in-solution digestion with Lys-C and analysed 
using LC-MS. The RIA was calculated from the most abundant MUP peptide in each urine 
sample. The RIAs for [D4] lysine and [D9] lysine were calculated for three MUP peptide in 
each urine sample (error ± SD, n=3). The isotope distribution patterns for the 1569 Da 
[M+2H]2+ MUP peptide are shown for each female urine sample – the [D4] lysine peptides 
are shown in green and the [D9] lysine peptides are shown in red.  The unlabelled peptides 
are shown in green for females assigned the [D4] lysine diet, and red for females assigned 
the [D9] lysine labelled diet. 
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 Chapter 4: Communal nursing in the house mouse 
and 4, and were analysed in the same way.  All analysis was carried out as described 
in section 4.2.4.1. 
Non-communal litter 1 (from related pair 1) 
The 7 pups in the non-communal litter all belonged to female B.  The precursor RIAs 
calculated for each liver protein of interest for pups were visualised using boxplots 
(Figure 4.40).  Only female B invested in the litter – the [D9] lysine RIAs in the two 
selected liver proteins in pups averaged at 0.13 in the low turnover protein (glutamate 
dehydrogenase 1) and at 0.20 in the high turnover protein (non-specific lipid transfer 
protein). Female A did not invest in any of her sister’s pups, with no evidence of [D4] 
lysine in the two liver proteins. The Welch two sample t-test confirmed that this 
difference in investment from the two females was highly significant (t = -18.4109, df 
= 13, p = 1.077e-10).   
Non-communal litter 2 (from unrelated pair 2) 
In this unrelated pair, all 4 pups in the non-communal litter belonged to female A.  The 
precursor RIAs calculated for each liver and muscle protein of interest for pups were 
visualised using boxplots (Figure 4.41).  Only female A invested in the litter – female 
B invested in none of Female A’s pups, with no evidence of [D9] lysine in any of the 
proteins.  The [D4] lysine RIAs in the pups averaged at 0.25, ranging from 
approximately 0.21 in the low turnover proteins (glutamate dehydrogenase 1 and 
beta-enolase) to 0.32 in the high turnover liver protein (non-specific lipid transfer 
protein). As expected, the Welch two sample t-test confirmed that this difference in 
investment from the two females was highly significant (t = 21.8468, df = 15, p = 
8.743e-13).   
Non-communal litter 3 (from unrelated pair 3) 
The 2 pups in the non-communal litter belonged to female A.  The precursor RIAs 
calculated for each liver and muscle protein of interest for pups were visualised using 
boxplots (Figure 4.42).  Again, only female A invested in the litter – female B invested 
in none of Female A’s pups, with no evidence of [D9] lysine in any of the proteins.  
The [D4] lysine RIAs in the pups averaged at 0.26, ranging from approximately 0.21 
in the low turnover proteins (glutamate dehydrogenase 1 and beta-enolase) to 0.32 
in the high turnover liver protein (non-specific lipid transfer protein).  The Welch two  
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Figure 4.40 The RIAs of heavy amino acid incorporation reached after 7 days in non-
communal Litter 1 pup liver samples as a result of investment from related mothers 
(Pair 1), who were assigned either [D
4
] lysine (female A) or [D
9
] lysine (female B) 
labelled diet.  
Tissue samples were taken from all pups on the final day of the communal nursing 
experiment and were subjected to homogenisation and in-solution digestion with Lys-C 
and analysed using LC-MS. The RIAs in each tissue sample were calculated for glutamate 
dehydrogenase 1 (low turnover in liver), non-specific lipid transfer protein (high turnover in 
liver). Boxplots show the average RIAs of the each litter in the communal nest, along with 
the variation of calculated RIAs amongst the litter. 
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 sample t-test confirmed that this difference in investment from the two females was 
highly significant (t = 15.8506, df = 7, p = 9.645e-07).   
Non-communal litter 4 (from unrelated pair 4) 
The 2 pups in the non-communal litter belonged to female A.  The precursor RIAs 
calculated for each liver and muscle protein of interest for pups were visualised using 
boxplots (Figure 4.43).  As with the other three non-communal litters, only the mother 
of the pups invested in the litter – female B invested in none of Female A’s pups, with 
no evidence of [D9] lysine in any of the proteins.  The [D4] lysine RIAs in the pups 
averaged at 0.27, ranging from approximately 0.21 in the low liver turnover protein 
(glutamate dehydrogenase 1) to 0.32 in the high turnover liver protein (non-specific 
lipid transfer protein).  The Welch two sample t-test confirmed that this difference in 
investment from the two females was highly significant (t = 21.7305, df = 11, p = 
2.19e-10).   
In the related pair and the three unrelated female pairs, only the mother of the single 
litter of pups appeared to invest in the litter.  As a result, the differences in female 
investment in all four non-communal litters were deemed highly significant.  As all the 
investing females had fully, correctly labelled precursor pools, the fact that the non-
investing females did not have fully, correctly labelled precursor pools did not need to 
be taken into account when calculating precursor RIA values in pup tissue samples. 
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4.3 Conclusions 
The aim of this study was to determine the proportion of lactation investment from 
communally nursing house mice to determine any discriminatory factors, mainly the 
relatedness of the female pairs (mothers) in the communal nest.  This was done by 
successfully incorporating two different labelled amino acids, one into each female in 
the pair, via a semi-synthetic diet until whole animal metabolic labelling had been 
achieved.  The labelled amino acid was then transferred to the pups which the 
females invested in via their milk, and so the amount of each label present in pup 
tissues determined the proportion of investment from each of the two females.  Label 
incorporation into proteins in the mother’s liver, milk and pup’s tissues was confirmed 
by mass spectrometric analysis of female urine, pup stomach contents and pup tissue 
samples.  The rate of incorporation of label into females was studied, followed by the 
development of a feeding mechanism that allowed two females living together to 
consume two differently labelled diets.  The incorporation of label into proteins in 
female’s milk was confirmed, as was the incorporation into proteins in pup tissues.  
These preparatory experiments allowed the successful tracking of labels, and 
therefore investment, from pairs of females in the pups in their communal litter.  
Statistical analysis enabled the determination of any significant differences in 
investment from either mother in the litters present in the communal nest. 
Incorporating labelled amino acids into adult female BALB/c mice via a semi-synthetic 
diet was successful – diets were 50% labelled with the chosen synthetic amino acid, 
so that mice found the diet palatable and so whole animal metabolic labelling was 
achieved.  To determine the rate of full incorporation of the labelled amino acids into 
all proteins in the animal, female mice were fed either a [2H8] valine or [13C6] lysine 
labelled diet.  Urine samples were taken from them daily, and mass spectrometric 
analysis of MUPs in the urine allowed analysis of the liver precursor pool.  Labelled 
and unlabelled MUP peptides were identified in the mass spectra, and precursor RIA 
values for the protein were calculated from the signal intensities of the labelled and 
unlabelled peptides.  A precursor RIA of 0.5 indicated a fully labelled precursor pool 
(as the diet provided was 50% labelled). Fully labelled precursor pools were reached 
in the animals within 2 – 3 days of being fed a labelled diet: at this point, all proteins 
being synthesised in the liver and all proteins degrading contain both labelled and 
unlabelled valine/lysine, returning an almost equal amount of these to the precursor 
pool (Figure 4.44).  In the feeders analysis and milk labelling experiments mice were 
fully labelled within 1 – 2 days of being fed a labelled diet.   
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Figure 4.44 Summary of incorporation of labelled amino acids into adult female 
BALB/c mice via labelled diets, using copies of Figure 4.2 and Figure 4.6. 
Top panel: Peptide mass fingerprint of female BALB/c mouse urine prior to labelled diet. 
Whole urine was digested with Lys-C and subjected to MALDI-ToF-MS analysis. Labelled 
are the MUP peptides identified by database search via Mascot search engine. Bottom 
panel: Urine samples were taken from the four BALB/c females at various time intervals 
over a six-day period of being fed a labelled diet. Samples were digested with Lys-C and 
analysed using MALDI-ToF-MS. An average RIA was calculated from the three most 
abundant valine-containing (a) and lysine-containing (b) peptides for each day (error ± 
SD). Average maximum RIAs reached for each mouse are shown by a red line. 
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A feeding mechanism in the communal nesting cages was developed at Leahurst 
which allowed two females, living in the same cage, to access two differently labelled 
diets whilst not having access to the other diet.  The feeding mechanism was tested 
with three pairs of mice – in each pair, one female was assigned a [2H8] valine diet, 
and the other, a [13C6] lysine diet.  Over the five day experiment, urine samples were 
taken from each animal daily, and the mass spectrometric analysis of MUPs in the 
urine allowed analysis of the liver precursor pool.  [2H8] valine and [13C6] lysine labelled 
and unlabelled MUP peptides were searched for in the mass spectra, with all MUP 
peptides analysed for the presence of the ‘correct’ label (the label arising from the 
labelled diet which the mouse was assigned), and also the presence of the ‘wrong’ 
label (the label from the diet which the other mouse in the pair was assigned to).  
Calculated precursor RIA values confirmed that mice were fully labelled with their 
assigned diet after 1 – 2 days of the experiment, with no evidence of any animal 
consuming any of the wrong, unassigned diet.  The mechanism allowed mice to 
access their assigned diet, whilst preventing it from accessing any of the unassigned 
diet (Figure 4.45). Come the communal nursing experiment, with this cage/feeding 
mechanism set-up, two female mice would be able to live, nest, and communally 
nurse their litters, allowing their investment in the pups can be tracked via the transfer 
of two different labels from the mothers to the pups.   
The rate at which labelled amino acids were incorporated into the milk of lactating 
females was assessed by feeding three pairs of communally nesting females a [13C6] 
lysine labelled diet once both females in the pair had given birth to their litter.  Analysis 
of the mothers’ urine, which was taken daily during the labelling stage, showed that 
MUPs were fully labelled within 1 - 2 days of being fed the labelled diet.  The stomach 
contents of a single pup were taken daily for the analysis of the labelling of milk 
proteins.  In the sample taken from a pup immediately prior to the labelling stage, no 
[13C6] lysine labelled peptides were observed in the MALDI-ToF spectrum, confirming 
that no label was present in the mothers’ milk prior to being fed the labelled diet.  Over 
the course of the experiment, the lactation elevation protein present in the milk 
samples labelled at the same rate as MUPs in the mothers’ urine.  A slightly lower 
precursor RIA was calculated in the milk samples recovered on days 2 and 3 of the 
experiment, and this is likely to be due to the time at which these samples were taken:  
in the initial kinetics experiment, where the labelling of the female liver precursor pool 
was assessed, precursor RIAs calculated in the MUP peptides were slightly lower in 
the urine samples taken in the morning than the ones taken in the afternoon/evening 
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Figure 4.45 Summary of the feeding mechanism developed to allow two communally 
nesting females to consume differently labelled diets, using copies of Figure 4.7 and 
Figure 4.9. 
Left panel: Two feeding traps, each containing a different diet, are positioned at each end 
of the cage, with both mice having access to all parts of the cage. Each female mouse has 
an RFID chip implanted, and this chip can be read by the sensor coil placed at the entrance 
of each feeding mechanism.  If a mouse approaches the correct diet, the feed will remain 
in reach of the mouse. If a mouse was to approach the incorrect diet, the feeding 
mechanism would sense this via the chip carried by the mouse, and would subsequently 
move the diet away from the cage, out of reach of the mouse. Right panel: The rate of 
heavy amino acid incorporation over 6 days in three mice fed [2H8] valine labelled diet (top) 
and three mice fed [13C6] lysine labelled diet (bottom).  Three nests with the feeding 
mechanism contained two female BALB/c mice in each, each mouse in the pair was 
assigned either the [2H8] valine diet or the [13C6] lysine diet.  Urine samples were taken 
from the six mice every day over the six-day period, digested with Lys-C and analysed 
using MALDI-ToF-MS. An average daily RIA was calculated from the two most abundant 
valine and lysine-containing MUP peptides for each mouse, each day (error ± SD). 
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 (Figure 4.46).  This is because mothers will have been inactive during their ‘day’ 
period overnight, and so will have been consuming less labelled diet prior to the 
morning samples being taken.  In this experiment, pup stomach contents were taken 
at 9 am, and so the slightly lower RIAs calculated for the milk proteins are likely to be 
as a result of the inactivity of the mothers during the previous night.  Taking into 
account that mothers’ urine was sampled at 5 pm daily, after their active period, the 
proteins in the mothers’ milk (in the pup stomachs) reaches a similar labelling 
maximum, at a similar rate, to the protein in the mothers’ urine. 
The rate at which labelled amino acids were incorporated into the pups was assessed 
by analysing pup urine, liver and muscle samples, which were taken at the same time 
as the stomach contents.  Precursor RIA values were calculated for two proteins in 
the urine, and were much lower than those calculated in the pup stomach contents, 
not reaching a maximum labelling plateau at any point during the experiment.  This is 
because label incorporation into the pups is much slower, as the label is introduced 
into the pups indirectly, and the rate of growth of pups means that the label is being 
diluted by a greater amount of unlabelled protein present in the precursor pool.  The 
precursor RIAs in serum albumin in the urine increase throughout the experiment, 
confirming that the label is being successfully incorporated into the pups.  Analysis of 
the proteins in liver and muscle samples was by LC-MS, whilst all previous samples 
had been analysed using MALDI-ToF-MS since for protein discovery, the separation 
of peptides and the use of ESI-QToF allowed the generation of better product ion 
information and therefore more accurate peptide identification.  The liver and muscle 
samples taken on the final day of the milk labelling experiment were analysed first, to 
determine the maximum RIAs reached in the top 20 proteins in each sample type.  
Maximum precursor RIAs in the pup liver ranged from 0.15 to 0.47, and in pup muscle 
from 0.15 to 0.36 (Figure 4.47).  The aim was to find a high and low turnover protein 
from each tissue type, with high turnover proteins incorporating the label more quickly 
(high precursor RIAs) than low turnover proteins (low precursor RIA).  Proteins with 
different turnover rates in pup tissues were hoped to give information regarding 
investment from mothers at different time points during communal nursing.  High 
turnover proteins degrade and return to the protein precursor pool quickly, with newly 
synthesised labelled proteins taking their place. This high turnover of proteins causes 
rapid labelling of the precursor pool, so recent changes in label investment can be 
identified through the analysis of these proteins.  The opposite is true for low turnover 
proteins, meaning that these proteins may be able to report on variations in label  
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Figure 4.46 Summary of the experimental set up of the milk labelling pilot and the 
rate of heavy amino acid incorporation over 6 days in adult female urine, pup 
stomach contents and pup urine. 
Three pairs of pregnant females lived and gave birth in in a communal nursing cage, 
consuming an unlabelled diet. When all females had given birth, a single pup was taken 
from one of the communal litters for analysis, along with urine samples from all females.  All 
females were then switched to a [13C6] lysine labelled diet.  Over days 1 – 6, urine from all 
females was sampled daily for analysis, and two pups were taken from one of the three 
communal litters (highlighted in red) for analysis each day over the course of the labelling 
experiment. Female urine samples were digested with Lys-C and analysed using MALDI-
ToF-MS. An average RIA for the three mice calculated from the most abundant lysine-
containing peptide for each day (n = 6, error ± SD). Pup stomach contents and urine 
samples were digested with Lys-C.  Samples were subjected to LC-MS analysis for protein 
discovery, further and analysis and RIA calculations were carried out in the same way as 
the mothers’ urine, using MALDI-ToF-MS.  
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investment over a longer period of time. For each pup tissue type, a protein with a 
high precursor RIA and one with a low precursor RIA on the final day of the 
experiment was selected, and the precursor RIAs of these proteins were observed in 
the tissues over the course of the labelling experiment to determine whether these 
proteins were high/low turnover and whether they could be used to report variations 
in labelling at different points during the later communal nursing experiment.  Whilst 
these different proteins incorporated the label at different rates and reached different 
maximum RIAs by the end of the experiment, indicating that these proteins had 
different turnover rates, none of the proteins reached a labelling plateau (Figure 4.47).  
The slow incorporation of label into pup proteins is due their rate of growth, as 
observed in the analysis of the proteins in pup urine samples.  Despite this, all four of 
these proteins in pup tissues labelled at a significant enough rate to be suitable for 
analysis of pup tissues to track investment from differently labelled females in the 
communal nursing experiment. 
For the communal nursing study, 8 related female pairs and 9 unrelated female pairs 
were set up to give birth and nurse their litters in the communal nest. In order to track 
the investment from each mother in a communal litter, each mother consumed a 
differently labelled diet (one labelled with [D4] lysine, the other with [D9] lysine) via the 
established feeding mechanism when the first litter in the nest to be born was 7 days 
old.   The mothers were fed these diets for 7 days.  This resulted in two different labels 
being incorporated, one into each mother, which were passed on to the communal 
litter via their milk, and incorporated into the pups they invested in (Figure 4.48).  The 
precursor RIAs of each label present in the proteins in the pup’s tissues indicated the 
proportion of investment from each mother. 
In communal nests where the two mothers were related (7 pairs of females and 7 
communal litters), only the females assigned the [D4] lysine labelled diet appeared 
fully labelled with the correct diet, with no evidence of consuming any of the 
unassigned [D9] lysine diet.  Only three out of seven females assigned the [D9] lysine 
diet were fully labelled with the correct diet; four were partially [D9] lysine labelled, and 
two of these showed evidence of having consumed some of the unassigned [D4] 
lysine diet.  The reason for these mice having lower [D9] lysine RIA values is likely to 
be as a result of them consuming less diet – as urine samples were only taken on the 
final day of the experiment, it is unknown whether these animals were consuming less 
diet throughout the experiment, or just on the day prior to sampling (as it had been 
established in previous experiments that precursor RIAs in MUPs were lower in  
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Figure 4.48 Summary of the experiment to track investment in communal litters. 
(a)Pregnant females lived and gave birth in pairs (8 related pairs, 9 unrelated pairs).  When 
both females had given birth, one female was fed [D4] lysine labelled diet and the other 
was fed [D9] lysine labelled diet.  These labels were then passed to the pups they invested 
in via their labelled milk, allowing the investment from each mother to be tracked due to 
the presence of labels in pup tissue samples. (b) Summary of the RIAs of heavy amino 
acid incorporation reached after 7 days in litters with related mothers, in litters with 
unrelated mothers and in non-communal litters, where only the pups from one mother in 
the pair survived.  Mothers were assigned either [D4] lysine (female A) or [D9] lysine (female 
B) labelled diet. Tissue samples were taken from all pups on the final day of the communal 
nursing experiment, homogenised, digested with Lys-C and analysed using LC-MS. The 
RIAs in each tissue sample were calculated for glutamate dehydrogenase 1 (low turnover 
in liver), beta-enolase (low turnover in muscle), parvalbumin alpha (high turnover in 
muscle) and non-specific lipid transfer protein (high turnover in liver). Boxplots show the 
calculated RIAs of [D4] lysine in A pups and B pups (green), and of [D9] lysine in A and B 
pups (red) for all related (bottom left) and unrelated (bottom centre) communal litters. The 
p-values are calculated from Welch t-tests between the [D4] lysine RIAs calculated for A 
and B litters in the nests, and the same between the [D9] lysine RIAs. For the non-
communal litters (bottom right), the boxplots show the calculated RIAs of the heavy label 
received from the mother of the litters (green) and the mother with no surviving pups (red).  
The p-value is calculated using the Welch two sample t-test. 
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samples taken after the ‘inactive’ period).  It is unknown whether these mice were 
consuming less diet because of a possible problem with the feeding mechanism, 
however this is unlikely due to no problems being encountered in any of the previous 
experiments.  The fact that two of the [D9] lysine assigned mice had very low intensity 
[D4] lysine peptides in their urine could be due to the [D4] lysine female bringing and 
dropping small amounts of their [D4] lysine diet into the communal nest, and so 
accessible by the [D9] lysine assigned female.  The precursor RIA values for [D4] and 
[D9] lysine labelled peptides were calculated for the four proteins selected in the milk 
labelling study in the tissue samples of pups from litters where both mothers were 
fully, correctly labelled.  The difference between group mean RIAs and the variation 
among and between group RIAs was assessed for each of the four proteins using 
analysis of variance (ANOVA) or in cases where litter sizes were too small for 
ANOVA, the Welch two sample t-test.  To determine whether either female invested 
significantly more (or less) in the entire communal litter, the difference between entire 
group mean RIAs was assessed using the Welch two sample t-test. This determined 
whether there was any statistical significance between the investment from a female 
in her own pups and in the pups from a related female.  There were no statistically 
significant differences between a mother’s investment in her own pups and her sisters 
in all communal litters (i.e. no difference between the [D4] lysine RIAs calculated in 
the pups belonging to the [D4] lysine mother and the pups belonging to the [D9] lysine 
mother, and vice versa).  However, in all litters, one female appeared to invest more 
in the entire communal litter than the other.  The reason for this cannot be determined 
due to the small number of communal litters studied.  There was no apparent link 
between size or age of litter and the proportion of communal investment from their 
mother, but when relating back to previous literature, Wilkinson and Baker, (1988) 
and Konig, (1989) state that in captivity, wild female house mice appear to take turns 
nursing each other’s offspring in communal nests.  Taking into account the growth 
rate and high protein turnover in pups,  it is possible that in this communal experiment, 
the females have been taking turns in indiscriminately investing in the entire 
communal litter, and it could be that the female who appeared to invest ‘more’ was in 
fact the last female to nurse the communal litter before the end of the experiment, 
and that throughout the experiment, both females were investing similarly, taking it in 
turns to nurse the entire communal litter. 
In communal nests where the two mothers were unrelated (6 pairs of females and 6 
communal litters), all females were fully labelled with the correct label, with no 
evidence of having consumed any of the unassigned diet, which indicates that the 
 
 
  
 243 
 
 Chapter 4: Communal nursing in the house mouse 
feeding mechanisms are functioning correctly.  In four of the six unrelated pairs, no 
female appeared to discriminate between their own offspring and their non-offspring 
in terms of investment (i.e. no difference between the [D4] lysine RIAs calculated in 
the pups belonging to the [D4] lysine mother and the pups belonging to the [D9] lysine 
mother, and vice versa).  In one pair, there appeared to be a significant difference 
between the two litters in the communal nest in the [D4] lysine RIAs calculated in one 
protein.  In another pair, in two proteins, there was a significant difference between 
the two litters in the [D9] lysine RIAs calculated.  Since these communal litters were 
large, the differences were not consistent amongst the four proteins, and the 
differences were not highly significant, it is likely that the differences were due to 
random sampling and not discrimination in investment by either female.  In three of 
the unrelated female pairs, both females appeared to invest similarly in the entire 
communal litter. In one pair, one female seemed to invest ‘highly’ significantly more 
than the other, and in two pairs, one female invested more in the communal litter.  
Again, there were no obvious reason for these differences, with no apparent link 
between size or age of litter and the proportion of communal investment from their 
mother, but the differences could be due to females taking turns in nursing the entire 
communal litter. 
In the four communal nests where the pups all belonged to only one of the females 
in the pair, in three pairs, only the mother of the pups in each pair was fully labelled.  
In one pair, both females were fully labelled, and in all four pairs, no female appeared 
to consume any of the unassigned diet.  The fact that the females with no surviving 
pups generally appeared partially labelled may be due to them consuming less diet 
due to stress, or the fact they did not need to consume as much since they were not 
expending energy investing in the pups.  In all four litters, pups received investment 
from their mothers only, and none from the other female in the communal nest.  This 
was the case in both the related pair and the unrelated pairs.  As a result, the 
differences in investment from each mother in the litter was highly significant. In this 
study, the proportion of lactation investment from communally nursing house mice in 
pup litters was successfully studied with the use of two different labels, and it was 
determined that both related and unrelated female pairs do not discriminate between 
nursing their own litters and the litter from the other female (Figure 4.48).  However, 
in pairs where only one female’s pups survived, only the mother of the litter invested 
in the pups, with the other lactating female not investing in any of the other female’s 
pups (Figure 4.48).  This supports the rejection of the hypotheses that in communal 
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nests, milk stealing occurs and that pup nursing is indiscriminate (Konig 2006), and 
also suggests that females alleviating discomfort by ridding themselves of excess milk 
is not a major reason why female house mice communally nurse.  Konig (2006) 
confirmed that communal nursing increased reproductive success, whether or not 
females were related, but that mutualistic cooperation was higher in nests where 
females were related.  Konig (1994) also stated that whilst familiar females 
(regardless of relatedness) nesting communally improved female reproduction and 
pup survival, female groups which were familiar and related also produced the largest 
litters with heaviest pups, suggesting that relatedness of females results in increased 
investment in litters.  In this study, both familiar related and familiar unrelated female 
pairs did not discriminate between their own and other female’s pups in terms of 
nursing, which supports the statements by Konig that increased reproductive success 
and pup survival results from communal nursing of females, regardless of their 
relatedness.  In the majority of related and unrelated female pairs, one female 
invested more in the entire communal litter than the other (in all three related pairs 
and in three of the six unrelated pairs).  This indicates no evidence of higher 
mutualistic cooperation in nests where females are related (Konig 2006). Konig 
(1994) stated related females produced the largest litters, but this was not found to 
be the case in this study (Welch two sample t-test: t = -0.55, df = 4.1, p = 0.61).  Also, 
there was no significant difference between the weights of the pups (after the 7 day 
experiment) in related and unrelated female communal nests (Welch two sample t-
test: t = 0.42, df = 101.6, p = 0.68).  Manning et al. (1995) found that in communal 
litters where there was an age difference of 3 - 4 days, mothers of the older litters 
preferentially retrieved their own pups, but the mothers of younger litters did not 
discriminate between their own offspring and alien offspring.  This was not found to 
be the case in this study, where communal litter age differences ranged from 0 - 5 
days, and no female preferentially retrieved their own pups.  This was only the case 
where only one mother had surviving pups.  Of interest was the fact that in most 
communal nests, one mother invested more in the entire communal litter than the 
other, so it was considered whether litter size or litter age differences linked to the 
female investing more than the other in the communal litter.  In the four nests where 
the pups born to the [D9] lysine female were older (age difference ranging from 1-3 
days), the [D9] lysine labelled female invested more in the entire communal litter in 
three of these nests.  In the four nests where the pups born to the [D4] lysine female 
were older (age difference ranging 3-5 days), the [D4] lysine female invested more in 
the entire communal litter in two of these nests.  Therefore, there is no definite link 
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between age differences and amount of communal investment from a mother.  There 
is also no apparent link between communal investment from a mother and litter sizes 
within the communal nest, so it is possible that the apparent differences in investment 
are actually due to the mothers taking turns in investing in the entire communal litter. 
Stable isotope labelling strategies and mass spectrometry have enabled investment 
from communally nursing female mice to be tracked in their pups to discover whether 
any discrimination in investment is evident in relation to relatedness of the female 
pairs in the nest. No females, related or unrelated, discriminated between their own 
pups and their female partners’ when investing.  As a result, there was no difference 
in pup weights and litter sizes from related and unrelated female nests; regardless of 
relatedness, familiar females cooperatively invest in communal litters to increase 
reproductive success. In order to determine why, in most cases, one female invests 
significantly more in the entire communal litter than the other, further communal 
nursing experiments would need to be carried out to discover whether there is a link 
between investment from a mother and the age of her pups – in more than half of the 
communal nests, the mother of the older litter invested more, so this is a possible link 
which is best explored with a greater sample size.  To determine whether the 
differences in investment are observed throughout the communal nursing experiment, 
or whether the apparent differences in investment are due to mothers taking turns, 
pup samples would be needed to be removed from the communal nest at intervals 
during the experiment as well as on the final day. 
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5.1 Introduction 
Major urinary proteins (MUPs) in mouse urine play a significant role in olfactory 
communication amongst conspecifics.  MUPs bind, protect and slowly release the 
volatile components in scent marks that elicit various behavioural and physiological 
responses in mice, including aggression between male mice (Novotny et al. 1985; 
Jemiolo et al. 1985) and the onset of puberty in female mice (Novotny et al. 1999).  
However MUPs, in the absence of volatile pheromonal ligands, also have roles in 
modulating identity signalling, attractiveness and aggressive responses (Hurst et al. 
2001; Chamero et al. 2007; Roberts et al. 2010).  Since the regulation of MUP 
expression of an individual is altered by situations such as reproductive status and 
social setting (Stopka et al. 2007), and that in wild mice, MUP profiles could be used 
by conspecifics in recognition and to avoid inbreeding, it is essential that as well as 
identifying the MUPs and their roles in chemical signalling, the differences in MUP 
expression profiles are quantified.  For a definitive assessment of the variation in MUP 
expression of an individual in different situations, and the differences in MUP 
expression profiles between individuals, a suitable quantification method needs to be 
developed. 
Previously, the absolute quantification of MUPs was based on QconCAT technology; 
a label–mediated methodology for absolute protein quantification.  A QconCAT is an 
artificial concatamer of different peptides from a number of different protein targets.  
This [13C6] lysine labelled standard is added to the sample prior to proteolysis, and 
upon digestion, the labelled ‘Q peptides’ are generated, which act as standards for 
the target peptides in the sample in LC-MS analysis (Beynon et al. 2005; Pratt et al. 
2006; Brun et al. 2009).  Quantification of analyte peptides is by the ratio between the 
analyte (‘light’ peptides) and previously-quantified QconCAT (‘heavy’) peptides (Pratt 
et al. 2006).   A QconCAT for the quantification of the inbred laboratory strain C57BL/6 
MUPs was designed by Dr S. Armstrong and Dr. D. Simpson, University of Liverpool, 
and the quantification method was developed and implemented by Dr. J. Unsworth 
(University of Liverpool).  However, problems were encountered using a QconCAT 
for the absolute quantification of MUPs (Beynon et al. 2014; 2015).  Firstly, the high 
sequence similarity between the MUP variants, particularly central MUPs, meant that 
for some MUPs, no unique peptide could be generated for use in the quantification of 
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that protein.  Other problems encountered included peptides undergoing 
deamidation, incomplete digestion of MUPs and peptides that ionised poorly in mass 
spectrometric analysis (Dr. J. Unsworth, Ph.D Thesis).  Despite these challenges, the 
QconCAT methodology was successfully implemented in the quantification of MUPs 
from the inbred C67BL/6 laboratory strain (Beynon et al. 2015). 
Whilst the QconCAT was effective for the quantification of the MUPs expressed by 
an inbred laboratory strain, further complications could arise from the high rate of 
evolution of these proteins (Beynon et al. 2014); wild–caught mice have been found 
to express new allelic variants of MUP (Robertson et al. 1996; Beynon et al. 2002) 
which upon proteolysis may generate peptides different to those in the designed MUP 
QconCAT.  The analysis of MUPs from different Mus subspecies may also reveal 
MUPs that are different in sequence to those present in the C57BL/6 laboratory 
mouse strain (Robertson et al. 2007), and in both of these cases, new QconCATs 
would have to be designed and constructed.  Given the challenges in the design of 
the existing MUP QconCAT, the development of a new method that is more suitable 
for the absolute quantification of highly homologous proteins to quantify new MUP 
variants is essential, and this method could be used alongside the existing QconCAT 
methodology that quantifies the known C57BL/6 MUPs. 
A popular method for the absolute quantification of proteins involves the use of 
isotope labelled full length proteins known as PSAQ standards, with the term ‘PSAQ’ 
being an abbreviation of ‘Protein Standards for Absolute Quantification’ (Brun et al. 
2007) (Figure 5.1).  As with QconCATs, PSAQ standards share the same biochemical 
properties as their targets, and so behave identically to the proteins in the sample 
throughout sample preparation and MS analysis (Dupuis et al. 2008; Brun et al. 2009).   
Also, because these standards are spiked in defined amounts at the beginning of 
sample preparation, there are no differences between standard and sample digestion 
efficiency, providing more accurate quantification at MS level (Kaiser et al. 2011).    
PSAQ provides greater sequence coverage due to the use of a full length protein 
standard, meaning isoforms and variants may also be distinguishable (Brun et al. 
2009).   Since the current challenges with MUP quantification are mainly based on 
the proteins’ sequence homology, the high rate of MUP evolution and the lack of a 
unique peptide for each protein, the use of a full length protein standard, based on 
the idea of the PSAQ methodology, may address these problems. Instead of using 
the ‘bottom up’ workflow employed with PSAQ standards prior to MS analysis (Brun 
et al. 2007), it was considered whether quantification could take place at the intact  
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Figure 5.1 Summary of a) QconCAT and b) PSAQ quantification workflows. 
a) MS–based absolute quantification of proteins using a QconCAT, an artificial concatamer 
of different isotope-labelled proteotypic peptide(s) of the target protein(s).  This is added 
prior to digestion, where the labelled ‘Q’ peptides are generated. b) MS–based absolute 
quantification using PSAQ, where an isotope labelled version of the target protein is added 
directly to the sample at the beginning of sample preparation. 
   
 249 
 
 Chapter 5: Quantification of mouse major urinary proteins 
protein level (‘top down’), since intact protein analysis, by electrospray ionisation 
mass spectrometry (ESI-MS), is already well established for the accurate 
identification of MUP isoforms (Evershed et al. 1993; Robertson et al. 1996; Beynon 
et al. 2002; Robertson et al. 2007). 
For the analysis of MUPs, ESI-MS has proved invaluable.  The urine of an individual 
mouse contains a number of MUP variants, and MUP expression can vary greatly in 
individuals and amongst wild-caught mice; ESI-MS is able to accurately identify and 
distinguish between the molecular weights of most MUP isoforms, which has allowed 
the comparison of MUP phenotype between mice of inbred strains and wild 
populations (Robertson et al. 1996; Beynon et al. 2002; Robertson et al. 2007).  Whilst 
the processed and deconvoluted spectra from ESI-MS analysis of MUPs primarily 
reports the molecular weights of the MUPs present in the sample, it can also provide 
an indication of the amount of each MUP present in the sample, relative to each other.  
MaxEnt is a method which ‘simplifies the electrospray spectra from complex mixtures’ 
based on maximum entropy, which measures molecular weight and quantitative 
relative intensities of the sample components’ (Ferrige et al. 1991; Ferridge et al. 
1992; Cottrell and Green 1993; Cottrell and Green 1998). Maximum entropy 
techniques, having previously been applied to Raman and NMR spectroscopy for 
signal to noise enhancement and spectral deconvolution, were first successfully 
applied to electrospray mass spectra in 1991 (Ferridge et al. 1991). Electrospray 
spectra of protein mixtures are complex, with each protein in the mixture represented 
by a multiply charged ion series (Ferridge et al. 1992). Therefore, to aid the 
interpretation of mass spectra of protein mixtures, a way to transform each 
component from the multiply charged ion series to a single peak on a molecular mass 
scale is required.  MaxEnt is a deconvolution method based on probability, that 
‘repeatedly processes different trial mass and charge spectra, comparing the results 
with the observed data’ (Ferridge et al. 1992).  The molecular weights of the sample 
components are generated from the MaxEnt result; the most probable result (MaxEnt 
spectrum) is presented from the probability distribution (MaxEnt result), which is 
calculated from trial spectra that both agree well with the observed data and have 
large entropy (Ferridge et al. 1992).  The quantitative data is generated from the 
summation of the peak intensities from the original multiply charged spectra, and this 
is represented by the area under the molecular weight peak in the processed MaxEnt 
spectra (Cottrell and Green 1998). 
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The MaxEnt software alone cannot be used to give an accurate representation of the 
amount of each MUP isoform present in a sample.  This is because although MUPs 
are very similar in sequence, they may ionise differently to each other in the source 
during ESI-MS due to differences in charge state distribution, charge accessibility and 
hydrophobicity (Grandori 2003; Heck and Van Der Heuvel 2004), and differences in 
ionisation efficiency may affect the accuracy in the resulting relative quantitation data.  
For this reason, adding a standard that has identical biochemical properties to its 
target but with the addition of a label in order to distinguish it from the analyte in mass 
spectrometry analysis, in a known amount to a sample prior to intact mass analysis 
by ESI-MS would be desirable, in conjunction with a standard curve. For the 
quantification of MUPs, recombinant forms of each protein would be ideal as full-
length protein standards, as these are the same structurally and in amino acid 
sequence (except for the addition of the hexa-histidine tag on the N terminal) as their 
target proteins whilst remaining distinguishable by ESI-MS due to presence of the N 
terminal hexa-histidine tag, which is added to the recombinant protein for purification. 
The aim of this chapter is to conduct a preliminary investigation as to whether ESI-
MS analysis of MUPs, in conjunction with the use of known amounts of recombinant 
MUPs (rMUPs) as standards, can allow absolute quantification of MUPs, using the 
measurement of the area under curve of the internal standard and the corresponding 
analyte protein.  ESI-MS analysis (using Micromass Q-ToF micro and Waters Synapt 
G1 Q-ToF mass spectrometers) of mouse urine has confirmed that the peak areas of 
MUPs (in the true mass spectra) increase linearly with increasing MUP load, and 
therefore intact mass analysis has been used to provide relative quantification of 
MUPs in mouse urine using MaxEnt (Mudge et al. 2008; Beynon et al. 2015; Sheehan 
et al. 2015).  However, due to the use of a new Q-ToF mass spectrometer in the 
laboratory for ESI-MS analysis of intact proteins, it was important that ESI-MS linearity 
of MUPs was revisited to confirm the data generated by the new instrument was 
quantitative.  The ionisation efficiencies of MUPs relative to one another in samples 
of differing complexity were also assessed to confirm that ESI-MS analysis of intact 
proteins was also suitable for the relative quantification of MUPs in urine samples.  
To do this, the predicted ionisation efficiencies of MUPs, based on differences in their 
number of protonatable sites, hydrophobicity and charge state distribution profiles, 
were assessed.  Recombinant versions of three of the MUP isoforms present in the 
male C57BL/6 urine (MUPs 7, 11 and 20) were subjected to ESI-MS analysis as 
single-protein samples to determine the ionisation efficiencies of MUPs relative to one 
another.  This confirmed whether differences in the ionisation efficiencies exhibited 
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by each MUP relative to each other could be accounted for by differences in the 
number of protonatable sites present and/or their charge state distributions, enabling 
ESI-MS responses for each MUP to be definitively determined, essential if rMUPs 
were to be used as standards for the absolute quantification of MUPs in urine.  ESI-
MS analysis of recombinant MUPs as single-protein samples and as part of equimolar 
mixtures of different complexities (i.e two-protein and three-protein equimolar 
mixtures), plotting the peak areas of each rMUP at different total protein loads, 
determined whether the ESI-MS responses and ionisation efficiencies of rMUPs as 
part of more complex samples remained the same, confirming whether ESI-MS 
analysis of intact MUPs was a suitable method for absolute quantification. ESI-MS 
responses of rMUPs (and MUPs) would be required to be the same in less complex 
(e.g. female C57BL/6 urine) samples as in more complex samples (e.g. the urine of 
wild-caught male house mice), to allow absolute quantification to take place at the 
intact protein level without the need for extensive chromatographic separation of urine 
prior to ESI-MS analysis.   
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5.2 Results 
 
5.2.1 Predicted ionisation efficiencies of MUPs 
ESI-MS has been instrumental in the identification and calculation of relative 
abundance of MUPs in mouse urine, allowing the accurate and precise determination 
of the molecular weights of these proteins.  ESI of a mouse urine sample, containing 
MUPs, generates a series of multiply charged protein profiles, which is subsequently 
deconvoluted using MaxEnt to generate a true mass spectrum from which the 
average mass of each of these proteins are calculated.  The urine of the inbred 
C57BL/6 mouse strain is commonly used for the study of MUPs, since sequencing of 
this genome is complete and the MUP locus has been subjected to in depth gene 
analysis (Mudge et al. 2008; Logan et al. 2008).   
Despite ESI-MS being a powerful tool for the identification of MUPs in a sample 
through the determination of their molecular weights, limitations arise due to the high 
homology of MUPs.  For example, MUPs with masses of 18693 Da and 18694 Da 
are often unable to be resolved and identified by mass spectrometry – highlighted in 
red in Table 5.1 are the MUPs with these masses that are therefore usually 
indistinguishable.  MUP masses 18708 Da and 18713 Da may also be incompletely 
resolved, so that although these two different masses may be distinguished, 
calculation of their relative abundances may be inaccurate. 
Other limitations of ESI-MS are related to the calculations of relative abundances of 
MUPs in a sample.  Whilst the area under the molecular weight peak in the true 
MaxEnt ESI-MS mass spectrum generally provides a relative concentration of that 
protein in the sample, it must be remembered that the differences between the 
ionisation efficiencies (the ratio of the number of ions formed to the number of 
molecules in the ion source) of different proteins in a sample means that the amount 
of each protein detected by the mass spectrometer may not be truly representative of 
the amount of protein in the sample.  For example, a protein that ionises less 
efficiently is less likely to successfully ionise and therefore be subjected to mass 
spectrometry analysis than a protein that ionises well.  Since MUPs are very similar 
in amino acid sequence and structure, it is expected that these proteins will have 
similar ionisation efficiencies, but differences in the number of protonatable sites, 
hydrophobicity and charge state distribution must be considered to determine 
whether ESI-MS analysis can be successfully used for MUP quantification. 
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Protonatable sites 
The protonatable sites in a protein are the amino acids with positively charged side 
chains, and these are histidine, lysine and arginine. The sequences of each MUP 
were studied for the presence of these amino acids, and the instances of these amino 
acids were identified (Figure 5.2) and summed (Table 5.1).  Whilst the number of 
protonatable sites in the highly homologous central MUPs were fairly similar (ranging 
from 23 to 25 protonatable sites), the number of protonatable sites in the less similar 
peripheral MUPs ranged from 18 to 28.  Evidence indicates that the number of 
protonatable sites a protein has is a major factor in determining the charge state 
distribution profiles for denatured proteins in ESI (Krusemark et al. 2009), so proteins 
with more protonatable sites are more likely to exhibit a higher charge state 
distribution, and thus ionise more efficiently in the ESI source. 
Hydrophobicity 
The number of amino acids with hydrophobic side chains in a protein will affect overall 
hydrophobicity of the protein – these amino acids are alanine, valine, isoleucine, 
leucine, methionine, phenylalanine, tyrosine and tryptophan.  Increased 
hydrophobicity increases ion yield in positive-ion ESI and therefore increase signal 
intensity (Fenn 1993; Cech et al. 2001; Null et al. 2003; Osaka and Takayama 2014) 
In electrospray ionisation, analytes with a greater hydrophobicity will partition to the 
surface of the hydrophilic electrospray droplet, thus tending to carry a greater 
proportion of the charge produced in the ionisation process (Cech and Enke 2001).  
The sequences of each MUP were studied for the presence of these hydrophobic 
amino acids, and the highly homologous central MUPs all have a total of 58 
hydrophobic amino acids in their sequences.  The sequences of each peripheral MUP 
contained slightly more hydrophobic amino acids, ranging from 62 in MUP 5 to 67 in 
MUP 21.  The similarity in hydrophobicity amongst all MUPs suggests that, in the ESI-
MS analysis of MUPs, hydrophobicity is unlikely to be a factor in any differing 
ionisation efficiencies observed. 
Charge state distribution 
ESI of denatured proteins generates a series of multiply charged ions which reflect 
the numbers of protons binding to different sites on the protein (Beynon et al. 2014).  
Proteins with a higher charge state distribution ionise more efficiently in the ESI 
source than those with a lower charge state distribution, and those with a lower 
charge state distribution may generate a lower-intensity mass spectrometry signal  
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MUP name Mature MUP 
mass (Da) 
MUP gene region Number of 
protonatable sites 
MUP 1 18693 Central 24 
MUP 2 18693 Central 23 
MUP 3 18956 Peripheral 21 
MUP 4 18816 Peripheral 28 
MUP 5 18863 Peripheral 18 
MUP 6 18985 Peripheral 26 
MUP 7 18645 Central 24 
MUP 8 18665 Central 23 
MUP 9 18694 Central 23 
MUP 10 18708 Central 24 
MUP 11 18694 Central 23 
MUP 12 18693 Central 24 
MUP 13 18682 Central 25 
MUP 14 18713 Central 23 
MUP 15 18692 Central 24 
MUP 16 18694 Central 23 
MUP 17 18683 Central 24 
MUP 18 18694 Central 23 
MUP 19 18694 Central 23 
MUP 20 (Darcin) 18893 Peripheral 23 
MUP 21 19109 Peripheral 18 
Table 5.1 MUP summary. 
Included in the summary are the MUP names, their mature masses, whether they originate 
from the central or peripheral region of the MUP gene, and the number of protonatable sites 
each MUP sequence possesses.  Highlighted in orange are the MUPs with masses of 
18693 Da and 18694 Da, and so are indistinguishable in intact protein analysis. 
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than expected.  In the ESI-MS analysis of MUPs, the charge state distribution profiles 
are usually distributed around the [M+17H]17+ ion.  Despite the high similarity of 
MUPs, which would indicate that their charge state distributions would be very similar, 
MUP 20 (darcin) exhibits a different, lower charge state distribution than other MUPs 
(Phelan et al. 2014).  This is consistent with MUP 20 retaining a more compact 
structure that is not completely unfolded under the conditions used for ESI-MS 
analysis, further confirmed by the fact MUP 20 migrates at a higher mobility than other 
MUPs on SDS-PAGE (Phelan et al. 2014). 
The similarity of MUP sequences means that there are unlikely to be any major 
differences in ionisation efficiencies amongst them due to differences in 
hydrophobicity.  The similarity of MUP sequences and structure indicate that there 
are also unlikely to be any notable differences in ionisation efficiencies due to differing 
charge state distributions in ESI-MS analysis.  The exception is MUP 20, which 
exhibits a lower charge state distribution profile, suggesting this MUP may generate 
a lower intensity mass spectrometry signal, and so differences in charge state 
distribution profiles will be considered in future analyses. The highly homologous 
central MUPs also have a very similar number of protonatable sites, again suggesting 
no differences in ionisation efficiencies will be observed.  However, the peripheral 
MUPs possess more variable numbers of protonatable sites, which may result in 
differences in charge state distributions and therefore ionisation efficiencies.  Since 
evidence indicates that the number of protonatable sites a protein has, rather than its 
shape and molecular mass, appears to determine ionisation efficiency for denatured 
proteins (Krusemark et al. 2009), this will be another consideration when assessing 
the relationship between MUP concentration and observed ESI-MS response, and 
whether ESI-MS analysis can be used as a tool for accurate quantification of MUPs. 
5.2.2 ESI-MS linearity of MUPs and rMUPs using the Waters Synapt G1 
The true MaxEnt ESI-MS mass spectrum of male C57BL/6 urine contains four 
predominant masses, which are 18645 Da, 18694 Da, 18708 Da and 18893 Da.  All 
these masses match those of previously identified MUPs, with the 18645 Da mass 
representing MUP 7, the 18708 Da mass representing MUP 10 and 18893 Da 
representing MUP 20 (darcin).  The 18694 Da mass represents one of the following: 
MUPs 1, 2, 9, 11, 12, 16, 18, 19 (Table 5.1; Figure 5.3).  The MUPs 9, 11, 16, 18 and 
19 have identical amino acid sequences and therefore identical mature masses of 
18694 Da.   MUPs 1, 2 and 12 have an identical mature mass of 18693 Da, and whilst 
MUPs 1 and 12 have identical amino acid sequences, MUP 2 has this mass from a  
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Figure 5.3 ESI-MS analysis of male C57BL/6 urinary MUPs. 
Urine (diluted in 0.1% (v/v) formic acid) was injected onto a C4 desalting trap and the 
masses of the MUPs present were determined by ESI-MS. Data was processed using 
maximum entropy software MAX ENT1 (MassLynx 4.1, Waters). a) The multiply charged 
ion series for each MUP. b) The deconvoluted, true mass spectrum, showing the intact 
mass for each MUP. c) The true mass spectrum viewed as peak areas, which give the 
relative concentrations of each MUP in the sample. 
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different primary sequence.  The 18693 Da mass cannot be distinguished from 18694 
Da in the ESI-MS analysis of intact proteins, and so a mass of 18694 Da in an ESI-
MS spectrum could arise from any of these MUPs.  In female urine, the true ESI-MS 
mass spectrum contains two of these dominant masses, 18694 Da and 18708 Da 
(Mudge et al. 2008) (not shown).  Previous work by Cheetham et al. 2008 and Mudge 
et al. 2008 confirms that these MUP expression patterns are consistent amongst 
individuals of the same sex of this strain. 
If ESI-MS is to be used as a quantitative method for the analysis of MUPs, there 
needs to be a linear relationship between MUP in a urine sample and the area under 
MUP peak in the deconvoluted, processed true mass spectrum.  Previous intact MUP 
ESI-MS analysis undertaken by Dr. S. Armstrong, University of Liverpool, (Ph.D 
Thesis) explored the relationship between protein load and ESI-MS response, 
however this experiment was based on the peak intensities of the MUPs in the true 
mass spectra rather than the peak areas. The peak intensity is less reliable as an 
indication of relative MUP intensity; it is conditioned by the software’s confidence that 
the reported molecular weight is the correct molecular weight.  It does give an insight 
into the possible relative amounts of MUP present, since the software will be more 
confident of assigning the correct molecular weight to a more abundant protein in a 
sample than it will be to a less abundant protein.  As described earlier, it is the area 
under the MUP peaks, generated from the summed intensities of all the multiply 
charged ions present in the mass spectrum, that gives relative quantification of the 
MUP in that sample. 
To assess the relationship between MUP concentration and MUP peak area, 
C57BL/6 male urine was diluted to a total protein concentration of 1.6 ng/µl.  Diluted 
urine (0.5, 1, 1.5, and 2 µl) was injected into the system and ESI-MS analysis was 
carried out using the method described in Chapter 2, using a Waters Synapt G1 Q-
ToF mass spectrometer.  The raw mass spectra were processed as described in 
Chapter 2, giving the molecular weight of each MUP and their peak intensities (Figure 
5.3).  The area under peaks (and therefore relative MUP concentration) increased 
with increasing amounts of MUP on column from 0.8 ng on column up to amounts of 
3.2 ng (Figure 5.4).  Each sample was run in triplicate, with minimal variation observed 
in the values obtained for the under-peak areas (Figures 5.4 and 5.5).  For each MUP, 
the linear relationship was tight, with r2 values of 0.99 for all MUPs in the sample.  
Whilst the relationships between protein load and area under peak of MUP 11 (18694 
Da) and MUP 20 (18893 Da) are very similar (suggesting a similar relative amount of  
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Figure 5.4 Linearity of ESI-MS peak area with increasing protein load for each MUP 
in the male C57BL/6 urine sample. 
Urine (diluted in 0.1% (v/v) formic acid) was injected onto a C4 desalting trap and the 
masses of the MUPs present were determined by ESI-MS. Data was processed using 
maximum entropy software MAX ENT1 (MassLynx 4.1, Waters).  Samples were injected 
in triplicate.  The area under peak values for the four main male C57BL/6 MUP variants 
were assessed as total MUP load on column increased.  Error bars represent SD (n = 3). 
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these proteins is present in the sample), the linear relationship for MUP 7 (18645 Da) 
is shallower (indicating there is less of this protein in the sample relative to the other 
MUPs), and the linear relationship for MUP 10 (18708 Da) is steeper (suggesting 
there is more of this MUP in the urine sample relative to all other MUPs in the urine 
sample).  The linear ESI-MS responses of all MUPs in the sample allowed the relative 
quantification of these proteins, as displayed in the ratios of linear slope values and 
the ratios of MUP peak areas at different protein loads in Figure 5.5, under the 
assumption that all MUPs in the sample have similar ionisation efficiencies. 
Upon assessment of the multiply charged ion series generated by the mixture of 
proteins, it was noted that two different charge state distribution profiles were present; 
a major distribution centred around the [M+17H]17+ ion (the usual distribution observed 
in the analysis of MUPs), and a second, less intense distribution centred around the 
[M+11H]11+ ion (Figure 5.6).  This was not observed in the analysis of horse heart 
myoglobin (analysed for instrument calibration), which exhibited one charge state 
distribution around the [M+21H]21+ ion, indicative of the protein being fully denatured 
under these experimental conditions (Figure 5.6).  The higher charge state distribution 
observed for horse heart myoglobin compared to the MUPs in male C57BL/6 urine is 
due to it having a greater number of protonatable sites (horse heart myoglobin has 
32 sites, MUPs 7 and 10 have 24 and MUPs 11 and 20 have 23).  The fact that two 
different charge state distribution profiles are present in the ESI-MS analysis of mouse 
urine suggests that at least one of the MUPs in the sample is present in two different 
conformational states, with the less intense charge state distribution profile resulting 
from a protein that is retaining some folding in the gas phase, which has fewer basic 
sites available for protonation.   Closer analysis of the multiply charged ion series 
indicated that all proteins in the sample exhibited a second distribution centred around 
the [M+11H]11+ ion, meaning that all four major MUP isoforms retained some structure 
in ESI-MS analysis. 
It was required that recombinant MUPs, the intended protein standards for absolute 
quantification of MUPs, also exhibited a linear relationship between protein load and 
peak area.  Since these proteins are identical in sequence to their native counterparts 
(except for the addition of the hexa-histidine tag used for purification), it would be 
assumed that this would be the case, however, due to native MUPs in male C57BL/6 
urine retaining some folding in the gas phase, it was essential to confirm that the 
recombinant forms of these proteins exhibited similar conformational states under the 
same experimental conditions.  Recombinant forms of MUPs 7, 11 and 20 (darcin)  
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Figure 5.6 The charge state distribution profiles for a) a MUP mixture and b) horse 
heart myoglobin. 
a) The multiply charged ion series for MUPs in a male C57BL/6 urine sample, with the two 
distinct distribution profiles indicating the proteins are retaining some structure under these 
experimental conditions. b) The multiply charged ion series for horse heart myoglobin, 
used as an external calibrant for the experiment.  This protein, under the same conditions, 
exhibits one, positively skewed normal distribution profile, meaning this protein is fully 
denatured in the ESI source.  
   
 263 
 
 Chapter 5: Quantification of mouse major urinary proteins 
with an N terminal hexa-histidine tag were expressed by Mrs L McLean as described 
in Chapter 2, and were purified using affinity chromatography, also described in 
Chapter 2.  The concentration of each protein was confirmed by protein assay - MUP 
7 (18645 Da) was 4.3 mg/ml; MUP 11 (18694 Da) was 5.4 mg/ml and MUP 20 (18893 
Da) was 14.4 mg/ml.  The rMUP samples were diluted to approximately 2 ng/µl, and 
0.5, 1, 1.5, and 2 µl of each rMUP sample was injected into the system and ESI-MS 
analysis was carried out using the method described in Chapter 2, using a Waters 
Synapt G1 Q-ToF mass spectrometer.  All injections were analysed in duplicate.  
Whilst the charge state distribution profiles in ESI-MS analysis are usually centred on 
the [M+17H]17+ ion for natural MUPs, the charge state distribution profiles in the ESI-
MS analysis of rMUPs are different; centred around the [M+20H]19+ ion for rMUP 20 
(darcin) and around the [M+21H]21+ ion for rMUPs 7 and 11 (Figure 5.7).  The higher 
charge states observed in the ESI-MS analysis of recombinant MUPs compared to 
natural MUPs is due to the addition of further protonatable sites to each protein in the 
form of the N-terminal hexa-histidine tag.  The lower charge state distribution 
observed in the ESI-MS analysis of rMUP 20 was observed as expected from 
previous analysis of natural MUP 20 (Phelan et al. 2014), confirming that both natural 
and recombinant forms of the protein are retaining a more compact structure in ESI-
MS analysis.  All three rMUPs exhibited two conformational states, with a second 
distribution profile centred around the [M+11H]11+ ion, suggesting that they all retain 
some degree of folding under these experimental conditions, as seen in the analysis 
of MUPs in male C57BL/6 urine. 
Raw mass spectra were processed as described in Chapter 2, giving the molecular 
weight of each rMUP and their peak intensities (Figure 5.7).  The area under peaks 
(and therefore relative rMUP concentration) increased linearly with increasing 
amounts of protein on column (Figure 5.8), and for each rMUP, the linear relationship 
was tight, with r2 values of 0.99 for all proteins.  For ESI-MS analysis of MUPs to be 
a suitable method for absolute quantification, knowledge of the responses of each 
individual MUP in ESI-MS analysis is needed, involving assessment of the 
relationship of MUP concentration and MUP peak area whilst considering how charge 
state distribution, protonatable sites and sample complexity may affect MUP 
ionisation and peak area.  This was explored using the recombinant forms of MUPs, 
which was deemed suitable for the analysis of individual MUPs without the need for 
complex and time-consuming chromatographic separation of mouse urine. 
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Figure 5.8 Linearity of ESI-MS peak area with increasing protein load for each rMUP 
using the Synapt G1. 
Samples (diluted in 0.1% (v/v) formic acid) were injected onto a C4 desalting trap and the 
masses of the MUPs present were determined by ESI-MS. Data was processed using 
maximum entropy software MAX ENT1 (MassLynx 4.1, Waters).  Samples were injected 
in duplicate.  The area under peak values for the rMUPs were assessed as total rMUP load 
on column increased.  Error bars represent SD (n = 2). 
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5.2.3 ESI-MS linearity of rMUPs using the Waters Synapt G2 
Recombinant forms of MUPs 7, 11 and 20 (darcin) with an N terminal hexa-histidine 
tag were expressed by Mrs L McLean as described in Chapter 2, and were purified 
using affinity chromatography, also described in Chapter 2. The concentrations of the 
purified proteins were confirmed by protein assay, as described previously.  To 
assess the relationship between rMUP concentration and ESI-MS peak area in 
mixtures and as a single protein, and therefore determine the responses of each of 
the rMUPs and the factors that affect them, each rMUP was diluted to the same 
concentration of 3 mg/ml prior to further analysis.  
To confirm that all three rMUP samples were at approximately the same 
concentration, a second protein assay was carried out alongside SDS-PAGE 
analysis.  rMUP samples (all at 3 mg/ml) were diluted ten-fold prior to analysis on a 
15% SDS-PAGE gel.  The intensities of the three stained protein bands 
corresponding to each rMUP were similar, indicating that the rMUP concentrations 
were approximately the same (Figure 5.9).  For the protein assay, rMUP samples 
were diluted 1 in 150.  The protein assay confirmed that the three rMUP samples 
were of very similar concentration (2.8 mg/ml – 3.0 mg/ml) (Figure 5.9), meaning that 
these samples were suitable for use in the comparison of ESI-MS linearity and 
response factors of rMUPs. 
All future experiments took place using the Waters Synapt G2 Q-ToF mass 
spectrometer due to the Waters Synapt G1 no longer being available.  To determine 
the dynamic range of this instrument, a number of dilutions of the rMUP 11 sample 
were performed and analysed (data not shown).  A 2 ng protein load presented no 
multiply charged ion series signal, and therefore the protein could not be detected at 
this load. A 5 ng load presented a reasonably intense ion series and resultant 
processed mass spectrum, and a 10 ng protein load resulted in a high intensity 
multiply charged ion series and true mass spectrum.  At a 15 ng protein load, the ESI-
MS response was less intense than that at 10 ng, indicating that this protein load 
resulted in the mass spectrometer detector becoming saturated.  A sample of rMUP 
11 (5 ng/µl) was injected at a range of injection volumes to result in protein loads of 
2.5, 5, 7.5, 10 and 12.5 ng to confirm the dynamic range of the instrument.  The lower 
limit of detection was approximately 2.5 ng and the peak area/protein load relationship 
remained linear up to a load of 10 ng; at 12.5 ng load, the relationship became non-
linear due to detector saturation (Supplementary Material).   
The three rMUP samples (of equal concentration) were diluted appropriately for ESI-  
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Figure 5.9 a) SDS-PAGE analysis and b) determination of concentration of the four 
rMUPs. 
a) 10 µl of each diluted rMUP sample was mixed 1:1 with sample buffer, loaded onto a 
15% (w/v) SDS gel and resolved by SDS-PAGE. The gel was stained with Coomassie blue 
to visualise the proteins. b) Protein concentration of the four rMUP samples was 
determined using a Coomassie Plus protein assay kit. A standard curve (0-50 μg/ml) was 
produced using serum albumin. Samples were diluted 1 in 150 in milliQ water. Absorbance 
readings were measured at 620 nm and protein concentration was calculated, taking into 
account dilutions (n = 4, error ± SD). 
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MS analysis within the dynamic range as confirmed in the analysis of rMUP 11, and 
each rMUP was analysed separately using ESI-MS to assess the relationship 
between rMUP concentration and peak area.  Each sample was diluted to 5 ng/µl, 
and a range of injection volumes (0.5 µl – 2 µl) of the samples resulted in total protein 
loads of 2.5, 5, 7.5 and 10 ng for each rMUP.  ESI-MS analysis was carried out using 
the method described in Chapter 2, and each sample was injected in triplicate.  The 
raw mass spectra were processed as described in Chapter 2, giving the molecular 
weight of each rMUP and its peak intensity, and the area under peaks were calculated 
(Figures 5.10 - 5.12).    Analysis of the responses of single rMUPs in ESI-MS would 
determine whether the linearity of ESI-MS response with different single rMUP loads 
is different for different  rMUPs, and if so, whether charge state distribution and/or the 
number of protonatable sites a single rMUP possesses affects its ionisation, and 
therefore resulting signal intensity and peak area. 
As in the analysis of rMUPs using the Synapt G1 Q-ToF,  the charge state distribution 
profiles in the ESI-MS analysis of rMUPs are different to one another; however, 
distribution profiles are also different to those observed in the Synapt G1 analysis – 
profiles in G2 analysis are centred around the [M+19H]19+ ion for rMUP 20 (darcin), 
around the [M+20H]20+ ion for rMUP 11 and around the [M+21H]21+ ion for rMUP 7 
(Figures 5.6 – 5.8).  Again, as in the previous experiment using the Synapt G1, a 
second distribution profile is observed for each rMUP, indicative of the proteins 
retaining structure under these experimental conditions.  In the Synapt G1 analysis 
of rMUPs, the intensity of the second profile, centred around the [M+11H]11+ ion for all 
rMUPs, was much higher intensity in relation to the ‘main’ distribution profile than in 
the Synapt G2 analysis, where the second profiles were centred around the 
[M+11H]11+ ion for rMUPs 7 and 11 but around the [M+10H]10+ ion for rMUP 20 (Figure 
5.13). This indicates that in the Synapt G1 analyses, where ionisation conditions are 
the same as in the G2 analysis, more protein is somehow retaining a more folded 
structure during ESI.  However, in the G2 analysis, rMUP 20, with both distribution 
profiles shifting to a slightly lower charge state distribution than in G1 analyses, 
appears to remain more folded than rMUPs 7 and 11.  When the charge state 
distribution profiles for all three rMUPs were normalised to 1 and compared (Figure 
5.14), it was confirmed that the highly homologous central rMUPs 7 and 11 exhibited 
very similar charge state distributions to each other, with both having two 
conformational states in the gas phase.  The less homologous rMUP 20 exhibited a 
different, lower charge state distribution to the central rMUPs in both distribution 
profiles, suggesting that this rMUP is more folded under these conditions and  
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Figure 5.10 ESI-MS analysis of recombinant MUP 20 (Darcin). 
rMUP 20 (diluted to 5 ng/µl in 0.1% (v/v) formic acid) was injected in triplicate over a range 
of injection volumes onto a C4 desalting trap and the mass of rMUP 20 was confirmed by 
ESI-MS in each case. Data was processed using maximum entropy software MAX ENT1 
(MassLynx 4.1, Waters). This figure shows the data from the 7.5 ng protein load. a) The 
multiply charged ion series for rMUP 20. b) The deconvoluted, true mass spectrum, 
showing the intact mass for rMUP 20. c) The true mass spectrum viewed as a peak area, 
which gives the relative concentration of the rMUP in each sample injection. 
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  Figure 5.11 ESI-MS analysis of recombinant MUP 11. 
rMUP 11 (diluted to 5 ng/µl in 0.1% (v/v) formic acid) was injected in triplicate over a range 
of injection volumes onto a C4 desalting trap and the mass of rMUP 11 was confirmed by 
ESI-MS in each case. Data was processed using maximum entropy software MAX ENT1 
(MassLynx 4.1, Waters). This figure shows the data from the 7.5 ng protein load. a) The 
multiply charged ion series for rMUP 11. b) The deconvoluted, true mass spectrum, 
showing the intact mass for rMUP 11. c) The true mass spectrum viewed as a peak area, 
which gives the relative concentration of the rMUP in each sample injection. 
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Figure 5.12 ESI-MS analysis of recombinant MUP 7. 
rMUP 7 (diluted to 5 ng/µl in 0.1% (v/v) formic acid) was injected in triplicate over a range 
of injection volumes onto a C4 desalting trap and the mass of rMUP 11 was confirmed by 
ESI-MS in each case. Data was processed using maximum entropy software MAX ENT1 
(MassLynx 4.1, Waters). This figure shows the data from the 7.5 ng protein load. a) The 
multiply charged ion series for rMUP 7. b) The deconvoluted, true mass spectrum, showing 
the intact mass for rMUP 7. c) The true mass spectrum viewed as a peak area, which gives 
the relative concentration of the rMUP in each sample injection. 
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Figure 5.14 Differences in charge state distribution of rMUPs in ESI-MS using the 
Synapt G2. 
The multiply charged ion series for each of the rMUPs in the linearity experiment were 
observed for differences. The intensities of each of the charge states observed in the raw 
spectra for each rMUP were recorded and normalised.  Error bars represent SD (n=3). 
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therefore experiencing a lower degree of charging than rMUPs 7 and 11 in both 
conformational states.  This could be explained by the structural analysis of native 
MUPs 11 and 20, where Phelan et al. (2014) were able to confirm that MUP 20 is 
significantly more structurally stable than MUP 11, resulting in part by the orientation 
of the disulphide bond (Phelan et al. 2014).  To determine whether the differences in 
protonation of each rMUP in ESI-MS analysis (resulting from the lower degree of 
charging of rMUP 20 than rMUPs 11 and 7 due to its more compact structure in the 
gas phase) led to variability in the intensity of ions generated by each rMUP, the 
responses of each rMUP at different protein loads were recorded and compared. 
The responses of the peak area values with protein load in ESI-MS analysis for 
rMUPs 7, 11 and 20 were assessed (Figure 5.15) and compared (Figure 5.16).  
rMUPs 7 and 11 exhibited a linear relationship between protein load and peak area, 
with peak areas increasing as protein load increased, and minimal variation in 
calculated peak areas amongst technical replicates (Figures 5.15 and 5.16)  These 
rMUPs exhibited tight linear relationships, with r2 values of 0.99.  The relationship 
between peak area and protein load for rMUP 20 was non-linear (r2 = 0.99), where 
the peak area values increase disproportionately with increasing load of rMUP.  It was 
expected that rMUP 20, with the lower charge state distribution, would have a linear 
response in ESI-MS analysis that was a shallower slope than those for rMUPs 7 and 
11 due to fewer accessible protonatable sites, poorer ionisation and thus, lower signal 
intensity in the mass spectra.  For central rMUPs 7 and 11, it was expected that the 
linear slopes would be very similar, due to the similar charge state distributions rising 
from a similar number of protonatable sites.  Figure 5.15 gave a numerical 
comparison of the linear peak area/protein load responses by rMUPs 7 and 11 in ESI-
MS analysis, whilst Figure 5.16 provided a visual comparison.  Unexpectedly, for 
rMUP 7, the gradient of the slope was considerably shallower than that of rMUP 11, 
meaning that a lower ESI-MS response per ng was observed compared to rMUP 11. 
The non-linear power function fitted to the peak area/protein load relationship 
exhibited by rMUP 20 meant that at a 2.5 ng rMUP load, the peak area was 
approximately the same as that for rMUP 7, lower than that for rMUP 11 at 5 ng load 
but significantly greater than both rMUPs 7 and 11 at 7.5 ng and 10 ng loads.   
Whilst the peak areas for each rMUP, obtained through deconvolution of the multiply 
charged protein envelopes, increased with increasing protein load, the peak areas for 
rMUP 20 increased disproportionally and the peak areas for rMUPs 7 and 11 
increased proportionally.  The difference in peak areas between the different rMUPs  
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Figure 5.15 Relationship of ESI-MS peak area with increasing protein load for three 
rMUPs. 
Samples of rMUPs 20, 11 and 7 (diluted to 5 ng/µl in 0.1% (v/v) formic acid) were injected 
over a range of injection volumes (0.5 - 2 µl), resulting in a range of protein loads, onto a 
C4 desalting trap. The mass of each rMUP was confirmed by ESI-MS. Each sample 
analysis was in triplicate. Data was processed using maximum entropy software MAX 
ENT1 (MassLynx 4.1, Waters). The area under peak values for each rMUP were assessed 
as total protein load on column increased.  Error bars represent SD (n=3). 
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Figure 5.16 Differences in ESI-MS peak area/protein load responses for three rMUPs. 
The area under peak values for each rMUP were assessed as total protein load on column 
increased in Figure 5.15.  These were plotted on the same scale to visualise the differences 
in the relationship of ESI-MS peak area with rMUP load between each rMUP. Error bars 
represent SD (n=3). 
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at the same protein loads indicates that intact rMUPs have different responses and 
ionisation efficiencies in ESI-MS analysis.  These differences cannot be explained by 
different charge state distributions or the number of protonatable sites the protein 
possesses.  However, the responses exhibited by each rMUP, although different to 
one another, are similar enough to confirm that intact mass analysis of MUPs may be 
of use for the relative quantification of MUPs in a sample (Figure 5.16). 
To determine whether ESI-MS of intact proteins is suitable for absolute quantification 
of MUPs in mouse urine, the next experiment needed to confirm that the three rMUPs 
would exhibit the same responses in ESI-MS analysis whilst in an equimolar mixture.  
If this was the case, the ESI-MS responses of rMUPs (and therefore natural MUPs in 
urine samples) could be determined, meaning that rMUPs corresponding to the 
natural MUPs in a urine sample could be added to urine samples in a known quantity 
to produce standard curves for absolute quantification, with rMUP and MUP 
responses not being affected by sample complexity.  The use of an rMUP for each 
MUP in the sample would account for the differences in ionisation efficiencies 
observed in this experiment. 
5.2.4 ESI-MS responses of rMUPs in an equimolar mixture 
The purified rMUP 7, 11 and 20 samples (of equal concentration) used for the analysis 
of the ESI-MS linearity of single rMUPs were mixed 1:1:1 and diluted to 5 ng/µl.  
Protein assays were undertaken to confirm that the all samples were still of equal 
concentration prior to mixing.  A range of injection volumes (0.5 µl – 2 µl) of the 
samples resulted in total protein loads of 2.5, 5, 7.5 and 10 ng for the equimolar rMUP 
mixture.  Therefore, at each injection, 0.8, 1.7, 2.5 and 3.3 ng of each rMUP was 
loaded on column.  It was not possible to load 2.5, 5, 7.5 and 10 ng of each rMUP (in 
an equimolar mixture) as this would have resulted in total protein loads above the 
dynamic range of the instrument, resulting in detector saturation.  The peak areas for 
each rMUP at each total protein load would be expected to be smaller than those 
recorded for the single rMUP samples (since each rMUP in the equimolar mixture 
accounts for only one third of the total protein load), but the rMUP responses in ESI-
MS analysis would be expected (and required) to be the same if intact protein analysis 
was suitable for the absolute quantification of MUPs.  Based on the peak area/protein 
load ESI-MS responses observed for the single samples of rMUPs 7, 11 and 20 
(Figure 5.15), theoretically, the three-sample equimolar mixture would result in each 
rMUP having a peak area of approximately a third of the value it exhibited in a single 
rMUP sample at each protein load, and the gradient of the slope would be expected 
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to be approximately a third of the value.  For rMUP 20, where the ESI-MS response 
was a non-linear power function (y = ax^b), the coefficient parameter ‘a’ (that specifies 
slope) would be expected to have a value of approximately a third of the value 
calculated for the single-rMUP sample, and the power parameter ‘b’ (that specifies 
the rate at which peak area disproportionally increases with protein load) should have 
the same value. 
ESI-MS analysis and data processing was as described in Chapter 2, giving the 
molecular weight of each rMUP and its peak intensity, and the area under peaks (and 
therefore relative rMUP concentration) were calculated in the equimolar mixture.  
Each sample was injected in triplicate.  The charge state distribution profiles of the 
three rMUPs in the mixture were studied, and the profiles in the 7.5 ng equimolar 
mixture are shown in Figure 5.17.  Inset in the Figure is an enlargement of one of the 
charge states, showing the rMUP 7 [M+18H]18+ ion which is significantly lower in 
intensity than rMUPs 11 and 20, concurring with the ESI-MS response exhibited by 
this rMUP in a single-rMUP sample (Figures 5.15 and 5.16) and the charge state 
distribution profile observed for this protein (Figure 5.14).  At a 7.5 ng protein load, 
based on the similar responses confirmed for the single-rMUP samples for rMUPs 11 
and 20 (Figure 5.16) and the charge state distribution profiles for these rMUPs (Figure 
5.14), it would be expected that the rMUP 11 [M+26H]26+ - [M+20H]20+ ions would be 
higher intensity than the corresponding MUP 20 ions, and that the [M+19H]19+ - 
[M+12H]12+ ions would be lower intensity.  Whilst the lower charge states of rMUP 11 
were lower intensity than rMUP 20 as expected, rMUP 20 was more intense than 
rMUP 11 in the mass spectra at the [M+23H]23+, [M+22H]22+ and [M+21H]21+ ions 
(Figure 5.17).  This was the case in the spectra of 7.5 and 10 ng protein loads, but at 
2.5 and 5 ng loads, the intensity of the rMUP 11 [M+26H]26+ - [M+20H]20+ ions were 
higher intensity than the corresponding rMUP 20 ions, as they were in single-rMUP 
sample analyses (Figure 5.17). This indicates that at higher loads of the three-rMUP 
equimolar mixture, rMUP 20 exhibits a different multiply charged ion series than in 
single rMUP sample ESI-MS analysis, occupying a higher charge state distribution.  
The mass spectra were deconvoluted using the entire multiply charged ion series to 
ensure a true representation of the peak area/protein load ESI-MS responses of each 
rMUP in the equimolar mixture – if only part of the spectrum was analysed for 
molecular weight and peak area information, protein molecular weights would be 
accurate but peak areas calculated by the MaxENT software would be likely to be 
inaccurate.  For example, if spectra were only processed across the [M+19H]19+ - 
[M+12H]12+ ion range (where rMUP 20 ions are higher intensity than rMUP 7 and 11  
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ions), this would result in larger rMUP 20 and smaller rMUP 7 and 11 peak areas 
being calculated than if the entire ion series was used to calculate the peak areas of 
each rMUP.  The ESI-MS intact protein peak areas of rMUPs 7, 11 and 20 in the 
equimolar mixture at 2.5, 5, 7.5 and 10 ng loads (Figure 5.18) were plotted (Figure 
5.19) and the responses of the peak area values with protein load for each of the 
rMUPs were compared with each other and with the theoretical ESI-MS responses 
via the gradient of the slopes.  Figure 5.18 shows the deconvoluted true mass spectra 
and corresponding peak area spectra of the equimolar rMUP mixture at each protein 
load.  At 2.5 ng total protein load, the calculated peak areas for rMUPs 11 and 20 
were similar, with the rMUP 11 peak area being slightly greater.  The peak area for 
rMUP 7 is around 50 % of the peak area values obtained for the other two rMUPs in 
the equimolar mixture.  As protein load increased, the peak areas calculated for rMUP 
20 increased significantly relative to those calculated for rMUPs 7 and 11, with the 
peak areas calculated for these two rMUPs decreasing relative to rMUP 20 (Figure 
5.18).  This initial analysis suggests that in an equimolar rMUP mixture, the peak 
area/protein load relationship exhibited by rMUP 20 is a non-linear power function, as 
per the analysis of this rMUP as a single protein (Figure 5.15).  To confirm whether 
the three rMUPs exhibited the same responses in ESI-MS analysis whilst in an 
equimolar mixture to those observed in the single rMUP analyses, the responses of 
the peak area values with protein load in ESI-MS analysis for rMUPs 7, 11 and 20 
were assessed and compared.  In the equimolar mixture, rMUP 20 exhibited a non-
linear relationship between peak area and protein load (r2 = 0.98), as it did in the 
single rMUP analysis.  Whilst rMUPs 7 and 11 exhibited linear peak area/protein load 
relationships in the single rMUP analyses, as part of an equimolar mixture, both 
rMUPs exhibited a non-linear relationship (r2 = 0.99), meaning peak area values 
increase disproportionately with increasing load of rMUP (Figure 5.19).  Comparing 
the power parameters of the non-linear power function fits for each rMUP, the 
responses of rMUPs 11 and 20 increase at the same rate (with a ‘b’ value of 1.8), but 
a higher ‘b’ value of 2.3 fitted to the rMUP 7 slope indicates that the rMUP 7 peak 
areas increase with protein load at a greater rate.  The analysis of the peak 
area/protein load responses of rMUPs 7 and 11 confirm that they do not exhibit the 
same response in ESI-MS analysis as part of a mixture as they do in a single-rMUP 
sample (Figure 5.19).  To determine whether rMUP 20 exhibited the same response 
as part of a mixture as in a single-rMUP sample, the ESI-MS response in the 
equimolar mixture was plotted with the single-rMUP response and the theoretical 
response for rMUP 20 in the three-rMUP mixture (Figure 5.20).  The gradient of the  
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  Figure 5.18 ESI-MS analysis of the three-rMUP equimolar mixture at 2.5, 5, 7.5 and 
10 ng total protein loads. 
The equimolar mixture of rMUPs 7, 11 and 20 (diluted to 5 ng/µl in 0.1% (v/v) formic acid) 
was injected in triplicate over a range of injection volumes onto a C4 desalting trap and 
the masses of the rMUPs were confirmed by ESI-MS in each case. Data was processed 
using maximum entropy software MAX ENT1 (MassLynx 4.1, Waters). The figure shows 
the deconvoluted, true mass spectra, showing the intact masses for the rMUPs, and the 
true mass spectra viewed as a peak area. 
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Figure 5.19 Differences in peak area with increasing protein load for the three rMUPs 
in the equimolar mixture. 
The area under peak values for each rMUP were assessed as total protein load on column 
increased.  These were plotted on the same scale to visualise the differences in the ESI-
MS responses between each rMUP as part of an equimolar mixture. Error bars represent 
SD (n=3). 
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Figure 5.20 Comparing the different ESI-MS responses exhibited by each rMUP as 
part of a three-rMUP equimolar mixture and as a single rMUP sample. 
The area under peak values for each rMUP as total protein load on column increased were 
recorded for the proteins as single samples (black data points) as well as part of a three-
rMUP equimolar mixture (blue data points).  These were plotted on the same scale, along 
with theoretical area under peak values expected for the rMUPs in the three-rMUP mixture 
if the rMUPs were to exhibit the same ESI-MS responses as in single rMUP samples (red 
data points). This enabled the visualisation of the differences in the theoretical and actual 
ESI-MS responses exhibited by each rMUP as part of an equimolar mixture. Error bars 
represent SD (n=3). 
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non-linear slope for the observed peak area/protein load response for rMUP 20 in the 
equimolar mixture was significantly shallower than the theoretical slope (a coefficient 
value approximately 18 times smaller than expected), but the rate at which peak area 
disproportionally increased with protein load was higher than expected (a power value 
of 1.8, in comparison to the value of 1.5 expected from the single rMUP analysis).  
This confirms that along with rMUPs 7 and 11, rMUP 20 does not exhibit the same 
response in ESI-MS analysis as part of an equimolar mixture as it does in a single-
rMUP sample. 
The significant differences in ESI-MS responses exhibited by all three rMUPs when 
comparing the analysis of single-rMUP samples with equimolar mixtures indicate that 
ESI-MS of intact proteins is not currently suitable for the absolute quantification of 
MUPs in mouse urine. This experiment was repeated numerous times to ensure 
errors had not been made with respect to protein concentration calculations or sample 
dilutions, so there was confidence in the unusual results obtained for the equimolar 
mixtures.  rMUPs, or any isotopically labelled MUP protein standard, would not be 
suitable internal standards for absolute quantification since the response factors of 
rMUPs (and therefore MUPs) are different depending on the complexity of the 
sample.  Therefore, the ESI-MS responses of rMUPs and MUPs cannot be definitively 
determined in mouse urine samples where complexity varies (e.g. female C57BL/6 
urine contains fewer MUPs than male C57BL/6 urine, and MUP expression patterns 
can vary significantly amongst wild mice (Beynon et al. 2002; Cheetham et al. 2008)). 
Despite this, it was noted that in both single-rMUP and equimolar mixture cases, at 
the 2.5 ng total protein load, the peak area of the three rMUPs were fairly similar to 
one another; at 5 ng, the peak areas of rMUPs 11 and 20 were similar and rMUP 7 
lower; and at 7.5 ng and 10 ng, rMUP 20 peak area was slightly higher than rMUP 
11, and rMUP 7 lower than rMUP 11.  When comparing the differences in responses 
observed in each rMUP (Figure 5.14), it was also apparent that all three rMUPs 
ionised less efficiently to a very similar extent to one another in the equimolar mixture.  
This could possibly be due to a proton deficit during the ionisation process, where the 
three rMUPs in the mixture are competing for charge and so all proteins are ionising 
less successfully than as single-rMUP samples.  The next experiment was to 
determine whether this pattern of ESI-MS responses was also observed in a less 
complex equimolar rMUP sample; if so, ESI-MS analysis of intact MUPs can still be 
a suitable method for general relative quantification of MUPs present in urine 
samples, since the ionisation efficiencies of the three rMUPs have remained the same 
relative to one another despite different sample complexities.  Also, if the ESI-MS 
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response of the rMUPs as part of a two-sample mixture were not as low as those 
observed in three-rMUP mixture analysis, but not as expected based on the single-
rMUP analysis, this could further indicate a proton deficiency in the ionisation process.  
Compared to the three-rMUP analysis, a two-rMUP sample would give rise to less 
competition for charge and therefore more successful protein ionisation, but 
compared to the single-rMUP analysis, more competition for charge would result in 
less successful protein ionisation and therefore a lower than expected ESI-MS 
response. 
5.2.5 ESI-MS responses of rMUPs 7 and 11 in an equimolar mixture  
The aims of this experiment were to firstly determine whether the same pattern of 
ESI-MS responses observed in the previous experiments due to differing ionisation 
efficiencies remained the same in a two-rMUP sample as a single- and three-rMUP 
sample, confirming whether the ESI-MS analysis is suitable for relative quantification 
of intact MUPs in urine, and secondly to determine whether a proton deficit in the 
ionisation process could be the reason for the unexpectedly low ESI-MS responses 
of rMUPs as part of a three-rMUP mixture.  The rMUPs 7 and 11 were chosen for the 
analysis of a two-rMUP equimolar mixture, and the purified rMUP 7 and 11 samples 
(of equal concentration) used in previous analyses were mixed 1:1 and diluted to 5 
ng/µl.  A range of injection volumes (0.5 µl – 2 µl) of the samples resulted in total 
protein loads of 2.5, 5, 7.5 and 10 ng for the equimolar rMUP mixture (meaning that 
at each injection, 1.25, 2.5, 3.75 and 5 ng of each rMUP was loaded on column).  As 
in the previous experiment, loading 2.5, 5, 7.5 and 10 ng of each rMUP (in an 
equimolar mixture) would have resulted in total protein loads above the dynamic 
range of the instrument, resulting in detector saturation.  Theoretically, the peak areas 
for each rMUP at each total protein load would be expected to be approximately half 
the value, and the gradient of the slope would be expected to be approximately a half 
of the value of those observed in the single-rMUP analyses.  From the analysis of the 
three-rMUP equimolar mixture, it was expected that this would not be the case as it 
was confirmed that the ESI-MS responses of rMUPs cannot be definitively 
determined. 
ESI-MS analysis and data processing was as described in Chapter 2, giving the 
molecular weight of each rMUP and its peak intensity, and the area under peaks (and 
therefore relative rMUP concentration) were calculated in the equimolar mixture.  
Each sample was injected in triplicate.  The charge state distribution profiles of the 
two rMUPs in the mixture were studied, and the profiles in the 7.5 ng equimolar  
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Figure 5.21 Charge state distributions of rMUPs 7and 11 in an equimolar mixture. 
The equimolar rMUP mixture (diluted to 5 ng/µl in 0.1% (v/v) formic acid) was injected in 
triplicate over a range of injection volumes onto a C4 desalting trap.  The figure shows the 
multiply charged ion series observed in the 7.5 ng load.  Inset is an enlargement of the 
rMUP 7 and 11 [M+18H]18+ ions (highlighted in green). 
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mixture are shown in Figure 5.21.  Inset in the Figure is an enlargement of one of the 
charge states, showing the rMUP 7 [M+18H]18+ ion which is, again, significantly lower 
in intensity than the rMUP 11 [M+18H]18+ ion.  The charge state distribution profiles 
observed in the spectrum in Figure 5.21 are representative of those observed in all 
protein loads.  The multiply charged ion series exhibited by both rMUP 7 and 11 as 
part of a two-rMUP mixture are similar to those in the analysis of these rMUPs as 
single samples and in a three-rMUP mixture, suggestive that relative ionisation 
efficiencies of rMUPs remain the same regardless of sample complexity. 
The mass spectra were deconvoluted using the entire multiply charged ion series to 
ensure a true representation of the peak area/protein load ESI-MS responses of each 
rMUP in the equimolar mixture.  The ESI-MS intact protein peak areas of rMUPs 7 
and 11 at 2.5, 5, 7.5 and 10 ng total protein loads (Figure 5.22) were plotted (Figure 
5.23) and the responses of the peak area values with protein load for each of the 
rMUPs were compared with each other and with the theoretical ESI-MS responses 
via the gradient of the slopes.  Figure 5.23 is the deconvoluted true mass spectra and 
corresponding peak area spectra of the equimolar rMUP mixture at each protein load.  
At each protein load, the calculated peak areas for rMUP 7 were around 40 – 50 % 
of the rMUP 11 peak area, as they were for these proteins in the single- and three-
rMUP analyses. This is again indicative that the relative ionisation efficiencies of 
rMUPs are the same regardless of sample complexity.  The responses of the peak 
area values with protein load in ESI-MS analysis for rMUPs 7 and 11 were assessed 
and compared.  In the previous analysis of the three-rMUP equimolar mixture, these 
rMUPs exhibited non-linear peak area/protein load relationships and linear 
relationships in the single rMUP analyses; in this experiment, both rMUPs exhibited 
linear peak area/protein load relationships (r2 = 0.99) (Figure 5.23).  The actual ESI-
MS responses exhibited by rMUPs 7 and 11 in the two-rMUP equimolar mixture were 
plotted with the theoretical responses calculated, along with the single-rMUP 
responses observed (Figure 5.24).  As in the three-rMUP equimolar mixtures, rMUPs 
7 and 11 exhibited shallower gradients of the linear slopes for the peak area/protein 
load responses than the theoretical slopes calculated from the single-rMUP analyses. 
The gradients of the rMUPs 7 and 11 ESI-MS response slopes both had a value 
approximately 1.7 times lower than the theoretical value.   
In the single-rMUP, two-rMUP and three-rMUP sample analysis, the ESI-MS 
response exhibited by rMUP 7 was lower than those by rMUP 11, as portrayed by the 
shallower gradients plotted for the peak area/protein load relationships.  Taking into  
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  Figure 5.22 ESI-MS analysis of the two-rMUP equimolar mixture at 2.5, 5, 7.5 and 10 
ng total protein loads. 
The equimolar mixture of rMUPs 7 and 11 (diluted to 5 ng/µl in 0.1% (v/v) formic acid) was 
injected in triplicate over a range of injection volumes onto a C4 desalting trap and the 
masses of the rMUPs were confirmed by ESI-MS in each case. Data was processed using 
maximum entropy software MAX ENT1 (MassLynx 4.1, Waters). The figure shows the 
deconvoluted, true mass spectra, showing the intact masses for the rMUPs, and the true 
mass spectra viewed as a peak area. 
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Figure 5.24 Comparing the different ESI-MS responses exhibited by each rMUP as 
part of a two-rMUP equimolar mixture and as a single rMUP sample. 
The area under peak values for each rMUP as total protein load on column increased were 
recorded for the proteins as single samples (black data points) as well as part of a two-
rMUP equimolar mixture (blue data points).  These were plotted on the same scale, along 
with theoretical area under peak values expected for the rMUPs in the two-rMUP mixture 
if the rMUPs were to exhibit the same ESI-MS responses as in single rMUP samples (red 
data points). This enabled the visualisation of the differences in the theoretical and actual 
ESI-MS responses exhibited by each rMUP as part of an equimolar mixture. Error bars 
represent SD (n=3). 
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Figure 5.25 The ratio of slope and peak area values for rMUPs 7 and 11 as single 
samples and as part of a two-rMUP equimolar mixture. 
The ratio of the slopes of the linear relationship for each rMUP, normalised to 1 (the value 
of the steepest gradient), were almost identical for rMUPs 7 and 11 in single samples and 
as part of an equimolar mixture.  The average ratio of peak areas for each rMUP 
normalised to 1 (the largest rMUP peak area at each protein load) were identical for the 
rMUPs both as single samples and as part of an equimolar mixture (n = 4 (each protein 
load), error ± SD). 
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account the ratios of the slope values and the average ratio of peak areas, single-
sample rMUPs 7 and 11 had a slope and peak area ratio of 0.54:1, and in the two-
rMUP sample analysis, the ratio of slopes was 0.55:1 and the ratio of peak areas was 
0.54:1.  This further suggests rMUPs, and therefore MUPs, exhibit different ESI-MS 
responses dependent on sample complexity, but regardless of sample complexity, 
rMUPs (and therefore, also MUPs) exhibit the same relative ionisation efficiency, 
meaning ESI-MS analysis of intact proteins is a suitable method for the relative 
quantification of MUPs in urine samples (Figure 5.25). 
In the analysis of the three-rMUP equimolar mixture, the observed ESI-MS response 
for rMUPs 7 and 11 were significantly lower than expected – at the 10 ng total protein 
load, the peak area value for rMUP 7 was 270 times lower than the theoretical value, 
and for rMUP 11, the peak area value at this load was 230 times lower than the 
theoretical value.  Comparing this to the observed peak area values at the same total 
protein load for the two-rMUP mixture, where the value for rMUP 7 was only 1.7 times 
lower than the theoretical value, and for rMUP 11, only 1.8 times lower; there is a 
possibility that there is a proton deficit during the ionisation process and so proteins 
part of more complex mixtures have to compete more for charge and so ionise less 
efficiently, causing lower signal in the mass spectra.   
5.2.6 ESI-MS responses of MUPs in male C57BL/6 urine using the Synapt G2 Q-
ToF mass spectrometer 
In the initial ESI-MS analysis of male C57BL/6 urine, which was undertaken using a 
Synapt G1 Q-ToF mass spectrometer, all four major MUP isoforms exhibited linear 
peak area/protein load ESI-MS relationships.  In the analysis of an equimolar three-
rMUP mixture using the Synapt G2, however, the ESI-MS responses for each rMUP 
in the sample were non-linear rather than linear.  Whilst the lower signal observed in 
the two- and three-rMUP mixtures could be due to a proton deficiency during the 
ionisation process, a possible reason for the difference in the linearity of the 
responses, based on (and compared to) the results from the single-, two-and three-
rMUP sample analyses, could be due to sample complexity.  It would therefore be 
expected, due to rMUPs possessing identical biochemical properties to natural 
MUPs, that in a more complex sample (i.e urine), MUPs would also exhibit a non-
linear power function relationship between peak area and protein load.  To confirm 
that MUPs exhibit the same ESI-MS response as their recombinant counterparts in a 
more complex sample (containing four MUPs), and to confirm sample complexity 
effects the ESI-MS responses exhibited by rMUPs (and MUPs), the experiment 
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undertaken in Section 5.2.2 was repeated using the Waters Synapt G2 Q-ToF, and 
with a different urine sample. 
Male C57BL/6 urine was diluted to 5 ng/µl, and a range of injection volumes (0.5 µl – 
2 µl) of the sample resulted in total protein loads of 2.5, 5, 7.5 and 10 ng on column, 
as per the dynamic range of the instrument. Samples were injected into the system 
and ESI-MS analysis was carried out using the method described in Chapter 2.  Each 
sample was analysed in triplicate.  The raw mass spectra were processed as 
described in Chapter 2, giving the molecular weight, peak intensities and peak areas 
of each MUP in the sample. The mass spectra were deconvoluted using the entire 
multiply charged ion series to ensure a true representation of the peak area/protein 
load ESI-MS responses of each MUP in the urine sample (Figure 5.26).  The ESI-MS 
intact protein peak areas of MUPs 7, 10, 11 and 20 at 2.5, 5, 7.5 and 10 ng total 
protein loads were plotted (Figure 5.27) and the responses of the peak area values 
with protein load for each of the MUPs were compared with those observed for the 
rMUPs in the three-rMUP equimolar mixture.  As expected, analysis of the MUPs in 
male C57BL/6 urine using the Waters Synapt G2 confirmed that MUPs (and rMUPs) 
exhibit a non-linear peak area/protein load relationship in more complex samples.  
Each MUP in the sample exhibited a non-linear response (Figures 5.27 and 5.28). 
The ESI-MS response of MUP 10 relative to the other MUPs in the sample has not 
been confirmed by the respective rMUP in previous analyses, but due to it being a 
central MUP with the same number of protonatable sites as MUP 7, it is thought that 
it would exhibit a fairly similar response to MUPs 7 and 11.  Figure 5.28 indicates that 
the urine sample contains more MUP 10 (18708 Da) relative to the other MUPs in the 
sample (y = 241627x^1.5, r2 = 0.99).  Based on the analysis of the three-rMUP 
equimolar mixture, the urine contains a similar amount of MUP 11 and MUP 7.  Figure 
5.28 suggests that the urine sample contains more MUP 11 (y = 203851x^1.3, r2 = 
0.98) than MUP 7 (y = 13279x^2.0, r2 = 0.99), but knowledge of the differing ionisation 
efficiencies of these MUPs as a result of the rMUP analyses indicates that the urine 
contains similar amounts of these MUPs in relation to the other MUPs in the sample.  
Similarly, Figure 5.28 indicates that the urine contains slightly more MUP 20 (y = 
51332x^1.5, r2 = 0.99) relative to MUP 7, but again, knowledge of the ionisation 
efficiencies of the recombinant forms of these proteins suggests that the urine sample 
contains less MUP 20 relative to all other MUPs in the sample, due to rMUP 20 
ionising more efficiently in ESI-MS analysis than rMUPs 7 and 11. 
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It has been demonstrated that MUPs, like their recombinant counterparts, exhibit a 
non-linear power function between peak area and protein load when being analysed 
as part of a complex sample using ESI-MS.  The analysis of rMUPs as single samples, 
and as part of equimolar mixtures has confirmed that whilst ESI-MS analysis of MUPs 
in urine samples can provide useful information regarding the quantification of these 
MUPs relative to others in the sample, it is imperative that the ionisation efficiencies 
of each MUP in the sample is known prior to making relative quantification 
conclusions from the peak area data generated from ESI-MS analysis. 
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Figure 5.26 ESI-MS analysis of male C57BL/6 urine at 2.5, 5, 7.5 and 10 ng total 
protein loads. 
Urine (diluted to 5 ng/µl in 0.1% (v/v) formic acid) was injected in triplicate over a range of 
injection volumes onto a C4 desalting trap and the masses of the rMUPs were confirmed 
by ESI-MS in each case. Data was processed using maximum entropy software MAX 
ENT1 (MassLynx 4.1, Waters). The figure shows the multiply charged ion series, the 
deconvoluted, true mass spectra, showing the intact masses for the rMUPs, and the true 
mass spectra viewed as a peak area. 
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Figure 5.27 Relationship of ESI-MS peak area with increasing protein load for each 
MUP in male C57BL/6 urine. 
Urine (diluted in 0.1% (v/v) formic acid) was injected onto a C4 desalting trap and the 
masses of the MUPs present were determined by ESI-MS. Data was processed using 
maximum entropy software MAX ENT1 (MassLynx 4.1, Waters).  Samples were injected 
in triplicate.  The area under peak values for the four main male C57BL/6 MUP variants 
were assessed as total MUP load on column increased.  Error bars represent SD (n = 3). 
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Figure 5.28 Comparison of the relationship of MUP ESI-MS peak area with increasing 
protein load for the quantification of MUPs relative to each other in the sample. 
The area under peak values for the four main male C57BL/6 MUP variants assessed were 
plotted on the same scale for a comparison between the peak area/protein load 
relationships exhibited by each of the MUPs in the urine sample. Error bars represent SD 
(n = 3).  For relative quantification using peak areas, the ionisation efficiencies of each 
MUP need to be known and taken into account. 
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5.3 Conclusions 
The aim of this Chapter was to conduct preliminary experiments to discover whether 
ESI-MS analysis of intact proteins, which is an established valuable method for the 
identification of MUPs, was a suitable method for the absolute quantification of MUPs 
in urine samples. Whilst MaxEnt software is able to measure molecular weight and 
quantitative relative intensities of the sample components in ESI-MS analysis (Ferrige 
et al. 1991,1992; Cottrell and Green 1993, 1998), knowledge of the ionisation 
efficiencies of each sample component is required for more accurate relative 
quantification data. It was determined that whilst the ionisation efficiencies of rMUPs 
(and therefore MUPs) can be confirmed through the ESI-MS analysis of known 
amounts of rMUP, with ionisation efficiencies of rMUPs remaining the same relative 
to others regardless of sample complexity, the relationship between peak area and 
protein load in ESI-MS analysis (ESI-MS response) is different for each rMUP (and 
therefore MUP) depending on sample complexity.  There was also an indication of a 
proton deficiency during the ionisation process in analyses using the Synapt G2, with 
increasing sample complexity yielding much lower mass spectrometry signals than 
expected.  For these reasons, it was confirmed that ESI-MS analysis of MUPs in urine 
would require development to be a suitable method for the absolute quantification of 
MUPs without prior extensive chromatographic separation of urine, but that with 
knowledge of each MUP’s ionisation efficiency relative to others in the sample, and 
method development to ensure successful ionisation of all MUPs in a mixture, ESI-
MS analysis of MUPs in urine is suitable for relative quantification. 
Firstly, the predicted ionisation efficiencies of MUPs in ESI-MS analysis were 
assessed, based on differences in their number of protonatable sites, hydrophobicity 
and charge state distribution profiles.  The similarity of MUP sequences (particularly 
central MUPs) and structure indicated that there were unlikely to be any major 
differences in ionisation efficiencies amongst them as a result of minimal differences 
in hydrophobicity or charge state distribution.  The highly homologous central MUPs 
also have a very similar number of protonatable sites, again suggesting no differences 
in ionisation efficiencies would be observed.  However, the peripheral MUPs possess 
more variable numbers of protonatable sites, which may result in differences in 
ionisation efficiencies.  Evidence indicates that the number of protonatable sites a 
protein has, rather than its shape and molecular mass, appears to determine charge 
state distribution profiles for denatured proteins in ESI (Krusemark et al. 2009), and 
so this was the main consideration when assessing the relationship between MUP 
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concentration and observed ESI-MS response.  As MUP 20 (darcin) exhibits a lower 
charge state distribution profile than other MUPs in ESI-MS analysis, which is 
consistent with it retaining a more compact structure under these experimental 
conditions (Phelan et al. 2014), the effect of charge state distribution profiles on ESI-
MS response was also considered when observing ionisation efficiencies of three 
rMUPs – rMUPs 7, 11 and 20. 
The initial experiment was to determine whether there was a linear relationship 
between MUP in a urine sample and the area under MUP peak in the deconvoluted, 
processed true mass spectrum in ESI-MS analysis of male C57BL/6 urine. A linear 
ESI-MS response would be required so that, in quantitative experiments with the use 
of rMUPs as internal standards, with knowledge of each MUP’s ionisation efficiency, 
the measurement of the area under curve of the rMUP internal standard(s) and the 
corresponding MUP analyte protein(s) could provide absolutely quantitative data.  
This experiment was undertaken using a Waters Synapt G1 Q-ToF mass 
spectrometer, and it was apparent that all four major MUP isoforms retained some 
folding in the gas phase.  The area under peaks recorded for each MUP in the male 
C57BL/6 urine sample increased linearly with increasing amounts of total protein on 
column from 0.8 ng – 3.2 ng.  The relationships between protein load and area under 
peak of MUP 11 and MUP 20 were very similar (suggesting a similar relative amount 
of these proteins was present in the sample), the linear relationship for MUP 7 was 
shallower (indicating there was less of this protein in the sample relative to the other 
MUPs), and the linear relationship for MUP 10 was steeper (suggesting there was 
more of this MUP in the urine sample relative to all other MUPs in the urine sample).  
However, for absolute quantification and indeed, accurate relative quantification, 
knowledge of the responses of each individual MUP in ESI-MS analysis was required, 
which involved the assessment of the relationship of protein load and peak area whilst 
considering how charge state distribution, protonatable sites and sample complexity 
affected MUP ionisation and therefore peak area.  This was explored using 
recombinant forms of MUPs, which allowed the analysis of individual MUPs without 
the need for complex and time-consuming chromatographic separation of mouse 
urine.  It was confirmed that rMUPs 7, 11 and 20 also retained some folding under 
these experimental conditions, and that they too exhibited linear ESI-MS responses. 
All other experiments were conducted using a Waters Synapt G2 Q-ToF mass 
spectrometer, as the Synapt G1 became unavailable.  Once the dynamic range of 
this instrument was determined, recombinant MUPs 7, 11 and 20 (purified and diluted 
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to equal concentration, confirmed by protein assay and SDS-PAGE analysis) were 
diluted appropriately for ESI-MS analysis and each rMUP was analysed separately 
using ESI-MS to assess the relationship between rMUP protein load and peak area.  
Analysis of the responses of equal concentration, single-sample rMUPs in ESI-MS 
would determine differences in each protein’s ionisation efficiency, and whether the 
ionisation efficiency of an rMUP relative to those of other rMUPs could be explained 
and confirmed by the number of protonatable sites that rMUPs possess, and/or the 
charge state distribution profile exhibited in ESI-MS analysis.  rMUP 20 exhibited a 
lower degree of charging than rMUPs 7 and 11 due to its more compact structure, 
and rMUP 7 possessed one more protonatable site than rMUPs 11 and 20, so if these 
factors were to affect ionisation efficiency, it would be expected that rMUP 7 would 
have a slightly higher ionisation efficiency than rMUP 11, and the ionisation of rMUP 
20 would be lower than both rMUPs 7 and 11. However, the results proved the 
opposite – rMUP 20 had a slightly higher ionisation efficiency than rMUP 11, and the 
ionisation efficiency of rMUP 7 was lower than both.  This confirmed that whilst MUPs 
do have differing ionisation efficiencies in ESI-MS analysis, the efficiencies cannot be 
explained/confirmed by assessing protonatable sites or charge state distributions. 
For ESI-MS analysis to be suitable for the relative quantification of MUPs in urine 
samples, the ionisation efficiencies of rMUPs relative to one another would need to 
be the same in samples of greater complexity, and for the absolute quantification, 
rMUPs (and therefore MUPs) would need to exhibit the same peak area/protein load 
ESI-MS response in samples of greater complexity.  It was confirmed through the 
ESI-MS analysis of two-rMUP and three-rMUP equimolar samples that whilst the 
rMUPs ionisation efficiencies relative to one another remained unchanged in samples 
of differing complexities, the peak area/protein load responses exhibited by all three 
rMUPs changed depending on sample complexity.  It was therefore concluded that 
whilst ESI-MS analysis of MUPs in urine could be suitable for relative quantification, 
given that the ionisation efficiencies of all MUPs in the sample relative to one another 
were known, the differing relationships between peak area and protein load in ESI-
MS analysis (ESI-MS response) for each rMUP in different sample complexities 
meant rMUP spiked into urine in known amounts could not produce suitable standard 
curves for absolute quantification.  The only way that ESI-MS analysis of mouse urine 
with rMUPs as internal standards could be suitable for absolute quantification would 
be if a time consuming method chromatographic method was developed that was 
able to separate each MUP and its spiked rMUP counterpart into a single fraction 
prior to ESI-MS analysis.  The chromtagraphic separation of urine prior to spiking the 
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required rMUP into each MUP fraction would be a simpler method to develop, but 
unsuitable since losses of MUPs in the sample in all prior preparation steps would not 
be accounted for. 
The ESI-MS analysis of male C57BL/6 urine, with prior knowledge of the ionisation 
efficiencies of three of the four major MUP isoforms, confirmed the importance of the 
knowledge of the ionisation efficiencies of each MUP in the sample for accurate 
relative quantification.  In the urine sample analysed, if relative quantification was to 
take place without prior knowledge of each MUP’s ionisation efficiencies relative to 
one another, MUP peak areas (as determined by the MaxENT software) would 
determine the urine content as MUP 10 > MUP 11 > MUP 20 > MUP 7, but knowledge 
of the MUP 7, 11 and 20 ionisation efficiencies indicates that MUP 10 > MUP 11 = 
MUP 7 > MUP 20 is more accurate relative quantification. 
For more accurate relative quantification of the MUPs in male C57BL/6 urine, the 
ionisation efficiency of MUP 10 in relation to the other MUPs in the sample would 
need to be determined.  This would be done by assessing the peak area/protein load 
ESI-MS response using a recombinant form of this protein in the same way as for 
rMUPs 7, 11 and 20.  Knowledge of the ionisation efficiencies of these four MUPs 
would allow the accurate relative quantification of MUPs in the urine of male and 
female C57BL/6 and BALB/c (Mudge et al. 2008).  Further experiments would involve 
assessing the instrument responses observed in the Synapt G2 –is the low response 
for rMUP mixtures due to a proton deficiency in the ionisation process? Do 
recombinant MUPs with the hexa-histidine tag removed (and therefore identical to 
natural MUPs) exhibit this same low response in an equimolar mixture? The use of a 
stronger acid in sample preparation would address whether this issue was as a result 
of proton deficiency, and the endoprotease trypsin can be used to cleave the hexa-
histidine tag from purified rMUPs, allowing a comparison of the ESI-MS responses of 
rMUPs with and without the tag.  By conducting various experiments to ascertain why 
ESI-MS responses are a) lower than expected and b) non-linear should enable the 
identification of the causes and therefore allow the current ESI-MS method to be 
developed to ensure linear ESI-MS responses are exhibited by MUPs, for more 
accurate relative quantification of MUPs in samples of differing complexities.  This in 
turn may allow the identification of more significant differences in relative MUP 
expression patterns between an individual’s urine samples that may arise due to 
differences in situations such as reproductive status and social setting. In wild mice, 
MUP profiles are used by conspecifics in recognition and to avoid inbreeding.  In the 
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urine samples of wild mice, the MUPs expressed would need to be identified prior to 
relative quantification so the ionisation efficiencies of all the MUPs could be confirmed 
to allow accurate relative quantification.  It is important to remember, however, that 
current ESI-MS analysis of intact MUPs is unable to identify some MUP isoforms as 
the sequence homology of MUPs means the mass spectrometer is unable to resolve 
MUPs of similar mass (for example, the 18693 and 18694 Da MUPs), suggesting that 
for absolute quantification of MUPs in urine, peptide-level analysis is required.  
For mass spectrometry based quantification of proteins larger than around 15 kDa, 
such as MUPs, a ‘bottom up’ workflow is usually required, as the generated peptides 
are limited in the number of protonatable sites and usually have an m/z value that is 
within the detection range of most mass spectrometers.  As discussed previously, a 
MUP QconCAT was developed for the absolute quantification of MUPs, but problems 
including the high sequence similarity between the MUP variants, and poorly ionising 
peptides resulted in a limited choice of peptides suitable for absolute quantification.  
Although the implementation of a subtraction method allowed the quantification of 
MUPs in male and female C57BL/6 urine, the use of a multiple reaction monitoring 
(MRM) method with a triple quadrupole mass spectrometer could improve the 
quantification of MUPs in urine using QconCAT methodology, providing increased 
sensitivity and a greater dynamic range for the detection and quantification of less 
abundant MUP variants in complex sample mixtures (Lange et al. 2008).  Despite 
this, the use of the MUP QconCAT faces further limitations arising from the high 
evolution rate of MUPs.  It is possible that new MUP isoforms or allelic variants could 
contain peptides not represented by the current MUP QconCAT, meaning that further 
QconCATs would need to be designed (Beynon et al. 2014).   
The relative and absolute quantification of MUP isoforms in the urine samples of 
inbred laboratory strains of the house mouse, and some isoforms expressed in the 
urine of wild-caught mice, can be achieved by the ESI-MS analysis of intact proteins 
and by the use of a MUP QconCAT.  For further MUP isoforms expressed by wild-
caught mice, however, quantification methods would need to be developed further, 
either by confirming the ionisation efficiencies of these proteins (for relative 
quantification) or through the development of a new QconCAT based strategy (for 
absolute quantification). 
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6.1 General conclusions 
The overall aim of this thesis was to apply proteomic techniques, primarily mass 
spectrometry, to the understanding of behaviour in Mus species.  The analysis of 
major urinary proteins (MUPs), whose function is chemical signalling amongst various 
Mus species, enabled the discovery of MUPs in the urine of a Mus species where no 
genome sequence was available.  The analysis of MUPs also allowed the tracking of 
investment in communally nursing BALB/c mice, and ESI-MS analysis of M. m. 
domesticus MUPs determined whether intact protein mass spectrometry, established 
for the identification of MUP isoforms, was suitable for the quantification of MUPs. 
M. spicilegus are genetically close to the M. musculus group of the Mus species 
group, yet display very different mating and social behaviours to those observed in 
the house mouse, M. m. domesticus.  M. spicilegus female mice show a preference 
for one particular mate, which is suggestive of a monogamous mating system, whilst 
the house mouse exhibits polygamous mating behaviour (Patris and Baudoin 1998; 
Patris et al. 2000).  Female house mice have a sexual preference for dominant males 
and have developed a communal nesting system, whereas M. spicilegus are not 
cooperative breeders; they exhibit strong mating pair bonds and females appear 
aggressive towards one another (Tong et al. 2012).  Since urinary MUPs play a 
significant role in the reproductive and social behaviours displayed by the house 
mouse, Chapter 3 of this thesis evaluated M. spicilegus urinary MUP content and 
explored possible roles of these proteins in scent communication.  Four MUPs were 
identified and sequenced in the urine of M. spicilegus mice in the absence of genomic 
data, three of which were male-specific.  SDS-PAGE analysis, protein assays and 
creatinine assays confirmed male mice expressed more MUP in their urine than 
females, and that the amount of MUP expressed by different males varied quite 
significantly whilst female MUP expression was almost identical amongst individuals.  
ESI-MS profiling of the urine of a number of males and females highlighted two 
dominant MUP masses present in all male samples – 18742 Da and 18762 Da.  In 
some male urine samples, masses of 18585 Da and 18918 Da were identified, 
however all female samples only contained the 18918 Da mass, with no evidence of 
the 18742 Da, 18762 Da and 18585 Da masses.  This indicated that these three 
MUPs were male-specific, whilst the 18918 Da MUP was not sex specific.  The 
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molecular weights of the four identified M. spicilegus MUPs did not match the 
molecular weights of any previously identified house mouse MUPs, therefore further 
mass spectrometric analysis was required for the identification of the amino acid 
sequences of the M. spicilegus MUPs. 
To determine full amino acid sequences for each of the M. spicilegus MUPs, the male-
specific MUPs were separated using strong anion exchange chromatography prior to 
digestion and de novo sequencing analysis via LC-MS/MS and PEAKS software.  Full 
peptide sequence information for the three male-specific MUPs was acquired, 
however, only the majority of the non-sex specific 18918 Da MUP could be 
sequenced.  All M. spicilegus MUPs were aligned with all 21 M. m. domesticus MUPs 
and phylogenetic analysis was performed.  The three male specific M. spicilegus 
MUPs were very similar to central M. m. domesticus MUPs, with 18742 Da and 18585 
Da MUPs being very similar to the male-specific M. m. domesticus MUP 7 in 
particular.  The 18762 Da MUP is most similar to M. m domesticus MUPs 13 and 17, 
and the non-sex specific 18918 Da MUP is very similar to the peripheral M. m. 
domesticus MUP 6.  
The presence of male specific MUPs in male urine, along with the variance in MUP 
expression seen in male urine, suggested that these MUPs may have a functional 
role in the unusual sexual and social behaviour observed in M. spicilegus.  
Experiments were set up to determine whether contact between males and females, 
breeding between males and females and contact between males caused differences 
in their MUP expression output in the aim of determining a possible role of MUPs in 
their behaviour.  Female mice did not alter their MUP expression in any situation, but 
male mice increased their MUP expression fairly significantly upon contact with 
females.  Of particular interest was the increase in male specific 18762 Da MUP 
expression in male urine upon contact with females, but after male and female pairs 
were put together for breeding, all five males reduced their MUP expression, three of 
them significantly, including that of the 18762 Da MUP.   This indicated that this MUP 
may play a role in the attraction of females.  In male/male pairs, the only pair of mice 
that appeared to significantly alter their MUP output during contact and after 
interactions were the mice that displayed significant aggressive behaviour during the 
interactions.  One male in this pair, after interactions, significantly increased their 
MUP output; the other male significantly reduced their MUP output after interactions, 
along with their expression of the male-specific 18742 Da and 18762 Da MUPs, 
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suggesting that increased MUP output (especially of these two male-specific MUPs) 
may also have a role in signalling dominance.   
Whilst the determination of the roles of MUPs in scent communication in M. spicilegus 
is in its early stages, the role of MUPs in scent communication including modulating 
identity signalling, attraction and aggressive behaviour in M. m. domesticus is well 
established.  It has been confirmed very recently (Green et al. 2015, published 
October 2015) that MUPs have a role in kin recognition in the context of communal 
nursing in female house mice, who prefer to nest with partners sharing their own MUP 
genotype. Previous studies had suggested that kin recognition and selection were 
important factors in the communal nesting and nursing behaviour displayed be female 
house mice – it was confirmed that communal nursing increases reproductive 
success, regardless of the relatedness of female pairs (Konig 2006). However, 
mutualistic cooperation has been seen to be higher in nests where females are 
related, meaning females may invest more in the offspring of their closer relatives (i.e. 
sisters) than their more distant relatives (cousins).  It may be that females do not 
discriminate between their offspring and their non-offspring, and invest cooperatively 
more in larger, healthier pups.  In Chapter 4, whole animal metabolic labelling with 
stable isotope labelled amino acids was used to determine the proportion of lactation 
investment from communally nursing female house mice and to ascertain any 
discriminatory factors, such as the relatedness of the communally nursing females. 
In complex systems such as animals, protein turnover studies using stable isotope 
labelling involves the introduction of labelled amino acids via diet, however, 
incorporation of the labelled amino acid cannot be instantaneous due to the biomass 
of the animal tissues contributing to the precursor pool.  Claydon et al. (2012) 
designed an experiment to incorporate labelled amino acids into mice via a 50% 
labelled (therefore palatable to the mice) rodent diet, using MUPs in urine to monitor 
the labelling of the liver - there is no evidence of MUP uptake during renal filtration, 
and so MUPs reflect the properties of the precursor RIA in the liver.  This experimental 
technique was deemed suitable to be used in determining the proportion of lactation 
investment from communally nursing female mice – female mice were fed labelled 
diets, and the incorporation of labelling was determined by mass spectrometric 
analysis of MUPs in urine.  The resultant labelled/unlabelled MUP peptides behaved 
the same under mass spectrometric analysis whilst providing a mass difference to 
differentiate between isotopes for the calculation of label incorporation.  Label 
incorporation was calculated from precursor relative isotopic abundances (RIAs): 
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RIA = IH / (IH + IL) 
where IH is the signal intensity displayed by the heavy (labelled) peptide and IL is the 
signal intensity of the light (unlabelled) peptide.   
In the communal nursing experiment, female mice, feeding their pups, passed their 
labelled proteins onto their pups, which were then incorporated and tracked in their 
offspring.  LC-MS analysis of digested proteins from homogenised pup tissue 
samples were used to determine the proportion of lactation investment from mothers; 
label incorporation, and therefore investment, was observed in litters of pups where 
their mothers were related and in litters where their mothers were unrelated, to 
determine any discrimination in investment in relation to the relatedness of the female 
pairs in the nest.  The initial preparatory experiment confirmed the rate of 
incorporation of labelled amino acids into adult female BALB/c mice via a 50% 
labelled diet by analysing MUP peptides from daily urine samples. The testing of a 
feeding mechanism followed, that would enable two communally nesting females to 
exclusively consume differently labelled diets, allowing their investment in the pups 
to be tracked via the transfer of two different labels from the mothers to the pups.  An 
initial communal nursing experiment, with three pairs of females consuming the same 
labelled diet, confirmed that the labelled amino acids were being passed from mothers 
to pups over the course of six days.  MALDI-ToF-MS and LC-MS analysis of digested 
milk proteins from the pups’ stomach contents confirmed labelled amino acids were 
being passed from mothers to pups, and LC-MS analysis of digested proteins from 
pup liver and muscle samples confirmed that the labelled amino acids were being 
successfully incorporated into pup tissues.  The aim was to find a high and low 
turnover protein from each tissue type, with high turnover proteins incorporating the 
label more quickly (high precursor RIAs) than low turnover proteins (low precursor 
RIA); proteins with different turnover rates in pup tissues were hoped to give 
information regarding investment from mothers at different time points during the final 
communal nursing experiment.  High turnover proteins degrade and return to the 
protein precursor pool quickly, with newly synthesised labelled proteins taking their 
place. This high turnover of proteins cause rapid labelling of the precursor pool, so 
recent changes in label investment could be identified through the analysis of these 
proteins.  The opposite is true for low turnover proteins, meaning that these proteins 
may be able to report on variations in label investment over a longer period of time. 
The precursor RIAs of proteins with apparent high and low turnover rates were 
observed in the tissues over the course of the initial communal nursing experiment to 
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determine whether these proteins were indeed high/low turnover and whether they 
could be used to report variations in labelling at different points during the later 
communal nursing.  Whilst these different proteins incorporated the label at different 
rates and reached different maximum RIAs by the end of the experiment, indicating 
that these proteins had different turnover rates, none of the proteins reached a 
maximum labelling plateau. The slow incorporation of label into pup proteins is due 
their rate of growth; however, all four of these proteins in pup tissues labelled at a 
significant enough rate to be suitable for analysis of pup tissues to track investment 
from differently labelled females in the final communal nursing experiment. 
For the communal nursing study, 8 related female pairs and 9 unrelated female pairs 
were set up to give birth and nurse their litters in the communal nest. In order to track 
the investment from each mother in a communal litter, each mother consumed a 
differently labelled diet (one labelled with [D4] lysine, the other with [D9] lysine) via the 
established feeding mechanism when the first litter in the nest to be born was 7 days 
old.   The mothers were fed these diets for 7 days, resulting in two different labels 
being incorporated, one into each mother, which were passed on to the communal 
litter via their milk, and incorporated into the pups they invested in.  The precursor 
RIAs of each label present in the proteins in the pup’s tissues indicated the proportion 
of investment from each mother.  Of the 8 related pairs, 7 had communal litters; of 
the unrelated pairs, 6 had communal litters.  In the remaining four pairs, only one 
female had a litter that survived to the labelling stage.  Firstly, the MUPs in the 
mothers’ urine sampled on the final day of the experiment were analysed using LC-
MS to confirm the incorporation of label via diet.  In the 7 related pairs, only the 
females assigned the [D4] lysine labelled diet were fully labelled with the correct diet, 
with no evidence of consuming any of the unassigned [D9] lysine diet.  Only three out 
of seven females assigned the [D9] lysine diet were fully labelled with the correct diet; 
four were partially [D9] lysine labelled, and two of these showed evidence of having 
consumed some of the unassigned [D4] lysine diet.  The reason for these mice having 
lower [D9] lysine RIA values was likely to be as a result of them consuming less diet; 
it is unknown whether these mice were consuming less diet because of a possible 
problem with the feeding mechanism, however this is unlikely due to no problems 
being encountered in any of the previous experiments.  The fact that two of the [D9] 
lysine assigned mice had very low intensity [D4] lysine peptides in their urine could be 
due to the [D4] lysine female bringing and dropping small amounts of their [D4] lysine 
diet into the communal nest, and so accessible by the [D9] lysine assigned female.  In 
the 6 unrelated pairs, all females were fully labelled with the correct diet, with no 
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evidence of having consumed any unassigned diet, further suggesting that in the 
related pairs, the feeding mechanism was functioning correctly.  LC-MS analysis of 
the digested pup liver and muscle proteins enabled the precursor RIA values for [D4] 
and [D9] lysine labelled peptides to be calculated for the four proteins (selected in the 
milk labelling study) in the tissue samples of pups from litters where both mothers 
were fully, correctly labelled.  The difference between group mean RIAs and the 
variation among and between group RIAs was assessed for each of the four proteins 
using analysis of variance (ANOVA) or in cases where litter sizes were too small for 
ANOVA, the Welch two sample t-test.  To determine whether either female invested 
significantly more (or less) in the entire communal litter, the difference between entire 
group mean RIAs was assessed using the Welch two sample t-test. This determined 
whether there was any statistical significance between the investment from a female 
in her own pups and in her partner’s pups.  There were no statistically significant 
differences between a mother’s investment in her own pups and her partners in all 
communal litters where mothers were related (i.e. no difference between the [D4] 
lysine RIAs calculated in the pups belonging to the [D4] lysine mother and the pups 
belonging to the [D9] lysine mother, and vice versa); there were also no significant 
differences between a mother’s investment in her own pups and her partners in 
communal litters where mothers were unrelated.  However, in a number of communal 
litters, both with related and unrelated female pairs, one female appeared to invest 
more in the entire communal litter than the other.  The reason for this cannot be 
determined due to the small number of communal litters studied.  There was no 
definitive link between size or age of litter and the proportion of communal investment 
from their mother, but when relating back to previous literature, Wilkinson and Baker, 
1988 and Konig 1989 state that in captivity, wild female house mice appear to take 
turns nursing each other’s offspring in communal nests.  Taking into account the 
growth rate and high protein turnover in pups,  it is possible that in this communal 
nursing study, the females have been taking turns in indiscriminately investing in the 
entire communal litter, and it could be that the female who appeared to invest ‘more’ 
was in fact the last female to nurse the communal litter before the end of the 
experiment, and that throughout the experiment, both females were investing 
similarly, taking it in turns to nurse the entire communal litter. 
The lactation investment in the four non-communal litters was also studied; in three 
pairs, only the mother of the pups in each pair was fully labelled.  In one pair, both 
females were fully labelled, and in all four pairs, no female appeared to consume any 
of the unassigned diet.  The fact that the females with no surviving pups generally 
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appeared partially labelled may be due to them consuming less diet due to stress, or 
the fact they did not need to consume as much since they were not expending energy 
investing in the pups.  In all four litters, pups received investment from their mothers 
only, and none from the other female in the communal nest.  This was the case in 
both the related pair and the unrelated pairs.  As a result, the differences in investment 
from each mother in the litter was highly significant.   
In this Chapter, the proportion of lactation investment from communally nursing house 
mice in pup litters was successfully studied with the use of two different labels, and it 
was determined that both related and unrelated female pairs do not discriminate 
between nursing their own litters and the litter from the other female.  However, in 
pairs where only one female’s pups survived, only the mother of the litter invested in 
the pups, with the other lactating female not investing in any of the other female’s 
pups.  The fact that in most communal nests one mother invested in the entire 
communal litter than the other meant that it would be of interest to determine whether 
litter age differences linked to the a female investing more than the other in the 
communal litter, or whether the apparent differences in investment are actually due 
to the mothers taking turns in investing in the entire communal litter. 
The analysis of MUPs, particularly using mass spectrometry, has been used for 
determining labelled amino acid incorporation into inbred female house mice as well 
as for testing the feeding mechanism for the communal nursing experiment.  The 
analysis of mothers’ urinary MUPs in the communal nursing experiments was 
instrumental for the definitive assessment of the proportion of labelled amino acid, 
and therefore investment, pups in a communal litter received from each mother.  Mass 
spectrometry enabled the identification and characterisation of new MUPs in M. 
spicilegus, with the analysis of MUP expression patterns using ESI-MS in different 
social situations providing an insight into their possible roles in scent communication.  
Whilst ESI-MS of intact proteins has proved invaluable for the identification of the 
molecular weights of most MUP isoforms, it is essential that as well as identifying the 
MUPs and their roles in chemical signalling, the differences in MUP expression 
profiles are quantified.  For a definitive assessment of the variation in MUP expression 
of an individual in different situations, and the differences in MUP expression profiles 
between individuals, a suitable quantification method is required. 
Previously, the absolute quantification of MUPs was based on QconCAT technology, 
however, problems were encountered relating to the high sequence homology of 
MUPs.  Though the MUP QconCAT was effective for the quantification of the MUPs 
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expressed by an inbred laboratory strain, further complications could arise from the 
high rate of evolution of these proteins; new allelic variants of MUPs may generate 
peptides different to those in the designed MUP QconCAT upon proteolysis.  The 
analysis of MUPs from M. spicilegus has revealed MUPs that are different in 
sequence to those present in the C57BL/6 laboratory mouse strain, and in both of 
these cases, new QconCATs would have to be designed and constructed.  Since the 
current challenges with MUP quantification are mainly based on the proteins’ 
sequence homology, the high rate of MUP evolution and the lack of a unique peptide 
for each protein, the use of a full length protein standard may address these problems. 
It was considered whether quantification could take place at the intact protein level 
(‘top down’), since intact protein analysis by ESI-MS is already well established for 
the accurate identification of MUP isoforms.   ESI-MS can also provide an indication 
of the amount of each MUP present in the sample relative to each other, however, it 
cannot be used to give an accurate representation of the amount of each MUP 
isoform present in a sample.  This is because although MUPs are very similar in 
sequence, they may ionise differently to each other in the source during ESI-MS that 
may affect the accuracy in the resulting relative quantitation data.  For this reason, 
adding a standard that has identical biochemical properties to its target but with the 
addition of a label in order to distinguish it from the analyte in mass spectrometry 
analysis, in a known amount to a sample prior to intact mass analysis by ESI-MS 
would be desirable, in conjunction with a standard curve.   
Chapter 5 outlined preliminary experiments to investigate whether ESI-MS analysis 
of MUPs, in conjunction with the use of known amounts of rMUPs as standards, can 
allow absolute quantification of MUPs.  The ionisation efficiencies of MUPs relative to 
one another in samples of differing complexity were also assessed to confirm that 
ESI-MS analysis of intact proteins was also suitable for the relative quantification of 
MUPs in urine samples.  Firstly, it was determined that small differences in the 
number of protonatable and hydrophobic sites MUPs possessed (due to their 
sequence homology) were unlikely to result in differences in ionisation efficiency.  The 
same was true for charge state distributions, with the exception of MUP 20 (darcin), 
which retains a more folded structure in the gas phase and so exhibits a lower charge 
state distribution profile, suggesting this MUP may generate a lower intensity mass 
spectrometry signal.  The linearity of MUP ESI-MS response (the relationship 
between protein load and area under MUP peak in the processed true mass 
spectrum) was revisited and confirmed using the Synapt G1 mass spectrometer, 
since a linear response would be required if ESI-MS was to be used as a quantitative 
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method.  This was explored using male C57BL/6 urine and rMUPs, which needed to 
exhibit identical ESI-MS behaviour to their native counterparts if they were to be 
suitable absolute quantification standards, and this was the case, with both natural 
and recombinant MUPs exhibiting linear ESI-MS responses and two charge state 
distribution profiles, indicative of all MUPs retaining a second, more folded 
conformational state under these experimental conditions. 
All other preliminary experiments took place using a Synapt G2 mass spectrometer, 
since the G1 become unavailable.  To determine any differences in ionisation 
efficiency between MUPs, and whether they could be explained by charge state 
distribution profiles, rMUP samples (7, 11 and 20) were diluted to equal concentration 
(confirmed by SDS-PAGE and protein assay) and separately analysed using ESI-MS 
to assess the relationship between protein load and peak area.  In Synapt G1 
analysis, rMUP 20 exhibited a lower degree of charging than rMUPs 7 and 11 due to 
its more compact structure, it would be expected that the ionisation efficiency of rMUP 
20 would be lower than both rMUPs 7 and 11. However, the results proved the 
opposite – rMUP 20 had a slightly higher ionisation efficiency than rMUP 11, and the 
ionisation efficiency of rMUP 7 was lower than both.  Whilst rMUPs 7 and 11 exhibited 
linear ESI-MS responses as expected, rMUP 20 exhibited a non-linear response 
where peak area increased disproportionately with peak load.  This experiment 
confirmed that whilst MUPs do have differing ionisation efficiencies in ESI-MS 
analysis, the efficiencies cannot be explained/confirmed by assessing charge state 
distributions, and that rMUP 20 exhibited a different response in Synapt G2 analysis 
than in Synapt G1 analysis. 
For ESI-MS analysis to be suitable for the relative quantification of MUPs in urine 
samples, the ionisation efficiencies of rMUPs relative to one another were required to 
be the same in samples of greater complexity, and for the absolute quantification, 
rMUPs (and therefore MUPs) would need to exhibit the same peak area/protein load 
ESI-MS response in samples of greater complexity.  It was confirmed through the 
ESI-MS analysis of two-rMUP and three-rMUP equimolar samples that whilst the 
rMUPs ionisation efficiencies relative to one another remained unchanged in samples 
of differing complexities, the peak area/protein load responses exhibited by all three 
rMUPs changed depending on sample complexity.  In three-rMUP samples, rMUPs 
7 and 11 exhibited non-linear ESI-MS responses, when as single samples and as part 
of two-rMUP samples, they exhibited linear responses. In the analysis of the three-
rMUP equimolar mixture, the observed ESI-MS response for rMUPs 7 and 11 were 
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significantly lower than expected – at the 10 ng total protein load, the peak area value 
for rMUP 7 was 270 times lower than the theoretical value, and for rMUP 11, the peak 
area value at this load was 230 times lower than the theoretical value.  Comparing 
this to the observed peak area values at the same total protein load for the two-rMUP 
mixture, where the value for rMUP 7 was only 1.7 times lower than the theoretical 
value, and for rMUP 11, only 1.8 times lower; there is a possibility that there was a 
proton deficit during the ionisation process and so proteins part of more complex 
mixtures have to compete more for charge and so ionise less efficiently, causing lower 
signal in the mass spectra. 
The ESI-MS analysis of male C57BL/6 urine, with prior knowledge of the ionisation 
efficiencies of three of the four major MUP isoforms, confirmed the importance of the 
knowledge of the ionisation efficiencies of each MUP in the sample for accurate 
relative quantification.  In the urine sample analysed, if relative quantification was to 
take place without prior knowledge of each MUP’s ionisation efficiencies relative to 
one another, MUP peak areas would determine the urine content as MUP 10 > MUP 
11 > MUP 20 > MUP 7, but knowledge of the MUP 7, 11 and 20 ionisation efficiencies 
indicates that MUP 10 > MUP 11 = MUP 7 > MUP 20 is more accurate relative 
quantification. 
The preliminary work outlined in Chapter 5 highlights the unpredictable behaviour of 
rMUPs (and therefore MUPs) in the gas phase, as well as the fact that although highly 
homologous, different rMUPs have different ionisation efficiencies in ESI-MS analysis 
that cannot be explained by charge state distribution profiles.  The fact that rMUPs 
have the same ionisation efficiencies relative to one another in samples of differing 
complexity, however, indicates that ESI-MS analysis is suitable for the relative 
quantification of MUPs in mouse urine, given that the ionisation efficiencies of all 
MUPs in the sample relative to one another are known and considered in data 
analysis.  Developing the ESI-MS method could increase the accuracy of the relative 
quantification data and may allow the development of a protein-level absolute 
quantification method that does not require prior extensive chromatographic 
separation of urine. 
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6.2 Future work 
For more accurate relative quantification of the MUPs in male C57BL/6 urine, 
knowledge of the ionisation efficiency of MUP 10 in relation to the other MUPs would 
be required, by assessing the ESI-MS response of this protein using the respective 
rMUP.  Knowledge of the ionisation efficiencies of MUPs 7, 10, 11 and 20 would allow 
the accurate relative quantification of MUPs in the urine of male and female C57BL/6 
and BALB/c .  Further experiments would involve assessing the instrument responses 
observed in the Synapt G2 – to determine whether low rMUP responses in mixtures 
was due to a proton deficiency in the ionisation process, the use of a stronger acid in 
sample preparation would confirm whether this was the case. A comparison of the 
ESI-MS responses of rMUPs with the hexa-histidine purification tag removed (using 
trypsin) with the rMUPs analysed in Chapter 5 would determine whether the tagged 
rMUP exhibited identical ESI-MS behaviour and responses to the respective 
untagged rMUP (which is identical to the native MUP), to confirm whether an absolute 
quantification method could be developed using tagged rMUPs as a standard. 
Conducting various experiments to ascertain why ESI-MS responses are a) lower 
than expected and b) non-linear should enable the identification of the causes and 
therefore allow the current ESI-MS method to be developed to ensure linear ESI-MS 
responses are exhibited by MUPs, for more accurate relative quantification of MUPs 
in samples of differing complexities, and the possibility of the development of an 
absolutely quantitative method.  It must be remembered, however, that current ESI-
MS analysis of intact MUPs is unable to identify some MUP isoforms as the sequence 
homology of MUPs means the mass spectrometer is unable to resolve MUPs of 
similar mass (for example, the 18693 and 18694 Da MUPs), suggesting that for 
absolute quantification of MUPs in urine, peptide-level analysis is required.  The use 
of a multiple reaction monitoring (MRM) method with a triple quadrupole mass 
spectrometer could improve the quantification of MUPs in urine using QconCAT 
methodology, providing increased sensitivity and a greater dynamic range for the 
detection and quantification of less abundant MUP variants in complex sample 
mixtures.  Despite this, the use of the MUP QconCAT faces further limitations arising 
from the high evolution rate of MUPs.  It is possible that new MUP isoforms or allelic 
variants could contain peptides not represented by the current MUP QconCAT, 
meaning that further QconCATs would need to be designed.   
In Chapter 3, the male specific MUPs have been fully sequenced, and so it would be 
beneficial to obtain full accurate sequence information for the 18918 Da MUP.  The 
   
 314 
 
 Chapter 6: Conclusions 
development of a chromatography method that provides better resolution of MUPs 
may allow the 18918 Da MUP to be purified from male urine, or employing an 
alternative mass spectrometry method, such as electron transfer dissociation (ETD), 
may provide additional sequence coverage.  In relation to the behavioural 
experiments, further experiments need to be undertaken to definitively link male MUP 
expression and behaviour, as in this thesis, only a relatively small number of animals 
were sampled. The use of recombinant versions of all four M. spicilegus MUPs could 
then be used in further behavioural experiments, investigating female attraction to the 
male-specific MUPs, in particular the 18762 Da MUP, and whether any of the MUPs 
promote aggressive behaviour.  This would build significantly on the behavioural 
experiments conducted in Chapter 3, providing a deeper insight into the unusual 
social and sexual behaviours this species has been found to exhibit. 
The lactation investment from communally nursing female mice was successfully 
tracked in their pups confirming that no females, related or unrelated, discriminated 
between their own pups and their female partners’; familiar females cooperatively 
invest in communal litters to increase reproductive success. In most cases, however, 
one female invests significantly more in the entire communal litter than the other.  For 
this reason, further communal nursing experiments would be required to discover 
whether there is a link between investment from a mother and the age of her pups – 
in more than half of the communal nests, the mother of the older litter invested more, 
so this is a possible link which is best explored with a greater sample size.  To 
determine whether the differences in investment are observed throughout the 
communal nursing experiment, or whether the apparent differences in investment are 
due to mothers taking turns, pup samples would be needed to be removed from the 
communal nest at intervals during the experiment as well as on the final day. 
The continuing work on MUP quantification, focusing on the role of MUPs in chemical 
communication, is important for pest control strategies in developing countries. 
Research into animal welfare will also benefit from ongoing MUP quantification 
studies, as well as the work on the roles of M. spicilegus MUPs in chemical 
communication amongst conspecifics.  Animal welfare projects monitor the wellbeing 
of laboratory rodents, and so MUP quantification will aid the identification of the MUP 
patterns that trigger behavioural responses such as aggression, whereas the 
continuing investigation into M. spicilegus MUPs will identify whether any MUPs have 
a role in aggressive behaviour amongst laboratory-kept animals of this species.  
Continuing the M. spicilegus studies should also provide an insight into the of role 
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scent communication in mating preferences; when these mice first arrived at the 
Mammalian Behaviour and Evolution group,  difficulties arose trying to get them to 
successfully reproduce.  As discussed in Chapter 3, M. spicilegus are not cooperative 
breeders, and so a greater understanding of the biochemical basis of their mating 
behaviour will improve reproductive success in mice kept in behavioural research 
laboratories.   The study into the communally nursing BALB/c laboratory has also 
provided an insight into the social and reproductive behaviour, which will further 
benefit laboratories involved in behavioural research and assist in successful 
breeding.  Many animal welfare projects are based on information generated from 
experiments in behavioural laboratories, and complementing this knowledge with 
data from biochemistry experiments will enhance the understanding of complex 
behaviour in rodents.    
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Supplementary material A: 18742 Da M. spicilegus MUP peptides identified by PEAKS de novo 
sequence analysis. 
All sequences were assigned a high confidence score by the software. In the sequences, * signifies the 
post-translational modification carbamidomethylation. 
 
 
 
 
 
  
Peptide mass 
(Da) 
Peptide sequence Protease PEAKS™ 
confidence 
score (%) 
1566.7 EEASSTGRNFNVEK Lys-C 88 
1595.8 INGEWHTIILASDK Lys-C 94 
1013.6 VLENSLVLK Lys-C 88 
2103.9 VHTVRDEEC*SELSMVADK Lys-C 75 
1138.5 TERAGEYSVK Lys-C 89 
1301.6 YDGFNTFTIPK Lys-C 82 
1856.8 TDYDNFMMSHLINEK Lys-C 90 
2469.2 DGQTFQLMGL______LSSDIK Lys-C 75 
1179.5 ERFAQLC*EK Lys-C 96 
2591.3 HGILRENIIDLSNANRC*LQARE Lys-C 69 
1438.6 EASSTGRNFNVE Glu-C 84 
1467.8 WHTIILASDKRE Glu-C 90 
1593.8 KIEDNGNFRLFLE Glu-C 95 
746.6 HIHVLE Glu-C 93 
1637.9 NSLVLKVHTVRDEE Glu-C 94 
992.5 LSMVADKTE Glu-C 95 
2273.1 YSVKYDGFNTFTIPKTDYD Glu-C 82 
1234.5 NFMMSHLINE Glu-C 82 
1677.8 GLYGREPDLSSDIKE Glu-C 71 
979.4 RFAQLC*E Glu-C 92 
851.5 KHGILRE Glu-C 94 
1943.9 NIIDLSNANRC*LQARE Glu-C 74 
Peptide mass 
(Da) 
Peptide sequence Protease PEAKS™ 
confidence 
score (%) 
1566.7 EEASSTGRNFNVEK Lys-C 94 
1595.8 INGEWHTIILASDK Lys-C 94 
1263.7 IHVLENSLVLK Lys-C 89 
2121.9 FHLGRDEEC*SELSMVADK Lys-C 76 
2008.9 AGEYSVTYDGFNTFTIPK Lys-C 56 
1870.8 TDYDNFMMTHLINEK Lys-C 96 
2846.1 DGETFQLMGLYGREPDLSSDIK Lys-C 89 
1179.5 ERFAQLC*EK Lys-C 96 
1506.9 HGILRENIIDLSK Lys-C 97 
1116.5 ANRC*LQARE Lys-C 86 
1438.6 EASSTGRNFNVE Glu-C 95 
1979.9 EASSTGRNFNVEKINGE Glu-C 88 
1967.0 WHTIILASDKREKIEEH Glu-C 89 
1131.6 HGNFRLFLE Glu-C 98 
737.4 QIHVLE Glu-C 85 
1655.8 NSLVLKFHLGRDEE Glu-C 92 
2032.0 NSLVLKFHLGRDEEC*SE Glu-C 89 
1377.7 LSMVADKTEKAGE Glu-C 100 
1131.5 KAGEYSVTYD Glu-C 98 
1517.7 GFNTFTIPKTDYD Glu-C 84 
1248.6 NFMMTHLINE Glu-C 96 
1677.7 NFMMTHLINEKDGE Glu-C 95 
1525.7 TFQMGLYGREPD Glu-C 91 
922.4 RFAQLC*E Glu-C 90 
851.5 KHGILRE Glu-C 85 
1444.6 LSKANRC*LQARE Glu-C 75 
 
Supplementary material A: 18762 Da M. spicilegus MUP peptides identified by PEAKS de novo 
sequence analysis. 
All sequences were assigned a high confidence score by the software. In the sequences, * signifies the 
post-translational modification carbamidomethylation. 
 
 
  
Peptide mass 
(Da) 
Peptide sequence Protease PEAKS™ 
confidence 
score (%) 
1566.7 EEASSTGRNFNVEK Lys-C 88 
1595.8 INGEWHTIILASDK Lys-C 94 
801.5 ENSLVLK Lys-C 83 
1947.9 VHTVDEEC*SELSMVADK Lys-C 96 
1138.5 TERAGEYSVK Lys-C 91 
1301.6 YDGFNTFTIPK Lys-C 91 
1856.8 TDYDNFMMSHLINEK Lys-C 93 
2469.2 DGQTFQLMGL______LSSDIK Lys-C 75 
1179.5 ERFAQLC*EK Lys-C 96 
2591.3 ANRC*LQARE Lys-C 82 
1438.6 EASSTGRNFNVE Glu-C 84 
1979.9 EASSTGRNFNVEKINGE Glu-C 79 
1467.8 WHTIILASDKRE Glu-C 90 
1593.8 KIEDNGNFRLFLE Glu-C 95 
746.6 HIHVLE Glu-C 93 
1481.8 NSLVLKVHTVDEE Glu-C 98 
1857.9 NSLVLKVHTVDEEC*SE Glu-C 96 
992.5 LSMVADKTE Glu-C 89 
1405.7 LSMVADKTERAGE Glu-C 87 
2273.1 YSVKYDGFNTFTIPKTDYD Glu-C 82 
2298.1 TFQLMGLYGREPDLSSDIKE Glu-C 64 
922.4 RFAQLC*E Glu-C 92 
851.5 KHGILRE Glu-C 94 
1886.9 NIIDLSNANRC*LQARE Glu-C 74 
 
 
 
 
Supplementary material A: 18585 Da M. spicilegus MUP peptides identified by PEAKS de novo 
sequence analysis. 
All sequences were assigned a high confidence score by the software. In the sequences, * signifies 
the post-translational modification carbamidomethylation. 
 
 
 
 
 
 
 
 
 
Peptide mass 
(Da) 
Peptide sequence Protease PEAKS™ 
confidence 
score (%) 
1597.7 EEASSMGRNFNVEK Lys-C 88 
1622.8 INGEWYTIILASDK Lys-C 94 
1181.3 C*SEIFLVADK Lys-C 88 
1450.5 AGEYSVTYDGFNK Lys-C 75 
606.7 FTVLK Lys-C 89 
1881.1 TDYDNYIMIHLINKK Lys-C 82 
1606.8 SLYGREPDLNSDLK Lys-C 76 
1663.7 YGREPDLNSDLKEK Lys-C 50 
2039.3 LC*EEHGILRENIIDVTK Lys-C 75 
1179.5 TNRC*LQARE Lys-C 96 
1469.6 EEASSMGRNFNVE Glu-C 69 
1994.3 WYTIILASDKREKIEE Glu-C 84 
1075.3 HGSMRLFVE Glu-C 95 
746.6 HIHVLE Glu-C 95 
1976.1 NSLGFKFKWTDEKC*SE Glu-C 93 
1035.2 IFLVADKTE Glu-C 94 
992.5 IFLVADKTEKAGE Glu-C 95 
817.4 LNSDIKE Glu-C 79 
2273.1 KFVKLC*EE Glu-C 82 
1234.5 HGILRE Glu-C 82 
1677.8 NIIDVTKTNRC*LQARE Glu-C 71 
 
 
 
 
Supplementary material A: 18918 Da M. spicilegus MUP peptides identified by PEAKS de novo 
sequence analysis. 
All sequences were assigned a high confidence score by the software. In the sequences, * signifies the 
post-translational modification carbamidomethylation. 
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Supplementary material A: Mus spicilegus MUP peptide mass fingerprinting of male Mus 
spicilegus urine sample  
The MALDI-ToF-MS spectrum generated from a Lys-C in-gel digestion of SDS-PAGE gel piecesfrom 
SDS-PAGE analysis of male urine (top band) was searched against a custom made Mus spicilegus 
MUPs database using Mascot. The digested protein band from male urine showed peptides that 
matched peptides from all Mus spicilegus MUPs, the peptide maps of which are shown below the 
spectrum.  In the peptide maps, the coloured peptides are those masses observed in the spectrum. 
The red peptides are those with masses shared between two or more of the Mus spicilegus MUPs, 
and peptide masses unique to each MUP are coloured differently to one another – peptide masses 
unique to 18742 Da are coloured green; to 18762 Da, purple; to 18585 Da, pink; to 18918 Da; blue.   
 Behaviour 
Interaction Male Sniffing  Approach Retreat Chasing Escaping Aggression Avoidance 
Day 1 A        
 B       
Day 2 A       
 B       
Day 3 A       
 B       
 
 
 
 
 
 Behaviour 
Interaction Male Sniffing  Approach Retreat Chasing Escaping Aggression Avoidance 
Day 1 A        
 B       
Day 2 A        
 B        
Day 3 A        
 B        
 
 
 
 
 
 Behaviour 
Interaction Male Sniffing  Approach Retreat Chasing Escaping Aggression Avoidance 
Day 1 A        
 B        
Day 2 A        
 B        
Day 3 A        
 B        
 
 
 
 
 
Supplementary material A: Recording of the behaviour observed in the first male/male pair.   
During the controlled interactions, the behaviour by both mice was observed and recorded in the 
above table. Each mouse was identified by a fur clip on either their right shoulder or right rump.  A 
tick represents that that particular behaviour was observed.  More ticks indicates more persistent 
behaviour.  Aggressive behaviour was stopped by splitting the mice up to avoid injuries being 
sustained. 
Supplementary material A: Recording of the behaviour observed in the second male/male 
pair.   
During the controlled interactions, the behaviour by both mice was observed and recorded in the 
above table. Each mouse was identified by a fur clip on either their right shoulder or right rump.  A 
tick represents that that particular behaviour was observed.  More ticks indicates more persistent 
behaviour.  Aggressive behaviour was stopped by splitting the mice up to avoid injuries being 
sustained. 
Supplementary material A: Recording of the behaviour observed in the third male/male pair.   
During the controlled interactions, the behaviour by both mice was observed and recorded in the 
above table. Each mouse was identified by a fur clip on either their right shoulder or right rump.  A 
tick represents that that particular behaviour was observed.  More ticks indicates more persistent 
behaviour.  Aggressive behaviour was stopped by splitting the mice up to avoid injuries being 
sustained. 
Preparation of labelled diet 
To make 1 kg labelled diet: 
1. Identify the weight of labelled amino acid required to be added to the diet to achieve a 50 % labelled diet.  
2. Rinse all glassware & blender in RO water.  
3. In a large beaker, dissolve the appropriate amount of labelled amino acid in 1L RO water (equivalent volume for the weight of diet being 
prepared).  
4. Add 1 kg unlabelled diet (Certified Rodent Diet 5002) and stir.  
5. Leave for 2 hours then add a further 125 ml RO water and stir aggressively. 
6. Leave for a further 1 hour, then add mix to blender, using a further 125 ml RO water to rinse beaker.  
7. Blend for a minimum of 10 minutes until the mixture is a thick paste. 
8. Alternate between high and low speeds, scraping sides occasionally. 
9. Transfer food to a piping bag. 
10. Attach baking paper (shiny side up) to the dehydrator trays. 
11. Pipe food onto the trays and score pellet size lines across food.  
12. Place in dehydrator for approximately 48 hours at 40°C. 
13. If making two labelled diets at the same time, be sure to use two sets of clearly-labelled beakers & spatulas in order to prevent cross-
contamination. Ensure that the blender is washed thoroughly with RO water in between blending each diet.  
 
 
 
 
Supplementary material B: Full protocol for the preparation of the labelled diets used throughout the communal nursing study. 
  
 
 
Supplementary material B:  Assessing the rate of label incorporation 
Spreadsheet where MUP peptide intensities were recorded, along with the intensities of the corresponding labelled peptides, for the mice fed 
[13C6] lysine labelled diets over the course of six days. Precursor RIA values were calculated from this data. 
 
ID: Sample 
no. 
MUP 
peptide 
Light peptide Heavy lysine peptide IH/(IH+IL) Sample average RIA Time of sampling 
(hours) 
Day of 
sampling 
   1 2 3 Sum 1 2 3 Sum     
10910 34081 2471/2477 122541 170550 120315 413406 0 0 0 0 0 0 0 0 
  1823/1829 16631 17733 10348 44712 0 0 0 0 0    
10911 34082 2471/2477 909 1206 929 3044 0 0 0 0 0 0 0 0 
  1823/1829 1896 1812 1096 4804 0 0 0 0 0    
10911 34085 2471/2477 62118 84985 64830 211933 6405 6318 4792 17515 0.076335 0.094474 6 1 
  1823/1829 6602 5985 4016 16603 807 775 525 2107 0.112614    
10910 34086 2471/2477 14105 19791 15717 49613 2332 2374 1870 6576 0.117034 0.142572 6 1 
  1823/1829 1700 1488 944 4132 289 295 251 835 0.16811    
10911 34089 2471/2477 23522 32792 29011 85325 10797 12308 10669 33774 0.283579 0.30141 12 1 
  1823/1829 5556 5373 4175 15104 2788 2491 1804 7083 0.319241    
10910 34090 2471/2477 294815 370261 309143 974219 51366 52122 36842 140330 0.125907 0.114549 12 1 
  1823/1829 80312 87401 53223 220936 9277 9776 6369 25422 0.103191    
10911 34093 2471/2477 12157 18739 16394 47290 8149 10188 9579 27916 0.371194 0.37292 18 1 
  1823/1829 5218 5972 4033 15223 3262 3609 2249 9120 0.374646    
10910 34094 2471/2477 52074 72712 57327 182113 10782 11936 8552 31270 0.146544 0.152512 18 1 
  1823/1829 8744 9696 6060 24500 1603 1819 1192 4614 0.15848    
10911 34097 2471/2477 12623 19597 17390 49610 7060 9233 8602 24895 0.334139 0.3576 30 2 
  1823/1829 2491 2890 2175 7556 1686 1515 1451 4652 0.381062    
10910 34098 2471/2477 19986 31774 28644 80404 11587 15008 12729 39324 0.328444 0.338769 30 2 
  1823/1829 4493 4797 3540 12830 2510 2483 1888 6881 0.349094    
10911 34101 2471/2477 50529 56632 44000 151161 28841 26895 20964 76700 0.336609 0.388774 36 2 
  1823/1829 3132 4116 3278 10526 2988 3044 2270 8302 0.440939    
10910 34102 2471/2477 50313 76950 79221 206484 53409 67825 67466 188700 0.477499 0.471759 36 2 
  1823/1829 7883 9378 7316 24577 6967 8019 6463 21449 0.466019    
10911 34105 2471/2477 17490 26699 27728 71917 17323 21796 19700 58819 0.449907 0.440048 42 2 
  1823/1829 2103 2389 1850 6342 1546 1841 1401 4788 0.430189    
10910 34106 2471/2477 60735 87681 91461 239877 63494 80633 79638 223765 0.482625 0.481474 42 2 
  1823/1829 13011 16586 12370 41967 13165 14456 11168 38789 0.480323    
10911 34107 2471/2477 30202 47970 46950 125122 22849 28195 25624 76668 0.37994 0.361442 54 3 
  1823/1829 2944 3748 2742 9434 1727 1837 1360 4924 0.342945    
10910 34108 2471/2477 65061 96975 96640 258676 49400 60740 54517 164657 0.388954 0.378855 54 3 
  1823/1829 11596 12788 9914 34298 6795 7915 5326 20036 0.368756    
10910 34113 2471/2477 23431 38871 42430 104732 30934 42386 42027 115347 0.524116 0.510803 66 3 
  1823/1829 7669 9406 7251 24326 7688 9071 7324 24083 0.49749    
10911 34114 2471/2477 15328 25292 28331 68951 18457 25572 24095 68124 0.496983 0.484488 66 3 
  1823/1829 3775 3810 3170 10755 3175 3339 3100 9614 0.471992    
10911 34117 2471/2477 39812 63603 63462 166877 31505 42551 38302 112358 0.402378 0.392857 78 4 
  1823/1829 8267 10501 7632 26400 5482 6221 4708 16411 0.383336    
10910 34118 2471/2477 940 1658 1613 4211 762 812 732 2306 0.353844 0.381216 78 4 
  1823/1829 260 376 273 909 186 222 220 628 0.408588    
10911 34129 2471/2477 39861 65646 66034 171541 43364 58742 55696 157802 0.479142 0.475258 90 4 
  1823/1829 17328 21310 15690 54328 16651 18381 13412 48444 0.471374    
10910 34130 2471/2477 13052 20232 21750 55034 15644 21008 21071 57723 0.511924 0.509968 90 4 
  1823/1829 5907 6361 5630 17898 6355 6580 5546 18481 0.508013    
10911 34135 2471/2477 34993 60957 57969 153919 24974 33302 30639 88915 0.366155 0.373271 102 5 
  1823/1829 5577 6598 5352 17527 3592 3876 3292 10760 0.380387    
10910 34136 2471/2477 118819 183997 170223 473039 80445 103414 89349 273208 0.366109 0.353545 102 5 
  1823/1829 12513 14951 10226 37690 7039 7396 5066 19501 0.34098    
10911 34137 2471/2477 44254 70280 73637 188171 51389 68247 69103 188739 0.500753 0.502237 114 5 
  1823/1829 7082 9134 6860 23076 7892 8998 6532 23422 0.503721    
10910 34138 2471/2477 6131 10091 10359 26581 6713 8727 8220 23660 0.47093 0.47471 114 5 
  1823/1829 2354 2706 2153 7213 2322 2360 1936 6618 0.47849    
  
 
 
 
 
 
Supplementary material B:  Assessing the rate of label incorporation 
Spreadsheet where MUP peptide intensities were recorded, along with the intensities of the corresponding labelled peptides, for the mice fed 
[2H8] valine labelled diets over the course of six days. Precursor RIA values were calculated from this data. 
 
 
 
 
 
ID: Sample 
no. 
MUP 
peptide 
Light valine peptide Heavy valine peptide IH/(IH+IL) Sample average RIA Time of sampling 
(hours) 
Day of 
sampling 
   1 2 3 Sum 1 2 3 Sum     
10903 34079 2009/2017 2698 3090 1875 7663 0 0 0 0 0 0 0 0 
  1567/1575 1682 1272 499 3453 0 0 0 0 0    
10904 34080 2009/2017 1677 1339 1242 4258 0 0 0 0 0 0 0 0 
  1567/1575 234 192 132 558 0 0 0 0 0    
10904 34083 2009/2017 13954 17276 10361 41591 1786 1602 1049 4437 0.096398 0.133255 6 1 
  1567/1575 1571 1622 661 3854 337 239 214 790 0.170112    
10903 34084 2009/2017 32586 42986 27820 103392 9666 8657 4831 23154 0.182969 0.228568 6 1 
  1567/1575 2736 2500 1086 6322 991 767 630 2388 0.274168    
10904 34087 2009/2017 9495 11042 6550 27087 2097 1804 955 4856 0.152021 0.191343 12 1 
  1567/1575 1399 965 501 2865 211 363 285 859 0.230666    
10903 34088 2009/2017 7248 9105 5812 22165 5516 7446 5483 18445 0.454198 0.443219 12 1 
  1567/1575 1072 783 445 2300 472 771 508 1751 0.432239    
10904 34091 2009/2017 4343 5087 3285 12715 1993 1329 669 3991 0.238896 0.213103 18 1 
  1567/1575 1270 1137 526 2933 328 199 149 676 0.18731    
10903 34092 2009/2017 4194 4865 2983 12042 4971 3671 1663 10305 0.461136 0.410554 18 1 
  1567/1575 1317 904 526 2747 633 612 300 1545 0.359972    
10904 34095 2009/2017 11301 12700 7683 31684 1698 1698 953 4349 0.120695 0.193788 30 2 
  1823/1831 4163 4134 2842 11139 1584 1730 741 4055 0.266882    
10903 34096 2009/2017 1673 2167 1246 5086 1004 797 403 2204 0.302332 0.339845 30 2 
  1567/1575 515 438 202 1155 289 274 137 700 0.377358    
10903 34099 2009/2017 12596 17549 11735 41880 12790 12065 9377 34232 0.449758 0.431776 36 2 
  1567/1575 1806 1351 821 3978 1345 973 490 2808 0.413793    
10904 34100 2009/2017 2340 3272 1884 7496 1585 1254 939 3778 0.335107 0.335107 36 2 
10904 34103 2009/2017 4780 5186 3330 13296 3196 3208 1513 7917 0.373215 0.373215 42 2 
10903 34104 2009/2017 26039 35497 23888 85424 15932 13939 7254 37125 0.30294 0.401412 42 2 
  1567/1575 1804 1628 900 4332 1001 1917 1412 4330 0.499885    
10903 34109 2009/2017 10282 14476 8959 33717 6498 5904 2975 15377 0.313215 0.349735 54 3 
  1567/1575 922 852 414 2188 685 485 207 1377 0.386255    
10904 34110 1596/1604 1235 1060 629 2924 599 366 366 1331 0.312808 0.312808 54 3 
10904 34112 2009/2017 18090 22075 13979 54144 18013 16435 9290 43738 0.446844 0.448321 66 3 
  1567/1575 4053 3755 1897 9705 3840 2577 1517 7934 0.449799    
10904 34115 2009/2017 16835 1902 15835 34572 3949 12589 7326 23864 0.408378 0.409057 78 4 
  1567/1575 3545 3220 2439 9204 2457 2215 1717 6389 0.409735    
10903 34116 2009/2017 9965 12776 8137 30878 8575 7220 3577 19372 0.385512 0.402363 78 4 
  1567/1575 1168 1230 661 3059 975 686 547 2208 0.419214    
10904 34127 2009/2017 11326 13916 9146 34388 11737 9097 5186 26020 0.430738 0.418962 90 4 
  1567/1575 10921 9452 4457 24830 8659 5841 2555 17055 0.407186    
10903 34128 2009/2017 24222 34298 23942 82462 24416 19832 10063 54311 0.397089 0.427589 90 4 
  1567/1575 2590 2281 1439 6310 2474 1838 1022 5334 0.45809    
10904 34133 2009/2017 12991 16927 10444 40362 7055 5769 3027 15851 0.281981 0.374293 102 5 
  1567/1575 1533 403 931 2867 1042 843 623 2508 0.466605    
10903 34134 2009/2017 2074 2918 2036 7028 1360 1172 615 3147 0.309287 0.370733 102 5 
  1567/1575 676 653 425 1754 504 561 270 1335 0.432179    
10903 34139 2009/2017 1799 2235 1660 5694 2170 1743 1084 4997 0.467402 0.467402 114 5 
10904 34140 2009/2017 17195 20287 13034 50516 28040 20682 10204 58926 0.538422 0.47655 114 5 
  1567/1575 3312 2924 1588 7824 2724 1870 949 5543 0.414678    
 
 
 
 
  
 
 
 
Supplementary B: Proof-of-principle experiment 
Spreadsheet where MUP peptide intensities were recorded, along with the intensities of the corresponding labelled peptides, for the mice fed 
[12C6] lysine labelled diets over the course of six days. Precursor RIA values were calculated from this data. 
 
 
 
 
 
 
 
 
 
 
  Lysine 
peptide 
Light lysine peptide 
intensity 
 Heavy lysine peptide intensity Valine 
peptide 
Light valine peptide 
intensity 
 Heavy valine 
peptide intensity 
  
Sampl
e 
numb
er 
Day of 
labellin
g 
Light/hea
vy MUP 
peptide 
(Da) 
1 2 3 Sum 1 2 3 Sum Light/hea
vy MUP 
peptide 
(Da) 
1 2 3 Sum 1 2 3 Su
m 
Lysine 
IH/(IH+IL) 
Valine 
IH/(IH+I
L) 
10978 0 2471/247
7 
20980 28152 21552 70684 0 0 0 0 2009/201
7 
2119 2712 2335 7166 0 0 0 0 0 0 
  2009/201
5 
2119 2712 2335 7166 0 0 0 0 1567/157
5 
576 307 284 1167 0 0 0 0 0 0 
 1 2471/247
7 
10626 16642 16669 43937 8050 9442 8333 25825 2009/201
7 
2087 2142 1711 5940 0 0 0 0 0.370187 0 
  2009/201
5 
2087 2142 1711 5940 1273 1470 1215 3958 1567/157
5 
369 442 349 1160 0 0 0 0 0.399879 0 
 2 2471/247
7 
6466 10042 11728 28236 6831 8487 8752 24070 2009/201
7 
806 1029 905 2740 0 0 0 0 0.460177 0 
  2009/201
5 
806 1029 905 2740 751 743 608 2102 1567/157
5 
0 0 0 0 0 0 0 0 0.434118 0 
 3 2471/247
7 
11190 18382 18353 47925 10845 13520 13170 37535 2009/201
7 
1363 1796 1418 4577 0 0 0 0 0.439211 0 
  2009/201
5 
1363 1796 1418 4577 1334 1273 1022 3629 1567/157
5 
233 217 207 657 0 0 0 0 0.442237 0 
 4 2471/247
7 
15188 24314 23859 63361 11779 14653 13638 40070 2009/201
7 
3364 3637 2699 9700 0 0 0 0 0.387408 0 
  2009/201
5 
3364 3637 2699 9700 2120 2383 2212 6715 1567/157
5 
586 671 552 1809 0 0 0 0 0.409077 0 
 5 2471/247
7 
42706 65160 66975 17484
1 
37714 45357 41738 12480
9 
2009/201
7 
6245 6998 5324 18567 0 0 0 0 0.416516 0 
  2009/201
5 
6245 6998 5324 18567 4470 5789 4787 15046 1567/157
5 
1392 1289 1136 3817 0 0 0 0 0.447624 0 
10987 0 2471/247
7 
18788
3 
22700
2 
18825
4 
60313
9 
0 0 0 0 2009/201
7 
4087
1 
4569
1 
2815
5 
11471
7 
0 0 0 0 0 0 
  2009/201
5 
40871 45691 28155 11471
7 
0 0 0 0 1567/157
5 
7284 5448 2941 15673 0 0 0 0 0 0 
 2 2471/247
7 
36959 56954 55373 14928
6 
30715 38115 35601 10443
1 
2009/201
7 
1026
8 
1225
1 
8733 31252 0 0 0 0 0.411604 0 
  2009/201
5 
10268 12251 8733 31252 7361 7957 5871 21189 1567/157
5 
908 917 701 2526 0 0 0 0 0.404054 0 
 3 2471/247
7 
70254 10818
7 
10839
6 
28683
7 
62964 81331 77991 22228
6 
2009/201
7 
3338
3 
4150
9 
3133
5 
10622
7 
0 0 0 0 0.436606 0 
  2009/201
5 
33383 41509 31335 10622
7 
25872 31335 22433 79640 1567/157
5 
3906 3882 3216 11004 0 0 0 0 0.428478 0 
 4 2471/247
7 
14780 21617 21034 57431 10242 13628 12089 35959 2009/201
7 
1154
6 
1395
6 
9582 35084 0 0 0 0 0.385041 0 
  2009/201
5 
11546 13956 9582 35084 7290 8495 5913 21698 1567/157
5 
3019 2945 2223 8187 0 0 0 0 0.382128 0 
 5 2471/247
7 
51385 79893 77698 20897
6 
42680 55351 52378 15040
9 
2009/201
7 
3064
8 
3806
2 
2863
1 
97341 0 0 0 0 0.418518 0 
  2009/201
5 
30648 38062 28631 97341 22358 27034 20242 69634 1567/157
5 
2843 2454 1908 7205 0 0 0 0 0.417032 0 
10865 0 2471/247
7 
10303
2 
12828
6 
10164
5 
33296
3 
0 0 0 0 2009/201
7 
2926
3 
3308
1 
1957
4 
81918 0 0 0 0 0 0 
  2009/201
5 
29263 33081 19574 81918 0 0 0 0 1567/157
5 
4147 3147 1276 8570 0 0 0 0 0 0 
 1 2471/247
7 
77845 11452
7 
11287
2 
30524
4 
65001 80880 76170 22205
1 
2009/201
7 
3100
1 
3936
8 
2822
3 
98592 0 0 0 0 0.421113 0 
  2009/201
5 
31001 39368 28223 98592 29504 33776 26231 89511 1567/157
5 
5786 5652 4121 15559 0 0 0 0 0.475862 0 
 2 2471/247
7 
28558 47965 49984 12650
7 
37007 47526 46830 13136
3 
2009/201
7 
4685
5 
5751
4 
4420
4 
14857
3 
0 0 0 0 0.509416 0 
  2009/201
5 
46855 57514 44204 14857
3 
48483 54372 41825 14468
0 
1567/157
5 
4566 4025 3549 12140 0 0 0 0 0.493362 0 
 3 2471/247
7 
44160 65994 65857 17601
1 
41696 51513 47576 14078
5 
2009/201
7 
2115
3 
2468
1 
1764
3 
63477 0 0 0 0 0.444403 0 
  2009/201
5 
21153 24681 17643 63477 16555 18487 13680 48722 1567/157
5 
2297 2408 1832 6537 0 0 0 0 0.434246 0 
 4 2471/247
7 
16081
4 
23898
5 
22061
8 
62041
7 
11252
7 
14284
0 
14472
1 
40008
8 
2009/201
7 
3362
1 
4232
7 
3191
1 
10785
9 
0 0 0 0 0.392049 0 
  2009/201
5 
33621 42327 31911 10785
9 
32169 39629 35869 10766
7 
1567/157
5 
4249 4011 2818 11078 0 0 0 0 0.499555 0 
 5 2471/247
7 
25550 40417 42084 10805
1 
32085 42065 42224 11637
4 
2009/201
7 
1386
9 
1781
1 
1474
3 
46423 0 0 0 0 0.518543 0 
  2009/201
5 
13869 17811 14743 46423 15650 18118 14278 48046 1567/157
5 
969 960 940 2869 0 0 0 0 0.50859 0 
10827 0 2471/247
7 
56907 75626 55238 18777
1 
0 0 0 0 2009/201
7 
6380 7121 4606 18107 0 0 0 0 0 0 
  2009/201
5 
6380 7121 4606 18107 0 0 0 0 1567/157
5 
1889 1606 858 4353 0 0 0 0 0 0 
 1 2471/247
7 
94966 13866
5 
13390
6 
36753
7 
79652 99629 92546 27182
7 
2009/201
7 
1783
5 
2232
8 
1619
5 
56358 0 0 0 0 0.425152 0 
  2009/201
5 
17835 22328 16195 56358 13612 16299 11395 41306 1567/157
5 
1612 1390 1240 4242 0 0 0 0 0.42294 0 
 2 2471/247
7 
29263 45206 45596 12006
5 
27495 34788 33316 95599 2009/201
7 
5273 6322 4384 15979 0 0 0 0 0.443278 0 
  2009/201
5 
5273 6322 4384 15979 4123 4709 3353 12185 1567/157
5 
727 735 597 2059 0 0 0 0 0.432645 0 
 3 2471/247
7 
42569 63331 66698 17259
8 
46788 59222 57937 16394
7 
2009/201
7 
1789
3 
2178
5 
1659
1 
56269 0 0 0 0 0.487147 0 
  2009/201
5 
17893 21785 16591 56269 17559 21085 14973 53617 1567/157
5 
2475 2214 2002 6691 0 0 0 0 0.487933 0 
 4 2471/247
7 
64185 94788 88620 24759
3 
46537 58420 50494 15545
1 
2009/201
7 
1954
9 
2464
6 
1629
9 
60494 0 0 0 0 0.385692 0 
  2009/201
5 
19549 24646 16299 60494 12338 14166 9218 35722 1567/157
5 
2231 2068 1312 5611 0 0 0 0 0.371269 0 
 5 2471/247
7 
48253 76273 82839 20736
5 
64349 83414 85617 23338
0 
2009/201
7 
2158
8 
2620
8 
2047
8 
68274 0 0 0 0 0.529513 0 
  2009/201
5 
21588 26208 20478 68274 23969 27369 20456 71794 1567/157
5 
2418 2322 2161 6901 0 0 0 0 0.512565 0 
10954 0 2471/247
7 
20861
0 
27903
8 
23686
4 
72451
2 
0 0 0 0 2009/201
7 
3520
3 
4245
2 
2640
1 
10405
6 
0 0 0 0 0 0 
  2009/201
5 
35203 42452 26401 10405
6 
0 0 0 0 1567/157
5 
1313
1 
1084
9 
7154 31134 0 0 0 0 0 0 
 1 2471/247
7 
99455 14813
9 
14549
8 
39309
2 
89825 11295
5 
10674
6 
30952
6 
2009/201
7 
4066
6 
4930
4 
3633
9 
12630
9 
0 0 0 0 0.440532 0 
  2009/201
5 
40666 49304 36339 12630
9 
32729 38082 27430 98241 1567/157
5 
1628 1779 1511 4918 0 0 0 0 0.437502 0 
 2 2471/247
7 
62854 96494 96104 25545
2 
51855 65908 61553 17931
6 
2009/201
7 
2018
3 
2396
0 
1703
8 
61181 0 0 0 0 0.412441 0 
  2009/201
5 
20183 23960 17038 61181 13788 15906 11174 40868 1567/157
5 
1959 1803 1378 5140 0 0 0 0 0.400474 0 
 3 2471/247
7 
16022 24954 25056 66032 15566 20125 18422 54113 2009/201
7 
7800 1036
1 
7471 25632 0 0 0 0 0.450397 0 
  2009/201
5 
7800 10361 7471 25632 6969 7934 5821 20724 1567/157
5 
2205 2240 1896 6341 0 0 0 0 0.447062 0 
 4 2471/247
7 
68058 10367
4 
10626
8 
27800
0 
71169 89285 87195 24764
9 
2009/201
7 
2696
9 
3389
9 
2643
1 
87299 0 0 0 0 0.47113 0 
  2009/201
5 
26969 33899 26431 87299 23937 27815 20705 72457 1567/157
5 
2949 2883 2281 8113 0 0 0 0 0.453548 0 
 5 2471/247
7 
37831 56367 51356 14555
4 
23921 30742 26167 80830 2009/201
7 
1680
5 
2022
0 
1438
0 
51405 0 0 0 0 0.357048 0 
  2009/201
5 
16805 20220 14380 51405 9340 10576 7614 27530 1567/157
5 
2357 2112 1365 5834 0 0 0 0 0.348768 0 
 
 
 
 
 
  
 
 
 
 
 
 
Supplementary B: Proof-of-principle experiment 
Spreadsheet where MUP peptide intensities were recorded, along with the intensities of the corresponding labelled peptides, for the mice fed 
[2H8] valine labelled diets over the course of six days. Precursor RIA values were calculated from this data. 
 
 
 
 
 
 
 
  Lysine/valine 
peptide 
Light valine/lysine peptide intensity Heavy lysine peptide intensity Heavy valine peptide intensity   
Sample 
number 
Day of 
labelling 
Light/heavy 
MUP 
peptide (Da) 
1 2 3 Sum 1 2 3 Sum 1 2 3 Sum Lysine IH/(IH+IL) Valine IH/(IH+IL) 
10977 0 2009/2017 37361 44346 27096 108803 0 0 0 0 0 0 0 0 0 0 
  1567/1575 2461 2196 1858 6515 0 0 0 0 0 0 0 0 0 0 
 1 2009/2017 5199 6417 4456 16072 0 0 0 0 3736 2977 1929 8642 0 0.34968 
  1567/1575 999 861 623 2483 0 0 0 0 662 889 735 2286 0 0.479346 
 2 2009/2017 2646 3193 2070 7909 0 0 0 0 1302 2321 2142 5765 0 0.421603 
 3 2009/2017 17868 21295 13705 52868 0 0 0 0 17873 15304 8781 41958 0 0.442474 
  1567/1575 1555 1568 1338 4461 0 0 0 0 1173 1480 1323 3976 0 0.471258 
 4 2009/2017 978 2070 2183 5231 0 0 0 0 710 1257 1119 3086 0 0.371047 
  1567/1575 184 201 158 543 0 0 0 0 176 322 153 651 0 0.545226 
 5 2009/2017 11820 14525 9944 36289 0 0 0 0 13018 11390 6180 30588 0 0.457377 
  1567/1575 1644 1425 1029 4098 0 0 0 0 1906 1189 944 4039 0 0.496375 
10986 0 2009/2017 422 538 404 1364 0 0 0 0 0 0 0 0 0 0 
  1567/1575 399 402 401 1202 0 0 0 0 0 0 0 0 0 0 
 1 2009/2017 5346 5801 4281 15428 0 0 0 0 5184 4168 3025 12377 0 0.445136 
  1567/1575 2416 2452 2179 7047 0 0 0 0 2674 2283 1855 6812 0 0.491522 
 2 2009/2017 4523 5322 3430 13275 0 0 0 0 3545 2973 1743 8261 0 0.38359 
  1567/1575 715 725 538 1978 0 0 0 0 654 536 498 1688 0 0.460447 
 3 2009/2017 12908 14741 9124 36773 0 0 0 0 10031 8393 4737 23161 0 0.386442 
  1567/1575 3774 3347 2093 9214 0 0 0 0 2752 1986 1609 6347 0 0.407879 
 5 2009/2017 15255 18922 11824 46001 0 0 0 0 10234 9225 5255 24714 0 0.349487 
  1567/1575 3747 3569 2017 9333 0 0 0 0 3120 2177 1517 6814 0 0.421998 
10840 0 2009/2017 19361 21942 13248 54551 0 0 0 0 0 0 0 0 0 0 
  1567/1575 4615 3574 2009 10198 0 0 0 0 0 0 0 0 0 0 
 1 2009/2017 4395 4922 3302 12619 0 0 0 0 4310 3648 2268 10226 0 0.447625 
  1567/1575 1854 1870 1247 4971 0 0 0 0 1709 1508 1095 4312 0 0.464505 
 2 2009/2017 15412 18620 11885 45917 0 0 0 0 18699 15969 9451 44119 0 0.490015 
  1567/1575 2539 1833 1033 5405 0 0 0 0 2527 1540 993 5060 0 0.483516 
 3 2009/2017 20630 26597 16172 63399 0 0 0 0 20712 18432 10310 49454 0 0.438216 
  1567/1575 2870 2380 1415 6665 0 0 0 0 2477 1781 1290 5548 0 0.45427 
 4 2009/2017 10513 12766 7932 31211 0 0 0 0 11180 9646 5628 26454 0 0.458753 
  1567/1575 2148 1946 872 4966 0 0 0 0 1983 1546 776 4305 0 0.464351 
 5 2009/2017 26678 32729 20737 80144 0 0 0 0 28390 25811 14740 68941 0 0.462427 
  1567/1575 4133 3590 1941 9664 0 0 0 0 4376 2929 1768 9073 0 0.484229 
10829 0 2009/2017 8096 8923 5391 22410 0 0 0 0 0 0 0 0 0 0 
  1567/1575 1724 1254 746 3724 0 0 0 0 0 0 0 0 0 0 
 1 2009/2017 838 776 620 2234 0 0 0 0 607 620 376 1603 0 0.417774 
  1567/1575 358 348 227 933 0 0 0 0 330 277 192 799 0 0.461316 
 2 2009/2017 10464 13026 7605 31095 0 0 0 0 8601 7865 4141 20607 0 0.398573 
  1567/1575 1413 1346 664 3423 0 0 0 0 1124 747 503 2374 0 0.409522 
 3 2009/2017 6787 8741 5695 21223 0 0 0 0 3686 3406 1650 8742 0 0.29174 
  1567/1575 1050 1046 618 2714 0 0 0 0 1203 881 484 2568 0 0.486179 
 4 2009/2017 9187 11674 7674 28535 0 0 0 0 7380 7006 3756 18142 0 0.388671 
  1567/1575 1236 958 538 2732 0 0 0 0 956 750 453 2159 0 0.441423 
 5 2009/2017 10745 12655 8424 31824 0 0 0 0 9002 8543 4350 21895 0 0.407584 
  1567/1575 2086 1754 966 4806 0 0 0 0 1646 1088 815 3549 0 0.424776 
10952 0 2009/2017 29903 33881 20774 84558 0 0 0 0 0 0 0 0 0 0 
  1567/1575 2487 2043 1397 5927 0 0 0 0 0 0 0 0 0 0 
 1 2009/2017 22505 26292 16456 65253 0 0 0 0 22707 19417 11049 53173 0 0.448998 
  1567/1575 2120 1647 911 4678 0 0 0 0 1760 1181 891 3832 0 0.450294 
 2 2009/2017 20860 25291 15974 62125 0 0 0 0 20020 17257 10353 47630 0 0.433967 
  1567/1575 3083 2390 1287 6760 0 0 0 0 2729 1959 1286 5974 0 0.469138 
 3 2009/2017 6201 6986 5004 18191 0 0 0 0 3571 7170 6730 17471 0 0.489905 
  1567/1575 1247 939 694 2880 0 0 0 0 1362 1168 681 3211 0 0.527171 
 4 2009/2017 15778 19513 13050 48341 0 0 0 0 19188 16849 10075 46112 0 0.4882 
  1567/1575 2776 2322 1573 6671 0 0 0 0 2953 2114 1302 6369 0 0.48842 
 5 2009/2017 35203 42452 26641 104296 0 0 0 0 31222 27108 14512 72842 0 0.411216 
  1567/1575 3914 3426 1901 9241 0 0 0 0 3513 2719 1536 7768 0 0.456699 
 
 
 
 
 
 
 
 
 
 
 
 
Sample 
no. 
Day of 
sample 
MUP 
peptide Light peptide Heavy lysine peptide IH/(IH+IL) 
Day 
average 
   1 2 3 Sum 1 2 3 Sum   
34965 0 2471/2477 266641 366065 304321 937027 80668 93988 77120 251776 0.21179 0.283576 
34966 0 2471/2477 74121 107889 90682 272692 30131 34365 28102 92598 0.253492  
34967 0 2471/2477 186806 266038 248873 701717 131180 160735 148202 440117 0.385447  
34974 1 2471/2477 37276 59851 67516 164643 49733 61958 64321 176012 0.516687 0.470132 
34975 1 2471/2477 2055 2986 2443 7484 2275 2011 2056 6342 0.458701  
34976 1 2471/2477 177839 271406 273638 722883 166053 200401 190117 556571 0.435007  
35283 2 2471/2477 126450 202947 227332 556729 165922 209927 216300 592149 0.515415 0.433976 
35284 2 2471/2477 4312 6068 5700 16080 3532 4611 4607 12750 0.442248  
35285 2 2471/2477 124387 183206 174204 481797 77936 93940 81072 252948 0.344266  
35292 3 2471/2477 200646 315405 327221 843272 220807 274256 271354 766417 0.476127 0.495727 
35293 3 2471/2477 33857 55044 61009 149910 44591 56652 59089 160332 0.516797  
35294 3 2471/2477 9094 16446 17469 43009 11508 15466 15058 42032 0.494256  
35301 4 2471/2477 34688 57733 65308 157729 51617 64813 65807 182237 0.536045 0.48667 
35302 4 2471/2477 3831 4478 4452 12761 3211 3457 3249 9917 0.437296  
35309 5 2471/2477 39326 61200 70654 171180 56303 72035 76036 204374 0.544193 0.535173 
35310 5 2471/2477 28430 48545 54774 131749 40136 51811 54345 146292 0.526153  
35317 6 2471/2477 78347 127933 144965 351245 109003 140628 146386 396017 0.529957 0.529702 
35318 6 2471/2477 12202 20870 24361 57433 17911 22536 24174 64621 0.529446  
 
Supplementary material B: Milk labelling pilot 
Spreadsheet where MUP peptide intensities were recorded, along with the intensities of the corresponding labelled peptides, for the mice fed 
[13C6] lysine labelled diets over the course of six days. Precursor RIA values were calculated from this data. 
 
ID: 
Day of 
sample 
Milk 
peptide Light peptide Heavy lysine peptide IH/(IH+IL) 
Day 
average 
   1 2 3 Sum 1 2 3 Sum   
34963 0 2433 5653 7101 6339 19093 0 0 0 0 0 0 
34968 1 2433 6504 8916 8309 23729 6534 6971 6596 20101 0.458613 0.409958 
34969 1 2433 1891 2648 2700 7239 1303 1335 1457 4095 0.361302  
34977 2 2433 302 414 384 1100 285 344 354 983 0.471916 0.428103 
34978 2 2433 31381 42979 39651 114011 22062 26675 22422 71159 0.38429  
35286 3 2433 1474 2153 1897 5524 1204 1407 1299 3910 0.414458 0.413974 
35287 3 2433 1068 1309 1023 3400 845 877 675 2397 0.41349  
35295 4 2433 6418 8812 8274 23504 6487 6934 6572 19993 0.459641 0.48362 
35296 4 2433 392 417 422 1231 461 341 467 1269 0.5076  
35303 5 2433 4469 5813 5414 15696 3800 4844 3832 12476 0.442851 0.466156 
35304 5 2433 2805 3712 3584 10101 2796 3603 3285 9684 0.489462  
35311 6 2433 1332 2086 1903 5321 1503 1972 1966 5441 0.505575 0.491051 
35312 6 2433 22501 32617 30774 85892 24154 29256 24779 78189 0.476527  
 
 
 
Supplementary material B: Milk labelling pilot 
Spreadsheet where the lactation elevation protein peptide intensities in pup stomach contents were recorded, along with the intensities of the 
corresponding labelled peptides, for the pups whose mothers were fed [13C6] lysine labelled diets over the course of six days. Precursor RIA 
values were calculated from this data. 
 
ID: 
Day of 
sample 
Urine 
peptide Light peptide Heavy lysine peptide IH/(IH+IL) 
Day 
average 
   1 2 3 Sum 1 2 3 Sum   
34972 1 2000 11971 12956 7057 31984 669 724 586 1979 0.058269 0.100266 
34973 1 2000 7649 8968 5836 22453 964 1297 1463 3724 0.142262  
35281 2 2000 8558 11517 7610 27685 999 1202 895 3096 0.100582 0.083762 
35282 2 2000 11388 13167 7851 32406 864 796 665 2325 0.066943  
35290 3 2000 4936 5675 3690 14301 867 1079 753 2699 0.158765 0.180883 
35291 3 2000 704 758 662 2124 141 201 199 541 0.203002  
35300 4 2000 24365 29195 18700 72260 5774 6308 4222 16304 0.184093 0.184093 
35308 5 2000 5407 6718 4126 16251 1428 1392 1307 4127 0.202522 0.202522 
35316 6 2000 1549 2131 2071 5751 763 944 517 2224 0.278871 0.278871 
 
 
 
Supplementary material B: Milk labelling pilot 
Spreadsheet where the serum albumin peptide intensities in pup urine were recorded, along with the intensities of the corresponding labelled 
peptides, for the pups whose mothers were fed [13C6] lysine labelled diets over the course of six days. Precursor RIA values were calculated 
from this data. 
 
 
 
  
 
 
 
 
Supplementary material B: Milk labelling pilot 
Spreadsheet where the peptide intensities of the top 20 pup liver proteins were recorded, along with the intensities of the corresponding 
labelled peptides, for the pups whose mothers were fed [13C6] lysine labelled diets over the course of six days. Precursor RIA values were 
calculated from this data. 
 
 
 
 
 
  Light peptide intensity  Heavy peptide intensity   
Sample 
ID Protein/peptide 1 2 3 Sum 1 2 3 Sum IH/(IH+IL) 
 P02089          
35313 912.47 6896 3550 1090 11536 1752 816 256 2824 0.196657 
 1091.6 1044 604 455 2103 215 135 85 435 0.171395 
 1294.6 95194 70309 30088 195591 18784 15406 6461 40651 0.172074 
35314 912.47 1251464 523167 168050 1942681 204000 102350 28506 334856 0.147025 
 1091.6 497551 288602 102659 888812 81747 44500 15293 141540 0.137371 
 1294.6 739675 522655 211779 1474109 127890 89967 41293 259150 0.149516 
 P12710          
35313 1788.8 32935 32864 24678 90477 11650 12588 7070 31308 0.257076 
 1196.6 154994 112388 48951 316333 56410 34937 16712 108059 0.254621 
 892.5 133783 64928 23603 222314 44010 20682 6680 71372 0.243021 
35314 1788.8 21185 22746 14189 58120 7745 8398 6287 22430 0.278461 
 1196.6 117150 84373 37516 239039 43542 27282 12654 83478 0.258833 
 892.5 126536 61288 18962 206786 43282 17808 5606 66696 0.243877 
 B1AXW4          
35313 1263.7 32557 25415 10942 68914 14412 9331 4731 28474 0.292377 
 1164.5 36510 24371 12290 73171 15097 9842 4310 29249 0.285579 
 954.5 42708 24216 7630 74554 18321 9070 3279 30670 0.291473 
35314 1263.7 23454 20709 8816 52979 9530 6356 2730 18616 0.260018 
 1164.5 25526 19348 9351 54225 10696 6638 3182 20516 0.274495 
 954.5 31793 17306 6369 55468 12294 5942 2346 20582 0.270638 
 P26443          
35313 1583.8 16780 15915 9468 42163 5677 3718 2449 11844 0.219305 
 716.4 18548 6467 1439 26454 6102 1779 617 8498 0.243133 
 1125.5 40049 24615 9128 73792 11846 6733 2578 21157 0.222825 
35314 1583.8 8157 6430 3114 17701 2419 2125 914 5458 0.235675 
 716.4 12770 5287 1528 19585 4424 1518 389 6331 0.244289 
 1125.5 27618 16723 6099 50440 8777 4678 2217 15672 0.237052 
 Q9QXD6          
35313 1328.7 26474 19890 9719 56083 10458 7257 3447 21162 0.273959 
 1608.8 5730 6571 2943 15244 2542 2194 1242 5978 0.281689 
 1292.7 8981 7486 2920 19387 3821 2695 1523 8039 0.293116 
35314 1328.7 24393 20238 9035 53666 9405 6994 3687 20086 0.272345 
 1608.8 56579 53041 29871 139491 24330 19711 10508 54549 0.281122 
 1292.7 9940 6626 3420 19986 2854 2809 1119 6782 0.253362 
 P09103          
35313 1409.7 4354 4107 3107 11568 3997 2150 1196 7343 0.388293 
 1216.6 6271 4362 2403 13036 2469 1830 626 4925 0.274205 
 1052.6 8813 5767 1974 16554 3451 1940 771 6162 0.271263 
35314 1409.7 5234 4286 2369 11889 2975 2285 1481 6741 0.361836 
 1216.6 2460 1665 860 4985 724 785 415 1924 0.278477 
 1052.6 10168 5579 2207 17954 3592 1786 811 6189 0.256348 
 P99027          
35313 1242.6 7983 6151 4543 18677 2384 2073 844 5301 0.221078 
 1772.9 7605 9085 4416 21106 2579 2057 385 5021 0.192177 
 2774.4 5414 5104 3814 14332 859 1795 1580 4234 0.228051 
35314 1242.6 6855 5587 3065 15507 2260 2453 818 5531 0.262905 
 1772.9 10054 10417 6387 26858 2909 3279 2186 8374 0.237682 
 2774.4 4181 5938 6500 16619 2213 1747 1126 5086 0.234324 
 Q8C196          
35313 1723.8 12075 11037 7029 30141 4200 3535 2297 10032 0.24972 
 1217.6 24736 19487 8922 53145 8399 6229 2878 17506 0.247781 
 1163.7 15216 11905 4817 31938 5032 4140 1099 10271 0.243337 
35314 1723.8 10302 10980 5857 27139 4359 3837 2950 11146 0.291132 
 1217.6 22841 17797 9175 49813 9711 6067 3768 19546 0.281809 
 1163.7 15655 12945 4790 33390 6021 4507 1601 12129 0.26646 
 P54869          
35313 1053.5 60108 33826 15322 109256 20202 11206 5071 36479 0.25031 
 878.4 66232 35824 12878 114934 23419 10731 4324 38474 0.250795 
 997.5 100355 57740 20816 178911 34524 17479 6998 59001 0.247995 
35314 1053.5 34321 23874 11082 69277 11635 7041 4042 22718 0.246948 
 878.4 34602 16813 5438 56853 10455 5116 2124 17695 0.237364 
 997.5 42460 24242 8368 75070 15673 7599 3976 27248 0.266307 
 P32020          
35313 1138.7 32644 20506 9123 62273 13615 9212 4052 26879 0.301496 
 1046.5 22960 14729 6053 43742 12472 6898 6578 25948 0.372335 
 1335.7 11716 8288 4022 24026 8916 6109 2870 17895 0.426874 
35314 1138.7 15146 10747 4801 30694 7637 3894 2102 13633 0.307555 
 1046.5 11058 6390 2574 20022 4108 3152 3175 10435 0.342614 
 1335.7 8065 5788 3426 17279 6761 4390 2569 13720 0.442595 
 P02088          
35313 912.8 214084 91347 31661 337092 38969 18729 5984 63682 0.158898 
 1756.9 39081 39860 20455 99396 9143 8410 3706 21259 0.176197 
 938.5 41463 20821 7294 69578 7561 3743 1390 12694 0.154293 
35314 912.8 1251464 523167 168050 1942681 204000 102350 28506 334856 0.147025 
 1756.9 517829 514769 249071 1281669 103773 93183 49095 246051 0.161058 
 938.5 267512 134266 42758 444536 52423 25997 7016 85436 0.161209 
 Q05816          
35313 1139.5 23711 13829 6698 44238 9334 5612 2012 16958 0.27711 
 1055.7 19472 12290 4733 36495 8052 4095 1959 14106 0.278769 
 2448.1 8355 11712 9541 29608 3752 5633 4153 13538 0.313772 
35314 1139.5 15249 9050 3555 27854 4422 3050 1415 8887 0.241882 
 1055.7 14911 8653 3086 26650 4340 2150 1332 7822 0.226909 
 2448.1 5440 7482 6299 19221 2253 2853 2388 7494 0.280517 
 P06151          
35313 1118.6 47965 28814 11426 88205 16709 12469 3748 32926 0.271821 
 1250.7 38502 28759 13723 80984 14942 9614 4496 29052 0.264023 
 1385.8 35689 28676 14422 78787 11408 10311 3948 25667 0.245725 
35314 1118.6 39719 26408 9612 75739 12812 8469 2981 24262 0.242618 
 1250.7 62172 72529 40956 175657 16904 12614 6404 35922 0.169781 
 1385.8 24441 19131 10047 53619 8580 6914 3667 19161 0.263273 
 B1ATY1          
35313 1161.6 29651 20855 9917 60423 12837 7093 3429 23359 0.278807 
 923.6 12904 7675 2640 23219 4792 2532 1166 8490 0.267747 
 1966.9 5584 7500 4506 17590 1973 2256 1382 5611 0.241843 
35314 1161.6 25183 15573 8291 49047 9520 6782 2608 18910 0.278264 
 923.6 12624 6757 2661 22042 4098 2527 878 7503 0.253952 
 1966.9 5315 6600 4255 16170 2335 2412 1271 6018 0.271228 
 Q64433          
35313 1285.7 14217 9016 4520 27753 4448 2464 1499 8411 0.232579 
 1076.6 19934 12609 4171 36714 5390 3302 1767 10459 0.221716 
 1044.6 19134 11525 3787 34446 4654 2657 1365 8676 0.201197 
35314 1285.7 8942 6536 3418 18896 3849 2408 997 7254 0.2774 
 1076.6 12185 7454 2694 22333 3804 2397 1256 7457 0.250319 
 1044.6 12225 6704 3008 21937 3683 2325 984 6992 0.241695 
 P16460          
35313 1186.7 5723 5008 2454 13185 2675 1646 1116 5437 0.291966 
 936.5 27399 16304 6770 50473 13058 5633 2653 21344 0.2972 
 806.5 24727 11439 3594 39760 9763 4834 1292 15889 0.285522 
35314 1186.7 11701 7416 3557 22674 5647 3519 1287 10453 0.315543 
 936.5 56400 30718 11443 98561 27478 12866 4438 44782 0.312411 
 806.5 41075 17105 5712 63892 18715 9211 2607 30533 0.323357 
 O35490          
35313 1721.9 70929 71946 42785 185660 28938 31999 20196 81133 0.304105 
 975.5 40506 23644 9698 73848 17898 9820 4810 32528 0.305783 
 2286.2 2568 2646 2702 7916 1245 963 897 3105 0.281735 
35314 1721.9 70320 69821 43871 184012 29410 28846 15871 74127 0.287159 
 975.5 29098 17616 8118 54832 12980 6726 3551 23257 0.297827 
 2286.2 7963 7142 5581 20686 3116 3445 2306 8867 0.300037 
 P07724          
35313 1149.6 45232 29825 12504 87561 21763 13373 5725 40861 0.318178 
 972.6 48702 26569 8562 83833 23971 11548 4605 40124 0.323693 
 761.4 17582 7858 2758 28198 9275 3945 1246 14466 0.339068 
35314 1149.6 87335 57565 22792 167692 38137 22312 11513 71962 0.300275 
 972.6 92934 52236 18212 163382 41141 24062 7153 72356 0.306934 
 761.4 33197 15247 4664 53108 16805 5644 1653 24102 0.312162 
 Q6PHC1          
35313 1960.9 4621 5790 3749 14160 1423 1785 1194 4402 0.237151 
 944.5 12530 7311 3038 22879 5017 2954 1176 9147 0.285612 
 2194.1 2825 4682 3989 11496 1416 1722 1329 4467 0.279835 
35314 1960.9 4436 5624 3585 13645 2057 2138 1113 5308 0.280061 
 944.5 12911 7608 3243 23762 3335 2267 1174 6776 0.221887 
 2194.1 7875 10264 6981 25120 3015 4057 1833 8905 0.261719 
 Q8QZT1          
35313 1024.5 22454 11485 4498 38437 8131 4887 1873 14891 0.279234 
 829.5 25869 12253 4322 42444 8311 3404 1683 13398 0.239927 
 1171.7 38431 26691 10948 76070 13663 9226 3670 26559 0.258787 
35314 1024.5 16937 10774 3841 31552 5960 3717 1542 11219 0.262304 
 829.5 21607 9172 2646 33425 7625 2842 1001 11468 0.255452 
 1171.7 26622 16641 6921 50184 8748 5832 2178 16758 0.250336 
 
  
 
 
 
 
Supplementary material B: Milk labelling pilot 
Spreadsheet where the peptide intensities of the top 20 pup muscle proteins were recorded, along with the intensities of the corresponding 
labelled peptides, for the pups whose mothers were fed [13C6] lysine labelled diets over the course of six days. Precursor RIA values were 
calculated from this data. 
 
 
 
 
 
  Light peptide intensity  Heavy peptide intensity   
Sample 
ID Protein/peptide 1 2 3 Sum 1 2 3 Sum IH/(IH+IL) 
 P32848          
35313 1536.8 2183 1780 1039 5002 1778 774 606 3158 0.38701 
 1420.7 112591 97000 47271 256862 49179 38998 19757 107934 0.295875 
 788.5 8073 9598 4526 22197 7046 6096 2433 15575 0.412342 
35314 1536.8 333767 286606 138827 759200 145443 117553 55081 318077 0.29526 
 1420.7 302079 275252 132734 710065 137181 108244 52332 297757 0.295446 
 788.5 236916 106050 27334 370300 103496 37416 8854 149766 0.287975 
 P17751          
35313 1602.9 48369 46605 23620 118594 13567 12861 6704 33132 0.218367 
 1466.7 90470 73659 36748 200877 24503 21016 9703 55222 0.215628 
 758.4 113157 62246 20694 196097 37397 20051 5706 63154 0.243602 
35314 1602.9 112059 104967 51897 268923 32984 30810 15446 79240 0.227595 
 1466.7 195880 151243 80120 427243 56993 45604 22835 125432 0.226954 
 758.4 286074 158119 52180 496373 94980 51857 18780 165617 0.250181 
 P02089          
35313 1294.6 135785 99450 48634 283869 30417 22722 19197 72336 0.203074 
 912.5 66538 35259 10311 112108 14661 7008 1723 23392 0.172635 
 1091.6 126548 82167 30365 239080 22409 12509 4559 39477 0.14172 
35314 1294.6 384733 284979 118978 788690 71568 51601 13221 136390 0.147436 
 912.5 149516 79055 25239 253810 28655 14812 3256 46723 0.155467 
 1091.6 187140 104435 40614 332189 31408 17173 6344 54925 0.141883 
 P07310          
35313 1507.8 85231 76355 38362 199948 27073 21582 11143 59798 0.230217 
 1723.9 249854 256101 142371 648326 134246 130280 72282 336808 0.341891 
 1302.6 79253 54367 30841 164461 27116 16656 9733 53505 0.245474 
35314 1507.8 263432 214438 106671 584541 87166 68448 32171 187785 0.243142 
 1723.9 649448 639989 347492 1636929 361682 355454 197248 914384 0.358397 
 1302.6 166329 117225 58881 342435 52985 37270 19547 109802 0.242797 
 P21550          
35313 2743.3 21598 33553 28138 83289 8276 8703 8342 25321 0.233137 
 1134.6 142568 105954 42536 291058 41702 28516 10973 81191 0.218109 
 917.5 79966 36723 14982 131671 22667 10612 6644 39923 0.23266 
35314 2743.3 64953 96472 86038 247463 22822 30342 23474 76638 0.236463 
 1134.6 271450 177364 75513 524327 83545 54621 20383 158549 0.232178 
 917.5 117185 56886 21472 195543 34259 16094 4967 55320 0.220519 
 P05064          
35313 1342.7 112194 89890 37036 239120 38896 25671 12886 77453 0.244661 
 951.5 143203 88220 31055 262478 54233 30732 10912 95877 0.267548 
 1288.7 5999 4473 1843 12315 2093 1649 1000 4742 0.278009 
35314 1342.7 100945 82060 35718 218723 34788 26533 12619 73940 0.252646 
 951.5 224078 123569 47645 395292 82073 42878 14772 139723 0.261157 
 1288.7 10453 7229 4056 21738 4382 3410 1902 9694 0.308412 
 E9Q5U3          
35313 829.4 59978 27310 9116 96404 19494 8002 3149 30645 0.241206 
 869.5 12347 8298 4040 24685 6046 2674 2559 11279 0.313619 
 739.4 28484 12556 4980 46020 9357 4380 1970 15707 0.254459 
35314 829.4 114782 51813 19108 185703 39814 17082 5757 62653 0.252271 
 869.5 29890 17081 6800 53771 11380 4930 2686 18996 0.261052 
 739.4 82961 39805 11357 134123 26988 10583 4447 42018 0.238548 
 P16065          
35313 1361.7 10658 9911 4421 24990 3302 3490 916 7708 0.235733 
 1942.9 48894 54865 33086 136845 15074 12687 8948 36709 0.211513 
 1338.7 45116 34431 15941 95488 13703 9589 4622 27914 0.226204 
35314 1361.7 37484 29102 14110 80696 10386 6781 3172 20339 0.201306 
 1942.9 78047 82305 51281 211633 24155 17597 11529 53281 0.201126 
 1338.7 89352 65454 27864 182670 21205 17286 6532 45023 0.197736 
 Q9R0Y5          
35313 1130.7 41432 31646 11261 84339 13596 8832 3010 25438 0.231724 
 2209.1 12626 18369 12368 43363 3745 5281 3283 12309 0.221099 
 791.4 8900 4254 1710 14864 3288 1106 915 5309 0.263174 
35314 1130.7 77872 52076 17666 147614 25897 14027 5155 45079 0.233942 
 2209.1 48768 63934 49128 161830 18977 24797 15430 59204 0.26785 
 791.4 19489 8016 3918 31423 6722 2697 1983 11402 0.266246 
 P68134          
35313 1198.5 57285 40274 17617 115176 17520 10304 3970 31794 0.21633 
 923.6 17848 9925 3907 31680 5092 2659 876 8627 0.214032 
 1161.6 37861 25678 11326 74865 11820 6296 3407 21523 0.223295 
35314 1198.5 107808 68983 29841 206632 32298 21126 9025 62449 0.232083 
 923.6 48590 26641 9596 84827 14749 7714 3013 25476 0.230964 
 1161.6 70621 41493 21627 133741 22297 12569 6963 41829 0.238247 
 P11499          
35313 1242.7 15635 11693 4186 31514 5502 3730 1372 10604 0.251769 
 1416.6 15151 12661 6173 33985 5383 4320 2669 12372 0.266885 
 891.4 18811 9736 3673 32220 7490 4287 1802 13579 0.296491 
35314 1242.7 27128 17733 7764 52625 10637 5791 2264 18692 0.262097 
 1416.6 29806 22254 11150 63210 9358 8302 4089 21749 0.255994 
 891.4 35723 20074 7120 62917 14587 6685 2452 23724 0.27382 
 P09411          
35313 1219.7 31484 20717 8264 60465 9913 6754 3506 20173 0.250167 
 1318.7 30544 26634 11139 68317 9592 7474 2895 19961 0.226115 
 1769 27380 26815 17978 72173 8677 7885 5131 21693 0.231106 
35314 1219.7 40138 25401 11771 77310 13490 8123 3501 25114 0.245196 
 1318.7 46195 35488 17293 98976 13625 11413 4227 29265 0.228203 
 1769 73003 69885 43206 186094 22679 22954 14431 60064 0.244006 
 P52480          
35313 1636.9 30144 26864 14483 71491 9371 9375 4801 23547 0.247764 
 1779.9 8815 9701 4667 23183 3013 2851 1880 7744 0.250396 
 990.5 14541 8987 4091 27619 6129 3359 2257 11745 0.298369 
35314 1636.9 61329 55007 31602 147938 20915 18155 9355 48425 0.24661 
 1779.9 6167 6081 3714 15962 2404 1845 1196 5445 0.254356 
 990.5 28237 14247 5943 48427 9009 4549 1626 15184 0.238701 
 Q6PHC1          
35313 815.5 6425 3186 901 10512 1741 694 416 2851 0.21335 
 800.3 85139 41395 11180 137714 25100 11104 2579 38783 0.219737 
 2194.1 16393 24035 15354 55782 4983 5765 4984 15732 0.219985 
35314 815.5 14447 6702 2246 23395 4559 1998 786 7343 0.23889 
 800.3 194176 93003 26572 313751 65136 24194 7426 96756 0.235699 
 2194.1 37570 51180 34975 123725 13141 12863 10087 36091 0.225828 
 Q921I1          
35313 915.5 16449 9522 6181 32152 10781 5530 3614 19925 0.382607 
 1238.6 21273 14909 6829 43011 11650 8313 3500 23463 0.352965 
 1313.7 19996 14967 7554 42517 9873 7936 4361 22170 0.342727 
35314 915.5 22259 12324 6053 40636 12375 7108 4487 23970 0.371018 
 1238.6 53653 36443 17712 107808 26866 19503 8001 54370 0.335249 
 1313.7 33586 27139 14379 75104 19221 14236 6665 40122 0.348203 
 P62631          
35313 870.5 20419 9472 3221 33112 5518 2585 1001 9104 0.215653 
 1120.6 20076 12384 4711 37171 5380 4293 1216 10889 0.226571 
 1257.5 2457 1415 596 4468 954 478 311 1743 0.280631 
35314 870.5 63817 30249 9493 103559 21016 9202 3134 33352 0.243604 
 1120.6 26662 16877 6168 49707 9567 5631 1768 16966 0.254466 
 1257.5 5926 3718 2306 11950 2224 1364 860 4448 0.271253 
 Q5SX49          
35313 1616.9 7705 7015 3305 18025 2341 2334 864 5539 0.235062 
 1213.6 21531 17793 6900 46224 7682 4606 2699 14987 0.244842 
 1725.9 7083 7786 3763 18632 2591 3055 1148 6794 0.267207 
35314 1616.9 17173 16650 9025 42848 5725 4629 2630 12984 0.232555 
 1213.6 37192 28047 11220 76459 12595 7737 3705 24037 0.239184 
 1725.9 11096 13849 8175 33120 2764 3754 2400 8918 0.212141 
 P14152          
35313 917.5 24195 10937 4920 40052 6314 4320 1767 12401 0.236421 
 1650.9 20875 20743 12487 54105 6153 6397 3491 16041 0.22868 
 1007.5 18402 11271 5571 35244 6422 3058 1455 10935 0.236796 
35314 917.5 42688 21005 7273 70966 14162 6825 3034 24021 0.252887 
 1650.9 51432 49539 26443 127414 18563 15728 8683 42974 0.252213 
 1007.5 345477 296701 149808 791986 134399 112199 52055 298653 0.273833 
 O70250          
35313 1112.5 19618 13033 4705 37356 7234 4574 1523 13331 0.263006 
 975.5 23045 14297 7158 44500 8407 4570 3252 16229 0.267236 
 1360.6 22643 17796 9218 49657 6871 6582 4210 17663 0.262374 
35314 1112.5 125180 78806 24733 228719 40937 22459 8541 71937 0.239267 
 975.5 44942 25117 14438 84497 15516 9900 4854 30270 0.263752 
 1360.6 32606 27247 15206 75059 11061 9116 7000 27177 0.265826 
 P31001          
35313 1046.5 20177 11123 5426 36726 8115 4204 2003 14322 0.280559 
 1268.6 21738 17519 8030 47287 10042 7961 3028 21031 0.30784 
 1981 14907 18879 10989 44775 6088 7866 4066 18020 0.286966 
35314 1046.5 38104 24253 9208 71565 16905 9747 4458 31110 0.302995 
 1268.6 44269 39922 24789 108980 15014 11971 8759 35744 0.24698 
 1981 26182 29779 20973 76934 8970 10705 6479 26154 0.253706 
 
  
 
 
 
Supplementary material B: Milk labelling pilot 
Spreadsheet where the peptide intensities of the low turnover liver protein were recorded, along with the intensities of the corresponding 
labelled peptides, for the pups whose mothers were fed [13C6] lysine labelled diets over the course of six days. Precursor RIA values were 
calculated from this data. 
 
 
 
 
 
 
 
 
 
    Light peptide intensity  Heavy peptide intensity   
Sample 
ID 
Day of 
labelling Peptide 1 2 3 Sum 1 2 3 Sum IH/(IH+IL) 
35270 1 1583.8 7831 6537 3116 17484 263 158 115 536 0.029745 
  1125.5 29499 15307 5720 50526 918 641 539 2098 0.039868 
35271 1 1583.8 7505 5762 2603 15870 433 309 242 984 0.058384 
  1125.5 68691 38339 15918 122948 3402 2007 1399 6808 0.052468 
35280 2 1583.8 10801 9844 5181 25826 645 507 480 1632 0.059436 
  1125.5 41244 22911 7994 72149 2209 1528 771 4508 0.058807 
35288 3 1583.8 14962 13138 7717 35817 1945 1846 878 4669 0.115324 
  1125.5 43041 23709 11101 77851 6538 3888 1784 12210 0.135575 
35289 3 1583.8 15211 13593 6664 35468 2027 1932 1282 5241 0.128743 
  1125.5 51294 31381 11494 94169 7526 4017 2102 13645 0.126561 
35297 4 1583.8 12355 11337 5790 29482 2621 2547 1075 6243 0.174752 
  1125.5 53417 32257 12633 98307 12445 6515 3298 22258 0.184614 
35298 4 1583.8 24206 21077 11890 57173 4570 3787 1847 10204 0.151446 
  1125.5 57175 33173 13896 104244 12172 6248 2686 21106 0.168377 
35305 5 1583.8 12792 12720 6337 31849 3324 2146 1209 6679 0.173354 
  1125.5 36094 21233 8020 65347 8492 6221 3382 18095 0.216857 
35306 5 1583.8 20436 18006 9070 47512 4149 3359 1975 9483 0.166383 
  1125.5 57448 32017 12425 101890 12566 7588 3757 23911 0.19007 
35313 6 1583.8 26109 24605 15307 66021 9409 6424 4008 19841 0.23108 
  1125.5 57674 35818 13354 106846 18158 10341 5031 33530 0.238858 
35314 6 1583.8 16955 13691 6783 37429 4929 4300 2250 11479 0.234706 
  1125.5 35913 20282 8528 64723 11106 6314 3374 20794 0.243156 
 
  
 
 
 
 
Supplementary material B: Milk labelling pilot 
Spreadsheet where the peptide intensities of the high turnover liver protein were recorded, along with the intensities of the corresponding 
labelled peptides, for the pups whose mothers were fed [13C6] lysine labelled diets over the course of six days. Precursor RIA values were 
calculated from this data. 
 
 
 
 
 
 
 
 
 Sample 
ID 
Day of 
labelling Peptide 1 2 3 Sum 1 2 3 Sum IH/(IH+IL) 
35270 1 916.5 14044 7598 2251 23893 515 577 285 1377 0.054491 
  1046.5 11904 7213 3035 22152 829 818 335 1982 0.082125 
35271 1 916.5 28552 14644 4960 48156 1541 1678 997 4216 0.080501 
  1046.5 22134 13840 9001 44975 1281 2004 1486 4771 0.095907 
35280 2 916.5 14538 7607 2439 24584 1785 1541 580 3906 0.137101 
  1046.5 12085 7677 2481 22243 1298 875 1192 3365 0.131404 
35288 3 916.5 26925 13836 4675 45436 4975 2616 1929 9520 0.173229 
  1046.5 22970 13163 5285 41418 4517 2895 2205 9617 0.188439 
35289 3 916.5 24541 16084 4219 44844 5481 3037 1391 9909 0.180976 
  1046.5 22660 14595 4602 41857 4782 2850 2445 10077 0.194035 
35297 4 916.5 27504 14800 5907 48211 8586 5012 2554 16152 0.250952 
  1046.5 13954 9536 3958 27448 5183 2848 2970 11001 0.286119 
35298 4 916.5 26303 13540 6080 45923 7938 4644 2065 14647 0.241819 
  1046.5 23499 14770 5528 43797 7970 3586 5330 16886 0.278266 
35305 5 916.5 12690 6716 2201 21607 4261 2759 2114 9134 0.297128 
  1046.5 11757 8259 3636 23652 4587 2720 2404 9711 0.291071 
35306 5 916.5 25424 13853 5255 44532 9251 6144 2202 17597 0.283233 
  1046.5 12328 9805 4568 26701 4755 3641 2738 11134 0.294278 
35313 6 916.5 21962 11742 4068 37772 10501 5523 2383 18407 0.327649 
  1046.5 23808 15240 6535 45583 13019 7350 8818 29187 0.390357 
35314 6 916.5 10316 6591 2770 19677 5070 3061 2813 10944 0.357402 
  1046.5 5859 3032 1218 10109 2371 1450 2472 6293 0.383673 
 
 
  
 
 
 
 
Supplementary material B: Milk labelling pilot 
Spreadsheet where the peptide intensities of the low turnover muscle protein were recorded, along with the intensities of the corresponding 
labelled peptides, for the pups whose mothers were fed [13C6] lysine labelled diets over the course of six days. Precursor RIA values were 
calculated from this data. 
 
 
 
 
 
 Sample 
ID 
Day of 
labelling Peptide 1 2 3 Sum 1 2 3 Sum IH/(IH+IL) 
35270 1 800.4 24692 12883 2701 40276 1037 466 223 1726 0.041093 
  1296.6 6692 3955 1898 12545 171 94 292 557 0.042513 
35271 1 800.4 65067 31012 8226 104305 2036 1026 466 3528 0.032717 
  1296.6 18919 14693 4961 38573 1042 1010 400 2452 0.059768 
35280 2 800.4 43481 20909 5096 69486 2346 797 254 3397 0.046609 
  1296.6 11778 9045 3901 24724 772 674 545 1991 0.074527 
35288 3 800.4 110047 53910 14237 178194 12222 6279 1813 20314 0.102333 
  1296.6 27086 20663 9300 57049 3631 3303 1648 8582 0.130761 
35289 3 800.4 39287 18368 5847 63502 4789 2601 531 7921 0.110903 
  1296.6 6509 5046 2966 14521 652 507 232 1391 0.087418 
35297 4 800.4 78772 38196 11062 128030 15838 6859 1810 24507 0.160663 
  1296.6 21175 13831 6979 41985 3531 2324 1439 7294 0.148014 
35298 4 800.4 104455 51978 13953 170386 20184 8128 1621 29933 0.149427 
  1296.6 26739 20139 10191 57069 5137 4217 2042 11396 0.16645 
35305 5 800.4 127248 62198 18342 207788 33154 12007 3848 49009 0.190847 
  1296.6 31681 23156 10575 65412 7553 6674 2793 17020 0.206473 
35306 5 800.4 86814 44204 12033 143051 21061 8073 2165 31299 0.179518 
  1296.6 21867 14979 7158 44004 4299 3114 1596 9009 0.169939 
35313 6 800.4 103624 49747 14334 167705 31179 13411 3392 47982 0.222461 
  1296.6 21288 15779 8071 45138 6407 5275 2982 14664 0.245209 
35314 6 800.4 190130 91047 25789 306966 64132 23354 7229 94715 0.235797 
  1296.6 55560 41008 23117 119685 17539 11004 6031 34574 0.22413 
 
 
  
 
 
 
 
Supplementary material B: Milk labelling pilot 
Spreadsheet where the peptide intensities of the high turnover muscle protein were recorded, along with the intensities of the corresponding 
labelled peptides, for the pups whose mothers were fed [13C6] lysine labelled diets over the course of six days. Precursor RIA values were 
calculated from this data. 
 
 
 
 
 
    Light peptide intensity  Heavy peptide intensity   
Sample 
ID 
Day of 
labelling Peptide 1 2 3 Sum 1 2 3 Sum IH/(IH+IL) 
35270 1 1536.8 2990 1842 1006 5838 341 119 42 502 0.07918 
  871.5 0 0 0 0 0 0 0 0 0 
35271 1 1536.8 22580 18506 8227 49313 1325 964 452 2741 0.052657 
  871.5 20532 9252 3121 32905 1270 579 752 2601 0.073255 
35280 2 1536.8 17355 14630 7311 39296 1389 1299 606 3294 0.077342 
  871.5 13250 8447 2242 23939 1518 548 298 2364 0.089876 
35288 3 1536.8 24143 19587 9450 53180 5160 4028 1533 10721 0.167775 
  871.5 39236 19980 9104 68320 9200 3784 2288 15272 0.182697 
35289 3 1536.8 5777 4846 2556 13179 1452 1110 483 3045 0.187685 
  871.5 10774 4929 1757 17460 2038 1692 412 4142 0.191742 
35297 4 1536.8 69441 62969 31269 163679 19843 17120 7923 44886 0.215213 
  871.5 22964 11289 3030 37283 6444 2512 713 9669 0.205934 
35298 4 1536.8 55244 45047 23659 123950 15674 12934 6140 34748 0.218957 
  871.5 27954 16483 5520 49957 9629 4360 1699 15688 0.238982 
35305 5 1536.8 124119 106371 53539 284029 46547 34450 17214 98211 0.256935 
  871.5 79183 42375 13284 134842 30846 14816 3896 49558 0.268753 
35306 5 1536.8 93685 83724 37848 215257 33673 26772 12662 73107 0.253523 
  871.5 64958 35889 11712 112559 22135 10348 2974 35457 0.239548 
35313 6 1536.8 91724 84531 40084 216339 41126 32967 16274 90367 0.294637 
  871.5 31172 17488 5144 53804 14700 6833 1802 23335 0.302506 
35314 6 1536.8 377772 327584 158155 863511 165233 135351 64502 365086 0.297157 
  871.5 222060 122405 33944 378409 99738 45451 14078 159267 0.296214 
 
  
 
 
 
 
Supplementary material B: Communal nursing study 
Spreadsheet where the peptide intensities of the low turnover pup liver and muscle proteins and the mother’s urine were recorded, along with 
the intensities of the corresponding labelled peptides, where mothered were fed either a [D4] or [D9] lysine labelled diet over the course of the 
experiment.  Precursor RIA values were calculated from this data. Pup IDs/mother IDs in red are pups from the [D9] lysine labelled mother/mothers 
fed [D9] lysine labelled diet.  Those in green are the pups from the [D4] lysine labelled mother/mothers fed [D4] lysine labelled diet. 
 
 
 
 
 
 
 
 
ID: 
Sample 
type  
Peptid
e Light peptide   D4 peptide   D9 peptide   IH/(IH+IL) 
Unrelated1  1 2 3 Sum 1 2 3 Sum 1 2 3 Sum D4 D9 
36286 Liver 1584 62659 50278 23812 
13674
9 9248 6102 3036 18386 9525 6562 3958 20045 
0.118
5 
0.127
8 
  Muscle 800.4 70789 35054 8100 
11394
3 9519 3770 1629 14918 11243 6050 1869 19162 
0.115
8 0.144 
36287 Liver 1584 32757 24122 12609 69488 5754 3409 1976 11139 5157 3758 1973 10888 
0.138
2 
0.135
5 
  Muscle 800.4 66521 30601 8912 
10603
4 7591 4202 1080 12873 8680 4106 1288 14074 
0.108
3 
0.117
2 
36288 Liver 1584 33920 25050 12844 71814 4984 3728 2103 10815 5404 3887 2047 11338 
0.130
9 
0.136
4 
  Muscle 800.4 55375 25721 6902 87998 7855 3268 1335 12458 7347 3072 1279 11698 0.124 
0.117
3 
36289 Liver 1584 69475 53292 22148 
14491
5 10218 6953 3628 20799 12065 8916 3914 24895 
0.125
5 
0.146
6 
  Muscle 800.4 53442 26612 6752 86806 6118 3184 720 10022 8536 3699 624 12859 
0.103
5 0.129 
36290 Liver 1584 42839 30751 13309 86899 6577 4071 1702 12350 6175 4176 1890 12241 
0.124
4 
0.123
5 
  Muscle 800.4 56296 26868 7518 90682 6246 3387 702 10335 7358 3380 1419 12157 
0.102
3 
0.118
2 
36291 Liver 1584 70460 53261 23672 
14739
3 10213 7714 3340 21267 11118 7279 3721 22118 
0.126
1 
0.130
5 
  Muscle 800.4 
10532
8 45943 11419 
16269
0 13248 6049 1485 20782 13122 6034 2077 21233 
0.113
3 
0.115
4 
36292 Liver 1584 30956 23555 10796 65307 5043 3983 1853 10879 4084 3415 1371 8870 
0.142
8 
0.119
6 
  Muscle 800.4 67357 30044 8663 
10606
4 8951 4134 1269 14354 7292 3210 1400 11902 
0.119
2 
0.100
9 
36293 Liver 1584 61972 45058 18539 
12556
9 8512 6497 2700 17709 9896 7755 3477 21128 
0.123
6 0.144 
  Muscle 800.4 80072 36395 10212 
12667
9 9237 4571 1000 14808 12498 4595 1504 18597 
0.104
7 0.128 
36294 Liver 1584 36036 25617 10978 72631 6081 4300 1602 11983 5107 4007 1911 11025 
0.141
6 
0.131
8 
  Muscle 800.4 22327 10440 2914 35681 3475 1576 336 5387 2880 1336 346 4562 
0.131
2 
0.113
4 
36295 Liver 1584 72826 49803 20547 
14317
6 12429 9079 3467 24975 12904 7635 4448 24987 
0.148
5 
0.148
6 
  Muscle 800.4 41940 20567 5772 68279 6112 2613 874 9599 6043 2367 900 9310 
0.123
3 0.12 
36296 Urine  66721 54513 30412 
15164
6 66595 54619 30767 
15198
1 2350 1099 265 3714 
0.500
6 
0.023
9 
36297 Urine  14018 13025 7933 34976 1991 555 0 2546 14705 15612 8523 38840 
0.067
9 
0.526
2 
                 
Related 
1                 
36329 Liver 1584 62558 46735 20572 
12986
5 6963 4882 2353 14198 6233 4982 1834 13049 
0.098
6 
0.091
3 
  Muscle 800.4 
25173
5 
11721
1 32495 
40144
1 24854 11797 3808 40459 30150 12475 4728 47353 
0.091
6 
0.105
5 
36330 Liver 1584 44790 32285 14495 91570 5286 3655 1511 10452 4135 3806 1400 9341 
0.102
4 
0.092
6 
  Muscle 800.4 77240 34437 8933 
12061
0 8182 3379 1185 12746 8019 3533 1218 12770 
0.095
6 
0.095
7 
36331 Liver 1584 30444 14101 5527 50072 2524 1133 419 4076 3403 1341 634 5378 
0.075
3 0.097 
  Muscle 800.4 
21172
1 95185 24988 
33189
4 17387 7885 2390 27662 22114 9396 3272 34782 
0.076
9 
0.094
9 
36332 Liver 1584 30762 21729 9839 62330 3898 2477 1189 7564 2543 1645 891 5079 
0.108
2 
0.075
3 
  Muscle 800.4 
14469
9 63893 16896 
22548
8 12444 6633 1958 21035 11716 5554 2194 19464 
0.085
3 
0.079
5 
36333 Liver 1584 42929 29618 12687 85234 5396 3557 1690 10643 3944 3002 1348 8294 0.111 
0.088
7 
  Muscle 800.4 96984 43402 11443 
15182
9 8876 4352 1284 14512 8259 4432 1007 13698 
0.087
2 
0.082
8 
36334 Liver 1584 16500 11289 5296 33085 2184 1624 750 4558 1427 1089 584 3100 
0.121
1 
0.085
7 
  Muscle 800.4 
10571
6 45361 13193 
16427
0 10641 5732 1335 17708 10498 5059 1500 17057 
0.097
3 
0.094
1 
36335 Liver 1584 37731 28152 12362 78245 4792 2997 1088 8877 4143 2961 1363 8467 
0.101
9 
0.097
6 
  Muscle 800.4 
14433
5 62950 18345 
22563
0 14249 6557 1640 22446 14921 7352 2720 24993 
0.090
5 
0.099
7 
36336 Liver 1584 22466 17037 6460 45963 3000 1649 920 5569 2443 1531 1093 5067 
0.108
1 
0.099
3 
  Muscle 800.4 
16781
3 74511 19238 
26156
2 16534 7460 2422 26416 19173 8895 2663 30731 
0.091
7 
0.105
1 
36337 Liver 1584 27721 19873 8262 55856 3694 2266 1036 6996 2533 1423 927 4883 
0.111
3 
0.080
4 
  Muscle 800.4 
10699
8 45407 13414 
16581
9 11128 5765 1519 18412 9260 4034 1575 14869 
0.099
9 
0.082
3 
36338 Liver 1584 13000 8364 3661 25025 1479 1258 619 3356 1276 912 608 2796 
0.118
2 
0.100
5 
  Muscle 800.4 99434 47737 13469 
16064
0 10251 4329 1508 16088 11090 4525 2115 17730 0.091 
0.099
4 
36339 Urine  73102 65273 34438 
17281
3 72721 62716 30898 
16633
5 4339 1850 1079 7268 
0.490
4 
0.040
4 
36340 Urine  80169 71733 36479 
18838
1 4968 2788 741 8497 30209 24939 12455 67603 
0.043
2 
0.264
1 
                 
Related
2                 
36472 Liver 1584 35893 25869 12406 74168 6376 4820 2381 13577 3531 1977 1263 6771 
0.154
7 
0.083
7 
  Muscle 800.4 77329 34669 10049 
12204
7 11689 5954 2009 19652 6473 2883 1753 11109 
0.138
7 
0.083
4 
36473 Liver 1584 54330 38992 18668 
11199
0 8587 5713 2249 16549 3666 2971 1253 7890 
0.128
7 
0.065
8 
  Muscle 800.4 83234 39286 12174 
13469
4 13742 10294 3785 27821 10585 4806 2432 17823 
0.171
2 
0.116
9 
36474 Liver 1584 30824 23940 11093 65857 6684 5649 2464 14797 3639 1929 1175 6743 
0.183
5 
0.092
9 
  Muscle 800.4 62180 29570 6820 98570 11733 5633 1462 18828 5851 2302 996 9149 
0.160
4 
0.084
9 
36475 Liver 1584 38044 30249 13171 81464 7473 5017 2565 15055 2693 2151 989 5833 0.156 
0.066
8 
  Muscle 800.4 17499 8634 2771 28904 3294 1759 627 5680 1941 921 732 3594 
0.164
2 
0.110
6 
36476 Urine  22791 22976 11566 57333 27313 22802 11669 61784 2003 1652 764 4419 
0.518
7 
0.071
6 
36477 Urine  1701 1857 897 4455 257 171 103 531 1149 936 586 2671 
0.106
5 
0.374
8 
                 
Unrelated2                
36679 Liver 1584 24123 14967 5366 44456 2609 2209 838 5656 3493 2093 930 6516 
0.112
9 
0.127
8 
  Muscle 800.4 24329 11133 2990 38452 2440 1106 281 3827 2768 2008 371 5147 
0.090
5 
0.118
1 
36680 Liver 1584 18760 10440 4470 33670 2569 1671 764 5004 2659 1798 769 5226 
0.129
4 
0.134
4 
  Muscle 800.4 46399 21059 5663 73121 5759 2405 916 9080 7060 3316 1135 11511 
0.110
5 0.136 
36681 Liver 1584 15625 10186 4592 30403 2588 1872 789 5249 2989 2010 724 5723 
0.147
2 
0.158
4 
  Muscle 800.4 38116 18724 4677 61517 5861 2879 822 9562 6893 3274 913 11080 
0.134
5 
0.152
6 
36682 Liver 1584 19886 15560 7921 43367 4215 3105 1364 8684 2801 2265 1796 6862 
0.166
8 
0.136
6 
  Muscle 800.4 26479 13186 3755 43420 2994 1601 566 5161 3340 2287 741 6368 
0.106
2 
0.127
9 
36683 Liver 1584 21828 13591 5574 40993 2842 2136 798 5776 2176 1965 1100 5241 
0.123
5 
0.113
4 
  Muscle 800.4 
11873
4 53806 14781 
18732
1 17235 7782 2428 27445 17050 7972 2727 27749 
0.127
8 0.129 
36684 Liver 1584 9640 6730 2781 19151 1826 858 484 3168 1799 1046 511 3356 
0.141
9 
0.149
1 
  Muscle 800.4 18064 10401 2395 30860 2038 1299 348 3685 3317 1567 315 5199 
0.106
7 
0.144
2 
36685 Liver 1584 19920 10248 4700 34868 2547 1338 607 4492 2818 1537 662 5017 
0.114
1 
0.125
8 
  Muscle 800.4 24122 10783 2916 37821 2908 1325 393 4626 3090 1456 416 4962 0.109 0.116 
36686 Liver 1584 24778 14039 6583 45400 3098 2119 874 6091 3939 2618 995 7552 
0.118
3 
0.142
6 
  Muscle 800.4 21048 10089 3091 34228 2219 1393 367 3979 3410 1690 442 5542 
0.104
1 
0.139
4 
36687 Liver 1584 3232 1717 757 5706 596 378 299 1273 526 283 210 1019 
0.182
4 
0.151
5 
  Muscle 800.4 62463 28981 8628 
10007
2 7106 3520 1169 11795 9498 4235 1549 15282 
0.105
4 
0.132
5 
36478 Urine  82028 79470 46306 
20780
4 13508 7976 4257 25741 83474 78744 44778 
20699
6 
0.110
2 0.499 
36688 Urine  16890 14329 8559 39778 19829 18432 9852 48113 711 249 177 1137 
0.547
4 
0.027
8 
                 
Related
3                 
37251 Liver 1584 8116 4338 2341 14795 946 673 414 2033 995 510 315 1820 
0.120
8 
0.109
5 
  Muscle 800.4 913 408 217 1538 142 32 0 174 149 36 19 204 
0.101
6 
0.117
1 
37252 Liver 1584 21668 15067 6112 42847 2557 1297 402 4256 2993 1927 620 5540 
0.090
4 
0.114
5 
  Muscle 800.4 73388 33982 9935 
11730
5 7347 3941 1131 12419 9224 4726 1778 15728 
0.095
7 
0.118
2 
37253 Liver 1584 29461 20421 9797 59679 3295 2118 1033 6446 3162 2521 1404 7087 
0.097
5 
0.106
1 
  Muscle 800.4 97911 43096 13286 
15429
3 8672 4223 1225 14120 12310 5133 2067 19510 
0.083
8 
0.112
3 
37254 Liver 1584 60316 49460 21085 
13086
1 7464 5233 1847 14544 8489 5944 2769 17202 0.1 
0.116
2 
  Muscle 800.4 
10454
3 46913 13029 
16448
5 10244 5276 1792 17312 17029 7658 3483 28170 
0.095
2 
0.146
2 
37255 Liver 1584 23620 16765 7961 48346 2656 1384 650 4690 2899 2313 958 6170 
0.088
4 
0.113
2 
  Muscle 800.4 
11653
9 54332 14794 
18566
5 9241 5587 1459 16287 15881 6974 2647 25502 
0.080
6 
0.120
8 
37256 Liver 1584 20979 13141 6560 40680 1823 1002 572 3397 2943 1399 836 5178 
0.077
1 
0.112
9 
  Muscle 800.4 37119 16849 3361 57329 3239 1540 313 5092 5548 2038 834 8420 
0.081
6 
0.128
1 
37257 Liver 1584 18861 13284 5741 37886 1801 1260 531 3592 1335 1345 845 3525 
0.086
6 
0.085
1 
  Muscle 800.4 18238 8947 2816 30001 2191 679 278 3148 1570 1334 441 3345 0.095 
0.100
3 
37258 Urine  
11840
4 
10639
9 62920 
28772
3 8478 2797 978 12253 
10911
4 98158 54222 
26149
4 
0.040
8 
0.476
1 
37259 Urine  
15829
3 
14369
3 74462 
37644
8 
14986
8 
12349
4 64412 
33777
4 3604 2295 880 6779 
0.472
9 
0.017
7 
                 
Related
4                 
37260 Liver 1584 33593 28667 11869 74129 5236 4477 1793 11506 5656 3428 2228 11312 
0.134
4 
0.132
4 
  Muscle 800.4 42786 22714 5161 70661 5783 2443 780 9006 6661 2537 827 10025 0.113 
0.124
2 
37261 Liver 1584 
12896
9 98190 40326 
26748
5 15888 10376 5792 32056 19578 13035 4958 37571 0.107 
0.123
2 
  Muscle 800.4 34912 15124 4419 54455 3016 1257 610 4883 4834 1957 689 7480 
0.082
3 
0.120
8 
37262 Liver 1584 19931 14031 5671 39633 2943 2437 824 6204 3949 2165 879 6993 
0.135
3 0.15 
  Muscle 800.4 42689 18635 5307 66631 6057 3188 925 10170 7603 3461 1478 12542 
0.132
4 
0.158
4 
37263 Liver 1584 24284 13675 5474 43433 2399 1258 702 4359 3303 1949 1146 6398 
0.091
2 
0.128
4 
  Muscle 800.4 46530 21236 6599 74365 4800 2011 827 7638 8213 3563 922 12698 
0.093
1 
0.145
8 
37264 Liver 1584 7101 4811 2366 14278 1380 729 367 2476 944 835 558 2337 
0.147
8 
0.140
7 
  Muscle 800.4 35429 17009 4120 56558 5396 2535 586 8517 6902 4205 1117 12224 
0.130
9 
0.177
7 
37265 Liver 1584 5234 5382 2678 13294 984 907 328 2219 973 610 294 1877 0.143 
0.123
7 
  Muscle 800.4 32401 16756 4713 53870 3585 1542 533 5660 4169 2462 783 7414 
0.095
1 0.121 
37266 Liver 1584 27094 20405 7899 55398 4406 2964 1163 8533 4444 2390 1112 7946 
0.133
5 
0.125
4 
  Muscle 800.4 38485 18023 5228 61736 6197 2560 748 9505 6020 3428 1430 10878 
0.133
4 
0.149
8 
37267 Liver 1584 9272 8148 3106 20526 1207 910 798 2915 1004 933 538 2475 
0.124
4 
0.107
6 
  Muscle 800.4 29459 12703 3540 45702 3094 1540 467 5101 3111 2031 337 5479 
0.100
4 
0.107
1 
37268 Liver 1584 32232 19876 7902 60010 4260 2418 1253 7931 3988 2800 1118 7906 
0.116
7 
0.116
4 
  Muscle 800.4 61255 31037 7757 
10004
9 6434 3481 1207 11122 10504 4258 1919 16681 0.1 
0.142
9 
37269 Liver 1584 12289 9987 3717 25993 2132 1428 657 4217 2152 1235 890 4277 
0.139
6 
0.141
3 
  Muscle 800.4 27818 11879 3530 43227 2866 1570 433 4869 4370 1450 692 6512 
0.101
2 
0.130
9 
37270 Liver 1584 
14033
9 
10522
2 48473 
29403
4 17019 12290 5925 35234 20643 14813 6603 42059 0.107 
0.125
1 
  Muscle 800.4 
17772
1 73562 19388 
27067
1 17780 7206 3269 28255 23753 10434 6559 40746 
0.094
5 
0.130
8 
37271 Liver 1584 
11901
1 82993 37379 
23938
3 17209 10874 5546 33629 17046 12109 6044 35199 
0.123
2 
0.128
2 
  Muscle 800.4 63977 26325 8836 99138 7408 2976 677 11061 9166 4408 3005 16579 
0.100
4 
0.143
3 
37272 Liver 1584 
17435
3 
12503
0 52136 
35151
9 21507 13329 6766 41602 24686 14861 7843 47390 
0.105
8 
0.118
8 
  Muscle 800.4 86243 35108 8790 
13014
1 7470 4009 911 12390 10345 4200 3180 17725 
0.086
9 
0.119
9 
37273 Liver 1584 82384 59560 25579 
16752
3 15255 8968 3799 28022 10581 8523 3737 22841 
0.143
3 0.12 
  Muscle 800.4 63078 29385 7610 
10007
3 8205 4098 885 13188 7773 3823 3126 14722 
0.116
4 
0.128
2 
37274 Liver 1584 45649 31748 13156 90553 7123 5386 2690 15199 5633 3509 2119 11261 
0.143
7 
0.110
6 
  Muscle 800.4 95287 40577 11018 
14688
2 13338 5932 1612 20882 11643 5373 4867 21883 
0.124
5 
0.129
7 
37275 Urine  64364 64272 36255 
16489
1 5702 2093 665 8460 63194 63570 37081 
16384
5 
0.048
8 
0.498
4 
37276 Urine  44886 40171 21888 
10694
5 52548 45668 26814 
12503
0 1720 819 477 3016 0.539 
0.027
4 
                 
Related
5                 
37293 Liver 1584 
10953
6 76780 33426 
21974
2 17632 11275 4713 33620 12141 7679 4212 24032 
0.132
7 
0.098
6 
  Muscle 800.4 
17718
8 72796 19803 
26978
7 22643 10163 2698 35504 18023 8778 5833 32634 
0.116
3 
0.107
9 
37294 Liver 1584 
10180
4 78463 40614 
22088
1 17648 13691 6255 37594 12626 8787 5054 26467 
0.145
4 0.107 
  Muscle 800.4 92041 41573 11106 
14472
0 10942 5418 1680 18040 10363 4228 1129 15720 
0.110
8 0.098 
37295 Liver 1584 93288 77660 40750 
21169
8 19537 16253 8172 43962 12930 10676 6663 30269 0.172 
0.125
1 
  Muscle 800.4 
13412
8 59423 15406 
20895
7 21137 10003 2634 33774 13482 5928 1747 21157 
0.139
1 
0.091
9 
37296 Liver 1584 77059 61692 27434 
16618
5 14240 10370 3526 28136 8609 7800 4095 20504 
0.144
8 
0.109
8 
  Muscle 800.4 
16916
2 69483 20303 
25894
8 18753 8747 1836 29336 17187 8338 1868 27393 
0.101
8 
0.095
7 
37297 Liver 1584 
10046
0 79515 33901 
21387
6 19532 17046 7072 43650 13357 9438 4974 27769 
0.169
5 
0.114
9 
  Muscle 800.4 
13703
0 60074 16835 
21393
9 22928 10258 2628 35814 18004 7953 2214 28171 
0.143
4 
0.116
4 
37298 Liver 1584 75715 67004 29810 
17252
9 16336 15948 6236 38520 11246 8942 4758 24946 
0.182
5 
0.126
3 
  Muscle 800.4 
11448
7 54152 12560 
18119
9 16575 7555 2359 26489 11725 4754 1767 18246 
0.127
5 
0.091
5 
37299 Liver 1584 72299 43159 17900 
13335
8 10978 7506 2920 21404 10834 5556 2749 19139 
0.138
3 
0.125
5 
  Muscle 800.4 
12518
5 53309 14614 
19310
8 16351 8774 2400 27525 15499 6447 1756 23702 
0.124
8 
0.109
3 
37300 Liver 1584 
11666
0 80006 34827 
23149
3 24020 15860 6961 46841 13144 8896 3913 25953 
0.168
3 
0.100
8 
  Muscle 800.4 68451 27694 7238 
10338
3 10005 5615 1582 17202 7982 2485 713 11180 
0.142
7 
0.097
6 
37301 Liver 1584 67496 61211 28980 
15768
7 12972 10503 3017 26492 8107 5645 3091 16843 
0.143
8 
0.096
5 
  Muscle 800.4 
19380
9 76306 22725 
29284
0 25155 11360 3626 40141 16303 6977 1782 25062 
0.120
6 
0.078
8 
37302 Liver 1584 80799 48565 19318 
14868
2 13333 9381 3905 26619 10664 7295 2677 20636 
0.151
8 
0.121
9 
  Muscle 800.4 
10794
5 45540 12412 
16589
7 13609 6069 1918 21596 10816 5736 1164 17716 
0.115
2 
0.096
5 
37303 Liver 1584 97070 76689 30596 
20435
5 18873 13761 5604 38238 12501 8529 3421 24451 
0.157
6 
0.106
9 
  Muscle 800.4 
12728
8 52614 13164 
19306
6 18307 7696 2311 28314 15904 6041 1706 23651 
0.127
9 
0.109
1 
37304 Urine  26480 23866 12503 62849 29250 25488 14450 69188 758 335 0 1093 0.524 
0.017
1 
37305 Urine  2065 2259 1119 5443 492 99 0 591 1031 1249 1090 3370 
0.097
9 
0.382
4 
                 
NC1                 
37306 Liver 1584 31390 21589 10389 63368 0 0 0 0 4832 3257 1728 9817 0 
0.134
1 
37307 Liver 1584 27986 19728 9203 56917 0 0 0 0 4404 3175 1349 8928 0 
0.135
6 
37308 Liver 1584 22066 15492 7275 44833 0 0 0 0 3237 2558 1389 7184 0 
0.138
1 
37309 Liver 1584 42216 30968 13725 86909 0 0 0 0 6055 4672 2182 12909 0 
0.129
3 
37310 Liver 1584 6470 4376 2136 12982 0 0 0 0 1036 883 337 2256 0 
0.148
1 
37311 Liver 1584 57744 40969 17724 
11643
7 0 0 0 0 9655 6460 2871 18986 0 
0.140
2 
37312 Liver 1584 44543 31377 13482 89402 0 0 0 0 6304 4057 2211 12572 0 
0.123
3 
37313 Urine  52208 52022 29879 
13410
9 4557 1306 922 6785 61415 57571 33339 
15232
5 
0.048
2 
0.531
8 
37314 Urine  
21320
8 
17293
7 78849 
46499
4 48916 37813 18272 
10500
1 8602 6340 2997 17939 
0.184
2 
0.037
1 
                 
Related
6                 
37316 Liver 1584 16978 11427 4627 33032 2510 1368 703 4581 1904 1721 762 4387 
0.121
8 
0.117
2 
  Muscle 800.4 67371 26953 8397 
10272
1 7425 3286 1071 11782 8102 3660 1294 13056 
0.102
9 
0.112
8 
37317 Liver 1584 45725 32564 13959 92248 5034 3512 1844 10390 7304 5170 2616 15090 
0.101
2 
0.140
6 
  Muscle 800.4 
16226
4 73592 19161 
25501
7 13061 6569 1661 21291 23784 11208 3215 38207 
0.077
1 
0.130
3 
37318 Liver 1584 60908 43835 19359 
12410
2 7426 4967 2460 14853 7915 5969 2964 16848 
0.106
9 
0.119
5 
  Muscle 800.4 
16983
4 77430 21337 
26860
1 16258 7324 2603 26185 20878 9509 3346 33733 
0.088
8 
0.111
6 
37319 Liver 1584 25567 18977 7625 52169 3852 2158 1158 7168 3953 2454 1473 7880 
0.120
8 
0.131
2 
  Muscle 800.4 84554 39239 10257 
13405
0 9022 3734 1880 14636 10955 5073 1669 17697 
0.098
4 
0.116
6 
37320 Liver 1584 43388 32680 16262 92330 4857 3575 1763 10195 7629 5323 2779 15731 
0.099
4 
0.145
6 
  Muscle 800.4 89236 40986 10630 
14085
2 7498 3329 1121 11948 12063 5483 2947 20493 
0.078
2 0.127 
37321 Liver 1584 61525 43880 20736 
12614
1 10104 6389 3042 19535 9420 6505 2999 18924 
0.134
1 
0.130
5 
  Muscle 800.4 79644 35924 10658 
12622
6 8914 4181 1262 14357 10526 3568 1651 15745 
0.102
1 
0.110
9 
37322 Liver 1584 31779 23205 10598 65582 3225 2118 823 6166 4512 2940 1803 9255 
0.085
9 
0.123
7 
  Muscle 800.4 
12508
3 61608 15607 
20229
8 9142 5197 1728 16067 17137 8407 2255 27799 
0.073
6 
0.120
8 
37323 Liver 1584 44323 31885 14451 90659 5741 4402 1790 11933 7176 4868 2218 14262 
0.116
3 
0.135
9 
  Muscle 800.4 71621 32351 8801 
11277
3 6039 3356 1118 10513 9047 4455 1864 15366 
0.085
3 
0.119
9 
37324 Liver 1584 24315 17499 8462 50276 2591 1934 796 5321 4240 2724 1194 8158 
0.095
7 
0.139
6 
  Muscle 800.4 
15505
5 73022 17766 
24584
3 11659 6248 1456 19363 23197 11064 3554 37815 0.073 
0.133
3 
37325 Liver 1584 36826 28157 12820 77803 3782 2871 1629 8282 7466 5289 2732 15487 
0.096
2 0.166 
  Muscle 800.4 76848 33302 8156 
11830
6 4851 3236 1324 9411 11720 4684 2737 19141 
0.073
7 
0.139
3 
37326 Liver 1584 8317 5512 2609 16438 836 572 247 1655 1107 933 663 2703 
0.091
5 
0.141
2 
  Muscle 800.4 
13950
5 66975 18065 
22454
5 14024 5725 1611 21360 20032 10186 3124 33342 
0.086
9 
0.129
3 
37327 Liver 1584 26321 18797 8568 53686 4248 2312 1726 8286 3734 2477 1234 7445 
0.133
7 
0.121
8 
  Muscle 800.4 50404 24860 6097 81361 6208 3020 725 9953 6123 3017 1058 10198 0.109 
0.111
4 
37328 Liver 1584 37882 26574 13059 77515 5044 3325 1595 9964 6006 5056 2474 13536 
0.113
9 
0.148
7 
  Muscle 800.4 
11870
0 58007 13478 
19018
5 11065 5266 1510 17841 16664 8384 2446 27494 
0.085
8 
0.126
3 
37729 Urine  
15681
3 
13928
4 72987 
36908
4 23785 14344 6574 44703 63095 54035 28908 
14603
8 0.108 
0.283
5 
37730 Urine  35837 32440 17934 86211 36411 30276 14088 80775 913 375 199 1487 
0.483
7 0.017 
                 
Unrelated3                
37731 Liver 1584 
12203
8 93489 40491 
25601
8 18687 13008 5907 37602 13830 9160 5571 28561 
0.128
1 
0.100
4 
  Muscle 800.4 76792 34485 8517 
11979
4 9306 5120 1357 15783 7978 3848 951 12777 
0.116
4 
0.096
4 
37732 Liver 1584 34192 25758 12368 72318 5978 3846 1964 11788 3790 2848 1378 8016 
0.140
2 
0.099
8 
  Muscle 800.4 97757 41606 10726 
15008
9 12769 6190 2314 21273 11444 5049 1170 17663 
0.124
1 
0.105
3 
37733 Liver 1584 31891 22324 9969 64184 4880 3210 1746 9836 6955 4130 2309 13394 
0.132
9 
0.172
7 
  Muscle 800.4 29877 13783 3481 47141 3840 1750 890 6480 5286 2476 841 8603 
0.120
8 
0.154
3 
37734 Liver 1584 43975 32630 15038 91643 6005 4331 2339 12675 8377 5595 2985 16957 
0.121
5 
0.156
1 
  Muscle 800.4 42895 19400 5262 67557 4837 2216 628 7681 7063 3398 906 11367 
0.102
1 0.144 
37735 Liver 1584 34952 24601 11383 70936 6854 3887 1556 12297 3729 2859 1347 7935 
0.147
7 
0.100
6 
  Muscle 800.4 87331 38333 9869 
13553
3 13966 6329 1982 22277 9139 4365 1326 14830 
0.141
2 
0.098
6 
37736 Liver 1584 81483 58418 27138 
16703
9 14710 10296 4974 29980 16410 10259 6637 33306 
0.152
2 
0.166
2 
  Muscle 800.4 52748 22748 6460 81956 7996 3220 868 12084 10297 4365 1317 15979 
0.128
5 
0.163
2 
37737 Liver 1584 31775 22044 9349 63168 5706 3570 1569 10845 5509 4174 1862 11545 
0.146
5 
0.154
5 
  Muscle 800.4 22106 10185 3205 35496 3370 1887 647 5904 4728 2485 654 7867 
0.142
6 
0.181
4 
37738 Liver 1584 35806 25599 12223 73628 5107 3890 1601 10598 6236 5456 2017 13709 
0.125
8 0.157 
  Muscle 800.4 51499 21852 7192 80543 5984 2643 1180 9807 9697 4818 1506 16021 
0.108
5 
0.165
9 
37739 Liver 1584 
13030
0 90370 43495 
26416
5 22626 16680 6780 46086 13736 9295 5498 28529 
0.148
5 
0.097
5 
  Muscle 800.4 
11451
0 48825 13410 
17674
5 17368 7131 1844 26343 11010 4803 1639 17452 
0.129
7 
0.089
9 
37740 Liver 1584 60804 44093 19986 
12488
3 10406 6272 2616 19294 7141 5437 2234 14812 
0.133
8 0.106 
  Muscle 800.4 84090 38589 11299 
13397
8 10910 5434 1589 17933 8439 3809 1238 13486 0.118 
0.091
5 
37741 Liver 1584 49033 37330 15389 
10175
2 7883 5336 2216 15435 8956 6827 3469 19252 
0.131
7 
0.159
1 
  Muscle 800.4 40440 16947 5188 62575 4356 2484 850 7690 6378 3321 1014 10713 
0.109
4 
0.146
2 
37742 Liver 1584 53202 40052 18238 
11149
2 8110 5202 3696 17008 5481 4034 2085 11600 
0.132
4 
0.094
2 
  Muscle 800.4 
21724
4 92211 27676 
33713
1 26678 11376 3294 41348 21781 9225 2911 33917 
0.109
2 
0.091
4 
37743 Liver 1584 40579 29149 12974 82702 6893 5078 2551 14522 3914 2664 1645 8223 
0.149
4 
0.090
4 
  Muscle 800.4 38289 16673 4847 59809 4865 2215 652 7732 6849 3493 1048 11390 
0.114
5 0.16 
37744 Liver 1584 33210 25864 11188 70262 5929 4685 1962 12576 3720 2620 1767 8107 
0.151
8 
0.103
4 
  Muscle 800.4 73716 31898 9442 
11505
6 7946 3781 954 12681 13672 6550 1565 21787 
0.099
3 
0.159
2 
37745 Liver 1584 41730 32774 15339 89843 5768 3421 1291 10480 8353 6180 2575 17108 
0.104
5 0.16 
  Muscle 800.4 
10680
1 48199 13864 
16886
4 13614 6428 2169 22211 9220 4713 1339 15272 
0.116
2 
0.082
9 
37746 Urine  9356 7735 4869 21960 10670 8989 4966 24625 914 299 63 1276 
0.528
6 
0.054
9 
37747 Urine  12958 13041 8239 34238 1461 466 133 2060 13828 10853 6782 31463 
0.056
8 
0.478
9 
                 
Unrelated4                
37748 Liver 1584 41228 27761 11991 80980 6126 4381 2353 12860 5674 3775 3026 12475 0.137 
0.133
5 
  Muscle 800.4 12504 5743 1721 19968 1684 1258 437 3379 1870 912 396 3178 
0.144
7 
0.137
3 
37749 Liver 1584 29839 21887 8659 60385 6296 4953 2012 13261 4673 3655 1930 10258 
0.180
1 
0.145
2 
  Muscle 800.4 13318 6431 1833 21582 2720 1158 193 4071 1966 719 302 2987 
0.158
7 
0.121
6 
37750 Liver 1584 35163 23229 10852 69244 6599 4352 2836 13787 4928 3451 1625 10004 0.166 
0.126
2 
  Muscle 800.4 11228 5643 1362 18233 1568 1432 223 3223 1943 757 111 2811 
0.150
2 
0.133
6 
37751 Liver 1584 10116 6834 2777 19727 2461 1485 905 4851 1277 818 356 2451 
0.197
4 
0.110
5 
  Muscle 800.4 8503 3652 1237 13392 2358 723 139 3220 847 693 173 1713 
0.193
8 
0.113
4 
37752 Liver 1584 19140 12948 6491 38579 4332 2599 1075 8006 2627 1434 1611 5672 
0.171
9 
0.128
2 
  Muscle 800.4 18427 8227 2061 28715 2803 1015 661 4479 3181 927 367 4475 
0.134
9 
0.134
8 
37622 Urine  72167 64017 33481 
16966
5 70285 57302 29169 
15675
6 2044 1722 336 4102 
0.480
2 
0.023
6 
37623 Urine  48314 43186 24861 
11636
1 4816 1993 659 7468 51572 45159 27240 
12397
1 
0.060
3 
0.515
8 
                 
Unrelated5                
37753 Liver 1584 23590 15563 7816 46969 4387 2952 1494 8833 2831 1390 1224 5445 
0.158
3 
0.103
9 
  Muscle 800.4 29252 12623 3245 45120 4958 2137 509 7604 3521 1296 641 5458 
0.144
2 
0.107
9 
37754 Liver 1584 17295 11519 4751 33565 4376 2881 1060 8317 2364 1948 831 5143 
0.198
6 
0.132
9 
  Muscle 800.4 7413 4060 764 12237 1342 867 145 2354 754 357 142 1253 
0.161
3 
0.092
9 
37755 Liver 1584 12926 7284 3631 23841 2247 1560 687 4494 1519 1105 472 3096 
0.158
6 
0.114
9 
  Muscle 800.4 5465 3161 952 9578 979 490 124 1593 784 180 115 1079 
0.142
6 
0.101
2 
37756 Liver 1584 26970 20916 7911 55797 6040 4871 2076 12987 3997 3039 1822 8858 
0.188
8 0.137 
  Muscle 800.4 14670 6717 1730 23117 2363 1489 407 4259 1624 1489 435 3548 
0.155
6 
0.133
1 
37757 Liver 1584 30335 19133 8277 57745 7944 5648 2063 15655 3996 2459 1595 8050 
0.213
3 
0.122
3 
  Muscle 800.4 28056 11518 3569 43143 4944 3231 693 8868 2196 1312 418 3926 
0.170
5 
0.083
4 
37758 Liver 1584 10667 7463 3295 21425 3566 2067 1082 6715 1876 1915 645 4436 
0.238
6 
0.171
5 
  Muscle 800.4 4491 2236 503 7230 1033 473 358 1864 509 558 206 1273 0.205 
0.149
7 
37759 Liver 1584 45873 32507 13460 91840 9808 6889 3156 19853 4425 3697 966 9088 
0.177
7 0.09 
  Muscle 800.4 24244 10308 2808 37360 5043 1910 568 7521 2420 923 325 3668 
0.167
6 
0.089
4 
37760 Liver 1584 54665 38372 16250 
10928
7 9802 6408 3734 19944 5387 3972 1811 11170 
0.154
3 
0.092
7 
  Muscle 800.4 26233 11259 2604 40096 4782 2320 643 7745 2647 791 386 3824 
0.161
9 
0.087
1 
37761 Liver 1584 18169 11809 5291 35269 4426 3080 948 8454 2322 1574 935 4831 
0.193
4 
0.120
5 
  Muscle 800.4 14050 5813 2134 21997 2291 884 446 3621 937 699 139 1775 
0.141
3 
0.074
7 
37762 Liver 1584 16365 11703 4726 32794 3098 2195 984 6277 1690 988 618 3296 
0.160
7 
0.091
3 
  Muscle 800.4 42514 18052 6358 66924 6942 3756 1113 11811 4488 2055 736 7279 0.15 
0.098
1 
37763 Urine  24093 19315 11404 54812 29777 23202 12746 65725 918 592 469 1979 
0.545
3 
0.034
8 
37764 Urine  17475 18979 10386 46840 2234 826 236 3296 18339 19181 10627 48147 
0.065
7 
0.506
9 
                 
Related
7                 
37765 Liver 1584 18111 12024 4955 35090 3624 2096 1227 6947 2109 1055 892 4056 
0.165
3 
0.103
6 
  Muscle 800.4 48584 22160 5554 76298 6259 2810 1031 10100 3457 2019 610 6086 
0.116
9 
0.073
9 
37766 Liver 1584 14472 8703 3774 26949 2705 1640 879 5224 1987 1442 512 3941 
0.162
4 
0.127
6 
  Muscle 800.4 18751 7590 1938 28279 2612 1399 448 4459 1317 516 391 2224 
0.136
2 
0.072
9 
37767 Liver 1584 30208 18298 9238 57744 5491 3730 1380 10601 2972 1852 1112 5936 
0.155
1 
0.093
2 
  Muscle 800.4 22212 9861 3421 35494 3345 1596 839 5780 1421 651 244 2316 0.14 
0.061
3 
37768 Liver 1584 26002 16340 6699 49041 4069 2904 1282 8255 2118 2200 1937 6255 
0.144
1 
0.113
1 
  Muscle 800.4 26337 12593 3519 42449 4935 1578 439 6952 2239 1338 471 4048 
0.140
7 
0.087
1 
37769 Liver 1584 32895 22531 8666 64092 5372 3978 1859 11209 3362 2105 1463 6930 
0.148
9 
0.097
6 
  Muscle 800.4 33351 15394 4300 53045 4001 1792 650 6443 2699 1177 244 4120 
0.108
3 
0.072
1 
37770 Liver 1584 33943 23649 9652 67244 6048 4103 1746 11897 3651 2335 1640 7626 
0.150
3 
0.101
9 
  Muscle 800.4 51634 23625 5676 80935 7830 2822 615 11267 3736 1380 654 5770 
0.122
2 
0.066
5 
37771 Liver 1584 13328 8730 2883 24941 2970 1668 1015 5653 1853 848 491 3192 
0.184
8 
0.113
5 
  Muscle 800.4 13858 5609 1614 21081 1600 689 329 2618 608 350 315 1273 
0.110
5 
0.056
9 
37772 Liver 1584 31209 22480 9997 63686 4731 3746 1887 10364 3203 2076 1377 6656 0.14 
0.094
6 
  Muscle 800.4 24777 10940 2997 38714 2809 1246 463 4518 1275 404 239 1918 
0.104
5 
0.047
2 
37773 Liver 1584 60976 41188 18941 
12110
5 10603 6731 2941 20275 5134 3638 2752 11524 
0.143
4 
0.086
9 
  Muscle 800.4 15151 7747 1787 24685 1605 617 309 2531 553 492 163 1208 0.093 
0.046
7 
37774 Urine  51779 47342 27831 
12695
2 4078 1500 565 6143 43624 41261 24875 
10976
0 
0.046
2 
0.463
7 
37775 Urine  89990 79417 42954 
21236
1 
10986
2 98747 50592 
25920
1 2241 814 421 3476 
0.549
7 
0.016
1 
                 
NC2                 
37776 Liver 1584 10110 6843 2891 19844 2643 1809 1003 5455 0 0 0 0 
0.215
6 0 
  Muscle 800.4 
13725
2 64578 19023 
22085
3 34922 14181 4692 53795 0 0 0 0 
0.195
9 0 
37777 Liver 1584 30687 19703 9184 59574 8367 7407 3044 18818 0 0 0 0 
0.240
1 0 
  Muscle 800.4 47593 24071 6679 78343 14617 5658 1527 21802 0 0 0 0 
0.217
7 0 
37778 Liver 1584 39996 26008 11795 77799 9730 6939 3671 20340 0 0 0 0 
0.207
3 0 
  Muscle 800.4 
10377
0 51011 14092 
16887
3 29062 12595 3482 45139 0 0 0 0 
0.210
9 0 
37929 Liver 1584 28247 16817 7991 53055 7207 4407 2556 14170 0 0 0 0 
0.210
8 0 
  Muscle 800.4 89564 41624 12278 
14346
6 24680 11459 3564 39703 0 0 0 0 
0.216
8 0 
37930 Urine  
27316
4 
25089
9 
13333
1 
65739
4 
32955
0 
27316
2 
14501
0 
74772
2 6339 2049 468 8856 
0.532
1 
0.013
3 
37931 Urine  29398 27546 13857 70801 2532 1039 536 4107 15372 12523 6220 34115 
0.054
8 
0.325
2 
                 
Unrelated6                
38243 Liver 1584 88664 67445 29411 
18552
0 17190 11367 5487 34044 13140 8382 4813 26335 
0.155
1 
0.124
3 
  Muscle 800.4 38222 17138 6049 61409 7305 2671 1266 11242 5354 2283 905 8542 
0.154
7 
0.122
1 
38244 Liver 1584 62636 41373 19520 
12352
9 11191 5713 2645 19549 13577 8671 4015 26263 
0.136
6 
0.175
3 
  Muscle 800.4 25676 10926 4080 40682 2903 1229 311 4443 4314 1598 322 6234 
0.098
5 
0.132
9 
38245 Liver 1584 77437 41404 15530 
13437
1 11772 7162 2502 21436 14860 7855 3454 26169 
0.137
6 0.163 
  Muscle 800.4 44271 20141 5232 69644 5617 1689 674 7980 5791 2124 627 8542 
0.102
8 
0.109
3 
38246 Liver 1584 88667 57788 24326 
17078
1 15148 9202 4241 28591 14584 9554 4661 28799 
0.143
4 
0.144
3 
  Muscle 800.4 41610 16445 5455 63510 5381 3023 477 8881 5329 2327 708 8364 
0.122
7 
0.116
4 
38247 Liver 1584 72193 48590 20941 
14172
4 11698 7239 3157 22094 12792 8088 4026 24906 
0.134
9 
0.149
5 
  Muscle 800.4 40577 17909 4327 62813 4822 2235 605 7662 6880 2875 1005 10760 
0.108
7 
0.146
2 
38248 Liver 1584 61842 40168 16708 
11871
8 10565 6447 3907 20919 12845 6783 3406 23034 
0.149
8 
0.162
5 
  Muscle 800.4 56923 26613 7386 90922 9552 4160 1483 15195 12011 5019 1214 18244 
0.143
2 
0.167
1 
38249 Liver 1584 45030 26625 11395 83050 10242 5768 2838 18848 7712 6102 2084 15898 0.185 
0.160
7 
  Muscle 800.4 30307 13233 4129 47669 5671 2952 1013 9636 5696 2488 1252 9436 
0.168
2 
0.165
2 
38250 Liver 1584 51242 24259 9711 85212 8782 4567 2118 15467 8816 5110 1963 15889 
0.153
6 
0.157
2 
  Muscle 800.4 27867 13023 2967 43857 4867 2114 763 7744 4443 1822 1082 7347 
0.150
1 
0.143
5 
38251 Liver 1584 16726 7808 3129 27663 3714 1930 823 6467 3774 1712 597 6083 
0.189
5 
0.180
3 
  Muscle 800.4 31327 14011 3680 49018 6184 2493 822 9499 5639 2744 687 9070 
0.162
3 
0.156
1 
38252 Liver 1584 98086 69202 32432 
19972
0 16363 11145 5467 32975 18972 9992 6579 35543 
0.141
7 
0.151
1 
  Muscle 800.4 42082 19717 5942 67741 5116 2529 818 8463 6443 3370 1056 10869 
0.111
1 
0.138
3 
38253 Liver 1584 68791 42003 17555 
12834
9 12352 6875 3347 22574 16308 8986 4725 30019 
0.149
6 
0.189
6 
  Muscle 800.4 35046 17042 5047 57135 5304 2256 632 8192 5708 2392 996 9096 
0.125
4 
0.137
3 
38254 Urine  24936 25701 15211 65848 3183 1823 661 5667 23117 23863 12901 59881 
0.079
2 
0.476
3 
38255 Urine  76186 66400 32548 
17513
4 62475 51415 26031 
13992
1 1302 625 338 2265 
0.444
1 
0.012
8 
                 
NC3                 
38256 Urine  55332 52119 29578 
13702
9 11641 7411 5115 24167 32050 29150 14845 76045 
0.149
9 
0.356
9 
38257 Urine  
34305
1 
28872
5 
16019
8 
79197
4 
31185
2 
25927
1 
13009
6 
70121
9 6574 3070 912 10556 
0.469
6 
0.013
2 
38258 Liver 1584 17849 9631 4627 32107 4637 2665 1335 8637 0 0 0 0 0.212 0 
  Muscle 800.4 82608 40683 11326 
13461
7 24396 10723 3143 38262 0 0 0 0 
0.221
3 0 
38259 Liver 1584 16322 10410 5427 32159 5292 2655 1384 9331 0 0 0 0 
0.224
9 0 
  Muscle 800.4 
12978
7 61055 18523 
20936
5 33999 16303 4853 55155 0 0 0 0 
0.208
5 0 
                 
NC4                 
38261 Liver 1584 21336 14452 7471 43259 8056 4563 2300 14919 0 0 0 0 
0.256
4 0 
  Muscle 800.4 
10728
6 54060 15890 
17723
6 29301 13369 5495 48165 0 0 0 0 
0.213
7 0 
38262 Liver 1584 19294 12855 5744 37893 5917 3845 2368 12130 0 0 0 0 
0.242
5 0 
  Muscle 800.4 50829 23428 6571 80828 14903 5560 2093 22556 0 0 0 0 
0.218
2 0 
38263 Liver 1584 20150 12467 5584 38201 6726 4369 1328 12423 0 0 0 0 
0.245
4 0 
  Muscle 800.4 69767 35593 9786 
11514
6 20086 8480 3052 31618 0 0 0 0 
0.215
4 0 
38264 Urine  
21950
0 
20953
3 
11500
7 
54404
0 18283 6532 2802 27617 
21640
4 
19697
1 
10401
5 
51739
0 
0.048
3 
0.487
4 
38265 Urine  68510 64718 33741 
16696
9 78209 69724 35620 
18355
3 7248 5117 2562 14927 
0.523
7 0 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
Supplementary B: Communal nursing study 
Spreadsheet where the peptide intensities of the high turnover pup liver and muscle proteins and the mother’s urine were recorded, along with 
the intensities of the corresponding labelled peptides, where mothered were fed either a [D4] or [D9] lysine labelled diet over the course of the 
experiment.  Precursor RIA values were calculated from this data. Pup IDs/mother IDs in red are pups from the [D9] lysine labelled mother/mothers 
fed [D9] lysine labelled diet.  Those in green are the pups from the [D4] lysine labelled mother/mothers fed [D4] lysine labelled diet. 
 
 
 
 
 
 
 
 
 
 
ID: 
Sampl
e type  
Peptid
e mass Light peptide   D4 peptide   D9 peptide   IH/(IH+IL) 
Unrelated1  1 2 3 Sum 1 2 3 Sum 1 2 3 Sum D4 D9 
36286 Liver 916.5 69300 45070 17168 
13153
8 
1250
7 8652 3813 24972 17231 11735 4872 33838 
0.159
6 
0.20
5 
  
Muscl
e 871.5 
21473
6 
12205
5 42586 
37937
7 
4098
3 
2076
3 
1016
4 71910 55122 29688 8389 93199 
0.159
3 
0.19
7 
36287 Liver 916.5 23401 16132 7436 46969 5420 3025 1596 10041 5557 3605 1844 11006 
0.176
1 0.19 
  
Muscl
e 871.5 68211 35027 10416 
11365
4 
1258
0 6984 2077 21641 14998 6955 2137 24090 0.16 
0.17
5 
36288 Liver 916.5 23298 16446 6164 45908 5128 3899 1484 10511 5923 3490 1632 11045 
0.186
3 
0.19
4 
  
Muscl
e 871.5 
17744
0 90784 26974 
29519
8 
2878
2 
1425
5 4895 47932 30926 15498 4504 50928 
0.139
7 
0.14
7 
36289 Liver 916.5 46874 30975 12560 90409 
1060
4 6040 2874 19518 11057 7377 3173 21607 
0.177
6 
0.19
3 
  
Muscl
e 871.5 
19228
5 93997 28459 
31474
1 
3268
7 
1649
2 5504 54683 42136 21104 6043 69283 0.148 0.18 
36290 Liver 916.5 23430 16218 5684 45332 4514 3242 1460 9216 6274 4018 1666 11958 0.169 
0.20
9 
  
Muscl
e 871.5 
16488
2 80955 26659 
27249
6 
2309
9 
1331
2 3959 40370 30855 14121 4030 49006 0.129 
0.15
2 
36291 Liver 916.5 58442 40175 15719 
11433
6 
1234
3 7899 3726 23968 14186 9924 3853 27963 
0.173
3 
0.19
7 
  
Muscl
e 871.5 
26936
6 
13404
5 39313 
44272
4 
4252
7 
2169
9 8774 73000 54991 27063 9562 91616 
0.141
5 
0.17
1 
36292 Liver 916.5 22943 14547 6244 43734 5657 3615 1568 10840 5489 3560 1388 10437 
0.198
6 
0.19
3 
  
Muscl
e 871.5 
26807
9 
13657
6 39952 
44460
7 
4884
1 
2869
4 8857 86392 54848 27256 8717 90821 
0.162
7 0.17 
36293 Liver 916.5 48744 33231 13164 95139 9056 5992 3009 18057 10221 6637 3164 20022 
0.159
5 
0.17
4 
  
Muscl
e 871.5 
15271
2 77663 23999 
25437
4 
2508
6 
1363
8 4075 42799 34875 17378 4801 57054 0.144 
0.18
3 
36294 Liver 916.5 21649 15239 5316 42204 5133 2828 1463 9424 5247 3225 1363 9835 
0.182
5 
0.18
9 
  
Muscl
e 871.5 53699 29294 9701 92694 
1003
3 6062 1825 17920 12410 5738 1693 19841 0.162 
0.17
6 
36295 Liver 916.5 47337 32433 12795 92565 
1119
5 7369 3918 22482 13556 8231 3752 25539 
0.195
4 
0.21
6 
  
Muscl
e 871.5 92567 48242 14536 
15534
5 
1677
4 9209 4096 30079 16978 8197 2619 27794 
0.162
2 
0.15
2 
36296 Urine  36217 55644 31022 
12288
3 
6791
8 
5566
7 
3134
5 
15493
0 2368 1144 334 3846 
0.557
7 0.03 
36297 Urine  14458 13333 8168 35959 2090 665 0 2755 15286 16236 8733 40255 
0.071
2 
0.52
8 
                 
Related
1                 
36329 Liver 916.5 33722 22695 8959 65376 6023 3941 2154 12118 6932 4709 1753 13394 
0.156
4 0.17 
  
Muscl
e 871.5 
98986
7 
47736
0 
14204
5 2E+06 
1E+0
5 
6375
4 
2681
7 
21760
7 
16049
6 76887 21612 
25899
5 
0.119
1 
0.13
9 
36330 Liver 916.5 18321 12557 4616 35494 3395 2607 1229 7231 4169 2789 1086 8044 
0.169
2 
0.18
5 
  
Muscl
e 871.5 
21441
8 
10647
3 32163 
35305
4 
2840
7 
1465
0 5236 48293 37240 16481 5699 59420 
0.120
3 
0.14
4 
36331 Liver 916.5 46999 30741 11950 89690 7345 5393 1915 14653 10093 6369 2596 19058 
0.140
4 
0.17
5 
  
Muscl
e 871.5 1E+06 
53350
1 
14676
0 2E+06 
1E+0
5 
5987
7 
1996
7 
19434
4 
16922
4 79215 23043 
27148
2 
0.097
6 
0.13
1 
36332 Liver 916.5 20515 13359 5011 38885 3480 1789 866 6135 2929 2164 715 5808 
0.136
3 0.13 
  
Muscl
e 871.5 
63281
2 
31248
2 88643 1E+06 
7032
8 
3790
2 
1148
9 
11971
9 81419 38091 11505 
13101
5 
0.103
8 
0.11
2 
36333 Liver 916.5 16698 10871 4163 31732 3452 2473 1252 7177 2942 2111 959 6012 
0.184
5 
0.15
9 
  
Muscl
e 871.5 
44504
8 
21953
7 62226 
72681
1 
5839
3 
3242
2 
1031
4 
10112
9 68565 32766 9709 
11104
0 
0.122
1 
0.13
3 
36334 Liver 916.5 10543 7067 2975 20585 2088 1245 503 3836 1141 1298 790 3229 
0.157
1 
0.13
6 
  
Muscl
e 871.5 
26242
5 
13076
2 39272 
43245
9 
3621
1 
1964
1 6531 62383 39028 17765 5649 62442 
0.126
1 
0.12
6 
36335 Liver 916.5 15560 11319 3891 30770 3036 1862 979 5877 3068 1951 925 5944 
0.160
4 
0.16
2 
  
Muscl
e 871.5 
40660
9 
19580
6 58719 
66113
4 
5006
5 
2622
6 8889 85180 65968 31449 9511 
10692
8 
0.114
1 
0.13
9 
36336 Liver 916.5 9112 6549 2513 18174 1816 772 488 3076 1388 1230 445 3063 
0.144
8 
0.14
4 
  
Muscl
e 871.5 
42365
9 
19797
4 61733 
68336
6 
5132
6 
2761
1 9166 88103 66324 33697 9407 
10942
8 
0.114
2 
0.13
8 
36337 Liver 916.5 16016 11183 4425 31624 3239 2168 794 6201 2810 2291 900 6001 
0.163
9 
0.15
9 
  
Muscl
e 871.5 
61256
9 
30208
7 85012 
99966
8 
7737
4 
4271
0 
1292
6 
13301
0 76322 35252 9438 
12101
2 
0.117
4 
0.10
8 
36338 Liver 916.5 8695 6085 2568 17348 1851 1111 688 3650 1697 1142 578 3417 
0.173
8 
0.16
5 
  
Muscl
e 871.5 
61075
4 
38749
3 84151 1E+06 
7736
0 
4016
1 
1236
4 
12988
5 98655 48955 13703 
16131
3 
0.107
1 0.13 
36339 Urine  73649 65705 34548 
17390
2 
7375
5 
6321
0 
3100
6 
16797
1 1888 1125 592 3605 
0.491
3 0.02 
36340 Urine  80886 72295 36681 
18986
2 5118 2832 775 8725 30326 25103 12477 67906 
0.043
9 
0.26
3 
                 
Related
2                 
36472 Liver 916.5 3274 1893 921 6088 3042 1354 833 5229 554 403 249 1206 0.462 
0.16
5 
36473 Liver 916.5 27957 18002 7440 53399 6623 4636 1881 13140 3326 2463 1013 6802 
0.197
5 
0.11
3 
  
Muscl
e 871.5 
23263
4 
11661
6 35702 
38495
2 
4480
8 
2225
6 8355 75419 23141 12464 4192 39797 
0.163
8 
0.09
4 
36474 Liver 916.5 23002 16725 6481 46208 7197 4188 1918 13303 3159 2506 891 6556 
0.223
5 
0.12
4 
  
Muscl
e 871.5 
11484
3 55923 17738 
18850
4 
3012
2 
1386
6 4637 48625 12132 6454 1972 20558 
0.205
1 
0.09
8 
36475 Liver 916.5 23398 15245 6232 44875 6123 4309 1699 12131 2956 1865 919 5740 
0.212
8 
0.11
3 
  
Muscl
e 871.5 
32301
6 
15887
1 48938 
53082
5 
7184
6 
3647
6 
1015
6 
11847
8 33162 16680 5907 55749 
0.182
5 
0.09
5 
36476 Urine  22959 23281 11741 57981 
2740
5 
2292
3 
1180
4 62132 2026 1652 770 4448 
0.517
3 
0.07
1 
36477 Urine  2329 1956 1115 5400 473 188 127 788 1208 1133 646 2987 
0.127
3 
0.35
6 
                 
Unrelated2                
36679 Liver 916.5 10434 6711 2933 20078 2014 1232 490 3736 2106 998 449 3553 
0.156
9 0.15 
  
Muscl
e 871.5 46254 23153 6908 76315 8043 3769 994 12806 9415 5441 1524 16380 
0.143
7 
0.17
7 
36680 Liver 916.5 17404 11296 4838 33538 4241 2336 1448 8025 4612 3289 1290 9191 
0.193
1 
0.21
5 
  
Muscl
e 871.5 1017 593 387 1997 281 111 66 458 419 158 19 596 
0.186
6 0.23 
36681 Liver 916.5 13156 8421 3555 25132 2321 1804 715 4840 2665 1471 847 4983 
0.161
5 
0.16
5 
  
Muscl
e 871.5 
11242
2 55802 16409 
18463
3 
2074
0 
1097
7 3737 35454 23905 14151 3734 41790 
0.161
1 
0.18
5 
36682 Liver 916.5 25004 16048 6914 47966 6624 3407 1637 11668 5004 3132 1400 9536 
0.195
7 
0.16
6 
  
Muscl
e 871.5 52257 26601 8019 86877 
1017
4 5737 1691 17602 11205 6501 1889 19595 
0.168
5 
0.18
4 
36683 Liver 916.5 16148 10581 4459 31188 4349 2872 1135 8356 4102 2928 860 7890 
0.211
3 
0.20
2 
  
Muscl
e 871.5 
12543
2 62455 16264 
20415
1 
2408
0 
1204
9 3999 40128 24132 11795 3701 39628 
0.164
3 
0.16
3 
36684 Liver 916.5 10860 6801 3113 20774 2502 1630 792 4924 2581 1856 659 5096 
0.191
6 
0.19
7 
  
Muscl
e 871.5 
10406
6 51047 15667 
17078
0 
1841
0 9233 2854 30497 18567 10808 3304 32679 
0.151
5 
0.16
1 
36685 Liver 916.5 2969 2490 820 6279 797 505 203 1505 722 381 283 1386 
0.193
3 
0.18
1 
  
Muscl
e 871.5 64028 30381 9688 
10409
7 
1185
8 5902 1563 19323 12339 5788 1873 20000 
0.156
6 
0.16
1 
36686 Liver 916.5 12095 7445 3309 22849 3043 1627 447 5117 2425 2130 840 5395 0.183 
0.19
1 
  
Muscl
e 871.5 
14062
5 69682 18882 
22918
9 
2251
9 
1195
3 3515 37987 30870 15364 3959 50193 
0.142
2 0.18 
36687 Liver 916.5 2091 1246 439 3776 522 540 167 1229 623 308 321 1252 
0.245
6 
0.24
9 
  
Muscl
e 871.5 12731 6936 2085 21752 1908 1347 465 3720 2702 2083 508 5293 0.146 
0.19
6 
36478 Urine  83234 80404 46570 
21020
8 
1368
7 8080 4270 26037 84082 79480 45196 
20875
8 
0.110
2 
0.49
8 
36688 Urine  17271 14608 8596 40475 
2018
7 
1865
2 
1005
6 48895 764 298 177 1239 
0.547
1 0.03 
                 
Related
3                 
37251 Liver 916.5 7342 4787 2131 14260 342 100 69 511 76 24 21 121 
0.034
6 
0.00
8 
  
Muscl
e 871.5 22762 9969 3342 36073 2602 1245 400 4247 3374 1894 366 5634 
0.105
3 
0.13
5 
37252 Liver 916.5 16004 10633 4737 31374 3065 2587 1028 6680 2854 2486 987 6327 
0.175
5 
0.16
8 
  
Muscl
e 871.5 
10694
6 53706 18172 
17882
4 
1663
6 8928 3590 29154 20194 11397 3103 34694 
0.140
2 
0.16
2 
37253 Liver 916.5 19326 12145 5266 36737 3122 2091 917 6130 3805 2996 994 7795 0.143 
0.17
5 
  
Muscl
e 871.5 
22780
3 
11550
6 35246 
37855
5 
2879
9 
1520
6 5977 49982 41021 22116 5974 69111 
0.116
6 
0.15
4 
37254 Liver 916.5 42446 27708 11743 81897 6449 4137 1673 12259 8165 5564 2244 15973 
0.130
2 
0.16
3 
  
Muscl
e 871.5 
27000
0 
13423
5 43478 
44771
3 
3423
0 
1804
2 5596 57868 58383 30428 9289 98100 
0.114
5 0.18 
37255 Liver 916.5 16312 11377 4508 32197 2836 1560 694 5090 2646 2150 745 5541 
0.136
5 
0.14
7 
  
Muscl
e 871.5 
33136
1 
16063
5 46721 
53871
7 
3726
6 
1655
4 5744 59564 57751 31174 7979 96904 
0.099
6 
0.15
2 
37256 Liver 916.5 24730 17518 6569 48817 3371 2413 1086 6870 5048 3366 983 9397 
0.123
4 
0.16
1 
  
Muscl
e 871.5 92689 44440 13169 
15029
8 9405 4825 1896 16126 16690 8073 2148 26911 
0.096
9 
0.15
2 
37257 Liver 916.5 20159 12510 4899 37568 3326 2184 1029 6539 3547 2089 1109 6745 
0.148
3 
0.15
2 
  
Muscl
e 871.5 37453 18334 6331 62118 6345 3805 969 11119 6220 3319 998 10537 
0.151
8 
0.14
5 
37258 Urine  
11913
2 
10705
6 63157 
28934
5 8576 2807 991 12374 
10962
5 98541 54432 
26259
8 0.041 
0.47
6 
37259 Urine  
15973
8 
14471
6 75066 
37952
0 
2E+0
5 
1E+0
5 
6436
3 
33982
7 3628 2320 880 6828 
0.472
4 
0.01
8 
                 
Related
4                 
37260 Liver 916.5 55722 37006 15106 
10783
4 
1110
6 7079 3130 21315 13623 9409 3348 26380 0.165 
0.19
7 
  
Muscl
e 871.5 
12906
2 60392 19895 
20934
9 
2089
7 
1075
3 3024 34674 28902 15200 4659 48761 
0.142
1 
0.18
9 
37261 Liver 916.5 54918 36041 16761 
10772
0 9830 7415 3030 20275 17715 12432 4921 35068 
0.158
4 
0.24
6 
  
Muscl
e 871.5 
11027
1 58201 17140 
18561
2 
1644
3 8928 2877 28248 23184 12226 3324 38734 
0.132
1 
0.17
3 
37262 Liver 916.5 22333 14228 7432 43993 4645 3140 1463 9248 5519 3808 1308 10635 
0.173
7 
0.19
5 
  
Muscl
e 871.5 
12185
8 59042 16963 
19786
3 
2544
0 
1177
1 3876 41087 25600 14165 3919 43684 
0.171
9 
0.18
1 
37263 Liver 916.5 18741 11761 5920 36422 2643 1515 912 5070 4350 3180 1125 8655 
0.122
2 
0.19
2 
  
Muscl
e 871.5 
21730
4 
11288
5 32672 
36286
1 
2392
3 
1300
9 4069 41001 51381 25111 6681 83173 
0.101
5 
0.18
6 
37264 Liver 916.5 12262 8701 3238 24201 2722 2207 832 5761 3060 2165 1390 6615 
0.192
3 
0.21
5 
  
Muscl
e 871.5 99081 51000 15988 
16606
9 
1889
8 9381 3005 31284 28818 13234 4736 46788 
0.158
5 0.22 
37265 Liver 916.5 14500 9609 4757 28866 2488 1840 796 5124 2980 2215 1163 6358 
0.150
8 
0.18
1 
  
Muscl
e 871.5 
12802
4 61615 18630 
20826
9 
1661
4 8516 2789 27919 25658 13670 3535 42863 
0.118
2 
0.17
1 
37266 Liver 916.5 23317 15596 7022 45935 5303 3408 2030 10741 5512 3930 1799 11241 
0.189
5 
0.19
7 
  
Muscl
e 871.5 
10451
0 53763 15132 
17340
5 
2027
5 
1041
6 3780 34471 22741 12044 3322 38107 
0.165
8 0.18 
37267 Liver 916.5 15354 10620 5801 31775 4400 2686 1128 8214 2975 2842 1177 6994 
0.205
4 0.18 
  
Muscl
e 871.5 77798 38510 13516 
12982
4 
1477
7 8138 1868 24783 14456 8376 1644 24476 
0.160
3 
0.15
9 
37268 Liver 916.5 27795 18587 7300 53682 5619 4470 1943 12032 7396 5175 1890 14461 
0.183
1 
0.21
2 
  
Muscl
e 871.5 
18498
5 96253 30687 
31192
5 
3278
4 
1680
4 5513 55101 44772 21935 5938 72645 
0.150
1 
0.18
9 
37269 Liver 916.5 21502 14440 5533 41475 4456 2584 1158 8198 5807 3669 1825 11301 0.165 
0.21
4 
  
Muscl
e 871.5 26686 13890 4010 44586 5907 3432 1320 10659 6973 3032 887 10892 
0.192
9 
0.19
6 
37270 Liver 916.5 
12064
8 77948 31252 
22984
8 
2265
3 
1453
6 6073 43262 27135 18689 7144 52968 
0.158
4 
0.18
7 
  
Muscl
e 871.5 13383 6697 2429 22509 1722 1322 699 3743 2368 1367 1504 5239 
0.142
6 
0.18
9 
37271 Liver 916.5 
21171
7 
10604
8 32439 
35020
4 
3199
6 
1547
5 5067 52538 43490 21789 5891 71170 
0.130
5 
0.16
9 
  
Muscl
e 871.5 
15088
4 74916 24462 
25026
2 
2354
8 
1328
2 4632 41462 36454 17893 5458 59805 
0.142
1 
0.19
3 
37272 Liver 916.5 52119 37560 14171 
10385
0 
1149
2 8585 4629 24706 16818 10689 3879 31386 
0.192
2 
0.23
2 
  
Muscl
e 871.5 
25183
0 
13244
6 39900 
42417
6 
3430
6 
1844
4 6004 58754 51717 24850 7384 83951 
0.121
7 
0.16
5 
37273 Liver 916.5 37184 26502 12276 75962 
1125
6 6424 3020 20700 11581 6636 2227 20444 
0.214
1 
0.21
2 
  
Muscl
e 871.5 50176 26411 8546 85133 
1029
6 5045 2358 17699 10600 5575 1280 17455 
0.172
1 0.17 
37274 Liver 916.5 23291 13173 5335 41799 5659 3443 1437 10539 5158 3352 1251 9761 
0.201
4 
0.18
9 
  
Muscl
e 871.5 
16337
7 81467 26425 
27126
9 
3190
6 
1655
6 5762 54224 30609 15168 4868 50645 
0.166
6 
0.15
7 
37275 Urine  64928 64806 36597 
16633
1 5803 2111 692 8606 63795 64152 37653 
16560
0 
0.049
2 
0.49
9 
37276 Urine  45610 41195 22179 
10898
4 
5317
8 
4627
8 
2505
0 
12450
6 1827 911 545 3283 
0.533
2 
0.02
9 
                 
Related
5                 
37293 Liver 916.5 
11298
8 72678 28866 
21453
2 
3053
7 
1863
3 8164 57334 22328 14884 6695 43907 
0.210
9 0.17 
  
Muscl
e 871.5 
87001
0 
43902
3 
13298
9 1E+06 
2E+0
5 
8098
2 
2382
1 
25592
8 
13362
0 65071 18624 
21731
5 
0.150
7 
0.13
1 
37294 Liver 916.5 
14687
3 
10159
1 39972 
28843
6 
3944
3 
2468
3 
1288
3 77009 26929 19475 7774 54178 
0.210
7 
0.15
8 
  
Muscl
e 871.5 
77940
9 
38784
3 
11603
0 1E+06 
1E+0
5 
7148
0 
2155
9 
23308
2 
11951
0 56879 14740 
19112
9 
0.153
7 0.13 
37295 Liver 916.5 
13821
6 93314 35982 
26751
2 
4170
6 
2653
9 
1151
1 79756 24324 15420 5699 45443 
0.229
7 
0.14
5 
  
Muscl
e 871.5 
47997
9 
23876
8 71984 
79073
1 
1E+0
5 
5884
4 
1888
8 
18731
6 80595 38516 11724 
13083
5 
0.191
5 
0.14
2 
37296 Liver 916.5 
10144
8 68135 26470 
19605
3 
2459
3 
1547
9 6528 46600 21347 16172 6421 43940 0.192 
0.18
3 
  
Muscl
e 871.5 
44642
4 
22548
5 68046 
73995
5 
7182
4 
3863
2 
1247
3 
12292
9 68444 33917 10590 
11295
1 
0.142
5 
0.13
2 
37297 Liver 916.5 31535 19852 8265 59652 8353 6634 2553 17540 7625 4833 1751 14209 
0.227
2 
0.19
2 
  
Muscl
e 871.5 
49889
4 
25767
6 72686 
82925
6 
1E+0
5 
6081
6 
1833
9 
19761
1 89883 43648 13076 
14660
7 
0.192
4 0.15 
37298 Liver 916.5 91633 62719 24346 
17869
8 
2577
0 
1740
0 6555 49725 17557 11241 4246 33044 
0.217
7 
0.15
6 
  
Muscl
e 871.5 
44408
2 
22110
1 63464 
72864
7 
1E+0
5 
5282
0 
1718
4 
17038
4 70033 33659 10877 
11456
9 
0.189
5 
0.13
6 
37299 Liver 916.5 43508 28552 11123 83183 
1088
1 7195 3631 21707 9431 6252 2630 18313 0.207 0.18 
  
Muscl
e 871.5 
26678
8 
13341
8 40580 
44078
6 
5476
7 
2799
4 
1025
0 93011 55104 29390 8037 92531 
0.174
2 
0.17
4 
37300 Liver 916.5 46237 30106 13360 89703 
1645
9 
1055
4 4580 31593 10666 7106 3155 20927 
0.260
5 
0.18
9 
  
Muscl
e 871.5 
40965
5 
20874
5 59848 
67824
8 
9648
5 
5291
8 
1580
8 
16521
1 67306 33362 9960 
11062
8 
0.195
9 0.14 
37301 Liver 916.5 
14031
0 91932 37242 
26948
4 
3983
7 
2616
2 
1016
2 76161 24108 18622 7410 50140 
0.220
3 
0.15
7 
  
Muscl
e 871.5 
88266
0 
43524
9 
12602
0 1E+06 
1E+0
5 
8760
5 
2474
1 
26200
1 
11490
3 53172 14998 
18307
3 
0.153
6 
0.11
3 
37302 Liver 916.5 39141 26095 11096 76332 
1013
1 7825 3058 21014 9340 6327 3180 18847 
0.215
9 
0.19
8 
  
Muscl
e 871.5 
24171
2 
11732
6 34367 
39340
5 
4725
7 
2724
1 8073 82571 43782 21504 6182 71468 
0.173
5 
0.15
4 
37303 Liver 916.5 27896 18518 8833 55247 9491 6153 2698 18342 10335 5920 2313 18568 
0.249
2 
0.25
2 
  
Muscl
e 871.5 
44656
7 
22044
9 65771 
73278
7 
9863
4 
5217
5 
1743
3 
16824
2 81223 39995 12513 
13373
1 
0.186
7 
0.15
4 
37304 Urine  26835 24393 12588 63816 
2977
3 
2568
6 
1465
0 70109 771 359 0 1130 
0.523
5 
0.01
7 
37305 Urine  2164 2415 1227 5806 523 154 0 677 1250 1636 1183 4069 
0.104
4 
0.41
2 
                 
NC1                 
37306 Liver 916.5 9168 5516 2354 17038 0 0 0 0 1890 2478 499 4867 0 
0.22
2 
37307 Liver 916.5 14544 8948 3946 27438 0 0 0 0 3888 2212 809 6909 0 
0.20
1 
37308 Liver 916.5 13552 9185 3619 26356 0 0 0 0 3195 2411 846 6452 0 
0.19
7 
37309 Liver 916.5 24384 16310 6291 46985 0 0 0 0 6564 3682 1647 11893 0 
0.20
2 
37310 Liver 916.5 2847 1630 726 5203 0 0 0 0 627 462 156 1245 0 
0.19
3 
37311 Liver 916.5 16468 9814 4154 30436 0 0 0 0 3118 2465 1179 6762 0 
0.18
2 
37312 Liver 916.5 15981 9784 4250 30015 0 0 0 0 3483 2678 715 6876 0 
0.18
6 
37313 Urine  56432 55944 32232 
14460
8 5271 1474 930 7675 63467 60383 34780 
15863
0 
0.050
4 
0.52
3 
37314 Urine  
21603
2 
17544
3 79987 
47146
2 
4964
2 
3853
1 
1851
4 
10668
7 8792 6445 3112 18349 
0.184
5 
0.03
7 
                 
Related
6                 
37316 Liver 916.5 12253 8530 3404 24187 2520 1950 506 4976 1949 1744 602 4295 
0.170
6 
0.15
1 
  
Muscl
e 871.5 
20926
9 
10558
9 30464 
34532
2 
3122
7 
1720
3 6212 54642 33694 15853 5347 54894 
0.136
6 
0.13
7 
37317 Liver 916.5 26969 19297 7601 53867 4845 3013 1421 9279 7686 5408 2171 15265 
0.146
9 
0.22
1 
  
Muscl
e 871.5 
69061
8 
32857
2 92961 1E+06 
7095
3 
3714
9 
1154
0 
11964
2 
13522
9 63831 19713 
21877
3 
0.097
1 
0.16
4 
37318 Liver 916.5 28530 17849 7067 53446 5378 4129 1271 10778 6654 4294 1891 12839 
0.167
8 
0.19
4 
  
Muscl
e 871.5 
76873
9 
37286
8 
11028
6 1E+06 
9157
1 
4682
9 
1825
3 
15665
3 
13104
9 64457 17651 
21315
7 
0.111
2 
0.14
5 
37319 Liver 916.5 12787 7376 3207 23370 2781 1527 550 4858 2490 1807 635 4932 
0.172
1 
0.17
4 
  
Muscl
e 871.5 
30073
6 
14845
6 46853 
49604
5 
4481
3 
2563
1 8986 79430 63765 31797 10047 
10560
9 0.138 
0.17
6 
37320 Liver 916.5 14450 9684 3327 27461 2313 1696 650 4659 4147 2730 764 7641 0.145 
0.21
8 
  
Muscl
e 871.5 
27983
9 
13488
9 40795 
45552
3 
3674
5 
1929
2 8959 64996 53837 30109 8929 92875 
0.124
9 
0.16
9 
37321 Liver 916.5 35611 23296 9250 68157 8902 5555 2397 16854 8056 5185 2131 15372 
0.198
3 
0.18
4 
  
Muscl
e 871.5 
24383
0 
11690
8 37074 
39781
2 
4503
9 
2369
7 
1044
9 79185 45924 25842 7595 79361 0.166 
0.16
6 
37322 Liver 916.5 18386 11691 4792 34869 2780 1675 940 5395 4230 2798 906 7934 0.134 
0.18
5 
  
Muscl
e 871.5 
69450
9 
32160
8 87812 1E+06 
6931
0 
3623
1 
1544
8 
12098
9 
11347
3 62248 18094 
19381
5 
0.098
8 
0.14
9 
37323 Liver 916.5 25646 18638 7036 51320 4300 3206 1423 8929 7144 4725 1802 13671 
0.148
2 0.21 
  
Muscl
e 871.5 
18662
6 92258 27877 
30676
1 
2698
3 
1350
0 6285 46768 36841 21707 7158 65706 
0.132
3 
0.17
6 
37324 Liver 916.5 12413 8345 3820 24578 1806 1544 781 4131 4023 3230 940 8193 
0.143
9 0.25 
  
Muscl
e 871.5 
73734
9 
34589
0 93495 1E+06 
8434
9 
4014
4 
1407
4 
13856
7 
13329
0 72729 20370 
22638
9 
0.105
4 
0.16
1 
37325 Liver 916.5 25572 17461 6060 49093 3335 2367 1232 6934 8300 5867 2202 16369 
0.123
8 0.25 
  
Muscl
e 871.5 
27613
4 
13133
6 38936 
44640
6 
2818
1 
1417
7 4882 47240 62611 33448 10403 
10646
2 
0.095
7 
0.19
3 
37326 Liver 916.5 4020 3006 1300 8326 1035 647 286 1968 1399 1032 437 2868 
0.191
2 
0.25
6 
  
Muscl
e 871.5 
90178
3 
41361
1 
12173
6 1E+06 
1E+0
5 
5138
5 
1900
0 
17377
7 
17040
7 83124 23505 
27703
6 
0.107
9 
0.16
2 
37327 Liver 916.5 16351 10990 4687 32028 3217 2409 1046 6672 2710 1612 794 5116 
0.172
4 
0.13
8 
  
Muscl
e 871.5 
15497
5 75438 22849 
25326
2 
2318
2 
1166
3 3325 38170 22080 10912 3157 36149 0.131 
0.12
5 
37328 Liver 916.5 18789 12724 5683 37196 4268 2641 1052 7961 5295 3139 1353 9787 
0.176
3 
0.20
8 
  
Muscl
e 871.5 
36049
0 
18015
7 57037 
59768
4 
5754
1 
2725
3 
1204
1 96835 81262 43583 11682 
13652
7 
0.139
4 
0.18
6 
37729 Urine  
15789
4 
14043
5 75356 
37368
5 
2400
7 
1488
1 6676 45564 63770 54604 29114 
14748
8 
0.108
7 
0.28
3 
37730 Urine  36188 33251 18268 87707 
3693
4 
3080
2 
1421
0 81946 981 381 218 1580 0.483 
0.01
8 
                 
Unrelated3                
37731 Liver 916.5 
11373
6 76068 29434 
21923
8 
2873
7 
1659
9 6876 52212 21871 16098 6208 44177 
0.192
3 
0.16
8 
  
Muscl
e 871.5 
16616
8 77934 22630 
26673
2 
2880
2 
1438
1 5741 48924 22586 12117 3464 38167 0.155 
0.12
5 
37732 Liver 916.5 31322 19583 7506 58411 7778 5259 2427 15464 5413 3374 1450 10237 
0.209
3 
0.14
9 
  
Muscl
e 871.5 
40085
0 
19343
2 52049 
64633
1 
7357
2 
3837
7 
1128
3 
12323
2 54925 29948 8746 93619 
0.160
1 
0.12
7 
37733 Liver 916.5 25720 16960 6285 48965 5467 2689 1445 9601 7176 4340 2072 13588 
0.163
9 
0.21
7 
  
Muscl
e 871.5 39224 19066 6872 65162 6628 3726 1103 11457 10903 5195 1876 17974 
0.149
5 
0.21
6 
37734 Liver 916.5 36905 24578 9677 71160 7291 5148 1848 14287 7946 5982 2096 16024 
0.167
2 
0.18
4 
  
Muscl
e 871.5 50579 26164 9131 85874 
1039
3 4611 1749 16753 10552 5851 2059 18462 
0.163
2 
0.17
7 
37735 Liver 916.5 19914 14058 5751 39723 5023 4084 1281 10388 3769 2349 1063 7181 
0.207
3 
0.15
3 
  
Muscl
e 871.5 
32009
8 
15738
6 49247 
52673
1 
5959
6 
3228
2 
1071
7 
10259
5 48923 22133 6915 77971 0.163 
0.12
9 
37736 Liver 916.5 5924 5015 2274 13213 6598 3980 2013 12591 2094 1345 537 3976 
0.487
9 
0.23
1 
  
Muscl
e 871.5 48865 22785 8861 80511 
1012
5 4871 2529 17525 12188 5888 2558 20634 
0.178
8 
0.20
4 
37737 Liver 916.5 23724 15620 6308 45652 5509 3083 1508 10100 6755 3465 1576 11796 
0.181
2 
0.20
5 
  
Muscl
e 871.5 33166 17320 6634 57120 8390 3931 1225 13546 10033 4532 1659 16224 
0.191
7 
0.22
1 
37738 Liver 916.5 22258 14534 5499 42291 4624 2361 1169 8154 4775 3505 1077 9357 
0.161
6 
0.18
1 
  
Muscl
e 871.5 47243 23499 9374 80116 9345 4369 1916 15630 12552 6719 2254 21525 
0.163
2 
0.21
2 
37739 Liver 916.5 93595 59085 24820 
17750
0 
2439
1 
1613
0 7226 47747 16494 11173 4562 32229 0.212 
0.15
4 
  
Muscl
e 871.5 
37180
9 
18275
4 51926 
60648
9 
6630
2 
3723
6 
1213
1 
11566
9 53830 25148 8740 87718 
0.160
2 
0.12
6 
37740 Liver 916.5 53006 34022 14601 
10162
9 
1208
5 7375 3515 22975 10585 6293 2267 19145 
0.184
4 
0.15
9 
  
Muscl
e 871.5 
27066
8 
13659
7 37390 
44465
5 
4252
2 
2362
9 7556 73707 41629 22730 5828 70187 
0.142
2 
0.13
6 
37741 Liver 916.5 40379 27103 10845 78327 7164 5195 1770 14129 10092 6471 2510 19073 
0.152
8 
0.19
6 
  
Muscl
e 871.5 27382 12671 5108 45161 5047 2440 1226 8713 8156 3630 1208 12994 
0.161
7 
0.22
3 
37742 Liver 916.5 31463 20675 8725 60863 7714 4456 2354 14524 4210 3587 1237 9034 
0.192
7 
0.12
9 
  
Muscl
e 871.5 
78481
8 
38578
4 
11006
5 1E+06 
1E+0
5 
6784
6 
2215
5 
22176
9 
10607
6 50658 15477 
17221
1 
0.147
6 
0.11
9 
37743 Liver 916.5 31505 18830 7459 57794 6967 5049 1962 13978 4706 3056 1052 8814 
0.194
8 
0.13
2 
  
Muscl
e 871.5 28493 14324 4988 47805 6095 3045 1057 10197 8155 4129 1337 13621 
0.175
8 
0.22
2 
37744 Liver 916.5 25584 17451 7811 50846 6345 3997 1383 11725 4695 3544 1143 9382 
0.187
4 
0.15
6 
  
Muscl
e 871.5 54050 26307 10918 91275 9901 4961 2366 17228 15426 6648 2235 24309 
0.158
8 0.21 
37745 Liver 916.5 31712 20450 7876 60038 5536 3036 1595 10167 9031 5687 2024 16742 
0.144
8 
0.21
8 
  
Muscl
e 871.5 
19273
2 93061 28571 
31436
4 
3457
3 
1915
3 5319 59045 27452 14210 4913 46575 
0.158
1 
0.12
9 
37746 Urine  9742 8125 5066 22933 
1116
3 9343 5162 25668 1052 265 0 1317 
0.528
1 
0.05
4 
37747 Urine  13778 13307 8340 35425 1500 569 224 2293 13887 11100 6896 31883 
0.060
8 
0.47
4 
                 
Unrelated4                
37748 Liver 916.5 32424 22801 8449 63674 8382 6798 1970 17150 8392 5591 2340 16323 
0.212
2 
0.20
4 
  
Muscl
e 871.5 33385 17203 5341 55929 6107 3467 1245 10819 7269 3561 1242 12072 
0.162
1 
0.17
8 
37749 Liver 916.5 21209 16296 6207 43712 7124 3828 1588 12540 5687 3563 1249 10499 
0.222
9 
0.19
4 
  
Muscl
e 871.5 30548 15600 5070 51218 7548 3697 1157 12402 7664 3159 767 11590 
0.194
9 
0.18
5 
37750 Liver 916.5 31094 21264 8624 60982 8431 6163 2254 16848 7754 4278 1991 14023 
0.216
5 
0.18
7 
  
Muscl
e 871.5 17894 8208 1927 28029 4029 2202 986 7217 2613 1344 692 4649 
0.204
8 
0.14
2 
37751 Liver 916.5 10010 6346 3159 19515 2812 1701 580 5093 1671 1602 464 3737 0.207 
0.16
1 
  
Muscl
e 871.5 19460 10563 2759 32782 4910 2503 931 8344 4391 1594 408 6393 
0.202
9 
0.16
3 
37752 Liver 916.5 12760 9462 3362 25584 3936 2393 1021 7350 3208 2042 921 6171 
0.223
2 
0.19
4 
  
Muscl
e 871.5 67631 37508 11445 
11658
4 
1358
4 7134 2153 22871 12903 6291 2127 21321 0.164 
0.15
5 
37622 Urine  72827 64542 33831 
17120
0 
7099
8 
5772
0 
2962
6 
15834
4 2074 1728 387 4189 
0.480
5 
0.02
4 
37623 Urine  48927 43482 25069 
11747
8 4840 1993 659 7492 52112 45654 27604 
12537
0 0.06 
0.51
6 
                 
Unrelated5                
37753 Liver 916.5 14944 10341 4034 29319 4757 3081 1601 9439 2573 2442 567 5582 
0.243
5 0.16 
  
Muscl
e 871.5 70668 36366 8859 
11589
3 
1469
9 8939 2271 25909 9265 4840 1556 15661 
0.182
7 
0.11
9 
37754 Liver 916.5 7503 4862 2361 14726 2426 1846 770 5042 2162 1429 868 4459 
0.255
1 
0.23
2 
  
Muscl
e 871.5 3882 1436 678 5996 1439 810 341 2590 549 463 224 1236 
0.301
7 
0.17
1 
37755 Liver 916.5 8622 5256 2263 16141 2064 1657 556 4277 1390 1178 448 3016 
0.209
5 
0.15
7 
  
Muscl
e 871.5 19418 9333 2788 31539 4935 3371 844 9150 3216 1782 661 5659 
0.224
9 
0.15
2 
37756 Liver 916.5 21735 14135 6807 42677 6997 5059 1875 13931 5062 3380 1420 9862 
0.246
1 
0.18
8 
  
Muscl
e 871.5 13052 5807 2181 21040 2886 1760 764 5410 2388 1713 500 4601 
0.204
5 
0.17
9 
37757 Liver 916.5 19388 13501 5639 38528 6652 4650 1923 13225 3809 3126 1040 7975 
0.255
5 
0.17
1 
  
Muscl
e 871.5 19295 10166 3422 32883 7006 3542 1394 11942 2896 1752 668 5316 
0.266
4 
0.13
9 
37758 Liver 916.5 7847 4393 2051 14291 3668 1967 616 6251 1337 1259 399 2995 
0.304
3 
0.17
3 
  
Muscl
e 871.5 18532 10061 2599 31192 6057 3141 1123 10321 3561 2247 561 6369 
0.248
6 0.17 
37759 Liver 916.5 28134 19979 7451 55564 9628 5389 3313 18330 5671 3827 1512 11010 
0.248
1 
0.16
5 
  
Muscl
e 871.5 81737 39744 12615 
13409
6 
2244
3 
1344
8 4195 40086 11297 6225 1450 18972 
0.230
1 
0.12
4 
37760 Liver 916.5 25967 20512 8604 55083 8208 5638 2041 15887 6376 3889 1841 12106 
0.223
9 0.18 
  
Muscl
e 871.5 46502 25238 6529 78269 
1412
3 4808 1426 20357 7713 3890 1295 12898 
0.206
4 
0.14
1 
37761 Liver 916.5 10091 8010 2869 20970 3679 2409 817 6905 1772 1591 627 3990 
0.247
7 0.16 
  
Muscl
e 871.5 90765 45137 13993 
14989
5 
2216
5 
1133
1 2984 36480 12093 5795 1473 19361 
0.195
7 
0.11
4 
37762 Liver 916.5 11855 8626 3154 23635 3388 2575 1213 7176 2144 1303 703 4150 
0.232
9 
0.14
9 
  
Muscl
e 871.5 
15933
0 78676 25449 
26345
5 
3329
2 
1655
6 5232 55080 19106 9495 3167 31768 
0.172
9 
0.10
8 
37763 Urine  24860 19568 11599 56027 
3028
8 
2361
2 
1295
3 66853 949 661 576 2186 
0.544
1 
0.03
8 
37764 Urine  17925 19312 10723 47960 2318 840 317 3475 18870 19602 10850 49322 
0.067
6 
0.50
7 
                 
Related
7                 
37765 Liver 916.5 16465 10302 4091 30858 4757 3698 932 9387 2424 1650 1118 5192 
0.233
2 
0.14
4 
  
Muscl
e 871.5 40639 22303 6712 69654 9291 5078 1442 15811 5722 3805 943 10470 0.185 
0.13
1 
37766 Liver 916.5 11686 8397 2973 23056 2675 2752 1087 6514 1959 985 415 3359 
0.220
3 
0.12
7 
  
Muscl
e 871.5 43191 21899 7158 72248 9413 5138 1281 15832 6064 2354 651 9069 
0.179
7 
0.11
2 
37767 Liver 916.5 29531 20047 8412 57990 8659 5065 2203 15927 4268 3074 1104 8446 
0.215
5 
0.12
7 
  
Muscl
e 871.5 14740 7330 2607 24677 3136 1565 713 5414 2304 648 565 3517 
0.179
9 
0.12
5 
37768 Liver 916.5 18243 12344 4663 35250 5066 2883 1320 9269 2759 1709 608 5076 
0.208
2 
0.12
6 
  
Muscl
e 871.5 46685 24124 6551 77360 9816 3584 1239 14639 7042 2962 1075 11079 
0.159
1 
0.12
5 
37769 Liver 916.5 25329 18486 6684 50499 6411 4937 1668 13016 3728 2131 1032 6891 
0.204
9 0.12 
  
Muscl
e 871.5 72519 35422 12114 
12005
5 
1438
4 8193 2696 25273 10069 5258 1264 16591 
0.173
9 
0.12
1 
37770 Liver 916.5 34874 22005 8560 65439 8703 5384 2080 16167 5748 3751 1566 11065 
0.198
1 
0.14
5 
  
Muscl
e 871.5 
16894
7 83819 24250 
27701
6 
3379
6 
1629
0 5546 55632 17732 9890 3733 31355 
0.167
2 
0.10
2 
37771 Liver 916.5 12796 9180 3546 25522 3222 2123 1271 6616 2486 1374 1277 5137 
0.205
9 
0.16
8 
  
Muscl
e 871.5 59907 31503 9767 
10117
7 
1459
6 6980 1922 23498 8665 3893 1611 14169 
0.188
5 
0.12
3 
37772 Liver 916.5 27349 19295 7233 53877 6446 4105 1585 12136 4706 3330 1339 9375 
0.183
8 
0.14
8 
  
Muscl
e 871.5 62039 32783 10111 
10493
3 
1040
2 6638 2026 19066 8013 3611 931 12555 
0.153
8 
0.10
7 
37773 Liver 916.5 49662 30890 14202 94754 
1228
6 7475 3294 23055 7037 4752 1675 13464 
0.195
7 
0.12
4 
  
Muscl
e 871.5 68989 34291 9866 
11314
6 
1610
6 7465 2794 26365 7963 3899 1182 13044 0.189 
0.10
3 
37774 Urine  52888 48280 28207 
12937
5 4124 1536 603 6263 44268 41670 25015 
11095
3 
0.046
2 
0.46
2 
37775 Urine  91538 80196 43554 
21528
8 
1E+0
5 
9935
2 
5130
3 
26165
2 2270 927 423 3620 
0.548
6 
0.01
7 
                 
NC2                 
37776 Liver 916.5 7057 4898 1614 13569 3009 2176 1146 6331 0 0 0 0 
0.318
1 0 
  
Muscl
e 871.5 
91592
5 
45163
5 
13030
3 1E+06 
3E+0
5 
2E+0
5 
4645
5 
47313
2 0 0 0 0 0.24 0 
37777 Liver 916.5 20777 14348 5313 40438 8598 6616 2838 18052 0 0 0 0 
0.308
6 0 
  
Muscl
e 871.5 
23311
4 
11919
2 38371 
39067
7 
9127
1 
4998
7 
1707
4 
15833
2 0 0 0 0 
0.288
4 0 
37778 Liver 916.5 29600 19549 10473 59622 
1405
5 9723 3314 27092 0 0 0 0 
0.312
4 0 
  
Muscl
e 871.5 
57770
4 
28861
5 90182 
95650
1 
2E+0
5 
1E+0
5 
3322
2 
33699
3 0 0 0 0 
0.260
5 0 
37929 Liver 916.5 24151 15396 5395 44942 
1104
2 8815 2701 22558 0 0 0 0 
0.334
2 0 
  
Muscl
e 871.5 
65792
0 
33226
8 
10367
6 1E+06 
2E+0
5 
1E+0
5 
3818
0 
38196
7 0 0 0 0 
0.258
8 0 
37930 Urine  
24763
0 
25302
8 
13441
2 
63507
0 
3E+0
5 
3E+0
5 
1E+0
5 
75299
8 6464 2063 468 8995 
0.542
5 
0.01
4 
37931 Urine  30290 28667 14614 73571 2743 1115 594 4452 15945 13037 6580 35562 
0.057
1 
0.32
6 
                 
Unrelated6                
38243 Liver 916.5 53222 34107 13848 
10117
7 
1585
4 
1107
6 4479 31409 10654 8730 3417 22801 
0.236
9 
0.18
4 
  
Muscl
e 871.5 11471 6441 2011 19923 2245 1519 573 4337 2316 1049 993 4358 
0.178
8 
0.17
9 
38244 Liver 916.5 41249 27940 10423 79612 9826 6769 2714 19309 14250 9772 3759 27781 
0.195
2 
0.25
9 
  
Muscl
e 871.5 8846 4756 1881 15483 1435 848 450 2733 2426 1036 1072 4534 0.15 
0.22
7 
38245 Liver 916.5 60330 40125 15777 
11623
2 
1424
3 
1039
6 4147 28786 16645 12943 4866 34454 
0.198
5 
0.22
9 
  
Muscl
e 871.5 21760 9705 3163 34628 3427 1860 560 5847 4715 1989 1038 7742 
0.144
5 
0.18
3 
38246 Liver 916.5 19406 14431 6021 39858 6510 3935 1765 12210 8301 5431 1926 15658 
0.234
5 
0.28
2 
  
Muscl
e 871.5 17625 8531 3034 29190 3308 1936 466 5710 2613 1691 815 5119 
0.163
6 
0.14
9 
38247 Liver 916.5 32346 19303 8684 60333 8871 4228 1999 15098 8900 5724 2917 17541 
0.200
2 
0.22
5 
  
Muscl
e 871.5 13404 6641 2434 22479 1929 826 509 3264 2638 1044 697 4379 
0.126
8 
0.16
3 
38248 Liver 916.5 30689 23106 8431 62226 9035 5778 3183 17996 11730 7164 2487 21381 
0.224
3 
0.25
6 
  
Muscl
e 871.5 30226 15398 4668 50292 6180 2842 1197 10219 5468 2739 1995 10202 
0.168
9 
0.16
9 
38249 Liver 916.5 25180 16543 5898 47621 7372 5059 2442 14873 6817 4865 2165 13847 0.238 
0.22
5 
  
Muscl
e 871.5 13186 7470 2442 23098 2448 1883 831 5162 2416 1260 1450 5126 
0.182
7 
0.18
2 
38250 Liver 916.5 29787 20955 7831 58573 6841 4821 2640 14302 11097 6963 3190 21250 
0.196
3 
0.26
6 
  
Muscl
e 871.5 14475 7689 3261 25425 2293 1723 523 4539 3156 1377 838 5371 
0.151
5 
0.17
4 
38251 Liver 916.5 28940 19545 8191 56676 5639 4129 2787 12555 7295 5048 2220 14563 
0.181
3 
0.20
4 
  
Muscl
e 871.5 11867 5787 1995 19649 2223 1667 469 4359 2189 941 1464 4594 
0.181
6 
0.18
9 
38252 Liver 916.5 53877 36077 12708 
10266
2 
1300
2 9370 3738 26110 18447 12315 4629 35391 
0.202
8 
0.25
6 
  
Muscl
e 871.5 20250 11069 2701 34020 2785 1696 641 5122 3948 2317 1736 8001 
0.130
9 0.19 
38253 Liver 916.5 48581 33525 12716 94822 
1210
3 7891 4355 24349 16551 13344 5408 35303 
0.204
3 
0.27
1 
  
Muscl
e 871.5 10592 6528 1804 18924 1757 1029 548 3334 2386 1417 1583 5386 
0.149
8 
0.22
2 
38254 Urine  25159 25945 15414 66518 3254 1921 747 5922 23215 24065 12934 60214 
0.081
8 
0.47
5 
38255 Urine  77155 67016 32880 
17705
1 
6295
5 
5183
8 
2637
3 
14116
6 1363 336 356 2055 
0.443
6 
0.01
1 
                 
NC3                 
38256 Urine  55947 53003 29969 
13891
9 7475 5484 1690 14649 32395 29564 15032 76991 
0.095
4 
0.35
7 
38257 Urine  
36474
1 
29200
4 
16197
7 
81872
2 
3E+0
5 
3E+0
5 
1E+0
5 
70903
3 6610 3220 969 10799 
0.464
1 
0.01
3 
38258 Liver 916.5 16987 11300 4089 32376 7197 4829 3183 15209 0 0 0 0 
0.319
6 0 
  
Muscl
e 871.5 
75524
2 
37969
6 
11147
4 1E+06 
3E+0
5 
1E+0
5 
4473
2 
48341
2 0 0 0 0 
0.279
5 0 
38259 Liver 916.5 15715 9900 3581 29196 6042 5678 1649 13369 0 0 0 0 
0.314
1 0 
  
Muscl
e 871.5 
38356
8 
18698
8 55842 
62639
8 
1E+0
5 
7116
7 
2436
1 
23847
7 0 0 0 0 
0.275
7 0 
                 
NC4                 
38261 Liver 916.5 19526 12081 2018 33625 9388 6258 2366 18012 0 0 0 0 
0.348
8 0 
  
Muscl
e 871.5 
13494
2 72030 23929 
23090
1 
5893
0 
2892
5 9973 97828 0 0 0 0 
0.297
6 0 
38262 Liver 916.5 16817 10404 4672 31893 6613 5055 1804 13472 0 0 0 0 0.297 0 
  
Muscl
e 871.5 
13382
4 64630 21136 
21959
0 
5365
8 
2507
2 7789 86519 0 0 0 0 
0.282
6 0 
38263 Liver 916.5 26344 17915 6981 51240 
1109
4 8134 3746 22974 0 0 0 0 
0.309
6 0 
  
Muscl
e 871.5 
14071
2 74867 25045 
24062
4 
5792
1 
2993
3 9261 97115 0 0 0 0 
0.287
5 0 
38264 Urine 916.5 
22012
0 
21036
8 
11557
6 
54606
4 
1852
6 6666 2967 28159 
21679
0 
19776
0 
10438
3 
51893
3 0.049 
0.48
7 
38265 Urine 871.5 69080 65626 34301 
16900
7 
7895
5 
7040
7 
3622
6 
18558
8 7283 5152 2605 15040 
0.523
4 
0.08
2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
Supplementary material B: Communal nursing study 
Spreadsheet where the peptide intensities of the related mother’s urine were recorded, along with the intensities of the corresponding labelled 
peptides, where mothered were fed either a [D4] or [D9] lysine labelled diet over the course of the experiment.  Precursor RIA values were 
calculated from this data. Mother IDs in red are fed the [D9] lysine labelled diet.  Those in green fed the [D4] lysine labelled diet. 
 
 
 
 
 
 
 
 
 
 
Sample 
no. Peptide Light peptide   D4 peptide   D9 peptide   IH/(IH+IL) 
  1 2 3 Sum 1 2 3 Sum 1 2 3 Sum D4 D9 
36339 1569 73649 65705 34548 173902 73755 63210 31006 167971 1888 1125 592 3605 0.491 0.02 
 2009 7539 8779 5663 21981 7235 7444 5272 19951 916 425 337 1678 0.476 0.071 
 2741 1608 2831 1962 6401 1490 2383 1892 5765 216 124 114 454 0.474 0.066 
36340 1569 80886 72295 36681 189862 5118 2832 775 8725 30326 25103 12477 67906 0.044 0.263 
 2009 9291 12516 7029 28836 2070 160 0 2230 3654 4653 2795 11102 0.072 0.278 
 2471 13763 20607 16843 51213 1378 514 214 2106 5321 6620 4619 16560 0.039 0.244 
36476 1569 22959 23281 11741 57981 27405 22923 11804 62132 2026 1652 770 4448 0.517 0.071 
 2009 2148 2357 1408 5913 1560 2067 1627 5254 337 292 123 752 0.47 0.113 
 2471 982 1651 1282 3915 1312 1192 1261 3765 271 239 0 510 0.49 0.115 
36477 1569 2329 1956 1115 5400 473 188 127 788 1208 1133 646 2987 0.127 0.356 
 2009 413 556 368 1337 159 87 0 246 466 428 245 1139 0.155 0.46 
                
37258 1569 119132 107056 63157 289345 8576 2807 991 12374 1E+05 98541 54432 262598 0.041 0.476 
 2009 70757 88570 60938 220265 10724 4365 2688 17777 63947 78818 50864 193629 0.075 0.468 
 2471 57822 90771 75067 223660 12161 4364 1178 17703 54478 78827 68243 201548 0.073 0.474 
37259 1569 159738 144716 75066 379520 2E+05 1E+05 64363 339827 3628 2320 880 6828 0.472 0.018 
 2009 4488 4779 4179 13446 4809 4707 3650 13166 231 195 0 426 0.495 0.031 
 2471 7316 11061 9598 27975 8583 10638 6808 26029 962 576 278 1816 0.482 0.061 
37275 1569 64928 64806 36597 166331 5803 2111 692 8606 63795 64152 37653 165600 0.049 0.499 
 2009 3939 4534 3500 11973 722 194 44 960 3822 5207 3487 12516 0.074 0.511 
 2471 9095 14511 14908 38514 2068 790 111 2969 11048 14457 13115 38620 0.072 0.501 
37276 1569 45610 41195 22179 108984 53178 46278 25050 124506 1827 911 545 3283 0.533 0.029 
 2009 247 333 304 884 224 307 168 699 0 0 0 0 0.442 0 
 2471 255 556 489 1300 633 529 328 1490 0 0 0 0 0.534 0 
37304 1569 26835 24393 12588 63816 29773 25686 14650 70109 771 359 0 1130 0.523 0.017 
 2009 1740 1988 1343 5071 2162 2239 1541 5942 299 83 0 382 0.54 0.07 
 2471 1385 1544 1784 4713 1772 2407 1426 5605 309 176 0 485 0.543 0.093 
37305 1569 2164 2415 1227 5806 523 154 0 677 1250 1636 1183 4069 0.104 0.412 
                
                
37729 1569 157894 140435 75356 373685 24007 14881 6676 45564 63770 54604 29114 147488 0.109 0.283 
 2009 250 758 892 1900 133 75 21 229 228 280 220 728 0.108 0.277 
 2471 398 673 310 1381 93 47 18 158 181 239 168 588 0.103 0.299 
37730 1569 36188 33251 18268 87707 36934 30802 14210 81946 981 381 218 1580 0.483 0.018 
 2009 427 852 565 1844 405 644 606 1655 86 0 0 86 0.473 0.045 
 2471 1078 1521 1285 3884 1431 1278 1151 3860 221 82 0 303 0.498 0.072 
37774 1569 52888 48280 28207 129375 4124 1536 603 6263 44268 41670 25015 110953 0.046 0.462 
 2471 87 131 149 367 0 0 0 0 136 163 78 377 0 0.507 
                
37775 1569 91538 80196 43554 215288 1E+05 99352 51303 261652 2270 927 423 3620 0.549 0.017 
 2009 455 642 457 1554 510 829 553 1892 0 0 0 0 0.549 0 
 2471 1329 1418 1586 4333 1879 1974 1836 5689 79 0 0 79 0.568 0.018 
 
 
 
 
 
 
 
 
  
 
 
 
 
Supplementary material B: Communal nursing study 
Spreadsheet where the peptide intensities of the unrelated mother’s urine were recorded, along with the intensities of the corresponding labelled 
peptides, where mothered were fed either a [D4] or [D9] lysine labelled diet over the course of the experiment.  Precursor RIA values were 
calculated from this data. Mother IDs in red are fed the [D9] lysine labelled diet.  Those in green fed the [D4] lysine labelled diet. 
 
 
 
 
 
Sample 
no. Peptide Light peptide   D4 peptide   D9 peptide   IH/(IH+IL) 
  1 2 3 Sum 1 2 3 Sum 1 2 3 Sum D4 D9 
36296 1569 36217 55644 31022 122883 67918 55667 31345 2E+05 2368 1144 334 3846 0.5577 0.0303 
 2009 21654 27466 18151 67271 24046 27895 17835 69776 1360 449 394 2203 0.5091 0.0317 
 2471 2327 2371 1564 6262 1941 2746 1735 6422 203 139 0 342 0.5063 0.0518 
36297 1569 14458 13333 8168 35959 2090 665 0 2755 15286 16236 8733 40255 0.0712 0.5282 
 2009 6206 8060 5566 19832 1222 156 99 1477 5226 6154 3828 15208 0.0693 0.434 
 2471 1204 2043 1956 5203 282 130 84 496 1446 1784 1947 5177 0.087 0.4987 
36478 1569 83234 80404 46570 210208 13687 8080 4270 26037 84082 79480 45196 208758 0.1102 0.4983 
 2009 19350 23084 17029 59463 5106 3224 965 9295 18909 22250 15777 56936 0.1352 0.4891 
 2471 27556 39615 33737 100908 8122 4215 2605 14942 26450 41095 33183 100728 0.129 0.4996 
36688 1569 17271 14608 8596 40475 20187 18652 10056 48895 764 298 177 1239 0.5471 0.0297 
 2009 1179 722 770 2671 883 744 659 2286 0 0 0 0 0.4612 0 
 2471 442 542 294 1278 511 492 344 1347 0 0 0 0 0.5131 0 
37746 1569 9742 8125 5066 22933 11163 9343 5162 25668 1052 265 0 1317 0.5281 0.0543 
 1607 5516 6676 4269 16461 6700 6413 3848 16961 664 365 92 1121 0.5075 0.0638 
     0    0    0 #DIV/0! ###### 
37747 1569 13778 13307 8340 35425 1500 569 224 2293 13887 11100 6896 31883 0.0608 0.4737 
                
                
37622 1569 72827 64542 33831 171200 70998 57720 29626 2E+05 2074 1728 387 4189 0.4805 0.0239 
 2009 31517 37274 24679 93470 28293 29617 18590 76500 4413 5096 2830 12339 0.4501 0.1166 
 2471 17456 27557 22503 67516 24519 27356 18432 70307 3296 1554 965 5815 0.5101 0.0793 
37623 1569 48927 43482 25069 117478 4840 1993 659 7492 52112 45654 27604 125370 0.06 0.5162 
 2009 11006 13501 8307 32814 1274 703 621 2598 12108 14201 9186 35495 0.0734 0.5196 
 2471 10577 18408 14391 43376 2478 873 866 4217 12236 20498 16047 48781 0.0886 0.5293 
37763 1569 24860 19568 11599 56027 30288 23612 12953 66853 949 661 576 2186 0.5441 0.0376 
 1607 13098 12436 8336 33870 14886 13196 7375 35457 1366 675 44 2085 0.5114 0.058 
 2471 4385 4265 3339 11989 5595 5321 2613 13529 457 281 0 738 0.5302 0.058 
37764 1569 17925 19312 10723 47960 2318 840 317 3475 18870 19602 10850 49322 0.0676 0.507 
 2009 127 200 206 533 0 0 0 0 219 220 79 518 0 0.4929 
 2471 134 188 251 573 0 0 0 0 213 174 192 579 0 0.5026 
38254 1569 25159 25945 15414 66518 3254 1921 747 5922 23215 24065 12934 60214 0.0818 0.4751 
 2009 2314 2380 1561 6255 297 420 145 862 1660 1872 1345 4877 0.1211 0.4381 
 2471 694 982 467 2143 112 79 66 257 865 826 86 1777 0.1071 0.4533 
38255 1569 77155 67016 32880 177051 62955 51838 26373 1E+05 1363 336 356 2055 0.4436 0.0115 
 2009 12714 14108 10557 37379 10266 13332 8350 31948 1201 1151 614 2966 0.4608 0.0735 
 2471 11231 14409 11328 36968 11380 13593 9204 34177 1114 586 0 1700 0.4804 0.044 
 
 
 
 
 
 
 
 
 
  
 
 
 
Supplementary material B: Communal nursing study 
Spreadsheet where the peptide intensities of the mother’s urine were recorded (mothers with non-communal litters), along with the intensities of 
the corresponding labelled peptides, where mothered were fed either a [D4] or [D9] lysine labelled diet over the course of the experiment.  
Precursor RIA values were calculated from this data. Mother IDs in red are fed the [D9] lysine labelled diet.  Those in green fed the [D4] lysine 
labelled diet. 
 
 
 
 
 
 
Sample 
no. Peptide Light peptide   D4 peptide   D9 peptide   IH/(IH+IL) 
  1 2 3 Sum 1 2 3 Sum 1 2 3 Sum D4 D9 
37313 1569 56432 55944 32232 144608 5271 1474 930 7675 63467 60383 34780 
15863
0 
0.050
4 
0.523
1 
 2009 1910 2636 1475 6021 477 0 0 477 2470 2420 1571 6461 
0.073
4 
0.517
6 
 2471 623 1089 996 2708 143 0 0 143 980 1002 707 2689 
0.050
2 
0.498
2 
37314 1569 216032 175443 79987 471462 49642 38531 
1851
4 
10668
7 8792 6445 3112 18349 
0.184
5 
0.037
5 
 2009 3993 3908 3028 10929 1211 1344 949 3504 349 249 218 816 
0.242
8 
0.069
5 
 2471 5209 5734 4833 15776 1818 1889 1145 4852 296 391 202 889 
0.235
2 
0.053
3 
37930 1569 247630 253028 134412 635070 
33168
7 
27491
6 1E+05 
75299
8 6464 2063 468 8995 
0.542
5 0.014 
 2009 7034 10056 6807 23897 9526 10496 8355 28377 722 464 210 1396 
0.542
9 
0.055
2 
 2471 10500 12953 11593 35046 14792 17143 
1256
3 44498 1659 490 322 2471 
0.559
4 
0.065
9 
37931 1569 30290 28667 14614 73571 2743 1115 594 4452 15945 13037 6580 35562 
0.057
1 
0.325
9 
 2009 421 357 569 1347 0 0 0 0 113 180 115 408 0 
0.232
5 
 2471 263 194 450 907 0 0 0 0 194 205 86 485 0 
0.348
4 
38256 1569 55947 53003 29969 138919 7475 5484 1690 14649 32395 29564 15032 76991 
0.095
4 
0.356
6 
 2471 4528 7505 5661 17694 1555 732 391 2678 2986 4420 3753 11159 
0.131
5 
0.386
8 
                
38257 1569 364741 292004 161977 818722 
31488
7 
26227
0 1E+05 
70903
3 6610 3220 969 10799 
0.464
1 0.013 
 2009 261157 306011 203246 770414 
25398
1 
27691
1 2E+05 
71068
9 10475 4533 2129 17137 
0.479
8 
0.021
8 
 2471 260459 393854 310029 964342 
31747
4 
37403
2 3E+05 
96594
9 30589 13200 4569 48358 
0.500
4 
0.047
8 
38264 1569 220120 210368 115576 546064 18526 6666 2967 28159 
21679
0 
19776
0 
10438
3 
51893
3 0.049 
0.487
3 
 2009 168095 217782 148693 534570 29864 12574 0 42438 
16699
6 
20075
9 
13662
2 
50437
7 
0.073
5 
0.485
5 
 2471 125581 210409 174796 510786 24692 9938 5715 40345 
13888
8 
18106
4 
15620
6 
47615
8 
0.073
2 
0.482
5 
38265 1569 69080 65626 34301 169007 78955 70407 
3622
6 
18558
8 7283 5152 2605 15040 
0.523
4 
0.081
7 
 2009 31539 36612 24298 92449 33426 38469 
2441
5 96310 3501 3504 1704 8709 
0.510
2 
0.086
1 
 2471 36034 51807 46591 134432 51762 62456 
4559
1 
15980
9 8394 5899 4592 18885 
0.543
1 
0.123
2 
 
 
 
 
 
 
Supplementary material B: Communal nursing study – statistical analysis 
 Tested for statistical significance between the mothers’ investment in their own pups and the other pups (so, for example, compared the 
amount of investment a D4 mother made in her own pups and the amount made in D9’s pups, and vice versa). 
 Did this in R using analysis of variance (anova), which analyses the difference between group means along with variation among and 
between groups. If sample sizes were too small, Welch two sample t-test was used. 
 The P value (Pr(>F)) is calculated from the anova table (f value, sum sq etc.). A low (>0.05) p value suggests that the difference 
between the two groups is down to more than just random sampling, and that the means are significantly different. These are 
highlighted in the tables below. 
 Statistical significance between mothers’ investment in the entire communal litter was tested for using Welch two sample t-test. 
 
Related litters 
Litter 1 
MOTHERS INVESTMENT IN ENTIRE LITTER 
Welch Two Sample t-test 
data:  data$D4 and data$D9 
t = -0.1549, df = 77.351, p-value = 0.8773 
alternative hypothesis: true difference in means is not equal to 0 
95 percent confidence interval: 
 -0.01403034  0.01200492 
sample estimates: 
mean of x mean of y  
0.1172974 0.1183101  
 
High turnover in liver 
 Df Sum sq Mean Sq F value Pr(>F) 
D4 
mother 
1 0.0000424 0.0000424 0.105 0.8 
D9 
mother 
1 8.5E-05 8.5E-05 0.274 0.693 
 
High turnover in muscle 
 Df Sum 
sq 
Mean 
Sq 
F value Pr(>F) 
D4 
mother 
1 1.49E-
04 
1.49E-
04 
2.605 0.353 
D9 
mother 
1 1.8E-
06 
1.8E-
06 
0.632 0.572 
 
Low turnover in liver 
 Df Sum sq Mean Sq F value Pr(>F) 
D4 
mother 
1 0.0007272 0.0007272 10.29 0.192 
D9 
mother 
1 5.27E-05 5.27E-05 1.851 0.404 
 
Low turnover in muscle 
 Df Sum sq Mean Sq F value Pr(>F) 
D4 
mother 
1 0.0001175 0.0001175 0.766 0.542 
D9 
mother 
1 1.19E-05 1.19E-05 0.521 0.602 
 
 
Litter 2 
MOTHERS INVESTMENT IN ENTIRE LITTER 
Welch Two Sample t-test 
data:  data$D4 and data$D9 
t = 4.3556, df = 16.783, p-value = 0.0004424 
alternative hypothesis: true difference in means is not equal to 0 
95 percent confidence interval: 
 0.04796167 0.13825076 
sample estimates: 
mean of x mean of y  
0.1936421 0.1005359  
 
High turnover in liver 
 t df p-value 
D4 
mother 
11.9955 1.001 0.05277 
D9 
mother 
1.6362 1.059 0.3389 
 
Low turnover in liver 
 t df p-value 
D4 
mother 
5.5812 1.003 0.1124 
D9 
mother 
5.3576 1.204 0.08743 
 
Low turnover in muscle 
 t df p-value 
D4 
mother 
11.5353 1.979 0.0077  
D9 
mother 
6.0117 1.01 0.1033 
 
 
Litter 3 
MOTHERS INVESTMENT IN ENTIRE LITTER 
Welch Two Sample t-test 
data:  data$D4 and data$D9 
t = -2.7058, df = 52.363, p-value = 0.009176 
alternative hypothesis: true difference in means is not equal to 0 
95 percent confidence interval: 
 -0.040163443 -0.005961826 
sample estimates: 
mean of x mean of y  
0.1075265 0.1305892  
 
High turnover in liver 
 Df Sum sq Mean Sq F value Pr(>F) 
D4 
mother 
1 0.0000247 0.0000247 0.0203 0.904 
D9 
mother 
1 0.005891 0.005891 23.06 0.131 
 
High turnover in muscle 
 Df Sum sq Mean Sq F value Pr(>F) 
D4 
mother 
1 0.000314 0.000314 0.084 0.821 
D9 
mother 
1 3.3E-05 3.3E-05 7.796 0.219 
 
Low turnover in liver 
 Df Sum sq Mean Sq F value Pr(>F) 
D4 
mother 
1 6E-07 6E-07 0.012 0.93 
D9 
mother 
1 0.0009295 0.0009295 9.224 0.202 
 
Low turnover in muscle 
 Df Sum sq Mean 
Sq 
F value Pr(>F) 
D4 
mother 
1 3.32E-
05 
3.32E-
05 
0.581 0.585  
D9 
mother 
1 0.00015 0.00015 1.143 0.479 
   
 
Litter 4 
MOTHERS INVESTMENT IN ENTIRE LITTER 
Welch Two Sample t-test 
data:  data$D4 and data$D9 
t = -3.5129, df = 117.3, p-value = 0.0006304 
alternative hypothesis: true difference in means is not equal to 0 
95 percent confidence interval: 
 -0.034294199 -0.009567269 
sample estimates: 
mean of x mean of y  
0.1390210 0.1609517  
 
High turnover in liver 
 Df Sum sq Mean 
Sq 
F value Pr(>F) 
D4 
mother 
1 0.00002 0.00002 0.02 0.895 
D9 
mother 
1 3.5E-06 3.5E-06 0.009 0.93 
 
High turnover in muscle 
 Df Sum sq Mean Sq F value Pr(>F) 
D4 
mother 
1 0.000203 0.000203 0.383 0.57 
D9 
mother 
1 0.0000014 0.0000014 0.008 0.932 
 
 
Low turnover in liver 
 Df Sum sq Mean Sq F value Pr(>F) 
D4 
mother 
1 7.91E0-6 7.91E0-6 0.226 0.66 
D9 
mother 
1 0.0000077 0.0000077 0.017 0.901 
 Low turnover in muscle 
 Df Sum sq Mean Sq F value Pr(>F) 
D4 
mother 
1 0.000345 0.000345 3.185 0.149 
D9 
mother 
1 1E-06 1E-06 0.008 0.933 
 
 
Litter 5 
MOTHERS INVESTMENT IN ENTIRE LITTER 
Welch Two Sample t-test 
data:  data$D4 and data$D9 
t = 4.4007, df = 85.341, p-value = 3.103e-05 
alternative hypothesis: true difference in means is not equal to 0 
95 percent confidence interval: 
 0.01943695 0.05147200 
sample estimates: 
mean of x mean of y  
0.1686868 0.1332323  
 
High turnover in liver 
 Df Sum sq Mean Sq F value Pr(>F) 
D4 
mother 
1 0.0003524 0.0003524 10.16 0.0859 
‘.’ 
D9 
mother 
1 2.29E-05 2.29E-05 0.154 0.733 
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1 
 
High turnover in muscle 
 Df Sum sq Mean Sq F value Pr(>F) 
D4 
mother 
1 2.45E-05 2.45E-05 0.825 0.46 
D9 
mother 
1 0.0001681 0.0001681 6.591 0.124 
 
Low turnover in liver 
 Df Sum sq Mean Sq F value Pr(>F) 
D4 
mother 
1 3.09E-05 3.09E-05 0.789 0.468 
D9 
mother 
1 0.0000105 0.0000105 0.02 0.901 
 
Low turnover in muscle 
 Df Sum 
sq 
Mean 
Sq 
F value Pr(>F) 
D4 
mother 
1 1.99E-
05 
1.99E-
05 
0.224 0.683 
D9 
mother 
1 1.48E-
05 
1.48E-
05 
0.131 0.752 
 
Litter 6 
MOTHERS INVESTMENT IN ENTIRE LITTER 
Welch Two Sample t-test 
data:  data$D4 and data$D9 
t = -5.2086, df = 99.43, p-value = 1.03e-06 
alternative hypothesis: true difference in means is not equal to 0 
95 percent confidence interval: 
 -0.04975739 -0.02230628 
sample estimates: 
mean of x mean of y  
0.1197495 0.1557814  
 
High turnover in liver 
 Df Sum sq Mean Sq F value Pr(>F) 
D4 
mother 
1 0.0005925 0.0005925 1.572 0.278 
D9 
mother 
1 6.47E-05 6.47E-05 0.088 0.781 
 High turnover in muscle 
 
 Df Sum sq Mean Sq F value Pr(>F) 
D4 
mother 
1 0.0000243 0.0000243 0.096 0.773 
D9 
mother 
1 7.55E-05 7.55E-05 2.391 0.197 
 
Low turnover in liver 
 Df Sum sq Mean Sq F value Pr(>F) 
D4 
mother 
1 0.0004386 0.0004386 4.593 0.0987 
‘.’ 
D9 
mother 
1 2.11E-06 2.11E-06 0.032 0.867 
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1 
 
Low turnover in muscle 
 Df Sum 
sq 
Mean 
Sq 
F value Pr(>F) 
D4 
mother 
1 6.33E-
04 
6.33E-
04 
42.85 0.00282 
‘**’ 
D9 
mother 
1 9.07E-
05 
9.07E-
05 
2.203 0.212 
 
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1 
 
Litter 7 
MOTHERS INVESTMENT IN ENTIRE LITTER 
Welch Two Sample t-test 
data:  data$D4 and data$D9 
t = 7.6728, df = 67.717, p-value = 8.81e-11 
alternative hypothesis: true difference in means is not equal to 0 
95 percent confidence interval: 
 0.04345687 0.07400832 
sample estimates: 
mean of x mean of y  
0.1641191 0.1053865  
 
High turnover in liver 
 Df Sum sq Mean Sq F value Pr(>F) 
D4 
mother 
1 0.0000586 0.0000586 0.186 0.708 
D9 
mother 
1 0.0004262 0.0004262 3.234 0.214 
 
High turnover in muscle 
 Df Sum sq Mean Sq F value Pr(>F) 
D4 
mother 
1 0.0002012 0.0002012 6.904 0.119 
D9 
mother 
1 0.0000038 0.0000038 0.017 0.908 
 
Low turnover in liver 
 Df Sum sq Mean Sq F value Pr(>F) 
D4 
mother 
1 0.0004973 0.0004973 4.93 0.157 
D9 
mother 
1 1.85E-04 1.85E-04 3.721 0.194 
 
Low turnover in muscle 
 Df Sum sq Mean Sq F value Pr(>F) 
D4 
mother 
1 0.0000023 0.0000023 0.01 0.931 
D9 
mother 
1 0.00065 0.00065 3.29 0.211 
 
Unrelated litters 
Litter 1 
MOTHERS INVESTMENT IN ENTIRE LITTER 
Welch Two Sample t-test 
data:  data$D4 and data$D9 
t = -1.742, df = 74.723, p-value = 0.08562 
alternative hypothesis: true difference in means is not equal to 0 
95 percent confidence interval: 
 -0.024563261  0.001645902 
sample estimates: 
mean of x mean of y  
0.1437995 0.1552582 
 
High turnover in liver 
 t df   P value 
D4 
mother 
-2.55 7.95   0.350 
D9 
mother 
-1.07 4.58   0.338 
 
High turnover in muscle 
 t df   P 
value 
D4 
mother 
-5.08 6.55   0.175 
D9 
mother 
-0.36 1.09   0.776 
 Low turnover in liver 
 t df   P 
value 
D4 
mother 
-0.11 1.92   0.393 
D9 
mother 
-0.21 3   0.850 
 
Low turnover in muscle 
 t df   P value 
D4 
mother 
-1.4 1.9   0.298 
D9 
mother 
-1.01 1.09   0.487 
 
 
Litter 2 
MOTHERS INVESTMENT IN ENTIRE LITTER 
Welch Two Sample t-test 
data:  data$D4 and data$D9 
t = -1.3797, df = 69.352, p-value = 0.1721 
alternative hypothesis: true difference in means is not equal to 0 
95 percent confidence interval: 
 -0.027375339  0.004989537 
sample estimates: 
mean of x mean of y  
0.1495456 0.1607385  
 
High turnover in liver 
 t df   P value 
D4 
mother 
1.6978 2.041   0.2292 
D9 
mother 
0.1441 1.411   0.9032 
 
High turnover in muscle 
 t df   P value 
D4 
mother 
-1.8057 1.545   0.2483 
D9 
mother 
-1.3518 1.116   0.3879 
 
Low turnover in liver 
 t df   P value 
D4 mother 0.9804 6.112   0.364 
D9 mother -
0.5999 
1.385   0.6318 
 
Low turnover in muscle 
 t df   P value 
D4 mother -2.3223 6.62   0.05779 
D9 mother -1.4261 1.521   0.3247 
 
Litter 3 
MOTHERS INVESTMENT IN ENTIRE LITTER 
Welch Two Sample t-test 
data:  data$D4 and data$D9 
t = 0.4614, df = 113.197, p-value = 0.6454 
alternative hypothesis: true difference in means is not equal to 0 
95 percent confidence interval: 
 -0.01314853  0.02113337 
sample estimates: 
mean of x mean of y  
0.1549398 0.1509474 
 
High turnover in liver 
 Df Sum sq Mean 
Sq 
F value Pr(>F) 
D4 mother 1 7E-07 7E-07 0.005 0.945 
D9 mother 1 0.03055 0.03055 2.659 0.164 
 
High turnover in muscle 
 Df Sum sq Mean Sq F value Pr(>F) 
D4 mother 1 0.0000134 0.0000134 0.057 0.82 
D9 mother 1 0.0003539 0.0003539 4.862 0.079 
‘.’ 
  Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1 
Low turnover in liver 
 Df Sum sq Mean Sq F value Pr(>F) 
D4 mother 1 7.19E-05 7.19E-05 0.927 0.38 
D9 mother 1 0.000170 0.000170 1.092 0.344  
 
Low turnover in muscle 
 Df Sum sq Mean Sq F value Pr(>F) 
D4 mother 1 3.80E-05 3.80E-05 0.289 0.614 
D9 mother 1 0.000762 0.000762 5.465 0.066 
‘.’ 
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1 
Litter 4 
MOTHERS INVESTMENT IN ENTIRE LITTER 
Welch Two Sample t-test 
data:  data$D4 and data$D9 
t = 3.2676, df = 37.998, p-value = 0.002305 
alternative hypothesis: true difference in means is not equal to 0 
95 percent confidence interval: 
 0.01139567 0.04850750 
sample estimates: 
mean of x mean of y  
0.1822597 0.1523081  
 
High turnover in liver 
 t df P value 
D4 mother 2.1904 2.637 0.1285 
D9 mother 0.4854 2.114 0.6731 
 
High turnover in muscle 
 t df P value 
D4 mother 0.5846  2.881  0.6014 
D9 mother 0.986 1.722 0.4421 
 
Low turnover in liver 
 t df P value 
D4 mother 2.1445 2.091 0.1596 
D9 mother 0.7088 2.666 0.5354 
 
Low turnover in muscle 
 t df P value 
D4 mother 1.192 2.018 0.3546 
D9 mother 0.8715 2.632 0.4556 
 
 
Litter 5 
MOTHERS INVESTMENT IN ENTIRE LITTER 
Welch Two Sample t-test 
data:  data$D4 and data$D9 
t = 7.7648, df = 75.227, p-value = 3.285e-11 
alternative hypothesis: true difference in means is not equal to 0 
95 percent confidence interval: 
 0.05192189 0.08775527 
sample estimates: 
mean of x mean of y  
0.2035713 0.1337328  
 High turnover in liver 
 Df Sum sq Mean Sq F value Pr(>F) 
D4 mother 1 0 0 0 0.994 
D9 mother 1 0.000307 0.000307 0.345 0.617 
 
High turnover in muscle 
 Df Sum sq Mean Sq F value Pr(>F) 
D4 mother 1 0.0002827 0.0002827 0.515 0.547 
D9 mother 1 0.000648 0.000648 0.305 0.636 
 
Low turnover in liver 
 Df Sum sq Mean Sq F value Pr(>F) 
D4 mother 1 0.000712 0.000712 0.546 0.537 
D9 mother 1 0.00072 0.00072 2.088 0.285 
 
Low turnover in muscle 
 Df Sum sq Mean Sq F 
value 
Pr(>F) 
D4 mother 1 0.0003876 0.0003876 9.171 0.0939 
‘.’ 
D9 mother 1 0.0004247 0.0004247 0.814 0.462 
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1 
 
 
Litter 6 
MOTHERS INVESTMENT IN ENTIRE LITTER 
Welch Two Sample t-test 
data:  data$D4 and data$D9 
t = -2.1432, df = 81.871, p-value = 0.03507 
alternative hypothesis: true difference in means is not equal to 0 
95 percent confidence interval: 
 -0.035564382 -0.001323534 
sample estimates: 
mean of x mean of y  
0.1628515 0.1812954  
 
High turnover in liver 
 Df Sum sq Mean Sq F 
value 
Pr(>F) 
D4 mother 1 0.0000001 0.0000001 0 0.99 
D9 mother 1 0.0003306 0.0003306 1.517 0.306 
 
High turnover in muscle 
 Df Sum sq Mean Sq F 
value 
Pr(>F) 
D4 mother 1 0.0001897 0.0001897 0.28 0.633 
D9 mother 1 0.0000975 0.0000975 0.208 0.68 
 
Low turnover in liver 
 Df Sum sq Mean Sq F 
value 
Pr(>F) 
D4 mother 1 0.0000195 0.0000195 0.036 0.862 
D9 mother 1 0.0004966 0.0004966 1.209 0.352 
 
Low turnover in muscle 
 Df Sum sq Mean Sq F 
value 
Pr(>F) 
D4 mother 1 0.0009762 0.0009762 1.258 0.344 
D9 mother 1 0.001541 0.001541 3.326 0.166 
 
 
 
 
 
 
 
Non Communal Litters 
 
Litter 1 
 
MOTHERS INVESTMENT IN ENTIRE LITTER 
Welch Two Sample t-test 
data:  data$D4 and data$D9 
t = -18.4109, df = 13, p-value = 1.077e-10 
alternative hypothesis: true difference in means is not equal to 0 
95 percent confidence interval: 
 -0.1861130 -0.1470223 
sample estimates: 
mean of x mean of y  
0.0000000 0.1665676  
 
Litter 2 
 
MOTHERS INVESTMENT IN ENTIRE LITTER 
Welch Two Sample t-test 
data:  data$D4 and data$D9 
t = 21.8468, df = 15, p-value = 8.743e-13 
alternative hypothesis: true difference in means is not equal to 0 
95 percent confidence interval: 
 0.2276477 0.2768703 
sample estimates: 
mean of x mean of y  
 0.252259  0.000000  
 
Litter 3 
 
MOTHERS INVESTMENT IN ENTIRE LITTER 
Welch Two Sample t-test 
data:  data$D4 and data$D9 
t = 15.8506, df = 7, p-value = 9.645e-07 
alternative hypothesis: true difference in means is not equal to 0 
95 percent confidence interval: 
 0.2186184 0.2952834 
sample estimates: 
mean of x mean of y  
0.2569509 0.0000000  
 
Litter 4 
 
MOTHERS INVESTMENT IN ENTIRE LITTER 
Welch Two Sample t-test 
data:  data$D4 and data$D9 
t = 21.7305, df = 11, p-value = 2.19e-10 
alternative hypothesis: true difference in means is not equal to 0 
95 percent confidence interval: 
 0.2407622 0.2950301 
sample estimates: 
mean of x mean of y  
0.2678961 0.0000000  
 
 
  
 
 
 
 
Supplementary material C: Linearity of ESI-MS intensity with increasing protein load. 
rMUP 11 (diluted in 0.1% (v/v) formic acid) was injected onto a C4 desalting trap and the mass of 
the rMUP was determined by ESI-MS. Data was processed using maximum entropy software MAX 
ENT1 (MassLynx 4.1, Waters).  Sample was injected in triplicate.  The area under peak values for 
rMUP 11 were assessed as total rMUP load on column increased.  Error bars represent SD (n = 3). 
